Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
UBE3A	"ANCR, AS, E6-AP, EPVE6AP, FLJ26981, HPVE6A"	ENSG00000114062	"Ubiquitin protein ligase E3A"	Q05086	15	25333728-25439056	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009723, HPA039410, HPA040380"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB009723: AB_639982, HPA039410: AB_10671997, HPA040380: AB_2676952"	"unprognostic (7.95e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.05e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.40e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.17e-2)"	19.3	19.4	20.3	23.1	25.0	17.8	20.2	30.0	25.1	21.7	19.9	14.3	19.8	14.1	21.0	22.1	19.8	18.5	17.2	24.0	22.2	20.8	20.2	24.6	19.7	23.1	19.1	19.5	23.0	17.2	26.1	24.6	20.1	20.9	20.6	17.9	13.3	19.3	21.5	70.2	18.4	18.8	21.2	19.9	18.8	16.9	26.4	16.4	36.4	25.0	26.6	19.5	19.9	26.6	15.6	11.9	11.6	14.8	21.1	16.0	5.7	19.3	10.9	27.6	16.4	16.1	19.2	13.6	29.8	18.7	21.1	19.2	25.3	9.7	34.7	22.6	22.2	17.9	34.9	21.0	25.8	17.9	11.7	28.8	18.4	14.9	24.2	34.7	21.3	22.6	19.8	19.9	25.5	16.5	29.0	24.8	33.1	10.5	28.7	10.1	17.9	15.9	29.5	41.2	15.3	19.1	30.4	28.3	21.4	24.1	26.2	34.2	21.4	19.6	21.2	37.0	30.6	17.7	21.7	28.4	33.5	46.8	21.2	18.9	19.2	8.6	8.7	11.6	13.3	7.6	15.2	12.0	14.0	15.9	11.9	15.6	16.0	14.2	2.0	21.1	14.8	11.1	10.1	5.7	20.3	25.0	30.0	25.1	22.2	20.8	19.1	19.5	20.9	16.4
UBE3B		ENSG00000151148	"Ubiquitin protein ligase E3B"	Q7Z3V4	12	109477402-109536705	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041012	Approved		Approved	"Nuclear speckles,Mitochondria"				"Nuclear speckles"	Mitochondria	"HPA041012: AB_10964435"	"unprognostic (1.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.37e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.92e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.93e-1)"	"unprognostic (4.46e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.23e-1)"	"prognostic favourable (2.49e-5)"	"unprognostic (3.35e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.26e-1)"	14.5	19.3	17.2	12.9	21.2	9.2	15.3	19.7	27.8	14.4	17.3	23.3	14.0	14.6	17.4	16.2	20.1	19.3	13.9	28.6	14.6	11.6	19.8	16.4	15.5	13.1	18.6	13.9	18.4	20.3	25.5	15.1	16.8	15.8	17.5	21.2	20.7	15.7	17.4	34.0	21.6	16.3	18.6	15.2	17.0	17.3	24.5	18.3	18.2	21.1	17.6	15.9	19.5	19.6	15.9	14.5	22.4	16.7	14.3	18.2	11.4	10.4	16.6	13.0	9.4	22.2	17.9	11.4	13.8	15.9	16.8	11.3	17.3	10.8	6.5	10.3	22.6	13.5	13.2	17.7	16.3	14.3	9.3	12.5	10.8	15.6	14.3	10.1	10.5	20.3	16.6	16.3	19.6	18.1	13.6	6.2	19.1	16.4	6.9	14.8	13.3	20.0	11.5	12.3	12.8	14.4	18.9	12.1	22.4	16.1	22.0	10.8	22.4	10.8	16.5	20.9	6.0	10.6	9.8	13.9	11.5	11.5	20.8	8.5	17.3	22.4	15.3	14.3	15.9	16.7	15.7	15.9	15.3	11.2	14.5	12.9	12.9	17.1	19.5	14.3	13.6	13.5	18.2	11.4	17.2	21.2	19.7	27.8	14.6	11.6	18.6	13.9	15.8	18.3
UBE3D	"C6orf157, DKFZp434A1520, H10BH, UBE2CBP, YJR141W"	ENSG00000118420	"Ubiquitin protein ligase E3D"	Q7Z6J8	6	82892398-83065841	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027231	Uncertain		Approved	"Rods & Rings"				"Rods & Rings"		"HPA027231: AB_2256689"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-2)"	"unprognostic (5.05e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.91e-3)"	"unprognostic (5.03e-2)"	"unprognostic (2.39e-5)"	"unprognostic (6.93e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.18e-1)"	4.6	9.0	6.3	6.2	9.5	3.0	8.7	13.1	10.6	6.7	5.5	6.0	4.9	7.5	6.9	5.0	6.7	14.0	5.1	5.4	6.1	9.1	7.9	4.9	4.1	7.6	7.4	7.2	8.0	10.1	8.9	11.0	4.2	5.9	4.1	6.8	6.4	6.5	5.6	8.8	4.1	4.2	8.7	5.8	8.2	6.3	3.7	7.7	4.5	10.0	5.2	7.8	8.6	6.0	6.6	3.1	0.3	2.7	1.3	8.2	3.2	2.7	3.8	3.7	3.4	3.1	5.0	3.0	3.0	3.6	3.8	6.5	5.4	1.5	12.5	4.6	1.8	2.9	7.3	3.6	6.0	5.3	16.5	7.2	2.1	5.9	4.2	6.2	3.6	3.9	5.1	4.1	5.0	4.9	10.3	5.7	3.2	3.1	3.8	7.8	4.7	6.1	5.7	8.5	5.0	7.1	3.7	6.7	4.2	1.7	4.3	2.6	2.7	4.5	1.5	1.6	4.4	3.5	7.2	6.3	12.7	4.2	2.8	11.4	3.4	0.0	1.0	0.3	4.7	2.7	6.1	6.6	5.2	3.7	3.1	4.4	5.6	8.2	0.0	1.3	1.2	2.3	5.2	3.2	6.3	9.5	13.1	10.6	6.1	9.1	7.4	7.2	5.9	7.7
G2E3	"FLJ20333, KIAA1333, PHF7B"	ENSG00000092140	"G2/M-phase specific E3 ubiquitin protein ligase"	Q7L622	14	30559123-30620063	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 39.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001601	Approved		Approved	"Golgi apparatus,Vesicles,Cytosol"				Cytosol	"Golgi apparatus, Vesicles"	"HPA001601: AB_1079198"	"unprognostic (4.75e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.86e-2)"	"unprognostic (9.10e-2)"	"unprognostic (3.99e-2)"	"unprognostic (5.44e-6)"	"unprognostic (1.17e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.12e-2)"	7.6	5.1	5.6	7.6	14.2	8.5	6.6	10.8	10.4	8.1	5.8	5.8	4.2	5.9	8.5	4.8	7.0	5.4	4.5	4.9	6.7	5.2	5.4	5.5	5.4	8.6	7.3	4.9	7.1	5.7	6.0	10.9	6.9	7.6	6.0	6.1	5.3	5.9	7.1	5.2	6.1	5.8	6.7	7.1	7.9	5.4	39.6	8.8	20.9	7.3	4.8	9.5	6.0	8.3	11.5	8.1	16.5	12.5	7.9	12.4	5.0	20.8	9.5	21.3	9.8	6.9	8.5	18.0	19.6	7.1	11.9	13.4	9.2	12.7	17.5	6.3	10.7	17.6	20.4	11.2	24.2	14.4	8.3	9.6	10.4	16.9	6.2	18.5	12.2	5.3	4.5	9.5	21.7	14.0	11.8	14.6	16.6	12.1	12.4	4.6	17.8	16.7	11.4	0.0	4.8	7.0	13.0	18.1	12.2	15.8	10.7	4.5	12.2	6.3	10.4	12.7	13.6	9.3	12.8	8.4	24.6	21.0	3.8	9.3	18.8	16.5	7.5	14.1	9.6	9.7	12.4	10.8	9.4	7.7	6.4	11.5	12.0	10.1	6.8	7.9	12.5	8.1	7.3	5.0	5.6	14.2	10.8	10.4	6.7	5.2	7.3	4.9	7.6	8.8
UBE2E3	UbcH9	ENSG00000170035	"Ubiquitin conjugating enzyme E2 E3"	Q969T4	2	180967248-181076585	"Enzymes, Predicted intracellular proteins"	"Growth regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 113.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003303, HPA030445"	Approved									"HPA003303: AB_1858521, HPA030445: AB_10669599"	"unprognostic (8.85e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavourable (8.08e-5)"	"prognostic unfavourable (9.11e-4)"	"unprognostic (1.00e-3)"	"unprognostic (4.99e-2)"	"unprognostic (8.46e-2)"	"prognostic unfavourable (1.78e-5)"	"unprognostic (8.75e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.40e-1)"	29.1	23.9	35.6	21.1	33.0	20.1	49.7	37.4	62.9	30.4	25.2	18.6	19.8	23.0	26.6	29.2	23.1	29.7	35.9	37.8	43.9	32.5	36.0	29.6	28.5	37.6	31.5	31.9	27.7	29.9	42.9	21.6	23.9	30.5	20.9	27.8	24.6	26.3	22.7	76.8	28.1	26.2	24.1	41.3	20.4	28.3	28.1	21.5	30.9	37.4	27.8	23.0	31.8	23.0	7.7	29.7	25.6	16.9	8.5	12.0	9.6	17.2	7.9	113.1	3.9	33.6	43.4	18.0	23.2	29.4	19.6	24.5	8.5	21.1	8.5	20.4	31.6	7.4	68.2	23.8	35.3	20.8	20.6	29.5	10.7	23.6	16.2	13.6	14.1	17.1	22.2	17.1	16.6	25.8	15.0	16.0	48.1	9.5	24.8	12.8	21.6	37.4	24.3	11.5	20.3	33.3	15.3	19.7	22.0	10.1	10.7	9.5	5.8	20.2	23.7	38.2	25.2	22.3	27.0	14.0	8.9	24.0	37.7	5.4	21.1	13.0	14.0	25.6	9.3	12.3	11.1	7.7	7.3	12.0	9.2	4.9	7.8	8.5	13.2	8.5	16.9	29.7	2.8	9.6	35.6	33.0	37.4	62.9	43.9	32.5	31.5	31.9	30.5	21.5
MDM2	"HDM2, MGC5370"	ENSG00000135679	"MDM2 proto-oncogene"	Q00987	12	68808176-68850686	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 93.7;U-698: 90.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000086, CAB016303"	Supported		Supported	Nucleoplasm				Nucleoplasm		"CAB000086: AB_563872, CAB016303: AB_627920"	"unprognostic (1.16e-1)"	"prognostic favourable (3.23e-4)"	"unprognostic (6.16e-2)"	"prognostic favourable (4.51e-7)"	"unprognostic (7.25e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.36e-1)"	"unprognostic (4.22e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.68e-1)"	"unprognostic (8.95e-2)"	16.6	15.3	11.1	12.5	10.8	23.1	12.5	12.0	11.3	13.1	16.6	13.6	11.9	5.2	8.8	9.4	14.2	12.6	12.3	9.0	8.8	8.6	11.2	25.7	15.9	13.3	14.2	7.1	11.0	21.4	11.4	10.4	24.5	11.9	12.6	21.5	7.8	10.5	11.1	19.5	9.8	7.2	10.8	10.8	15.3	9.8	6.5	11.5	29.5	13.6	10.8	14.1	13.5	12.6	4.9	4.0	19.3	6.4	3.6	4.4	3.0	3.1	7.3	7.7	3.9	10.0	9.3	39.4	8.7	8.7	4.6	7.4	4.4	1.4	32.6	2.4	5.7	1.8	5.2	93.7	7.5	8.6	3.7	6.0	6.2	19.8	9.8	5.3	5.5	14.3	8.0	18.4	12.5	12.9	6.1	7.9	8.8	5.0	7.0	1.7	6.5	1.4	24.8	5.3	2.7	2.8	26.1	5.9	3.4	5.5	4.3	1.9	10.1	3.5	13.8	3.5	6.7	2.9	3.1	12.1	7.6	90.1	5.4	2.1	14.4	5.3	5.4	4.8	4.4	4.0	3.9	4.7	3.7	4.1	2.8	4.9	4.0	3.7	19.3	3.6	6.4	4.0	3.8	3.0	11.1	10.8	12.0	11.3	8.8	8.6	14.2	7.1	11.9	11.5
PRKN	"AR-JP, PARK2, parkin, PDJ"	ENSG00000185345	"Parkin RBR E3 ubiquitin protein ligase"	O60260	6	161347420-162727771	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 41.8"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.6;HEL: 9.0;Karpas-707: 5.7;RPMI-8226: 5.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016257, HPA036012"	Enhanced		Supported	"Nuclear speckles,Cytosol"				"Nuclear speckles"	Cytosol	"CAB016257: AB_628104, HPA036012: "	"unprognostic (9.23e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.85e-2)"	"unprognostic (5.85e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.03e-3)"	"unprognostic (8.16e-2)"	"prognostic favourable (6.75e-12)"	"unprognostic (9.93e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.50e-1)"	6.8	7.1	7.9	2.3	12.2	1.5	4.2	7.2	13.4	5.3	4.3	6.3	4.6	2.8	7.8	4.4	6.1	3.4	4.3	17.7	9.2	6.2	17.4	3.6	2.6	3.0	5.8	5.2	6.4	3.0	5.6	8.6	2.0	5.5	4.0	2.4	8.3	3.5	4.8	41.8	4.0	3.3	6.6	5.9	2.7	3.5	10.3	6.8	0.6	3.8	4.7	2.7	4.9	2.1	4.6	1.2	4.2	0.8	1.8	4.6	1.3	0.0	0.3	1.2	3.6	0.9	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.2	0.0	0.0	0.2	0.2	0.0	0.4	0.6	9.0	0.2	0.0	0.8	0.2	0.1	3.1	0.1	0.0	0.5	0.0	0.4	5.7	0.9	0.5	0.1	0.1	0.2	0.8	0.0	0.0	5.7	0.6	0.1	0.9	2.5	0.0	0.0	0.3	0.0	0.6	0.0	0.1	0.3	0.1	0.3	0.8	0.1	0.0	0.1	0.1	2.2	2.8	0.8	4.2	2.1	0.5	3.5	1.5	2.0	2.2	1.2	4.6	4.4	4.6	1.5	1.8	0.4	0.3	0.2	1.3	7.9	12.2	7.2	11.7	9.2	6.2	5.8	5.2	5.5	6.8
RBX1	"BA554C12.1, RNF75, ROC1"	ENSG00000100387	"Ring-box 1"	P62877	22	40951347-40973309	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003038			Supported	Nucleoplasm				Nucleoplasm		"HPA003038: AB_1079827"	"unprognostic (2.34e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.60e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.61e-2)"	"prognostic favourable (6.63e-4)"	"unprognostic (5.01e-3)"	"unprognostic (2.19e-1)"	"unprognostic (4.99e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.05e-2)"	24.1	27.9	41.6	22.2	35.3	37.6	32.9	28.0	35.7	23.0	22.7	27.4	15.8	18.4	19.4	43.7	27.6	21.2	16.6	39.2	38.3	37.4	34.2	28.3	23.6	28.1	40.4	22.3	18.5	15.6	12.3	19.5	54.1	32.4	20.3	23.9	22.1	21.3	20.8	46.5	21.8	23.0	23.2	45.2	26.4	21.4	16.4	24.8	31.7	31.1	37.4	34.4	19.5	19.4	33.4	60.7	32.2	41.5	23.9	38.5	62.6	33.1	19.0	35.9	17.8	25.5	30.5	20.2	26.7	24.6	40.3	35.7	30.7	16.0	29.1	18.1	26.2	19.0	34.0	30.6	42.7	33.8	54.2	18.0	27.8	37.4	21.9	43.9	23.4	25.2	24.8	29.1	21.1	34.1	21.2	29.6	35.5	40.6	26.4	50.7	19.7	20.0	34.7	24.9	36.6	46.0	21.5	16.9	11.0	23.5	23.6	23.9	20.3	30.3	22.6	24.6	25.4	20.6	25.4	25.2	23.1	43.1	30.8	22.4	27.3	32.2	37.2	29.9	24.7	37.0	23.1	33.4	30.9	26.0	37.6	29.4	27.0	29.2	12.6	23.9	41.5	60.7	38.5	62.6	41.6	35.3	28.0	35.7	38.3	37.4	40.4	22.3	32.4	24.8
ARIH1	"ARI, HARI, HHARI, UBCH7BP"	ENSG00000166233	"Ariadne RBR E3 ubiquitin protein ligase 1"	Q9Y4X5	15	72474326-72602985	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003295, HPA073245"	Approved		Approved	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	Nucleoplasm	"HPA003295: AB_1845017, HPA073245: "	"unprognostic (3.31e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.18e-2)"	"unprognostic (8.21e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.43e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.96e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.93e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.70e-2)"	15.3	15.6	11.4	17.4	15.5	24.6	13.3	20.4	21.5	15.8	14.5	10.4	14.0	17.0	21.1	11.2	14.2	12.3	14.4	19.7	10.5	10.5	10.9	10.5	13.7	9.3	10.1	15.0	17.3	13.5	12.9	14.0	15.4	12.6	14.0	7.6	13.0	13.2	13.1	68.3	16.3	13.5	15.8	10.7	11.4	12.5	55.2	10.0	16.9	11.7	13.0	12.7	18.4	20.4	1.9	1.1	4.6	1.5	2.1	2.5	0.3	9.3	9.9	9.7	5.7	5.0	3.6	11.5	10.6	3.8	4.8	3.3	10.0	8.1	9.2	15.9	4.5	13.5	10.0	5.5	2.7	16.3	6.9	6.9	12.2	6.6	3.6	10.3	8.1	4.2	1.9	5.3	6.9	3.5	7.2	11.0	4.7	6.1	10.0	4.0	10.5	3.6	11.4	11.9	5.2	2.7	15.8	9.1	10.4	13.8	6.2	16.2	5.0	11.9	9.1	7.9	11.1	30.6	14.7	11.5	23.2	10.7	5.2	9.5	8.4	4.6	1.0	2.2	1.7	1.5	1.5	0.7	1.3	1.1	0.7	1.9	1.6	1.5	3.4	2.1	0.7	1.1	2.5	0.3	11.4	15.5	20.4	14.0	10.5	10.5	10.1	15.0	12.6	10.0
WWP2	AIP2	ENSG00000198373	"WW domain containing E3 ubiquitin protein ligase 2"	O00308	16	69762306-69941741	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.63e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.50e-2)"	"unprognostic (2.08e-2)"	"unprognostic (9.81e-2)"	"prognostic favourable (5.87e-11)"	"unprognostic (4.26e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.62e-1)"	21.8	27.0	18.0	21.5	24.4	31.0	19.1	19.1	29.0	18.9	22.8	29.7	19.6	23.9	31.9	17.2	21.3	23.9	19.3	12.2	18.0	17.4	26.9	14.9	22.7	20.6	20.0	15.9	22.5	27.3	34.1	15.9	24.1	21.7	17.7	20.7	28.1	29.0	19.4	17.6	24.4	25.3	15.3	19.7	26.2	24.1	17.0	18.4	25.2	19.7	14.6	37.7	16.5	17.3	7.1	8.2	28.0	15.5	4.6	9.5	8.1	12.5	12.7	8.3	8.6	7.0	5.9	12.7	8.4	9.8	14.6	15.4	11.7	9.7	14.6	9.2	14.8	15.0	10.9	12.7	11.1	6.8	9.4	8.1	7.8	20.2	13.2	14.3	12.1	8.6	9.5	19.9	13.9	13.4	12.3	8.3	9.3	22.2	7.8	16.0	11.6	5.7	17.6	7.0	24.8	14.2	12.2	10.3	11.3	36.0	10.4	7.7	16.2	17.7	13.3	11.4	16.8	15.9	10.1	19.2	12.8	22.1	12.3	12.2	20.1	18.2	10.0	15.6	9.5	12.9	7.3	6.4	7.1	7.6	8.2	7.1	7.5	5.1	28.0	4.6	15.5	4.0	6.3	8.1	18.0	24.4	19.1	29.0	18.0	17.4	20.0	15.9	21.7	18.4
ITCH	AIP4	ENSG00000078747	"Itchy E3 ubiquitin protein ligase"	Q96J02	20	34363235-34511393	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021126, HPA049032, CAB072824, CAB072825"	Supported		Enhanced	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"CAB072824: , CAB072825: , HPA021126: AB_1851941, HPA049032: "	"unprognostic (2.51e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.25e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.21e-1)"	20.7	16.7	18.9	15.4	26.9	20.5	17.5	19.8	26.7	23.9	18.2	37.9	15.2	16.9	18.4	15.1	35.9	14.5	14.5	17.9	20.4	15.9	21.1	46.5	18.5	16.8	29.2	16.5	19.3	17.1	21.6	26.3	26.9	29.0	17.5	20.4	16.7	20.1	18.4	24.0	19.2	20.3	19.8	30.4	17.3	17.3	34.8	32.3	22.3	22.7	13.0	23.6	19.6	21.0	7.3	11.4	19.6	6.2	6.2	11.4	2.7	20.0	13.2	13.5	9.7	14.9	21.3	16.2	16.3	18.7	20.4	20.0	37.2	30.9	9.8	15.8	20.8	25.4	20.5	32.9	24.9	7.4	6.6	28.4	11.2	22.2	15.6	11.6	12.9	10.8	16.8	17.2	27.0	15.3	16.1	17.0	15.9	10.0	17.0	6.2	6.5	15.7	14.3	28.5	22.6	12.1	34.8	8.3	6.1	30.5	11.9	18.3	14.3	10.5	14.8	24.4	14.7	15.9	12.0	13.5	14.1	14.3	15.1	7.5	14.3	3.6	5.8	6.1	10.8	6.2	11.4	7.3	3.8	5.7	4.5	6.9	3.3	4.9	19.6	6.2	3.8	11.4	4.8	2.7	18.9	26.9	19.8	26.7	20.4	15.9	29.2	16.5	29.0	32.3
NEDD4L	"KIAA0439, NEDD4-2, RSP5"	ENSG00000049759	"Neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase"	Q96PU5	18	58044367-58401540	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 50.1;SK-MEL-30: 39.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 8.1"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.7;T-cells: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024618	Approved									"HPA024618: AB_1854362"	"unprognostic (2.56e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.11e-3)"	"unprognostic (2.26e-2)"	"unprognostic (9.24e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.27e-1)"	"prognostic favourable (6.55e-15)"	"unprognostic (2.42e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.49e-3)"	"unprognostic (4.75e-2)"	5.9	6.8	9.1	5.4	38.8	13.2	15.8	21.4	24.7	5.0	22.6	3.2	18.2	11.1	3.6	6.1	7.0	6.0	7.6	12.7	9.8	7.1	29.9	10.1	26.9	2.5	7.2	14.9	3.0	33.2	9.2	16.5	13.0	4.1	30.6	25.2	12.2	16.5	23.2	38.3	5.9	26.8	8.2	3.2	3.1	26.0	4.6	8.8	0.8	9.1	5.5	5.1	14.9	9.3	1.4	0.4	4.7	0.7	0.9	8.1	0.5	18.4	6.6	3.9	5.8	1.4	0.5	13.6	5.2	23.7	13.4	20.5	7.7	10.0	3.9	16.1	2.0	13.4	5.2	23.1	27.7	9.2	4.6	2.8	4.1	50.1	0.7	0.1	1.7	3.5	15.1	18.1	22.0	1.0	4.8	1.7	5.5	4.5	0.2	0.2	3.4	10.2	3.8	5.3	4.5	13.3	24.1	4.9	1.3	4.3	1.3	39.1	7.9	1.6	7.9	36.2	10.9	2.0	22.3	2.3	3.9	2.4	7.4	2.8	2.9	4.7	0.6	1.7	0.4	0.7	1.0	1.4	1.3	0.3	0.3	0.6	0.8	0.6	0.3	0.9	0.1	0.4	8.1	0.5	9.1	38.8	21.4	24.7	9.8	7.1	7.2	14.9	4.1	8.8
RNF19A	"DKFZp566B1346, dorfin, RNF19"	ENSG00000034677	"Ring finger protein 19A, RBR E3 ubiquitin protein ligase"	Q9NV58	8	100257060-100336218	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011455, HPA023652"	Approved									"CAB011455: AB_2180446, HPA023652: AB_1847836"	"unprognostic (2.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.84e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.12e-2)"	"unprognostic (7.96e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.97e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.99e-1)"	"prognostic unfavourable (7.99e-5)"	"unprognostic (8.44e-2)"	"unprognostic (8.19e-2)"	"unprognostic (2.02e-1)"	"prognostic favourable (3.28e-5)"	28.2	13.8	30.2	21.8	20.8	34.9	26.7	16.3	29.5	40.6	22.8	26.4	11.4	17.0	29.4	19.0	17.6	24.7	30.8	20.1	28.7	16.1	23.0	33.9	28.4	35.2	19.7	25.2	24.8	20.3	14.5	15.7	18.6	23.6	20.7	19.2	11.5	19.8	14.2	23.0	26.6	38.5	32.7	30.1	22.7	21.5	35.4	27.7	25.1	17.0	14.7	29.5	33.9	23.7	13.5	11.4	17.6	10.5	4.8	14.4	4.5	8.4	5.4	4.8	5.5	9.1	7.9	6.2	7.6	7.3	7.2	6.6	2.9	5.6	5.0	14.0	7.8	6.0	3.7	5.6	9.9	21.1	3.1	8.4	25.2	4.2	7.6	1.6	5.4	7.8	8.6	5.8	10.9	11.1	4.6	58.8	7.1	4.2	7.6	2.7	1.7	5.1	3.1	3.3	9.8	19.8	13.3	3.8	8.2	7.9	4.8	7.3	4.2	6.5	11.0	8.4	6.7	6.2	4.6	28.6	18.3	3.4	5.5	5.6	5.0	17.6	7.5	6.5	14.4	5.6	9.0	13.5	11.8	10.8	4.6	12.7	6.1	8.8	16.6	4.8	10.5	11.4	12.0	4.5	30.2	20.8	16.3	29.5	28.7	16.1	19.7	25.2	23.6	27.7
NEURL2	"C20orf163, dJ337O18.6, FLJ30259, Ozz, Ozz-E3"	ENSG00000124257	"Neuralized E3 ubiquitin protein ligase 2"	Q9BR09	20	45888625-45891287	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043402, HPA059842"	Approved		Approved	Vesicles				Vesicles		"HPA043402: , HPA059842: "	"unprognostic (6.26e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.73e-3)"	"unprognostic (5.58e-2)"	"unprognostic (1.99e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.58e-1)"	7.9	6.3	2.8	3.0	2.6	1.3	4.8	5.5	3.3	4.6	7.6	2.9	4.5	5.2	5.7	6.0	3.3	5.2	9.0	7.6	1.9	1.6	8.8	12.3	2.4	1.5	1.5	2.3	8.7	2.8	6.2	4.2	3.7	2.7	5.7	2.7	5.9	4.0	3.7	21.6	4.3	10.3	10.2	2.3	4.5	3.3	3.2	1.1	1.1	4.0	21.5	2.1	6.6	2.8	5.4	0.8	3.6	1.3	2.3	3.8	0.9	0.9	0.9	2.4	1.8	4.0	1.6	2.3	1.4	2.1	1.7	0.8	9.8	6.4	1.4	2.1	1.1	3.3	2.0	0.2	1.1	0.8	1.8	0.8	7.1	9.8	5.5	0.7	1.7	3.8	1.4	1.7	0.7	1.6	0.6	2.5	0.9	3.9	1.1	0.7	1.6	3.6	1.9	1.7	0.6	1.0	0.8	5.6	4.6	2.0	5.1	6.1	4.1	2.0	2.5	2.0	1.5	1.3	1.3	8.1	1.4	0.2	2.1	1.0	1.6	0.0	1.3	3.6	0.9	0.7	0.5	5.4	1.8	1.6	0.4	2.6	3.8	3.5	0.7	2.3	0.4	0.8	1.0	0.9	2.8	2.6	5.5	3.0	1.9	1.6	1.5	2.3	2.7	1.1
SIAH2		ENSG00000181788	"Siah E3 ubiquitin protein ligase 2"	O43255	3	150741127-150763477	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061293, CAB069930"	Approved		Approved	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"CAB069930: AB_1217916, HPA061293: "	"prognostic favourable (1.17e-4)"	"unprognostic (1.04e-3)"	"unprognostic (3.83e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.95e-2)"	"prognostic unfavourable (8.21e-5)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.38e-2)"	"unprognostic (5.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.69e-2)"	9.6	48.0	7.6	11.8	10.3	22.7	23.5	10.9	17.2	30.0	10.5	8.4	20.3	7.9	23.5	13.9	28.8	14.9	11.0	10.7	7.2	7.3	8.4	35.5	11.8	19.1	9.9	7.5	19.0	14.6	6.4	8.1	31.4	7.9	18.8	9.2	8.3	11.2	21.7	8.3	19.3	9.5	17.4	9.4	16.9	12.0	8.7	8.6	23.6	11.4	10.6	25.1	22.7	25.6	3.0	3.1	10.0	2.7	1.6	3.6	1.1	16.6	4.1	3.2	6.4	11.1	8.4	13.1	6.9	8.0	8.4	10.3	8.4	7.5	9.3	10.2	7.2	10.3	8.7	6.2	7.9	7.8	6.2	18.2	5.0	27.9	15.9	10.0	5.4	7.6	14.5	5.0	11.5	6.5	4.5	36.7	5.3	20.0	18.3	5.1	10.5	8.2	13.5	7.0	33.3	5.3	5.8	12.5	5.9	5.2	4.9	12.3	32.9	15.1	4.5	5.8	5.2	12.6	9.3	43.7	16.6	13.0	5.5	14.5	2.9	9.5	2.7	10.0	2.1	1.5	3.2	2.5	3.6	3.2	2.4	3.0	1.9	1.9	5.9	1.6	1.5	3.1	2.0	1.1	7.6	10.3	10.9	17.2	7.2	7.3	9.9	7.5	7.9	8.6
HUWE1	"Ib772, KIAA0312, UREB1"	ENSG00000086758	"HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase"	Q7Z6Z7	X	53532096-53686729	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Differentiation, DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002548, CAB022718"	Approved		Enhanced	Nucleoplasm,Cytosol			3400	"Nucleoplasm, Cytosol"		"CAB022718: , HPA002548: AB_1080489"	"unprognostic (4.73e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.64e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.89e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.45e-1)"	24.6	28.2	27.7	23.8	43.3	22.4	28.0	37.0	41.1	31.8	25.9	34.3	26.6	17.1	31.9	52.4	27.4	26.5	23.1	27.1	28.0	31.8	30.3	26.2	20.3	23.1	30.0	30.2	43.3	27.8	59.8	34.2	27.2	34.6	27.3	22.7	25.6	26.4	29.6	59.1	50.1	22.1	33.9	23.9	26.6	25.7	28.4	27.7	32.4	27.6	20.7	28.6	27.0	22.9	5.1	7.2	8.2	7.0	6.9	8.9	3.5	50.1	30.9	20.1	14.2	35.3	21.1	24.8	15.1	19.5	15.9	16.7	23.5	16.2	26.3	10.3	27.4	24.1	45.4	25.3	21.8	37.9	20.1	20.9	27.7	18.3	32.5	31.3	12.9	20.1	19.0	38.2	43.9	27.5	20.8	17.1	20.6	30.9	16.9	17.5	27.5	22.3	15.7	27.8	15.9	26.4	34.8	16.8	12.1	42.6	19.0	13.6	27.2	15.2	35.0	14.7	21.1	20.9	19.2	15.0	14.7	23.0	15.7	30.7	21.1	4.0	4.7	8.2	7.2	3.8	8.9	5.1	6.9	7.6	6.7	5.1	4.9	4.9	4.2	6.9	7.0	7.2	5.7	3.5	27.7	43.3	37.0	41.1	28.0	31.8	30.0	30.2	34.6	27.7
ARIH2	TRIAD1	ENSG00000177479	"Ariadne RBR E3 ubiquitin protein ligase 2"	O95376	3	48918821-48986382	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067381, HPA069715, HPA070963"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA067381: , HPA069715: , HPA070963: "	"unprognostic (7.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.79e-3)"	"prognostic unfavourable (1.70e-4)"	"unprognostic (1.90e-2)"	"unprognostic (4.01e-2)"	"unprognostic (5.01e-2)"	"prognostic favourable (7.31e-4)"	"unprognostic (5.01e-3)"	"prognostic favourable (6.60e-4)"	"unprognostic (1.15e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.39e-2)"	15.0	16.2	14.1	12.8	20.6	16.0	19.2	22.7	22.5	14.1	18.6	25.4	13.9	10.0	18.7	29.2	14.9	16.2	12.8	38.5	15.8	14.9	14.3	17.2	14.5	17.8	24.7	18.3	18.3	20.5	23.1	19.8	15.3	19.7	16.5	15.5	19.2	13.2	19.5	71.3	11.4	14.4	23.0	18.8	17.5	15.7	27.5	21.4	17.7	18.7	15.2	17.2	16.4	14.1	20.6	21.7	27.6	24.5	15.8	32.6	25.3	14.2	14.4	13.9	19.6	20.6	11.3	18.8	16.8	19.6	21.0	23.3	15.0	12.7	29.1	7.9	17.9	8.6	28.5	17.1	25.8	19.5	17.3	29.9	19.0	12.3	18.6	22.1	14.4	12.1	25.9	26.2	35.6	15.7	23.6	20.0	18.6	9.8	22.3	9.1	23.6	21.8	8.3	15.9	24.2	12.3	19.2	6.1	16.4	16.5	20.7	16.1	10.5	15.7	15.0	12.8	18.5	19.1	26.3	26.1	50.3	36.8	14.0	18.5	16.0	27.6	24.5	26.2	32.6	21.6	22.1	19.5	20.9	26.7	21.7	20.6	21.6	27.8	17.2	15.8	13.5	18.7	22.9	25.3	14.1	20.6	22.7	22.5	15.8	14.9	24.7	18.3	19.7	21.4
DTL	"CDT2, DCAF2, L2DTL, RAMP"	ENSG00000143476	"Denticleless E3 ubiquitin protein ligase homolog"	Q9NZJ0	1	212035553-212107400	"Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA replication, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 10.8;lymphoid tissue: 41.2;testis: 37.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory CD8 T-cell: 1.5;T-reg: 5.2"	"Lineage enriched"	"Detected in single"	7	"T-cells: 5.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA028016, HPA032023, HPA032031"	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	"Nucleoli, Cytosol"	"HPA028016: AB_10611958, HPA032023: , HPA032031: "	"unprognostic (7.61e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.14e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.31e-2)"	"prognostic unfavourable (4.41e-5)"	"unprognostic (8.96e-3)"	"unprognostic (2.45e-3)"	"unprognostic (8.83e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.83e-2)"	"prognostic unfavourable (1.71e-9)"	"unprognostic (5.93e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.82e-1)"	1.3	0.7	0.4	5.4	0.6	10.8	1.3	0.4	0.5	1.2	2.8	0.3	0.1	1.7	1.0	0.6	4.0	0.4	1.5	0.6	0.4	0.4	0.8	1.0	1.6	4.4	0.4	0.1	0.6	0.5	0.6	0.7	5.4	0.2	0.6	4.2	0.2	1.1	0.1	0.4	1.6	3.3	1.4	0.4	4.6	1.1	37.2	0.1	41.2	0.9	5.7	7.5	0.9	1.6	0.7	0.3	0.0	0.4	0.6	5.2	0.7	12.5	10.7	18.4	9.2	1.1	2.3	9.0	15.8	9.8	14.9	22.3	6.6	11.1	9.5	5.9	6.0	9.8	24.2	13.3	21.6	11.5	11.6	15.2	14.1	8.1	0.0	19.9	9.5	1.0	0.4	24.2	12.9	6.8	18.1	19.4	17.2	5.0	26.6	9.1	21.2	12.4	21.1	32.4	18.4	4.2	8.7	11.5	18.0	15.0	14.4	6.5	12.2	9.1	3.7	15.0	11.2	15.4	17.7	7.1	11.1	22.0	7.6	13.2	14.5	0.0	0.0	0.0	0.6	0.4	0.0	0.7	0.8	1.5	0.3	0.1	0.0	0.3	0.0	0.6	0.0	0.0	5.2	0.7	0.4	0.6	0.4	0.5	0.4	0.4	0.4	0.1	0.2	0.1
MIB2	"FLJ39787, skeletrophin, ZZANK1, ZZZ5"	ENSG00000197530	"Mindbomb E3 ubiquitin protein ligase 2"	Q96AX9	1	1615415-1630610	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	"Actin-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 72.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 13.1;SCLC-21H: 14.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068322	Enhanced									"HPA068322: "	"unprognostic (3.93e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.34e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.70e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.01e-2)"	6.4	3.9	8.7	6.4	10.0	4.5	4.7	8.8	11.5	4.8	6.9	7.1	4.7	5.3	5.1	5.4	11.4	4.1	3.7	6.1	9.1	7.9	5.5	6.2	5.1	3.7	5.3	7.1	5.8	7.0	3.7	9.4	4.0	5.7	4.7	3.7	6.6	5.4	6.5	72.5	9.6	4.6	5.4	3.4	9.0	8.5	5.2	5.8	7.4	5.9	9.7	4.1	4.5	4.1	2.9	9.2	1.9	0.1	7.3	4.7	1.0	6.5	0.9	0.4	1.5	1.7	0.6	9.1	3.1	1.4	1.0	2.3	1.3	1.6	0.7	4.4	0.9	13.1	0.5	2.0	0.0	3.4	5.6	0.5	1.9	1.2	2.4	0.8	2.2	1.4	1.4	0.6	0.2	0.5	2.6	1.2	0.2	1.0	3.6	8.3	1.1	10.4	6.1	1.9	8.9	0.1	0.8	14.0	5.1	5.2	0.7	5.0	1.0	3.2	0.6	0.9	2.1	5.1	0.9	6.8	2.0	1.8	2.3	2.6	1.1	0.0	0.1	1.9	4.3	0.1	4.3	2.6	3.3	4.7	0.0	2.9	3.9	2.9	0.5	7.3	0.0	9.2	2.3	1.0	8.7	10.0	8.8	11.5	9.1	7.9	5.3	7.1	5.7	5.8
SIAH1	hSIAH1	ENSG00000196470	"Siah E3 ubiquitin protein ligase 1"	Q8IUQ4	16	48356364-48448402	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 102.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			CAB018724	Enhanced		Approved	Nucleoplasm,Mitochondria				Mitochondria	Nucleoplasm	"CAB018724: AB_2188865"	"unprognostic (7.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.25e-2)"	"unprognostic (7.93e-3)"	"unprognostic (1.12e-2)"	"unprognostic (9.22e-3)"	"unprognostic (3.26e-1)"	"unprognostic (8.02e-2)"	"unprognostic (7.84e-3)"	"unprognostic (7.67e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.00e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.26e-2)"	20.6	11.4	11.9	11.0	13.5	19.2	25.5	15.5	16.6	14.6	13.1	15.0	6.5	12.8	16.8	13.4	12.7	12.9	12.9	11.4	12.6	11.6	12.1	17.5	13.9	10.0	12.8	11.6	16.7	11.4	13.1	9.1	102.6	14.1	14.2	12.2	32.1	13.2	12.1	17.0	16.6	16.0	18.6	12.7	11.3	12.5	17.9	13.0	17.5	14.5	9.3	11.5	15.9	14.8	12.6	8.3	21.9	5.2	5.3	6.1	3.5	8.4	7.6	16.6	14.9	14.3	12.5	17.0	7.9	10.8	11.8	5.8	5.8	11.1	11.0	8.8	10.0	9.9	11.4	11.6	14.6	4.4	9.2	5.9	6.0	15.1	20.0	5.8	9.1	15.0	20.9	6.9	16.1	9.9	9.5	10.5	9.6	5.8	15.6	11.9	20.2	11.8	18.2	25.0	11.6	11.0	10.7	18.9	16.8	23.6	11.8	20.3	7.5	13.4	10.5	12.7	11.4	6.8	8.4	13.7	5.7	20.2	9.4	7.2	11.4	6.9	5.2	21.9	2.7	2.2	3.0	12.6	3.0	4.2	8.3	12.1	6.1	4.5	2.9	5.3	1.3	7.9	1.6	3.5	11.9	13.5	15.5	16.6	12.6	11.6	12.8	11.6	14.1	13.0
UBR2	"bA49A4.1, C6orf133, dJ392M17.3, KIAA0349"	ENSG00000024048	"Ubiquitin protein ligase E3 component n-recognin 2"	Q8IWV8	6	42564062-42693504	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 25.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 25.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027869, HPA027880"	Approved		Approved	"Nucleoplasm,Plasma membrane"				Nucleoplasm	"Plasma membrane"	"HPA027869: AB_10600416, HPA027880: AB_10601217"	"unprognostic (3.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.24e-2)"	"unprognostic (5.05e-2)"	"prognostic favourable (1.65e-4)"	"unprognostic (1.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.78e-2)"	"unprognostic (7.77e-3)"	19.8	18.8	14.4	21.8	16.7	22.1	18.6	26.6	20.4	17.2	19.3	17.8	17.8	20.1	29.5	16.8	16.2	15.6	16.2	16.8	13.8	13.2	17.8	24.0	19.3	18.0	16.7	12.9	20.8	24.6	28.0	26.3	16.3	17.2	16.5	20.1	15.8	18.3	15.6	33.5	18.0	24.6	19.9	15.9	21.3	18.2	9.2	17.2	26.1	20.1	14.9	17.7	18.9	29.8	3.6	3.5	25.2	5.7	3.9	4.4	1.9	15.7	8.0	9.3	14.6	19.2	18.5	12.6	12.2	13.2	10.8	11.3	11.5	6.5	10.9	9.7	13.1	16.0	13.4	10.4	13.8	14.6	9.4	17.2	11.9	14.9	15.6	16.6	11.9	13.0	11.4	10.7	11.8	12.2	20.1	13.8	10.4	12.8	13.0	14.7	8.5	7.8	11.6	13.9	16.2	12.4	13.8	11.1	8.8	12.3	11.9	11.9	11.6	16.1	17.6	9.9	7.7	12.0	8.8	12.8	11.3	16.8	5.2	12.5	6.0	10.4	4.6	9.2	4.4	4.8	3.7	3.4	2.9	3.4	3.5	3.6	3.0	3.3	25.2	3.9	5.7	2.6	3.3	1.9	14.4	16.7	26.6	20.4	13.8	13.2	16.7	12.9	17.2	17.2
HERC2	"D15F37S1, jdf2, p528"	ENSG00000128731	"HECT and RLD domain containing E3 ubiquitin protein ligase 2"	O95714	15	28111040-28322152	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 32.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017188, HPA048389, HPA074166"	Approved		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"CAB017188: , HPA048389: , HPA074166: "	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.64e-2)"	"unprognostic (6.62e-2)"	"unprognostic (5.74e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.87e-1)"	"unprognostic (4.11e-2)"	"unprognostic (9.40e-3)"	"unprognostic (3.60e-2)"	"prognostic favourable (1.41e-7)"	"unprognostic (7.66e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.71e-1)"	2.5	3.3	3.2	2.2	4.5	3.9	3.1	7.0	5.7	3.2	4.6			2.7	4.4	1.7	2.8	4.1	2.1	4.6	3.5	3.6	3.3	1.6	2.5	2.1	3.8		8.5	3.6	9.2	3.5	2.7		3.0	3.0		2.3	3.3	8.2	3.1	3.1	4.1	4.1	2.3	3.4	3.2			5.6		2.4	3.3	2.3	1.0	1.1	0.5	0.4	0.2	1.1	0.4	5.1	10.1	7.0	2.9	5.9	4.4	2.0	3.7	4.4	4.8	4.6	5.2	0.6	5.1	4.5	6.3	5.2	7.4	3.6	3.5	3.1	4.8	32.6	11.7	1.7	2.2	7.6	2.6	3.7	2.9	5.7	7.1	6.3	12.5	2.1	4.5	2.3	1.7	2.5	2.1	4.4	6.1	10.0	0.4	1.6	11.1	7.8	4.5	8.9	2.5	2.9	3.0	9.0	9.4	8.9	5.8	3.4	5.5	1.4	1.9	4.8	4.1	3.6	4.7	0.0	0.4	0.5	1.1	0.1	0.6	0.5	0.2	0.5	1.1	1.0	0.9	0.5	0.0	0.2	0.3	0.9	0.4	0.4										
HERC5	CEB1	ENSG00000138646	"HECT and RLD domain containing E3 ubiquitin protein ligase 5"	Q9UII4	4	88457117-88506163	"Predicted membrane proteins"	"Antiviral defense, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 48.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 32.1;BJ hTERT+ SV40 Large T+ RasG12V: 44.4;SK-MEL-30: 19.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 31.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA043929	Supported									"HPA043929: AB_10962492"	"unprognostic (2.87e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (4.46e-5)"	"unprognostic (3.00e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.58e-1)"	"unprognostic (9.00e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.61e-1)"	12.3	4.8	4.1	6.8	6.1	11.6	6.6	1.2	4.0	9.8	5.2	4.0	2.6	2.8	19.1	5.9	3.1	6.0	4.2	3.5	4.2	3.4	5.1	6.8	6.0	11.3	3.9	3.7	13.3	8.7	8.9	7.4	7.6	5.3	7.8	1.9	4.5	7.7	4.4	2.9	2.5	4.7	9.9	5.3	8.0	4.4	48.9	4.1	13.2	5.9	1.5	5.2	7.3	8.7	5.2	5.8	18.1	6.0	5.6	19.5	3.7	2.5	1.2	0.7	0.1	0.1	0.3	9.9	0.2	3.7	32.1	44.4	0.3	6.9	0.1	1.7	0.0	0.5	4.7	0.7	2.7	15.7	2.9	4.1	4.6	0.1	0.3	5.0	1.9	0.3	0.2	8.0	0.0	0.2	0.1	10.0	0.6	0.2	15.3	6.2	2.6	0.8	15.4	12.7	0.6	0.5	0.5	0.2	4.2	5.2	0.1	19.0	0.4	2.8	0.1	0.4	0.0	0.1	2.0	13.8	12.1	0.1	3.1	3.7	0.3	7.7	5.2	8.0	6.0	6.0	6.6	5.2	6.8	4.9	1.9	3.7	4.3	3.7	18.1	5.6	5.2	5.8	19.5	3.7	4.1	6.1	1.2	4.0	4.2	3.4	3.9	3.7	5.3	4.1
NEDD4	"KIAA0093, MGC176705, NEDD4-1, RPF1"	ENSG00000069869	"Neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase"	P46934	15	55826922-55993746	"Enzymes, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Neurogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 57.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001991, HPA039883, CAB072833"	Approved		Approved	Cytosol				Cytosol		"CAB001991: , CAB072833: , HPA039883: AB_10795683"	"unprognostic (1.18e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.18e-3)"	"prognostic unfavourable (5.14e-4)"	"unprognostic (1.36e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.43e-2)"	"prognostic unfavourable (3.74e-6)"	"unprognostic (6.38e-3)"	"unprognostic (2.98e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.35e-2)"	14.1	4.1	2.5	3.1	3.3	4.5	8.7	1.5	2.7	9.9	9.4	2.8	3.4	3.4	10.1	4.1	8.2	3.8	4.5	4.1	2.9	2.4	8.6	21.5	7.2	2.1	3.5	1.3	6.6	2.8	6.5	6.7	20.1	3.5	8.4	3.4	5.4	4.0	6.4	57.7	7.1	15.2	10.9	6.0	5.9	4.4	2.6	3.1	9.4	5.7	9.0	3.3	11.9	8.9	0.1	1.6	1.2	2.8	1.2	2.9	0.9	7.3	11.4	3.1	3.0	4.1	6.8	5.1	14.1	22.3	10.4	10.5	5.1	2.2	1.8	3.7	5.3	12.2	3.4	9.3	17.1	4.1	2.1	9.1	2.7	2.6	21.9	4.0	0.9	11.5	23.0	12.5	21.1	8.5	3.9	0.0	30.5	3.8	5.3	0.0	0.8	1.7	3.9	24.7	1.0	4.3	14.6	0.3	2.0	6.3	4.5	5.6	5.6	3.0	29.6	23.2	7.7	4.9	22.9	1.2	2.6	4.8	15.7	8.5	5.5	0.6	1.0	0.0	1.3	2.8	2.9	0.1	1.5	1.2	0.8	0.0	1.4	1.6	1.2	1.2	1.9	1.6	1.3	0.9	2.5	3.3	1.5	2.7	2.9	2.4	3.5	1.3	3.5	3.1
UBR5	"DD5, EDD, EDD1, HYD, KIAA0896"	ENSG00000104517	"Ubiquitin protein ligase E3 component n-recognin 5"	O95071	8	102253012-102412841	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053688			Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA053688: "	"unprognostic (3.79e-3)"	"unprognostic (7.44e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavourable (1.26e-4)"	"unprognostic (2.50e-1)"	"unprognostic (1.75e-2)"	"unprognostic (7.54e-3)"	"unprognostic (8.29e-3)"	"unprognostic (3.84e-2)"	"unprognostic (6.64e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.45e-1)"	27.0	16.7	27.1	29.5	31.7	30.3	29.2	40.8	32.8	24.9	25.0	19.1	21.1	14.4	26.8	24.0	23.8	22.0	17.6	22.7	25.5	15.3	17.9	17.0	24.2	29.6	21.9	20.6	29.7	22.2	32.4	25.5	25.0	23.6	20.2	17.1	19.7	22.9	21.8	39.9	29.7	22.4	29.3	17.5	21.9	21.1	39.7	28.3	37.9	20.3	15.9	27.0	27.5	28.6	5.0	4.0	6.3	5.5	2.4	7.1	2.1	23.2	10.4	20.2	10.3	19.9	20.3	18.6	17.6	15.6	13.8	12.1	10.4	15.7	46.4	15.2	16.5	14.2	17.2	15.3	19.4	20.0	8.4	38.7	14.2	18.7	17.7	12.0	21.4	23.2	15.3	14.2	24.8	16.5	18.6	26.4	13.5	21.0	30.5	14.4	15.2	11.8	17.8	11.9	22.0	12.6	22.9	14.9	12.4	12.3	12.0	12.2	19.2	12.8	16.5	14.7	17.2	13.2	12.2	14.1	13.6	47.7	14.6	18.8	11.9	3.1	3.4	5.0	5.6	3.4	5.6	5.0	6.0	5.9	4.0	3.9	4.8	7.1	6.3	2.4	5.5	3.6	7.1	2.1	27.1	31.7	40.8	32.8	25.5	15.3	21.9	20.6	23.6	28.3
WWP1	"AIP5, DKFZP434D2111"	ENSG00000123124	"WW domain containing E3 ubiquitin protein ligase 1"	Q9H0M0	8	86342738-86478420	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023180	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"				Cytosol	"Golgi apparatus, Plasma membrane"	"HPA023180: AB_10602587"	"unprognostic (3.89e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.81e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.09e-3)"	"unprognostic (1.48e-1)"	"prognostic favourable (5.45e-5)"	"unprognostic (2.35e-1)"	"unprognostic (4.63e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.01e-1)"	15.4	9.1	9.7	15.6	14.1	5.2	20.9	8.5	9.5	11.5	16.9	7.5	21.1	8.7	11.9	19.3	11.7	7.2	22.0	40.7	8.7	8.5	16.9	37.2	10.2	15.9	10.0	7.8	10.1	11.3	40.7	7.3	15.6	12.7	17.8	11.3	8.9	11.8	9.4	58.0	13.8	13.0	18.4	9.9	19.1	11.4	10.4	9.5	11.1	11.2	18.0	12.5	14.5	12.3	3.7	2.6	6.5	2.8	2.9	10.4	2.3	22.9	10.8	7.5	5.3	9.4	9.3	6.9	8.4	8.9	6.7	8.0	7.6	14.1	9.9	5.7	14.3	19.7	10.5	13.4	11.6	12.2	8.4	11.3	9.6	17.8	6.9	4.5	5.9	8.4	17.2	7.3	13.6	29.4	5.9	11.6	11.3	11.4	10.8	3.4	4.5	12.2	7.1	9.0	8.7	15.0	17.6	2.2	5.2	8.3	42.1	8.9	12.5	4.2	33.8	10.0	11.9	10.6	4.3	13.8	8.4	10.1	12.4	0.8	7.6	6.5	2.8	4.8	7.2	2.4	6.0	3.7	8.7	7.1	1.9	3.6	10.4	6.3	1.7	2.9	2.8	2.6	8.0	2.3	9.7	14.1	8.5	9.5	8.7	8.5	10.0	7.8	12.7	9.5
BTRC	"beta-TrCP1, betaTrCP, bTrCP, bTrCP1, FBXW1A, Fwd1"	ENSG00000166167	"Beta-transducin repeat containing E3 ubiquitin protein ligase"	Q9Y297	10	101354033-101557321	"Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Ubl conjugation pathway, Wnt signaling pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031156, CAB032986"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				Nucleoplasm	"Plasma membrane, Cytosol"	"CAB032986: AB_2243598, HPA031156: "	"unprognostic (1.43e-1)"	"unprognostic (2.35e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.41e-2)"	"unprognostic (9.25e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.80e-3)"	"unprognostic (5.05e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.07e-2)"	"unprognostic (2.23e-1)"	6.6	11.2	16.0	7.3	23.1	3.6	11.8	16.2	28.0	10.2	6.6	10.7	13.7	5.4	8.8	14.5	11.5	10.8	8.1	18.6	15.7	18.3	11.6	7.1	6.8	5.3	14.3	15.3	15.5	8.6	21.5	17.3	10.4	13.5	12.2	7.0	11.9	9.0	8.7	14.1	9.0	5.4	9.7	10.2	7.5	6.4	17.9	9.0	6.3	11.4	7.1	7.5	7.3	9.8	5.2	4.8	3.9	3.7	5.1	8.1	3.4	6.5	10.1	14.2	16.3	13.9	12.1	5.1	9.5	15.3	9.9	8.3	7.0	5.2	10.7	9.6	8.0	10.2	11.6	10.3	10.8	7.0	9.2	7.8	6.3	9.1	7.4	11.3	4.2	7.4	12.0	8.5	15.2	12.2	8.4	3.6	9.5	5.6	7.6	5.7	6.6	7.9	9.6	19.9	2.2	9.1	4.3	10.5	9.0	6.2	2.8	8.8	7.7	4.0	10.3	5.2	8.3	6.8	6.6	6.0	13.0	6.8	5.2	5.7	3.5	3.8	3.7	3.9	6.1	3.1	6.1	5.2	6.5	5.5	4.8	4.4	8.1	6.5	2.4	5.1	3.1	2.4	5.6	3.4	16.0	23.1	16.2	23.3	15.7	18.3	14.3	15.3	13.5	9.0
CBLB	"Cbl-b, RNF56"	ENSG00000114423	"Cbl proto-oncogene B"	Q13191	3	105655461-105869552	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 23.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018327, HPA019880"	Approved		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA018327: AB_1846097, HPA019880: AB_1846099"	"unprognostic (2.65e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.38e-1)"	"unprognostic (5.89e-3)"	"unprognostic (2.80e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.09e-2)"	38.4	9.0	3.7	19.5	4.9	15.5	16.3	24.4	3.8	13.7	18.7	5.9	7.7	9.3	13.8	12.2	8.3	12.5	13.4	27.5	3.8	4.8	7.4	6.7	16.3	19.1	4.4	1.9	17.7	6.8	3.4	13.5	25.4	7.9	12.9	8.0	11.6	9.1	6.3	10.3	8.5	13.8	25.6	5.7	16.4	12.4	9.2	5.2	11.6	13.5	7.0	18.0	24.9	24.1	5.1	3.1	2.8	2.1	10.3	9.9	1.6	1.6	2.2	7.6	3.7	8.7	8.8	4.9	5.6	2.8	1.6	2.7	2.9	1.9	3.6	4.0	3.0	2.8	1.0	1.0	2.0	2.7	2.9	1.9	11.7	1.8	12.8	1.3	1.4	8.4	3.0	4.4	12.0	5.5	2.0	11.5	3.5	2.0	1.9	0.9	2.7	3.2	4.1	2.3	0.6	4.0	7.2	5.8	6.4	6.7	0.8	8.8	1.6	2.9	3.1	23.4	2.0	3.2	1.3	6.5	0.5	5.6	6.2	1.2	1.5	0.7	1.5	2.8	9.9	0.9	8.8	2.2	5.1	5.6	1.3	5.1	4.4	8.0	1.0	10.3	2.1	3.1	5.6	1.6	3.7	4.9	24.4	3.8	3.8	4.8	4.4	1.9	7.9	5.2
COP1	"FLJ10416, RFWD2, RNF200"	ENSG00000143207	"COP1, E3 ubiquitin ligase"	Q8NHY2	1	175944831-176207493	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 13.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.99e-1)"	"unprognostic (3.76e-2)"	"unprognostic (4.17e-2)"	"prognostic unfavourable (3.96e-4)"	"unprognostic (2.95e-2)"	"unprognostic (4.33e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-2)"	"unprognostic (6.68e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-1)"	22.4	15.8	14.8	20.1	16.7	19.1	19.3	24.6	19.7	21.4	23.9	15.3	17.7	16.1	23.5	16.5	22.3	14.9	15.5	14.5	12.8	11.6	17.2	22.9	17.8	24.1	13.1	11.3	14.4	20.8	15.6	24.5	17.2	15.7	15.4	26.1	18.1	20.2	21.4	19.2	25.4	22.1	19.7	10.9	27.1	17.5	23.4	15.0	39.3	18.3	15.8	25.0	22.6	17.6	1.5	2.0	13.7	3.4	0.5	2.7	1.0	14.1	7.6	12.4	6.7	12.5	12.8	23.5	11.0	13.5	11.8	11.2	12.9	15.0	29.0	10.8	12.5	13.4	11.4	16.7	10.6	9.0	7.0	12.3	9.4	12.7	13.2	22.1	14.3	11.3	14.0	11.5	14.7	16.7	17.9	11.4	14.0	17.7	13.0	11.7	21.3	0.8	11.3	10.8	16.9	16.2	43.8	10.0	17.6	12.9	20.6	14.0	14.6	29.6	16.0	10.0	7.0	13.4	9.4	14.7	25.1	26.4	8.4	13.1	11.5	6.1	2.7	10.1	1.8	3.4	1.4	1.4	2.1	1.4	2.0	1.5	2.7	2.0	13.7	0.5	3.1	1.1	1.5	1.0	14.8	16.7	24.6	19.7	12.8	11.6	13.1	11.3	15.7	15.0
CUL4B		ENSG00000158290	"Cullin 4B"	Q13620	X	120524609-120575794	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Ubl conjugation pathway"		"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003046, HPA011880, CAB017786, HPA058979"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm		"CAB017786: , HPA003046: , HPA011880: AB_1847340, HPA058979: "	"unprognostic (2.34e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.69e-2)"	"unprognostic (7.73e-3)"	"unprognostic (9.66e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.88e-3)"	"unprognostic (8.99e-2)"	"unprognostic (8.12e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.87e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.84e-1)"	20.9	24.0	19.0	19.2	28.1	12.2	25.3	28.9	25.7	32.6	20.5	12.1	25.7	14.0	24.2	47.2	29.3	19.6	18.5	19.4	18.5	20.2	19.1	20.4	23.8	23.5	17.3	20.4	30.1	18.8	34.4	48.3	17.0	18.4	30.8	17.2	15.7	17.3	27.3	10.8	17.7	16.3	36.0	20.5	19.9	17.0	34.0	17.3	29.8	18.8	13.9	24.1	40.4	22.5	7.6	12.5	15.4	4.3	5.5	8.3	4.9	12.0	10.2	8.5	9.0	37.5	19.0	6.9	27.3	32.8	22.6	23.7	9.2	34.2	12.1	9.4	62.8	9.0	17.4	8.0	25.8	7.0	9.0	5.9	14.8	6.5	16.2	6.3	8.4	21.3	6.1	13.0	11.3	40.4	9.1	9.4	21.8	6.4	8.3	6.6	12.9	10.3	7.0	8.4	12.3	7.5	6.0	9.7	8.1	20.2	9.9	10.0	8.4	5.8	53.2	16.3	9.0	21.7	24.4	6.0	10.4	15.1	17.6	8.6	14.6	5.8	4.3	9.0	7.2	3.8	7.7	7.6	7.0	6.6	5.1	5.7	7.9	8.3	15.4	5.5	2.7	12.5	8.2	4.9	19.0	28.1	28.9	25.7	18.5	20.2	17.3	20.4	18.4	17.3
DTX3L	"BBAP, RNF143"	ENSG00000163840	"Deltex E3 ubiquitin ligase 3L"	Q8TDB6	3	122564238-122575203	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity, Protein transport, Transport, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 35.3;BJ hTERT+ SV40 Large T+ RasG12V: 43.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA010570	Uncertain		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA010570: AB_1847877"	"unprognostic (8.15e-2)"	"unprognostic (7.36e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.74e-3)"	"unprognostic (9.51e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.11e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (8.99e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.77e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.61e-2)"	32.3	13.0	5.9	22.7	8.4	8.1	11.2	2.0	6.8	14.2	18.5	5.9	6.0	14.8	14.0	12.8	17.9	12.0	15.1	21.5	5.0	5.1	17.3	39.2	21.3	18.3	6.4	3.3	21.7	18.5	10.3	13.9	22.2	6.5	20.9	12.1	7.6	13.9	9.8	14.6	6.2	31.8	10.8	9.7	35.2	12.4	4.9	6.9	24.8	23.9	8.0	18.3	17.0	22.1	6.4	6.5	21.9	13.6	7.8	10.2	6.7	11.4	3.5	1.0	3.0	4.7	10.9	3.9	3.0	11.1	35.3	43.7	3.4	11.8	1.3	5.9	4.9	11.6	3.5	4.8	7.8	9.7	1.3	10.0	2.6	3.6	9.3	5.1	7.9	9.4	5.7	5.3	3.0	6.6	1.2	7.2	2.6	3.5	12.4	3.6	0.6	6.5	13.8	8.1	2.2	9.0	7.4	1.5	1.6	6.2	2.8	22.3	3.2	6.5	8.1	4.0	5.7	0.4	3.8	2.6	1.4	6.1	7.0	6.7	4.1	12.5	8.5	8.7	9.3	13.6	10.2	5.9	7.8	10.0	6.5	6.4	7.1	7.6	21.9	7.8	13.5	0.7	7.4	6.7	5.9	8.4	2.0	6.8	5.0	5.1	6.4	3.3	6.5	6.9
LTN1	"C21orf10, C21orf98, FLJ11053, KIAA0714, LISTERIN, RNF160, ZNF294"	ENSG00000198862	"Listerin E3 ubiquitin protein ligase 1"	O94822	21	28928144-28992956	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029143, CAB034164, HPA055604"	Uncertain		Enhanced	Cytosol				Cytosol		"CAB034164: AB_2180094, HPA029143: AB_10671360, HPA055604: "	"unprognostic (3.67e-2)"	"unprognostic (7.07e-2)"	"unprognostic (7.78e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.42e-2)"	"unprognostic (3.66e-3)"	"unprognostic (5.38e-2)"	"unprognostic (5.40e-2)"	"unprognostic (9.98e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.52e-1)"	17.9	15.1	10.3	12.4	19.8	21.2	17.9	19.9	23.2	16.6	14.7	17.8	12.1	12.4	16.5	15.4	15.2	14.5	10.8	13.1	12.0	10.6	14.1	19.3	12.0	15.7	19.6	14.2	16.4	23.7	18.4	22.6	29.0	28.7	19.0	15.6	9.7	16.1	12.6	22.5	14.8	17.1	13.4	17.4	16.7	15.4	20.7	15.8	23.0	17.6	14.6	14.9	16.6	14.7	7.8	6.2	12.2	11.9	8.6	8.4	3.3	12.6	5.5	11.3	5.1	9.7	13.3	11.5	10.7	8.7	9.2	12.8	7.6	10.6	8.3	5.2	9.5	6.5	12.0	8.8	16.8	9.7	8.3	24.8	7.5	6.0	7.3	8.2	9.7	9.2	7.9	13.1	10.9	9.7	20.2	20.0	10.5	3.9	5.3	8.0	16.2	6.5	7.1	22.7	17.4	10.4	10.9	6.2	12.9	12.3	9.4	10.7	9.6	11.6	12.8	8.1	15.2	10.9	9.0	16.4	15.3	11.8	12.7	17.9	9.6	12.2	6.4	9.5	8.4	9.8	7.0	7.8	5.8	5.6	6.2	7.1	6.2	4.7	11.3	8.6	11.9	3.9	6.1	3.3	10.3	19.8	19.9	23.2	12.0	10.6	19.6	14.2	28.7	15.8
RNF128	"FLJ23516, GRAIL"	ENSG00000133135	"Ring finger protein 128, E3 ubiquitin protein ligase"	Q8TEB7	X	106693794-106796993	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 54.6;liver: 48.4;thyroid gland: 38.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 17.9;CAPAN-2: 14.8;Hep G2: 12.6;RPTEC TERT1: 13.0;RT4: 37.2;WM-115: 22.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019675	Uncertain									"HPA019675: "	"unprognostic (1.78e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.92e-4)"	"unprognostic (2.14e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavourable (1.07e-7)"	"unprognostic (1.11e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.30e-2)"	"unprognostic (5.30e-3)"	1.4	20.6	2.4	2.2	7.2	0.0	3.0	0.7	4.2	0.5	24.4	0.9	0.4	24.2	0.2	2.2	4.0	0.3	27.2	0.6	2.8	5.1	24.4	48.4	6.7	0.0	2.4	2.1	0.7	14.5	0.0	11.0	10.5	4.0	3.4	7.8	0.0	25.4	0.8	3.0	3.6	54.6	0.9	1.1	0.2	17.9	0.3	1.0	1.1	38.4	2.3	2.7	10.2	3.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	4.5	0.0	0.0	0.0	1.5	0.8	17.9	0.0	0.1	0.0	0.0	7.8	14.8	0.0	0.0	0.2	5.6	0.0	0.0	0.0	0.0	8.7	0.0	0.1	12.6	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	13.0	37.2	0.0	0.0	0.0	0.9	0.9	0.9	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	6.5	0.0	22.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	7.2	0.7	4.2	2.8	5.1	2.4	2.1	4.0	1.0
HECW2	"KIAA1301, NEDL2"	ENSG00000138411	"HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2"	Q9P2P5	2	196189099-196593692	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 26.6;HUVEC TERT2: 15.0;SCLC-21H: 17.4;TIME: 19.7;U-138 MG: 12.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 7.7;non-classical monocyte: 5.2"	"Group enriched"	"Detected in many"	9	"granulocytes: 7.7;monocytes: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034609	Enhanced									"HPA034609: AB_10669993"	"unprognostic (2.65e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.00e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.63e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.27e-1)"	"prognostic unfavourable (5.18e-5)"	"unprognostic (8.05e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.48e-2)"	8.8	3.3	6.7	2.6	12.6	0.6	4.2	15.7	17.2	4.6	1.2	11.6	0.0	1.1	3.0	1.0	5.5	6.3	4.8	14.0	6.7	4.3	3.4	5.6	16.4	3.5	8.2	9.3	1.3	2.1	14.7	5.9	15.5	9.5	1.5	1.3	1.2	2.2	1.3	2.7	2.7	1.7	3.1	5.8	11.6	2.1	5.8	8.8	0.0	7.9	1.6	4.2	2.4	2.5	0.6	0.7	7.7	5.2	0.0	0.1	0.1	0.0	0.7	1.2	0.0	0.7	2.3	0.9	1.5	3.9	1.2	1.4	0.1	0.0	0.7	0.3	7.2	1.7	0.5	0.1	2.5	26.6	0.9	0.0	1.1	0.1	0.1	0.2	0.2	0.5	0.7	8.9	3.1	15.0	0.1	0.0	3.6	0.9	0.0	0.3	1.4	0.6	0.0	0.3	0.0	0.0	0.0	17.4	1.4	1.1	0.2	0.0	0.0	0.1	19.7	12.0	0.8	2.6	0.3	0.1	0.0	0.7	3.0	0.0	0.1	0.2	0.5	1.3	0.0	1.9	0.0	0.5	0.1	0.0	0.7	0.6	0.1	0.0	7.7	0.0	5.2	0.0	0.1	0.1	6.7	12.6	15.7	17.2	6.7	4.3	8.2	9.3	9.5	8.8
NHLRC1	"bA204B7.2, EPM2B"	ENSG00000187566	"NHL repeat containing E3 ubiquitin protein ligase 1"	Q6VVB1	6	18120440-18122687	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"	Transferase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 9.0;K-562: 7.6;SCLC-21H: 8.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA066030			Uncertain	Vesicles				Vesicles		"HPA066030: "	"unprognostic (1.61e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.95e-2)"	"prognostic unfavourable (9.01e-4)"	"unprognostic (6.95e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.39e-1)"	"unprognostic (7.17e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.77e-2)"	"prognostic favourable (5.30e-4)"	2.5	3.6	5.0	1.8	6.5	2.1	4.6	2.6	8.5	1.9	3.3	7.1	1.7	3.2	2.0	6.1	2.4	3.5	2.7	3.9	5.0	5.1	1.9	9.0	5.1	4.7	5.4	3.9	3.5	12.2	2.4	2.8	1.0	5.2	3.4	3.0	3.3	5.1	2.8	5.2	8.5	4.3	1.8	5.4	2.4	3.0	2.1	3.8	2.4	3.6	0.9	1.8	2.5	1.8	3.3	7.2	0.6	7.2	2.2	2.5	2.6	3.3	2.0	0.8	0.1	1.8	1.7	0.0	3.4	1.1	1.3	0.7	0.1	2.8	0.1	9.0	2.5	4.0	0.0	2.2	1.0	0.1	1.1	0.5	1.0	0.2	2.8	0.0	2.2	2.9	3.3	1.3	1.2	2.8	7.6	0.1	2.8	3.5	0.0	0.0	0.0	2.0	0.0	0.0	0.1	1.8	3.6	8.0	0.1	6.8	5.7	2.0	4.1	2.2	0.5	0.2	1.7	2.4	0.0	0.1	0.0	0.1	0.1	0.0	3.4	0.5	6.6	0.6	1.1	7.2	1.2	3.3	1.7	0.8	7.2	2.3	2.5	1.6	0.5	2.2	3.2	0.9	1.8	2.6	5.0	6.5	2.6	8.5	5.0	5.1	5.4	3.9	5.2	3.8
RNF7	"CKBBP1, ROC2, SAG"	ENSG00000114125	"Ring finger protein 7"	Q9UBF6	3	141738204-141747560	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA036995	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA036995: AB_10673627"	"unprognostic (5.68e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.24e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.45e-1)"	"prognostic unfavourable (2.21e-4)"	"unprognostic (4.53e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.98e-3)"	"unprognostic (5.17e-3)"	"unprognostic (8.58e-3)"	"prognostic unfavourable (1.54e-9)"	"unprognostic (4.60e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.36e-2)"	26.0	44.0	31.4	21.7	37.0	30.7	38.3	19.4	28.6	26.1	37.0	17.5	36.3	38.6	30.4	42.0	37.1	22.9	41.8	47.6	27.4	27.6	33.2	35.3	27.2	32.1	26.7	21.6	30.5	57.6	16.2	33.9	40.6	20.5	37.3	34.5	29.2	36.2	28.9	69.9	35.7	42.7	36.2	23.9	23.7	26.8	44.4	18.7	27.0	35.1	50.6	27.4	37.5	35.2	32.7	44.9	36.3	52.2	22.5	41.7	42.9	48.2	19.6	29.1	23.5	27.8	38.5	19.2	27.1	25.6	23.3	24.7	22.8	24.1	16.2	63.6	30.0	23.6	18.0	25.5	29.6	15.6	33.7	16.0	18.5	32.9	37.1	25.1	15.7	35.9	28.8	18.5	31.8	32.9	16.9	22.8	34.4	37.1	15.9	28.3	30.9	32.6	17.4	18.7	35.0	49.7	21.4	16.1	20.1	31.1	32.2	45.1	30.1	33.1	24.9	23.3	22.4	41.2	22.7	21.8	18.1	33.4	36.4	27.9	26.4	36.3	52.2	33.7	33.0	44.5	33.1	32.7	35.6	35.0	44.9	29.3	34.7	35.9	18.5	22.5	46.6	41.4	41.7	42.9	31.4	37.0	19.4	28.6	27.4	27.6	26.7	21.6	20.5	18.7
CUL4A		ENSG00000139842	"Cullin 4A"	Q13619	13	113208193-113267108	"Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058979			Approved	Nucleoplasm				Nucleoplasm		"HPA058979: "	"unprognostic (3.01e-1)"	"unprognostic (5.93e-3)"	"unprognostic (6.19e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.53e-2)"	"unprognostic (6.41e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.66e-2)"	"unprognostic (3.52e-2)"	"unprognostic (5.16e-3)"	"unprognostic (3.57e-3)"	"prognostic favourable (2.84e-4)"	"unprognostic (2.95e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.48e-1)"	14.6	13.5	9.7	13.9	12.0	20.7	16.5	13.2	10.0	12.0	13.6	12.6	16.1	10.5	13.5	14.4	14.7	11.9	15.0	36.8	8.6	8.4	14.1	23.6	13.3	15.8	10.1	7.0	12.6	23.8	11.2	13.4	13.3	10.6	13.7	11.8	11.2	15.8	15.6	70.5	16.8	12.8	21.7	10.7	13.8	14.0	18.0	9.7	12.8	13.3	25.7	17.4	14.3	15.7	11.7	11.9	11.8	19.3	10.8	22.8	15.4	35.6	18.4	17.0	15.1	20.7	23.2	22.8	36.7	26.4	30.7	23.6	31.7	29.3	43.6	15.9	30.5	22.9	25.9	19.4	27.8	19.4	26.2	29.5	38.5	24.0	24.7	44.9	19.9	16.6	23.5	18.0	27.7	20.1	29.1	8.5	29.7	16.6	23.1	39.3	16.2	18.5	23.8	18.3	20.2	20.6	16.3	25.9	15.2	18.6	39.7	17.2	29.2	46.5	28.8	15.1	31.8	16.7	20.2	22.8	17.1	38.4	33.4	36.5	23.5	8.4	13.2	11.8	20.1	19.1	18.6	11.7	20.3	22.8	11.9	10.6	17.1	20.4	4.8	10.8	19.3	9.1	13.2	15.4	9.7	12.0	13.2	10.0	8.6	8.4	10.1	7.0	10.6	9.7
DDB1		ENSG00000167986	"Damage specific DNA binding protein 1"	Q16531	11	61299451-61342596	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032821, HPA045174, HPA068456"	Approved		Enhanced	Nucleoplasm			170000	Nucleoplasm		"CAB032821: AB_639050, HPA045174: , HPA068456: "	"unprognostic (3.45e-1)"	"unprognostic (8.38e-2)"	"prognostic favourable (7.09e-4)"	"unprognostic (1.21e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.33e-2)"	"unprognostic (9.74e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.42e-3)"	"unprognostic (3.11e-1)"	"prognostic favourable (1.51e-8)"	"unprognostic (3.44e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.25e-3)"	19.3	83.3	19.9	14.1	24.9	16.1	19.7	22.9	33.8	21.3	16.2	24.9	33.3	18.4	23.9	30.6	19.8	26.2	17.4	21.1	18.1	20.8	21.7	26.8	16.0	21.7	18.3	23.4	31.1	23.5	107.3	22.0	80.3	27.3	19.4	17.8	33.0	23.9	27.2	57.1	24.1	19.7	20.7	16.7	17.5	19.7	36.1	14.4	33.3	22.1	20.4	21.0	22.6	17.9	19.6	30.5	17.8	23.5	22.0	32.5	23.8	39.4	42.6	41.4	36.2	39.4	37.2	62.2	37.1	48.1	45.1	34.2	46.1	33.4	59.7	33.0	50.8	36.9	60.7	44.2	48.7	30.1	32.8	34.3	40.9	47.6	27.6	48.9	29.8	43.8	30.4	44.6	38.5	48.4	68.9	32.7	39.6	47.9	60.4	23.0	54.9	36.8	49.8	52.5	62.4	31.5	43.8	36.9	37.6	40.1	46.9	36.9	58.1	20.8	39.9	32.1	30.3	36.6	26.2	37.7	39.8	53.0	35.4	26.2	31.0	17.8	20.9	17.7	24.8	23.5	32.5	19.6	22.4	24.8	30.5	17.9	20.7	23.1	2.5	22.0	21.0	16.8	24.4	23.8	19.9	24.9	22.9	33.8	18.1	20.8	18.3	23.4	27.3	14.4
DTX2	"KIAA1528, RNF58"	ENSG00000091073	"Deltex E3 ubiquitin ligase 2"	Q86UW9	7	76461676-76505995	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 19.1;esophagus: 19.2"	"Cell line enhanced"	"Detected in all"		"A549: 28.0;CAPAN-2: 46.2"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042931	Approved		Supported	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"		"HPA042931: "	"unprognostic (1.72e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.58e-2)"	"prognostic unfavourable (8.47e-4)"	"unprognostic (2.85e-2)"	"unprognostic (1.28e-3)"	"unprognostic (7.54e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.10e-2)"	"unprognostic (6.56e-2)"	"prognostic unfavourable (1.13e-8)"	"unprognostic (2.87e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.19e-2)"	2.9	1.3	0.4	4.8	0.5	1.5	3.2	0.4	0.2	4.8	5.7			4.1	3.0	0.0	19.2	3.2	3.8	1.8	0.5	0.5	1.6	2.8	3.2	3.9	0.7		2.7	4.3	3.8	2.1	1.8		4.6	3.2		10.5	1.3	2.8	11.6	5.5	1.3	1.1	4.9	6.1	8.3			2.7		4.0	4.6	8.8	7.0	14.7	19.1	14.1	3.3	9.0	6.4	12.7	28.0	4.2	6.1	2.4	2.3	9.0	2.7	2.4	3.1	4.2	7.8	46.2	4.0	2.0	2.7	9.6	2.2	13.3	1.9	8.9	4.7	2.3	5.7	6.8	3.2	3.3	5.8	4.1	8.1	7.9	4.3	2.3	6.9	6.0	3.7	6.2	5.0	11.5	6.0	4.2	5.6	3.8	7.1	1.4	10.0	1.6	3.4	4.5	7.7	3.7	7.7	8.8	2.4	17.3	8.2	5.8	11.0	4.5	5.3	4.5	3.7	3.5	8.8	12.4	9.2	13.3	7.6	10.9	5.5	6.0	6.4	7.5	8.4	7.0	6.6	6.9	19.1	3.3	14.1	14.7	9.0	6.4										
DTX3	"FLJ34766, RNF154"	ENSG00000178498	"Deltex E3 ubiquitin ligase 3"	Q8N9I9	12	57604622-57609804	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"glioma: 54.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"NK-cells: 2.0;T-cells: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059654	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"				"Nucleoplasm, Nucleoli"	"Golgi apparatus"	"HPA059654: "	"unprognostic (2.31e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.91e-2)"	"prognostic favourable (9.87e-4)"	"unprognostic (1.84e-1)"	"unprognostic (4.26e-2)"	"prognostic favourable (1.44e-4)"	"unprognostic (8.62e-2)"	"unprognostic (5.44e-3)"	"unprognostic (7.99e-2)"	"unprognostic (8.81e-2)"	"unprognostic (9.51e-2)"	"unprognostic (3.48e-2)"	7.2	18.8	22.7	9.0	35.2	3.5	9.4	47.8	53.6	17.6	22.8	23.7	11.0	6.7	29.7	30.6	9.7	31.8	14.1	20.5	23.8	19.8	11.4	2.4	12.2	11.0	18.3	28.4	36.3	12.0	23.9	32.7	16.0	22.5	21.1	10.1	20.4	13.2	29.5	10.9	7.9	9.4	28.7	16.9	11.2	11.2	7.8	21.6	6.8	16.8	5.1	8.8	11.8	13.5	0.3	0.6	0.0	0.0	2.0	5.5	1.8	3.1	8.4	25.0	0.0	0.0	0.0	0.1	5.1	13.3	11.3	11.5	4.3	13.6	4.5	7.9	11.1	5.2	0.0	0.6	8.0	11.3	1.5	2.6	13.0	4.5	19.3	0.0	0.0	9.5	6.3	8.6	0.1	12.6	0.0	15.4	8.6	7.0	13.7	0.1	19.7	0.7	0.0	20.9	0.2	1.0	8.4	18.2	28.8	4.0	1.2	2.4	14.4	6.9	0.0	14.8	5.9	6.8	7.3	25.2	18.9	0.0	9.5	0.0	7.7	0.0	0.0	0.0	5.5	0.0	1.3	0.3	2.1	2.5	0.2	0.3	1.9	3.5	0.0	2.0	0.0	0.6	4.2	1.8	22.7	35.2	47.8	53.6	23.8	19.8	18.3	28.4	22.5	21.6
HERC3	KIAA0032	ENSG00000138641	"HECT and RLD domain containing E3 ubiquitin protein ligase 3"	Q15034	4	88592423-88708542	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 36.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039170	Approved		Approved	Cytosol				Cytosol		"HPA039170: AB_10673414"	"unprognostic (2.21e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.28e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.85e-2)"	"unprognostic (9.77e-2)"	"unprognostic (6.51e-3)"	"unprognostic (3.48e-3)"	"unprognostic (2.58e-2)"	"prognostic favourable (5.65e-7)"	"unprognostic (1.83e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.16e-2)"	12.7	13.3	16.9	13.0	27.1	21.0	15.3	37.8	20.1	14.4	12.0	17.9	11.6	11.2	12.0	10.5	16.8	10.7	12.1	22.0	15.2	13.7	15.8	13.0	15.0	15.3	21.9	15.0	12.7	9.7	33.8	16.1	10.0	21.1	22.0	13.4	22.0	14.0	14.0	17.3	19.1	12.8	13.8	16.3	15.7	12.9	3.6	21.5	16.6	15.7	12.6	16.4	13.3	16.7	5.2	7.0	18.2	9.7	3.1	9.0	3.9	7.2	1.1	1.3	2.3	7.7	16.4	4.6	8.2	15.0	8.6	5.7	1.8	8.4	7.7	3.9	27.0	2.5	1.9	7.4	8.2	3.4	2.2	5.3	3.3	1.2	4.4	13.1	9.6	7.8	9.2	8.1	36.8	9.4	3.8	3.4	17.3	2.1	9.0	3.1	0.4	2.0	10.2	9.5	3.1	5.5	1.3	1.9	1.8	9.4	6.0	3.2	1.0	5.9	14.7	9.7	5.3	9.1	6.1	6.4	1.6	4.4	6.1	6.0	4.0	5.7	5.7	7.7	4.7	6.2	5.5	5.2	5.5	4.7	7.0	4.9	8.2	5.8	18.2	3.1	9.7	2.4	9.0	3.9	16.9	27.1	37.8	20.1	15.2	13.7	21.9	15.0	21.1	21.5
MYCBP2	"FLJ10106, KIAA0916, PAM"	ENSG00000005810	"MYC binding protein 2, E3 ubiquitin protein ligase"	O75592	13	77044655-77327050	"Enzymes, Predicted intracellular proteins"	"Biological rhythms, Ubl conjugation pathway"	"Guanine-nucleotide releasing factor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 39.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058807			Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"HPA058807: "	"unprognostic (1.79e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.42e-2)"	"prognostic favourable (5.01e-5)"	"unprognostic (2.63e-1)"	"unprognostic (9.84e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.00e-1)"	28.0	13.4	31.0	26.1	28.8	24.1	22.4	31.3	32.7	15.5	10.9	8.1	11.5	8.0	16.2	26.7	18.9	11.7	11.1	13.5	24.1	18.6	12.3	13.2	12.4	29.8	15.3	31.1	22.8	12.6	14.5	17.2	9.6	20.0	17.9	11.5	9.6	12.9	12.4	13.7	57.6	13.6	13.2	14.0	24.1	10.3	14.1	16.2	18.6	11.6	12.6	30.7	13.3	34.0	8.3	4.6	3.3	3.7	4.2	7.3	2.5	7.7	3.9	4.8	5.2	24.0	10.7	2.8	4.9	7.3	4.3	5.5	3.5	4.0	22.1	3.1	9.6	7.1	8.2	9.0	5.8	8.7	8.2	18.7	8.0	7.2	8.2	39.2	6.6	12.0	7.5	3.9	7.9	9.7	3.9	7.0	7.6	4.6	10.7	26.5	2.5	5.0	12.2	4.9	5.3	7.2	7.7	7.5	3.5	5.9	8.6	4.4	3.2	30.1	12.8	4.1	3.4	2.7	4.7	7.6	5.2	15.7	8.3	32.3	4.1	2.0	3.5	3.2	5.8	3.7	5.1	7.9	6.5	5.0	3.2	8.3	7.3	5.8	3.3	4.2	2.5	4.6	7.3	2.5	31.0	28.8	31.3	32.7	24.1	18.6	15.3	31.1	20.0	16.2
PELI1		ENSG00000197329	"Pellino E3 ubiquitin protein ligase 1"	Q96FA3	2	64092652-64144454	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 105.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 21.3;U-698: 53.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 33.9"	"Group enriched"	"Detected in all"	4	"granulocytes: 33.9;monocytes: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053182	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments"				"Nucleoplasm, Nucleoli, Intermediate filaments"		"HPA053182: "	"unprognostic (3.33e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.79e-2)"	"prognostic unfavourable (5.33e-4)"	"unprognostic (1.91e-2)"	"unprognostic (3.12e-3)"	"unprognostic (6.73e-3)"	"unprognostic (8.01e-3)"	"unprognostic (4.16e-2)"	"unprognostic (3.52e-3)"	"unprognostic (5.99e-3)"	"unprognostic (3.33e-1)"	"prognostic unfavourable (5.67e-6)"	"unprognostic (6.72e-2)"	"unprognostic (6.22e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.03e-1)"	15.7	5.1	10.0	15.1	20.5	105.7	22.3	15.1	8.9	9.9	14.5	11.0	3.3	9.9	14.5	7.1	26.4	8.0	14.9	11.6	11.3	6.8	6.7	8.6	20.1	16.8	15.6	5.2	4.8	6.2	11.0	14.8	13.7	10.8	7.6	11.8	6.0	12.3	8.5	4.5	17.5	17.3	8.4	15.0	17.8	10.2	7.8	12.8	19.9	6.3	10.2	19.3	14.1	14.8	3.9	2.3	33.9	9.2	1.3	5.0	2.5	1.2	1.0	13.7	9.1	1.6	1.2	3.1	1.7	2.0	1.6	2.6	21.3	1.5	17.5	4.3	0.6	2.1	4.1	3.8	3.2	4.3	3.3	1.6	0.6	3.4	4.8	1.7	3.1	1.6	3.0	2.4	8.2	9.0	0.9	4.4	1.3	0.1	3.7	2.5	8.9	0.6	4.7	4.7	9.9	6.6	3.9	6.3	8.8	1.3	2.0	4.7	1.1	1.2	6.4	1.5	2.2	1.5	2.5	10.1	0.9	53.0	0.8	1.5	4.0	5.1	6.5	6.3	0.4	6.1	0.7	3.9	2.2	0.9	2.3	2.4	2.7	1.1	33.9	1.3	9.2	0.2	5.0	2.5	10.0	20.5	15.1	8.8	11.3	6.8	15.6	5.2	10.8	12.8
PELI2		ENSG00000139946	"Pellino E3 ubiquitin protein ligase family member 2"	Q9HAT8	14	56117814-56301526	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 20.7;MOLT-4: 23.2;REH: 11.4;SCLC-21H: 10.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	4	"cerebellum: 21.4"	"Cell type enhanced"	"Detected in many"		"neutrophil: 9.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053182	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments"				"Nucleoplasm, Nucleoli, Intermediate filaments"		"HPA053182: "	"unprognostic (3.26e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.14e-1)"	"prognostic favourable (1.53e-6)"	"unprognostic (3.64e-1)"	"unprognostic (2.15e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.22e-1)"	12.3	3.3	5.2	5.6	4.6	16.5	8.7	21.4	6.5	7.5	9.4	5.4	9.7	11.1	9.3	7.1	4.7	5.9	11.5	3.4	4.6	4.5	9.7	3.1	7.3	4.8	5.2	3.9	16.0	38.9	1.7	5.5	3.3	4.4	8.2	4.2	9.2	7.6	12.4	3.8	6.5	12.6	17.7	5.8	6.6	14.1	10.0	4.2	38.2	4.9	3.4	2.6	13.3	14.9	0.9	2.0	9.0	3.0	0.5	0.8	1.1	0.0	1.9	5.5	0.0	3.1	4.6	0.1	0.7	2.5	0.5	0.0	0.1	0.4	0.1	2.6	1.5	0.5	4.2	0.0	0.2	1.3	1.5	4.7	8.5	0.0	2.6	0.7	20.7	2.9	0.2	0.0	0.0	1.0	3.5	0.1	0.6	0.0	23.2	0.2	9.0	0.7	11.4	0.3	1.0	2.2	9.3	10.9	0.0	0.5	0.0	6.1	0.0	3.8	0.3	1.6	2.8	0.5	2.6	0.4	0.0	0.6	2.9	3.2	1.6	1.4	3.0	3.5	0.5	1.6	0.8	0.2	0.6	0.3	2.0	0.9	0.4	0.3	9.0	0.5	1.2	0.5	0.0	1.1	5.2	4.6	21.4	4.4	4.6	4.5	5.2	3.9	4.4	4.2
RAD18	RNF73	ENSG00000070950	"RAD18, E3 ubiquitin protein ligase"	Q9NS91	3	8775402-8963773	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006716, HPA006724, HPA008752"	Supported	Approved	Enhanced	"Nucleoplasm,Nuclear bodies"				"Nuclear bodies"	Nucleoplasm	"HPA006716: , HPA006724: , HPA008752: AB_2668129"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.73e-2)"	"unprognostic (6.15e-2)"	"prognostic unfavourable (1.12e-4)"	"unprognostic (2.01e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavourable (3.73e-4)"	"prognostic unfavourable (3.65e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.89e-2)"	6.2	5.7	7.4	5.6	12.7	7.9	9.5	16.4	11.4	5.5	6.6	3.9	5.4	17.7	6.5	3.7	7.6	4.9	5.6	4.4	4.7	3.3	4.3	5.7	5.9	7.6	8.4	6.9	7.1	4.2	3.4	6.9	6.9	5.7	7.4	9.0	3.5	7.5	3.5	3.7	8.5	10.5	6.0	7.8	8.5	5.1	9.5	9.8	16.6	6.7	4.7	7.5	6.1	6.8	3.7	6.3	8.7	3.0	4.3	5.5	1.5	9.7	9.3	7.8	4.6	1.9	4.2	9.5	15.5	5.3	15.0	10.3	8.4	6.3	12.1	3.0	8.8	3.4	8.2	8.0	15.3	7.4	10.3	10.3	9.3	5.0	1.2	13.5	8.9	1.5	2.9	14.8	10.1	4.8	10.9	12.0	13.0	11.3	13.7	9.6	10.8	17.1	10.9	8.6	9.5	4.3	7.5	3.2	7.4	6.9	6.6	5.0	6.9	6.0	4.0	12.4	6.8	10.6	13.2	6.1	9.3	26.3	9.2	15.0	9.1	7.4	2.7	8.7	3.0	3.0	5.5	3.7	4.0	5.2	3.4	3.7	4.3	3.2	1.2	4.3	1.8	6.3	5.0	1.5	7.4	12.7	16.4	11.4	4.7	3.3	8.4	6.9	5.7	9.8
RFFL	"CARP-2, CARP2, fring, rififylin, RNF189, RNF34L"	ENSG00000092871	"Ring finger and FYVE like domain containing E3 ubiquitin protein ligase"	Q8WZ73	17	35005990-35089319	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 56.8"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 40.5;Karpas-707: 37.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB008096, HPA017910, HPA019492"	Approved		Approved	Vesicles				Vesicles		"CAB008096: AB_2178607, HPA017910: AB_1856189, HPA019492: AB_1856190"	"unprognostic (2.59e-1)"	"unprognostic (2.87e-1)"	"prognostic favourable (4.92e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.73e-3)"	"unprognostic (4.34e-3)"	"unprognostic (2.31e-1)"	"unprognostic (9.26e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.63e-1)"	"prognostic unfavourable (2.43e-5)"	"unprognostic (1.44e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.36e-1)"	5.8	6.1	11.1	9.9	22.9	22.1	6.7	4.4	15.7	6.7	14.6	56.8	5.9	14.8	6.9	5.3	21.6	5.4	11.5	5.8	14.4	10.5	15.4	25.0	6.8	8.9	32.1	7.3	5.2	10.1	8.3	4.9	6.5	30.7	10.7	12.6	4.5	9.6	7.0	12.2	5.2	11.9	7.3	32.1	9.9	13.4	15.7	27.5	13.1	23.0	5.4	15.0	10.2	9.2	4.2	5.2	26.8	7.6	6.7	14.5	7.1	7.7	14.8	3.9	5.5	6.5	9.2	2.1	5.1	8.4	5.3	6.4	5.0	15.5	2.3	6.5	6.5	11.0	6.1	9.9	7.4	40.5	4.2	12.1	3.9	12.3	5.5	7.8	7.3	6.2	5.9	7.9	14.1	5.2	5.7	37.8	4.7	2.5	1.7	7.0	4.6	8.8	5.4	6.3	13.7	7.8	15.6	4.3	5.4	3.2	3.4	3.2	5.2	8.6	10.1	3.1	5.5	3.0	8.3	14.1	11.8	3.6	12.1	5.5	2.8	11.3	7.6	16.3	8.8	4.6	10.6	4.2	9.9	8.3	5.2	4.1	8.5	7.5	26.8	6.7	4.1	0.6	14.5	7.1	11.1	22.9	4.4	15.7	14.4	10.5	32.1	7.3	30.7	27.5
SMURF1	KIAA1625	ENSG00000198742	"SMAD specific E3 ubiquitin protein ligase 1"	Q9HCE7	7	99027438-99144100	"Enzymes, Predicted intracellular proteins"	"Differentiation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019671, HPA055245"	Approved		Uncertain	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"HPA019671: , HPA055245: "	"unprognostic (2.21e-1)"	"unprognostic (6.15e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.62e-2)"	15.0	11.1	8.7	10.5	15.0	23.8	12.4	12.1	16.5	11.8	10.9	20.9	6.9	9.5	11.6	5.7	19.3	10.2	12.5	7.9	9.3	8.4	10.3	10.1	16.0	8.1	15.4	9.4	19.6	22.5	9.0	15.1	15.4	14.9	11.7	10.6	14.3	13.4	9.6	10.7	17.3	10.3	9.8	10.6	9.1	19.5	26.0	11.8	6.6	7.8	6.6	12.7	11.5	13.3	1.2	1.2	2.4	1.9	1.0	2.1	0.6	13.8	7.9	6.4	4.6	5.1	5.4	9.6	7.8	7.5	6.3	5.9	4.0	11.5	4.3	8.4	7.2	7.6	3.6	10.0	6.6	3.3	3.0	2.3	4.6	3.8	4.8	2.6	5.7	4.9	7.0	9.9	11.5	6.0	7.0	7.7	5.8	11.2	4.5	5.5	7.5	8.5	4.3	6.0	2.6	6.9	11.4	2.8	6.4	7.4	9.8	6.8	3.1	5.0	8.7	10.0	10.3	17.9	15.4	6.9	4.7	4.6	5.0	5.2	15.5	2.0	1.4	2.3	1.3	1.5	1.6	0.9	2.1	1.3	1.1	1.2	1.2	1.0	2.4	1.0	1.9	1.2	2.0	0.6	8.7	15.0	12.1	16.5	9.3	8.4	15.4	9.4	14.9	11.8
SMURF2		ENSG00000108854	"SMAD specific E3 ubiquitin protein ligase 2"	Q9HAU4	17	64542295-64662068	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 54.0;HBF TERT88: 41.5;LHCN-M2: 41.5;TIME: 47.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071508	Enhanced		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA071508: "	"unprognostic (1.21e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.24e-1)"	"unprognostic (6.19e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.54e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.98e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.41e-1)"	12.3	9.2	10.5	9.0	15.0	11.5	10.2	16.7	10.0	9.2	9.1	11.5	8.1	9.3	7.9	6.9	7.6	7.8	10.5	8.2	12.6	4.6	9.4	5.7	19.0	8.6	9.5	4.8	8.5	9.0	8.2	10.7	15.3	10.1	10.6	8.2	9.6	9.9	7.6	7.5	11.0	13.7	8.9	6.6	9.9	9.8	21.6	10.6	8.9	11.4	4.1	9.6	9.4	11.7	3.0	3.0	4.8	2.2	7.3	3.5	1.7	15.6	4.3	3.7	2.8	2.6	10.0	1.8	54.0	24.6	21.1	18.4	2.4	12.0	2.1	3.4	9.2	3.5	3.5	9.3	41.5	1.1	2.3	2.2	2.6	2.9	2.3	2.9	1.4	2.7	3.6	29.3	11.2	24.3	3.2	2.1	41.5	3.4	6.7	1.3	2.2	5.7	1.5	9.0	1.3	5.8	2.8	3.5	3.1	3.3	1.7	2.5	2.8	2.3	47.8	24.0	13.0	9.2	35.8	2.4	2.8	3.8	5.9	1.7	7.2	2.8	2.2	4.8	3.3	2.0	2.8	2.0	2.4	3.5	3.0	3.0	2.3	2.6	4.4	7.3	1.0	2.6	1.1	1.7	10.5	15.0	16.7	10.0	12.6	4.6	9.5	4.8	10.1	10.6
STUB1	"CHIP, HSPABP2, NY-CO-7, SDCCAG7, UBOX1"	ENSG00000103266	"STIP1 homology and U-box containing protein 1"	Q9UNE7	16	680224-682870	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037202, CAB037209, HPA041222, HPA043531"	Enhanced		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB037202: AB_1840759, CAB037209: AB_1840757, HPA041222: AB_2677368, HPA043531: AB_2678533"	"unprognostic (5.70e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.89e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.06e-1)"	"unprognostic (4.09e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.31e-2)"	"unprognostic (5.78e-2)"	"unprognostic (6.77e-2)"	"prognostic favourable (6.49e-9)"	"unprognostic (9.67e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.30e-1)"	29.4	43.7	52.2	20.1	43.2	19.3	40.5	39.1	53.3	25.1	24.8	18.1	27.6	24.1	19.7	34.9	35.2	31.1	25.5	45.2	43.2	38.6	24.0	25.9	23.6	28.1	42.0	42.5	29.4	43.4	39.8	27.2	12.1	35.0	23.4	17.7	18.6	37.7	29.7	92.5	33.7	20.9	24.5	34.5	19.7	22.8	13.8	25.4	13.1	29.1	30.2	19.4	22.3	35.9	18.0	21.0	19.4	14.5	10.3	16.9	6.9	17.8	24.2	16.4	27.7	37.5	34.4	9.4	24.4	28.7	29.0	25.8	30.1	22.8	18.1	17.3	40.8	15.3	20.2	36.7	12.1	19.9	66.8	11.2	35.0	25.1	54.1	18.9	22.4	40.8	39.4	33.9	21.5	29.3	18.1	30.3	44.8	70.7	20.5	18.6	18.3	26.5	31.7	10.7	44.5	38.7	17.9	28.6	23.2	19.5	43.0	30.6	27.4	36.3	23.2	26.6	23.3	22.0	29.3	30.0	31.0	29.2	21.0	17.2	30.0	11.9	14.5	19.4	16.9	11.9	15.4	18.0	14.6	14.7	11.7	17.3	13.6	12.9	14.0	10.3	12.4	21.0	12.2	6.9	52.2	43.2	39.1	53.3	43.2	38.6	42.0	42.5	35.0	25.4
UBR1		ENSG00000159459	"Ubiquitin protein ligase E3 component n-recognin 1"	Q8IWV7	15	42942897-43106113	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038838	Approved		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"		"HPA038838: AB_10673120"	"unprognostic (1.07e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.79e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.27e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.89e-1)"	16.7	13.2	13.7	18.3	16.7	28.4	18.8	21.8	18.1	18.2	16.2	14.8	10.5	11.3	21.0	12.9	10.8	15.9	14.2	19.7	10.0	15.4	14.4	10.6	16.6	14.9	11.8	10.5	16.3	16.4	26.3	25.6	16.2	18.9	15.3	12.9	12.5	11.8	16.8	23.6	11.0	14.4	18.2	12.1	14.7	13.8	13.7	14.7	23.2	18.8	9.7	14.3	17.3	19.7	4.6	5.0	5.5	4.2	6.2	7.2	1.8	4.9	7.2	8.3	6.7	13.2	10.2	7.9	12.1	13.4	10.7	13.9	9.1	3.9	5.8	7.2	12.4	8.6	11.9	10.6	12.8	11.9	5.8	22.9	14.4	4.4	9.2	16.1	11.0	11.0	6.0	13.1	10.7	12.0	13.0	8.8	13.3	2.8	8.7	4.8	4.7	7.4	11.4	11.4	5.0	10.8	11.7	8.4	7.5	15.9	8.4	5.6	8.1	8.4	16.5	13.2	8.2	11.7	12.2	10.4	17.6	16.7	9.0	10.2	11.9	4.4	3.0	5.2	5.7	4.2	6.5	4.1	5.9	6.9	2.9	4.6	5.9	7.2	5.5	6.2	3.4	5.0	4.1	1.8	13.7	16.7	21.8	18.1	10.0	15.4	11.8	10.5	18.9	14.7
UBR3	"DKFZp434P117, FLJ37422, KIAA2024, ZNF650"	ENSG00000144357	"Ubiquitin protein ligase E3 component n-recognin 3 (putative)"	Q6ZT12	2	169827458-170084131	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035390	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA035390: AB_10670699"	"unprognostic (1.35e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.19e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.18e-1)"	11.9	15.5	10.9	6.1	18.3	5.4	9.6	15.5	18.9	9.9	10.0	9.8	9.1	6.7	11.5	7.1	10.7	8.1	7.8	23.1	10.3	7.2	12.9	16.9	9.2	5.6	11.9	14.0	8.9	9.8	20.9	14.9	7.2	14.7	11.2	7.3	8.0	11.1	9.2	76.3	11.5	8.4	9.6	10.2	6.9	9.2	7.9	11.4	6.3	14.9	10.9	6.0	12.8	8.7	2.0	2.8	1.9	2.1	2.4	4.3	1.2	8.8	7.5	8.0	10.6	16.0	12.7	6.8	16.0	9.3	9.3	7.5	11.5	5.6	10.0	13.9	12.4	11.7	9.5	8.1	11.6	10.4	8.2	36.6	8.0	12.2	8.0	12.1	11.9	7.6	7.6	12.1	8.1	9.1	19.0	10.9	15.7	8.3	7.8	5.9	6.3	6.3	7.5	13.2	10.6	6.7	12.5	15.8	8.6	11.2	10.4	6.5	6.8	6.8	11.5	14.0	5.7	10.9	10.0	8.9	6.9	9.2	11.5	7.1	7.7	0.0	2.1	1.7	3.2	1.8	4.2	2.0	1.9	2.7	2.8	1.2	3.3	4.3	1.9	2.4	1.6	2.4	3.1	1.2	10.9	18.3	15.5	18.6	10.3	7.2	11.9	14.0	14.7	11.4
UBR4	"KIAA0462, KIAA1307, RBAF600, ZUBR1"	ENSG00000127481	"Ubiquitin protein ligase E3 component n-recognin 4"	Q5T4S7	1	19074506-19210276	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction, Ubl conjugation pathway"	"Calmodulin-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013394, HPA021046"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol				Nucleoplasm	"Centrosome, Cytosol"	"HPA013394: , HPA021046: AB_1858578"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.78e-2)"	"unprognostic (9.77e-2)"	"unprognostic (1.14e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.96e-1)"	"unprognostic (9.14e-3)"	"unprognostic (7.48e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.68e-3)"	"unprognostic (4.30e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.52e-1)"	24.4	25.4	22.4	29.0	25.4	58.3	23.7	28.5	32.5	22.4	28.5	26.3	31.5	18.2	34.0	32.5	22.7	20.3	27.3	20.5	23.3	15.9	25.5	29.7	31.2	20.3	21.0	20.9	35.5	21.0	40.9	31.4	28.4	25.0	30.7	20.5	30.6	24.7	27.1	55.9	69.0	25.5	39.3	20.2	26.5	30.2	41.1	21.6	37.7	26.1	17.3	25.9	43.4	29.0	4.6	9.1	18.3	18.5	2.7	3.4	4.6	22.9	23.2	21.0	15.5	39.3	20.3	18.2	17.9	18.9	19.5	17.8	37.0	19.8	13.9	16.8	23.6	15.7	16.4	17.8	18.3	11.5	14.5	31.7	22.4	24.1	27.7	19.4	21.1	18.1	22.9	39.7	38.3	21.3	21.6	12.9	18.5	16.4	9.1	23.7	17.0	13.1	12.8	16.4	11.6	17.6	13.5	14.9	14.8	21.2	12.2	15.2	8.4	15.3	33.0	22.9	14.3	27.1	20.0	15.3	9.2	16.1	15.7	30.0	19.4	18.3	18.5	2.9	3.4	3.8	2.9	4.6	3.0	1.9	9.1	2.9	2.7	2.5	9.8	2.7	1.3	4.3	2.1	4.6	22.4	25.4	28.5	32.5	23.3	15.9	21.0	20.9	25.0	21.6
UBR7	C14orf130	ENSG00000012963	"Ubiquitin protein ligase E3 component n-recognin 7 (putative)"	Q8N806	14	93207056-93229215	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000861	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA000861: AB_1078321"	"unprognostic (9.60e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.11e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (8.12e-5)"	"unprognostic (1.14e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.94e-2)"	"prognostic favourable (9.76e-5)"	"unprognostic (3.61e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.78e-1)"	14.1	12.3	16.4	12.5	22.9	17.0	17.5	20.0	25.8	17.1	15.7	17.7	11.3	11.1	14.9	13.4	14.8	13.7	11.9	19.0	14.2	12.8	15.3	13.2	11.9	18.0	14.0	17.1	17.0	20.4	28.2	11.5	11.4	13.3	13.9	17.1	13.6	13.7	14.9	19.9	15.2	12.7	14.1	16.9	13.8	14.1	21.1	14.3	31.9	15.4	12.9	23.3	13.4	13.3	18.1	10.7	15.8	9.5	11.5	16.5	8.2	6.4	8.7	13.3	11.1	6.3	6.7	4.7	13.7	9.7	15.2	11.6	6.3	7.4	15.4	11.5	6.9	7.8	14.3	7.7	15.7	11.9	7.7	11.1	9.3	6.0	2.9	16.2	12.5	4.0	5.4	8.4	5.3	8.5	10.3	15.5	14.5	18.9	26.3	8.9	6.1	15.7	20.3	23.9	8.4	5.1	10.6	16.8	12.0	9.8	8.2	4.0	14.9	11.2	6.5	11.2	6.1	9.6	14.1	17.9	27.4	15.8	9.8	12.6	9.5	15.8	7.3	11.8	12.7	9.1	13.3	18.1	11.4	11.7	7.8	14.8	10.0	10.6	11.5	11.5	9.5	10.7	16.5	8.2	16.4	22.9	20.0	25.8	14.2	12.8	14.0	17.1	13.3	14.3
HACE1	KIAA1320	ENSG00000085382	"HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1"	Q8IYU2	6	104728093-104859919	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 41.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046071			Supported	"Nuclear bodies,Endoplasmic reticulum"				"Endoplasmic reticulum"	"Nuclear bodies"	"HPA046071: "	"unprognostic (6.32e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.22e-3)"	"unprognostic (4.63e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavourable (1.17e-5)"	"unprognostic (1.12e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (7.50e-4)"	"unprognostic (1.75e-1)"	6.4	5.4	12.7	3.7	16.1	4.3	6.1	15.5	13.1	6.6	4.8	6.8	2.5	3.6	8.5	2.9	8.1	5.4	5.0	5.2	7.5	8.6	9.4	2.9	5.7	3.5	8.8	9.6	6.4	3.8	12.0	7.4	41.9	10.2	6.1	3.3	7.7	6.2	6.9	4.4	4.8	3.6	6.5	9.5	4.1	3.9	14.1	8.9	5.4	7.1	2.7	3.9	6.4	5.8	2.9	2.4	2.2	2.9	2.2	3.9	1.6	3.5	2.5	10.7	13.4	6.4	8.5	12.7	7.2	11.1	4.6	6.9	2.3	2.1	2.0	3.2	5.4	2.4	2.7	4.9	9.7	8.2	6.8	7.1	2.3	3.1	6.4	6.1	2.3	5.7	4.5	5.9	5.0	7.5	6.8	2.3	9.0	2.6	4.5	3.6	4.7	2.4	7.2	12.2	0.8	3.7	6.1	5.8	8.7	3.9	4.1	2.1	2.6	8.4	7.9	3.7	3.1	9.9	6.8	3.3	3.6	6.9	3.9	5.8	6.7	0.0	1.9	2.2	3.7	2.9	3.9	2.9	3.7	3.6	1.9	2.7	3.9	3.0	0.4	2.2	1.5	2.4	1.2	1.6	12.7	16.1	15.5	13.1	7.5	8.6	8.8	9.6	10.2	8.9
HERC4	"DKFZP564G092, KIAA1593"	ENSG00000148634	"HECT and RLD domain containing E3 ubiquitin protein ligase 4"	Q5GLZ8	10	67921899-68075348	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 55.1;fHDF/TERT166: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045453, HPA070301"	Uncertain		Supported	"Nucleoli fibrillar center,Cytosol"				Cytosol	"Nucleoli fibrillar center"	"HPA045453: AB_10961917, HPA070301: "	"unprognostic (3.66e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.23e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.01e-3)"	"unprognostic (3.54e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.94e-3)"	"unprognostic (2.25e-2)"	"prognostic unfavourable (3.86e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.31e-2)"	25.3	29.4	21.9	28.0	28.4	14.6	22.7	30.5	24.9	24.2	20.5	22.2	26.7	20.0	28.1	24.3	22.2	19.2	20.2	20.5	21.9	22.7	20.6	24.5	20.6	30.2	30.9	14.8	24.5	17.1	25.2	35.6	23.8	26.8	19.4	23.9	17.8	17.7	24.1	19.6	20.9	25.8	23.0	28.7	27.0	17.3	22.2	33.6	23.6	19.5	13.8	28.3	24.7	47.9	7.7	10.4	13.5	9.3	9.9	11.5	6.5	22.4	8.0	5.1	8.5	13.2	18.1	4.6	55.1	34.1	20.7	13.4	4.5	10.6	7.9	4.3	61.8	11.9	5.6	8.1	28.0	5.2	2.7	3.6	13.3	3.5	7.0	4.4	6.5	8.9	9.5	11.0	9.8	12.8	3.8	4.0	31.9	9.6	3.1	5.2	3.0	14.0	4.2	2.1	2.8	9.4	6.4	2.4	2.8	17.9	7.7	7.8	4.8	5.6	17.4	10.9	6.1	26.8	9.4	2.8	3.3	5.0	20.0	8.6	3.7	13.5	9.3	11.1	8.2	7.9	11.5	7.7	9.1	9.8	10.4	7.5	8.8	9.0	11.7	9.9	7.6	2.7	10.6	6.5	21.9	28.4	30.5	24.9	21.9	22.7	30.9	14.8	26.8	33.6
HERC6	FLJ20637	ENSG00000138642	"HECT and RLD domain containing E3 ubiquitin protein ligase family member 6"	Q8IVU3	4	88378739-88443111	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"BJ hTERT+ SV40 Large T+: 46.0;BJ hTERT+ SV40 Large T+ RasG12V: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035846	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA035846: AB_10673487"	"unprognostic (1.95e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.67e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.78e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.22e-2)"	"prognostic favourable (7.14e-5)"	"unprognostic (1.80e-1)"	"unprognostic (2.59e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.77e-2)"	8.0	7.5	7.8	7.2	10.2	7.3	6.3	2.1	14.6	13.6	6.3	5.9	3.4	5.4	13.2	9.6	23.9	10.4	11.2	9.8	7.7	8.4	10.4	5.0	8.3	4.6	7.3	15.8	9.8	6.3	5.2	8.4	7.1	8.5	9.1	6.5	7.2	28.4	5.7	2.9	4.3	7.1	8.5	5.6	8.0	7.3	3.9	5.3	9.0	5.9	7.6	7.8	7.2	13.8	3.6	2.7	4.5	6.4	5.6	13.4	4.2	2.5	1.7	0.1	0.3	0.1	1.5	0.5	0.3	8.6	46.0	34.3	0.1	3.2	0.0	0.6	0.8	0.9	4.2	2.2	3.0	5.2	0.8	2.4	1.4	0.2	1.5	4.2	1.6	2.1	0.5	3.5	0.1	1.3	0.0	0.5	1.0	1.5	1.9	1.3	0.6	0.8	1.3	0.0	0.1	3.1	3.1	0.1	1.1	3.2	1.0	5.1	1.9	0.7	0.4	0.6	0.8	0.1	0.8	0.1	0.0	0.0	2.1	0.9	2.1	4.4	3.1	4.5	6.7	3.1	13.4	3.6	9.4	6.5	2.7	2.7	7.5	5.1	1.9	5.6	6.4	0.3	11.8	4.2	7.8	10.2	2.1	14.6	7.7	8.4	7.3	15.8	8.5	5.3
MARCH10	"FLJ35757, MARCH-X, RNF190"	ENSG00000173838	"Membrane associated ring-CH-type finger 10"	Q8NA82	17	62701314-62808344	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 80.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.8;EFO-21: 7.2;HSkMC: 3.2;SCLC-21H: 12.4"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA023322	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA023322: AB_1856351"	"unprognostic (2.79e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.60e-3)"	"unprognostic (6.95e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"		"unprognostic (1.03e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.99e-4)"	"unprognostic (3.16e-1)"	"unprognostic (2.85e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.83e-2)"	"unprognostic (9.37e-3)"	"unprognostic (2.66e-1)"	0.2	0.1	0.7	0.2	1.6	0.0	0.1	0.1	0.3	0.5	0.1	1.9	0.6	0.0	0.3	4.8	0.1	7.9	0.1	0.1	1.0	1.0	0.6	0.1	1.4	0.1	0.2	0.5	1.0	0.1	0.3	4.5	0.1	1.8	0.1	0.0	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	80.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.0	0.0	0.6	3.4	0.3	0.1	0.0	0.2	0.0	0.0	0.2	3.8	1.6	0.2	1.2	0.3	0.0	0.1	0.0	7.2	0.5	0.0	0.0	0.4	1.3	0.0	0.0	1.2	0.7	0.0	1.5	0.0	0.0	3.2	0.0	0.3	0.0	0.0	0.0	0.0	0.8	1.4	0.1	0.1	0.3	0.2	0.0	0.0	0.2	1.1	0.0	12.4	0.0	0.0	0.7	0.1	0.2	0.0	0.0	0.0	0.7	0.1	1.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	3.4	0.0	1.5	0.0	0.7	0.3	0.7	0.1	0.6	1.8	0.0	0.6	0.0	0.0	0.7	0.3	0.7	1.6	0.1	0.3	1.0	1.0	0.2	0.5	1.8	0.3
MIB1	"DIP-1, KIAA1323, MIB, ZZANK2, ZZZ6"	ENSG00000101752	"Mindbomb E3 ubiquitin protein ligase 1"	Q86YT6	18	21704957-21870957	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 51.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019100, CAB037044"	Approved		Supported	"Vesicles,Plasma membrane"				"Plasma membrane"	Vesicles	"CAB037044: AB_1841007, HPA019100: AB_1853934"	"unprognostic (1.38e-1)"	"unprognostic (6.92e-2)"	"unprognostic (7.29e-2)"	"unprognostic (6.99e-2)"	"unprognostic (5.66e-2)"	"unprognostic (3.23e-2)"	"unprognostic (8.45e-3)"	"unprognostic (2.70e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.78e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.33e-3)"	"unprognostic (4.91e-3)"	"unprognostic (1.73e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.85e-2)"	12.1	9.1	15.3	7.9	20.6	5.9	15.7	16.1	17.4	16.6	10.9	16.3	9.7	6.9	19.1	13.7	11.4	11.5	12.0	9.4	16.3	12.9	15.7	14.1	10.1	9.6	17.4	16.5	17.2	11.7	18.4	11.5	14.9	15.5	14.7	10.1	14.6	12.0	12.6	9.6	12.5	8.4	17.9	13.8	9.4	10.7	11.5	18.1	13.9	19.1	9.8	10.6	13.0	13.8	1.2	1.2	3.5	1.7	2.5	2.0	0.6	8.4	3.3	16.5	11.4	8.8	10.6	3.9	6.8	7.6	4.9	7.1	4.9	3.1	7.2	6.3	9.4	5.7	9.6	9.2	11.1	9.4	4.5	8.0	4.3	6.8	7.2	16.3	3.4	6.8	10.2	5.7	14.7	12.2	11.0	21.3	7.5	4.1	7.8	6.2	4.2	4.4	51.5	13.6	17.8	8.3	7.5	5.4	13.3	11.7	5.4	6.0	3.9	10.7	10.4	12.5	6.3	5.2	9.0	11.2	3.9	11.1	5.3	10.4	7.4	3.5	1.7	0.6	1.0	0.9	1.2	1.2	1.5	1.0	0.6	0.6	1.2	0.9	1.5	2.5	0.5	1.2	2.0	0.6	15.3	20.6	16.1	17.4	16.3	12.9	17.4	16.5	15.5	18.1
PIAS2	"ARIP3, miz, PIASX-ALPHA, PIASX-BETA, ZMIZ4"	ENSG00000078043	"Protein inhibitor of activated STAT 2"	O75928	18	46803224-46920160	"Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 61.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068792	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA068792: "	"unprognostic (9.59e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.05e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.77e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.92e-2)"	"prognostic unfavourable (1.27e-4)"	"unprognostic (1.71e-1)"	5.6	6.7	9.8	4.7	12.7	7.0	6.1	16.7	13.5	4.7	5.6	8.1	8.0	3.7	6.0	8.8	4.7	5.3	5.5	7.5	8.4	8.1	7.4	6.6	4.9	6.5	7.9	8.5	5.8	5.0	19.3	10.4	4.8	12.1	7.7	8.1	8.2	5.9	7.9	15.6	8.5	4.8	5.7	7.6	6.5	5.3	61.6	9.1	7.5	9.2	4.1	5.8	5.3	4.6	6.8	5.1	2.9	4.4	4.8	6.7	2.1	11.8	4.9	5.6	7.9	5.6	7.0	2.6	6.3	5.0	5.5	5.1	5.7	4.5	12.0	3.5	4.7	4.0	11.1	6.6	7.8	5.9	4.1	7.4	4.7	6.7	5.5	12.3	5.3	7.2	4.1	4.8	5.1	4.9	5.4	3.1	10.8	6.4	7.2	7.2	6.0	3.1	13.1	11.9	0.1	5.0	9.2	10.6	8.2	5.7	3.7	4.1	5.5	5.5	6.2	11.8	5.1	4.0	4.6	9.3	4.6	15.3	8.8	13.3	11.5	1.5	4.4	2.8	5.4	3.4	3.8	4.1	4.8	6.1	5.0	6.8	6.7	5.7	2.9	4.8	3.0	5.1	4.2	2.1	9.8	12.7	16.7	13.5	8.4	8.1	7.9	8.5	12.1	9.1
PJA1	"FLJ11830, RNF70"	ENSG00000181191	"Praja ring finger ubiquitin ligase 1"	Q8NG27	X	69160851-69165793	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 98.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 38.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000595	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA000595: AB_1079826"	"unprognostic (3.40e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.58e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.26e-3)"	"unprognostic (4.61e-2)"	"unprognostic (3.82e-3)"	"unprognostic (1.84e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (7.44e-5)"	"unprognostic (1.49e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.10e-1)"	12.6	9.9	21.6	5.5	35.7	2.6	7.9	13.4	23.7	12.2	5.8	8.9	19.3	4.7	9.2	98.7	5.7	10.2	7.1	7.5	18.4	23.4	7.5	4.4	7.4	5.9	14.9	16.7	16.2	6.0	27.1	12.5	10.7	11.7	9.9	5.3	7.2	6.4	20.3	4.7	7.1	4.4	9.8	12.0	5.9	6.5	13.7	9.5	3.0	13.8	2.9	7.4	7.8	7.9	11.2	4.3	2.7	4.5	14.8	17.8	9.0	10.4	8.0	25.1	17.5	8.8	9.3	7.5	7.0	8.4	6.6	8.9	6.5	9.9	1.6	10.9	11.0	9.1	38.5	13.6	8.3	7.8	13.7	3.1	6.6	4.3	11.0	1.8	6.0	9.7	9.1	11.2	6.7	7.4	2.9	1.1	6.7	5.6	0.8	3.5	17.1	13.1	7.5	11.2	2.5	10.6	8.8	18.6	12.1	11.2	1.9	8.5	3.1	2.6	6.7	5.7	9.2	16.9	3.2	0.0	0.1	3.8	6.2	5.1	7.6	2.7	3.3	1.0	15.5	4.5	17.8	8.7	13.7	14.2	3.6	11.2	14.4	16.6	1.1	14.8	2.9	4.3	8.3	9.0	21.6	35.7	13.4	23.7	18.4	23.4	14.9	16.7	11.7	9.5
AMFR	"gp78, RNF45"	ENSG00000159461	"Autocrine motility factor receptor"	Q9UKV5	16	56361452-56425538	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Receptor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026381, HPA029018, HPA077835"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus"				"Endoplasmic reticulum, Golgi apparatus"		"CAB026381: , HPA029018: , HPA077835: "	"unprognostic (1.72e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.60e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.16e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.28e-1)"	13.9	25.9	21.3	10.6	23.8	14.1	28.7	12.6	25.0	17.2	21.0	24.5	18.5	21.6	16.6	25.2	20.8	15.3	13.7	17.6	20.6	20.2	35.2	50.0	13.3	19.3	22.3	14.3	20.5	14.0	33.3	13.0	41.6	18.9	14.9	11.8	23.8	12.6	18.6	71.6	11.9	18.8	16.0	25.0	14.3	12.2	36.8	17.5	14.6	18.6	10.1	19.3	15.5	16.9	18.3	10.6	21.4	13.1	11.7	9.7	4.0	17.4	24.4	10.7	19.6	33.4	18.8	9.4	18.9	23.4	25.7	20.2	21.6	16.6	45.6	21.9	25.5	16.4	16.3	14.7	24.6	10.2	16.8	13.8	10.1	23.2	29.3	10.7	16.0	21.8	21.3	20.5	24.6	14.9	14.3	6.3	18.6	11.1	16.0	11.4	5.0	16.8	18.1	21.5	17.1	15.9	18.3	10.7	8.2	44.4	15.6	14.3	46.9	11.2	19.3	24.3	13.3	12.3	12.7	13.6	11.9	24.2	17.6	7.8	11.1	21.4	8.5	10.9	6.9	9.9	9.7	18.3	8.7	7.1	7.8	15.6	9.1	9.5	10.5	11.7	13.1	10.6	9.0	4.0	21.3	23.8	12.6	25.0	20.6	20.2	22.3	14.3	18.9	17.5
AREL1	"FIEL1, KIAA0317"	ENSG00000119682	"Apoptosis resistant E3 ubiquitin protein ligase 1"	O15033	14	74653437-74713115	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051306	Uncertain									"HPA051306: "	"unprognostic (1.92e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.58e-3)"	"unprognostic (9.32e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.12e-1)"	"prognostic favourable (4.67e-6)"	"unprognostic (6.73e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.52e-1)"	"unprognostic (7.18e-2)"	8.5	13.7	11.8	12.2	22.2	17.6	8.8	14.4	25.7	9.3	11.9	16.5	9.8	13.8	12.8	11.4	14.5	12.6	8.4	12.3	11.3	9.7	17.5	9.8	12.1	12.0	8.6	8.4	11.9	15.7	19.4	9.5	11.9	13.3	10.0	15.0	18.3	14.9	9.8	17.9	10.7	16.0	10.1	11.1	12.3	12.0	20.0	7.2	17.1	18.6	11.2	14.9	11.2	10.8	3.2	7.0	9.7	7.6	4.6	7.3	4.5	12.1	15.3	15.2	15.4	13.3	9.6	13.1	13.0	15.3	16.6	16.0	12.8	14.8	10.4	7.0	18.5	15.8	17.5	14.1	21.8	18.6	8.6	16.0	10.2	8.0	8.7	11.3	15.9	12.3	10.3	12.0	13.0	15.6	12.3	11.7	21.3	15.2	11.9	4.9	10.2	15.9	12.7	17.6	6.5	12.7	27.9	16.6	21.8	11.9	15.9	8.4	13.8	12.0	21.8	16.2	19.1	9.6	15.9	14.1	20.7	21.4	19.2	8.6	12.2	2.1	4.8	9.7	7.3	7.6	5.4	3.2	4.2	6.0	7.0	2.1	4.6	3.8	9.7	4.6	4.1	2.3	3.8	4.5	11.8	22.2	14.4	25.7	11.3	9.7	8.6	8.4	13.3	7.2
DET1	FLJ10103	ENSG00000140543	"DET1, COP1 ubiquitin ligase partner"	Q7L5Y6	15	88494440-88546675	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048873	Uncertain		Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"				"Nucleoplasm, Microtubules"	"Cytokinetic bridge, Cytosol"	"HPA048873: "	"unprognostic (9.21e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.20e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.82e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.69e-2)"	"unprognostic (4.67e-2)"	6.0	9.3	5.5	4.3	7.0	1.9	6.4	5.5	6.8	9.5	6.3	8.2	7.0	5.5	15.9	9.1	3.8	9.6	7.8	8.8	4.3	4.2	5.4	4.5	4.3	4.2	5.0	6.1	17.9	10.1	7.1	6.4	5.6	5.9	8.5	5.6	12.6	6.7	7.4	13.8	4.4	5.9	11.4	5.1	4.4	5.5	3.6	4.6	10.7	6.8	4.1	6.4	7.7	6.0	5.3	7.6	2.9	7.4	3.4	6.6	3.8	2.0	6.7	9.5	6.9	4.7	7.1	1.8	6.5	7.0	5.7	6.0	1.4	6.3	3.9	5.0	8.3	3.1	10.7	2.0	4.9	0.3	6.9	7.4	3.7	2.3	7.4	2.8	1.5	6.1	7.2	2.7	7.8	4.4	9.4	4.7	7.1	3.2	4.0	3.1	4.3	2.1	4.7	7.8	4.8	3.0	5.9	3.7	5.8	7.3	2.5	16.2	3.6	5.9	3.6	5.8	4.5	5.9	6.0	2.7	1.9	2.6	6.5	4.8	5.1	0.0	4.8	2.9	5.3	7.4	3.9	4.8	4.6	4.7	7.6	5.3	6.6	5.4	0.7	3.4	4.6	4.1	5.1	3.8	5.5	7.0	5.5	6.8	4.3	4.2	5.0	6.1	5.9	4.6
DTX1	"hDx-1, RNF140"	ENSG00000135144	"Deltex E3 ubiquitin ligase 1"	Q86Y01	12	113056709-113098028	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 9.7;lymphoid tissue: 13.3"	"Group enriched"	"Detected in some"	12	"Daudi: 40.0;REH: 16.4;U-698: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051249, HPA055275"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA051249: , HPA055275: "	"unprognostic (2.13e-3)"	"unprognostic (3.20e-3)"	"unprognostic (4.24e-4)"	"unprognostic (2.01e-1)"	"unprognostic (7.48e-3)"	"unprognostic (1.59e-3)"	"unprognostic (2.49e-3)"	"unprognostic (1.81e-1)"	"unprognostic (9.55e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.58e-1)"	"prognostic unfavourable (3.02e-5)"	"unprognostic (2.41e-2)"	"unprognostic (4.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.78e-3)"	9.7	2.3	6.1	8.9	7.0	3.2	3.9	7.3	8.3	0.8	0.7	1.1	0.5	1.6	2.0	0.5	1.2	1.7	1.0	2.7	5.4	5.9	1.7	6.4	0.5	13.3	3.7	4.2	0.5	2.0	0.0	2.2	0.9	4.6	0.8	0.2	1.4	3.2	0.5	0.5	0.5	2.2	0.5	1.1	9.8	1.0	4.9	0.5	0.5	1.3	0.5	8.1	0.5	0.5	2.3	0.0	0.0	0.0	1.0	0.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.6	0.0	0.7	0.0	16.4	0.0	0.9	0.0	0.0	1.0	2.7	0.1	0.1	0.9	0.0	0.1	0.4	0.0	1.5	0.0	0.0	0.2	0.0	40.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.5	0.0	0.0	2.3	0.6	0.0	0.0	1.0	0.0	0.0	0.0	0.2	6.1	7.0	7.3	7.1	5.4	5.9	3.7	4.2	4.6	0.5
HECTD1	KIAA1131	ENSG00000092148	"HECT domain E3 ubiquitin protein ligase 1"	Q9ULT8	14	31100112-31207804	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002929, HPA054461"	Approved		Enhanced	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA002929: AB_1850574, HPA054461: "	"unprognostic (6.71e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.51e-1)"	"prognostic favourable (1.20e-6)"	"unprognostic (6.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.91e-3)"	22.0	22.3	14.2	21.0	16.8	22.0	18.5	22.3	18.9	19.4	17.9	15.2	20.2	11.5	17.6	15.7	30.4	16.1	15.2	26.2	13.5	14.3	18.0	35.2	15.0	14.1	14.5	14.5	18.2	15.1	34.8	20.5	27.0	18.8	16.8	15.5	16.8	18.9	16.4	88.5	24.3	16.3	15.6	13.7	16.4	18.8	18.9	14.4	16.7	24.8	23.0	18.6	18.6	22.3	10.6	9.3	12.6	8.6	8.9	8.1	3.3	28.4	17.8	15.7	9.8	49.6	26.0	15.0	17.4	17.6	15.6	13.5	13.3	15.4	22.3	18.5	31.8	19.3	20.8	15.7	23.7	13.6	8.5	22.8	14.7	53.1	23.1	23.7	16.8	22.8	21.8	17.5	27.5	28.6	16.4	10.4	24.2	23.3	9.2	10.1	11.9	16.2	17.0	18.1	9.7	24.3	29.5	11.6	13.6	25.5	17.7	15.4	18.6	15.3	28.6	18.1	14.2	13.0	14.7	11.4	16.1	25.2	8.6	12.0	15.2	12.6	8.6	11.3	7.1	7.1	8.1	7.2	8.0	6.3	9.3	10.6	6.7	6.6	4.4	8.9	5.3	7.8	8.0	3.3	14.2	16.8	22.3	18.9	13.5	14.3	14.5	14.5	18.8	14.4
HECTD2	FLJ37306	ENSG00000165338	"HECT domain E3 ubiquitin protein ligase 2"	Q5U5R9	10	91409280-91514829	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 21.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"NK-cell: 6.7"	"Lineage enriched"	"Detected in many"	7	"NK-cells: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037767	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA037767: AB_10671378"	"unprognostic (6.35e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.37e-4)"	"unprognostic (1.42e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.54e-3)"	"unprognostic (4.44e-2)"	"prognostic unfavourable (1.67e-5)"	"unprognostic (6.98e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.84e-2)"	8.7	8.8	16.5	6.9	17.9	2.4	10.8	20.3	19.5	14.3	10.1	5.1	9.1	4.6	17.2	16.6	8.3	12.1	11.4	8.1	11.9	8.7	7.3	4.7	8.7	4.7	5.8	11.3	16.8	7.4	14.4	18.6	10.2	6.5	24.8	7.6	7.5	7.7	24.3	7.7	6.8	6.0	18.4	6.8	5.3	7.5	9.7	6.4	2.9	9.8	5.1	3.6	13.7	10.5	0.6	0.4	0.1	0.8	6.7	1.0	0.5	4.0	2.1	21.2	8.7	4.7	5.1	3.8	3.3	4.5	6.8	6.3	0.2	3.9	0.0	2.9	3.4	0.3	5.7	2.4	8.4	4.4	7.1	2.3	14.9	1.3	2.3	0.4	1.5	5.2	2.2	4.9	4.2	5.1	3.1	10.6	10.5	1.9	2.5	1.3	8.8	2.1	6.3	14.0	2.4	4.7	1.1	5.0	5.3	6.5	1.5	6.6	9.6	1.4	5.3	6.9	4.7	0.4	6.3	0.7	1.4	5.9	6.0	0.0	3.9	0.0	0.1	0.0	1.0	0.8	0.6	0.2	0.5	0.7	0.4	0.6	0.5	0.6	0.1	6.7	0.2	0.0	0.1	0.5	16.5	17.9	20.3	19.5	11.9	8.7	5.8	11.3	6.5	6.4
HECTD3	FLJ21156	ENSG00000126107	"HECT domain E3 ubiquitin protein ligase 3"	Q5T447	1	45002540-45011329	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027467	Approved						34000			"HPA027467: AB_10600710"	"unprognostic (1.86e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (2.14e-5)"	"unprognostic (1.74e-2)"	"unprognostic (2.92e-2)"	"unprognostic (7.42e-2)"	"unprognostic (2.47e-1)"	"unprognostic (8.39e-2)"	"unprognostic (2.65e-1)"	"unprognostic (7.52e-2)"	"unprognostic (3.35e-1)"	"prognostic favourable (1.85e-6)"	"unprognostic (3.19e-1)"	18.4	16.9	9.6	16.7	11.1	9.2	25.9	12.4	14.8	11.2	38.0	14.8	11.7	34.1	12.4	12.4	16.7	9.1	14.6	8.7	9.9	8.4	16.4	22.9	10.5	11.3	10.9	7.9	14.1	24.1	22.9	8.0	11.8	10.8	10.4	19.5	9.7	27.0	15.4	24.2	20.1	59.3	12.0	9.9	14.0	13.9	11.7	9.7	11.9	13.3	14.8	12.5	13.8	12.0	8.7	9.9	10.4	15.1	5.0	10.9	7.5	11.2	10.2	6.5	10.6	23.1	14.5	13.0	10.8	16.4	11.9	13.5	14.5	3.5	5.3	9.2	17.6	10.5	15.5	11.2	10.7	9.8	12.0	8.5	14.9	12.7	20.2	6.6	14.3	15.6	19.2	20.3	7.9	26.5	18.9	6.0	15.1	9.6	8.3	5.4	9.0	15.6	9.9	11.8	7.6	17.5	13.3	15.8	6.6	14.5	25.2	12.8	8.2	6.2	19.8	13.8	11.0	17.1	12.2	7.7	9.0	2.9	22.1	7.2	6.7	9.4	10.4	10.4	10.9	15.1	9.1	8.7	8.9	9.3	9.9	5.1	7.5	8.9	4.0	5.0	8.2	7.5	9.0	7.5	9.6	11.1	12.4	14.8	9.9	8.4	10.9	7.9	10.8	9.7
HECW1	"KIAA0322, NEDL1"	ENSG00000002746	"HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1"	Q76N89	7	43112599-43566001	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.0;kidney: 15.4"	"Cell line enhanced"	"Detected in some"		"A549: 5.5;U-266/70: 15.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 7.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007203, HPA007593, HPA007609"	Approved		Supported	Cytosol				Cytosol		"HPA007203: , HPA007593: AB_1852305, HPA007609: AB_2117518"	"unprognostic (1.40e-1)"	"unprognostic (2.85e-3)"	"unprognostic (2.57e-1)"	"unprognostic (4.39e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.80e-2)"	"unprognostic (8.65e-4)"	"unprognostic (6.93e-2)"	"unprognostic (7.30e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.23e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.42e-2)"	0.7	0.5	10.3	0.8	12.1	1.4	0.8	13.6	24.0	0.6	0.8	1.1	0.0	0.4	0.8	1.7	2.6	0.5	4.0	0.4	3.9	4.1	15.4	0.6	0.6	1.3	3.8	15.5	1.0	0.4	1.7	0.4	0.6	10.2	3.2	0.5	0.6	1.0	0.8	1.8	2.1	0.6	0.7	1.4	0.6	1.0	3.7	1.6	0.0	1.5	0.0	0.8	1.2	0.6	2.4	1.6	7.0	1.7	1.6	0.7	0.1	0.1	5.5	0.6	0.8	0.0	0.0	0.0	1.6	2.8	0.1	0.6	0.0	0.0	0.2	3.0	2.7	0.4	0.0	0.0	0.2	0.2	0.9	0.0	0.4	0.2	0.2	1.3	0.0	1.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	2.3	0.9	0.5	0.0	0.0	0.0	0.1	0.2	0.7	0.5	0.1	0.0	0.4	0.0	0.0	0.8	1.1	1.3	0.4	15.6	0.5	0.0	3.5	0.4	0.0	6.4	1.7	1.1	0.7	1.0	0.5	1.0	0.7	0.3	0.2	2.4	0.6	0.7	7.0	1.6	0.9	1.6	0.2	0.1	10.3	12.1	13.6	24.0	3.9	4.1	3.8	15.5	10.2	1.6
MKRN1	RNF61	ENSG00000133606	"Makorin ring finger protein 1"	Q9UHC7	7	140453040-140479569	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000567			Approved	"Nucleoplasm,Nuclear membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Nuclear membrane"	"HPA000567: AB_1079299"	"unprognostic (9.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.60e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.87e-3)"	"unprognostic (1.24e-2)"	"unprognostic (8.02e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.89e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-2)"	16.8	17.6	26.8	20.8	28.8	69.9	20.1	37.2	32.6	20.4	39.6	16.1	19.7	28.4	20.1	18.6	23.3	22.2	22.4	38.5	24.9	29.8	20.6	17.5	23.6	18.3	25.7	23.3	24.9	27.3	28.2	21.5	31.7	29.4	21.0	33.7	19.4	24.8	23.1	38.5	24.4	26.6	26.3	20.5	22.5	21.7	95.4	20.2	21.0	23.6	18.8	22.3	25.3	36.4	13.1	7.5	39.3	10.5	12.8	17.8	6.4	27.9	21.6	16.9	25.0	26.8	23.5	23.9	19.3	25.1	15.2	17.6	8.8	29.5	20.3	30.3	18.8	13.6	19.0	21.2	19.3	40.2	16.5	21.1	13.0	16.3	21.6	18.0	32.7	23.4	32.0	17.1	16.2	15.1	16.6	25.7	14.6	24.1	21.1	32.4	43.4	16.0	15.3	14.5	31.1	24.4	32.4	23.4	24.2	24.2	32.8	34.5	16.1	15.7	21.4	10.7	8.5	26.1	17.6	61.3	44.9	17.8	30.6	28.4	22.0	19.4	9.2	39.3	6.7	8.7	8.0	13.1	13.0	10.1	7.5	10.9	17.8	11.3	18.1	12.8	10.5	2.5	14.0	6.4	26.8	28.8	37.2	32.6	24.9	29.8	25.7	23.3	29.4	20.2
NEURL1	"h-neu, neu-1, NEURL, RNF67"	ENSG00000107954	"Neuralized E3 ubiquitin protein ligase 1"	O76050	10	103493979-103592552	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Translation regulation, Ubl conjugation pathway"	Transferase	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 37.1;skeletal muscle: 83.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 12.9;HeLa: 7.6;HMC-1: 6.5;SCLC-21H: 16.2;SiHa: 8.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"intermediate monocyte: 16.0;non-classical monocyte: 37.1"	"Lineage enriched"	"Detected in many"	17	"monocytes: 37.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044204	Enhanced									"HPA044204: AB_10959383"	"unprognostic (1.21e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.58e-4)"	"unprognostic (1.31e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.08e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.91e-4)"	"unprognostic (3.23e-1)"	1.1	3.9	18.5	3.0	17.5	2.0	1.0	28.2	27.2	6.1	8.6	0.6	1.2	7.7	13.2	11.0	3.6	2.1	2.0	1.1	12.0	7.6	1.3	1.1	1.3	1.3	4.5	18.9	2.1	12.8	2.9	6.5	13.3	6.1	2.8	7.3	7.8	1.5	1.7	83.5	1.9	11.7	11.7	1.2	2.0	4.4	7.5	2.1	0.0	1.2	8.5	1.1	9.2	1.7	0.4	2.1	1.0	37.1	0.2	0.4	1.2	0.8	0.2	1.3	0.0	0.4	0.1	12.9	0.5	0.8	0.2	0.1	0.3	0.3	0.4	0.7	0.1	0.7	0.4	0.2	0.1	0.3	0.7	0.2	7.6	0.6	0.0	0.3	6.5	0.2	0.5	0.1	0.6	0.0	2.1	0.4	0.2	1.1	1.3	0.8	0.0	3.9	0.2	0.6	1.4	0.0	0.5	16.2	5.5	8.1	0.0	0.4	0.7	1.5	0.0	0.1	0.9	0.2	0.2	0.9	0.2	0.3	0.5	0.0	0.3	0.2	1.0	0.2	0.3	16.0	0.4	0.4	0.4	0.4	2.1	0.3	0.4	0.3	1.0	0.2	37.1	1.7	0.1	1.2	18.5	17.5	28.2	27.2	12.0	7.6	4.5	18.9	6.1	2.1
NEURL1B	"DKFZP761M1511, Neur2, RNF67B"	ENSG00000214357	"Neuralized E3 ubiquitin protein ligase 1B"	A8MQ27	5	172641266-172691540	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 27.0;T-47d: 12.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037612	Approved		Supported	Vesicles				Vesicles		"HPA037612: AB_10795573"	"unprognostic (3.56e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.72e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.13e-3)"	"unprognostic (6.81e-2)"	"prognostic unfavourable (3.00e-6)"	"unprognostic (1.79e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.22e-3)"	26.6	11.8	7.5	10.3	3.2	1.5	23.9	0.6	7.0	21.4	17.5	5.6	31.2	5.7	26.7	24.7	14.0	15.8	23.0	19.2	10.7	4.2	7.6	4.4	10.5	7.8	3.1	3.2	20.9	4.8	4.1	6.0	5.1	2.7	20.7	11.6	6.1	4.9	28.4	12.3	14.7	12.1	29.1	1.5	0.6	5.9	6.6	2.8	3.6	7.2	13.9	5.4	16.0	30.8	0.0	0.6	0.0	0.2	0.0	0.2	0.0	4.4	2.3	1.2	5.6	0.4	0.2	0.1	5.0	2.2	2.7	3.9	8.5	2.0	0.0	1.4	3.2	1.3	0.5	2.2	1.8	8.1	0.3	6.1	8.1	0.0	0.4	0.0	1.9	0.0	9.7	0.6	2.7	0.4	0.0	1.9	5.7	4.9	1.4	0.1	0.8	0.2	27.0	6.0	0.8	0.1	1.0	1.0	5.8	4.8	7.6	0.2	12.7	0.9	0.8	2.0	11.9	1.4	3.1	0.8	0.2	0.0	5.8	0.1	1.7	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	7.5	3.2	0.6	7.0	10.7	4.2	3.1	3.2	2.7	2.8
NEURL3	"Lincr, LOC93082, RNF132"	ENSG00000163121	"Neuralized E3 ubiquitin protein ligase 3"	Q96EH8	2	96497643-96508109	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"pancreas: 26.3;salivary gland: 22.4;seminal vesicle: 10.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.1;CAPAN-2: 16.6;RPMI-8226: 10.5;RT4: 5.0"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"														"unprognostic (4.97e-2)"	"unprognostic (6.07e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.35e-2)"	"prognostic unfavourable (6.46e-4)"	"unprognostic (2.29e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.23e-2)"	"unprognostic (5.83e-2)"	"unprognostic (6.57e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.57e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.6	0.0	0.1	0.0	0.9	0.9	0.0	0.1	0.0	0.0	1.3	0.0	0.0		5.3	0.6	1.8	0.0	0.0	0.1	0.0	26.3	0.0	0.0	0.0	0.2	1.4	0.1	0.0	22.4	10.8	0.4	0.0	1.2	0.0	0.2	0.0	0.1	0.2	0.0	6.4	0.0	0.5	0.1	0.4	0.0	0.3	0.2	0.7	0.1	0.1	0.1	3.0	1.0	0.5	0.0	0.3	0.0	0.0	4.1	0.0	0.4	0.3	0.2	2.4	16.6	0.0	1.3	0.0	2.5	0.2	0.0	0.0	0.6	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	10.5	2.2	5.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.5	0.3	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.3	0.1	0.0	0.7	0.1	0.0	0.0	0.1	3.0										
PELI3	MGC35521	ENSG00000174516	"Pellino E3 ubiquitin protein ligase family member 3"	Q8N2H9	11	66466327-66477337	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033750, HPA038875, HPA062281"	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles				"Nucleoplasm, Vesicles"	Nucleoli	"CAB033750: AB_2161361, HPA038875: , HPA062281: "	"unprognostic (1.15e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.19e-3)"	"unprognostic (7.91e-3)"	"prognostic favourable (8.19e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.01e-2)"	6.7	9.5	14.5	3.8	17.0	1.8	7.4	19.6	33.1	7.4	8.3	6.7	6.4	4.8	10.3	9.1	10.6	8.2	10.1	7.7	17.4	13.5	4.6	3.2	7.1	4.3	13.0	12.5	15.3	9.9	21.5	8.3	3.8	15.8	11.5	2.9	6.4	10.4	22.3	10.8	11.2	4.7	11.3	6.2	5.0	5.8	6.2	7.8	0.3	8.5	2.7	3.4	9.0	11.8	3.3	3.3	1.3	6.8	1.2	3.1	1.4	15.3	6.5	5.3	4.1	8.5	3.3	4.2	4.9	6.4	4.7	4.0	9.5	3.5	3.8	4.9	5.4	8.2	3.5	6.2	1.9	7.5	3.0	1.0	5.4	2.8	5.4	0.8	7.5	3.1	7.0	4.8	1.7	0.9	1.8	6.1	2.0	9.4	3.1	2.4	3.3	6.7	10.7	3.9	4.0	2.6	4.9	6.4	3.5	2.5	7.1	16.7	8.3	4.2	2.7	4.2	6.4	18.1	4.1	5.6	3.2	2.0	8.7	2.5	3.4	1.3	2.5	0.4	2.5	1.8	2.0	2.8	2.1	3.1	3.3	3.3	2.2	1.8	0.1	1.2	6.8	1.0	2.4	1.4	14.5	17.0	19.6	33.1	17.4	13.5	13.0	12.5	15.8	7.8
TRIP12	KIAA0045	ENSG00000153827	"Thyroid hormone receptor interactor 12"	Q14669	2	229763838-229923239	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Autism spectrum disorder, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036835, HPA045893"	Enhanced		Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA036835: , HPA045893: "	"unprognostic (1.22e-1)"	"unprognostic (4.87e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.33e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavourable (3.60e-4)"	"unprognostic (3.37e-3)"	"unprognostic (3.49e-3)"	"unprognostic (4.87e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.83e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.01e-2)"	29.6	28.1	23.6	25.4	26.9	26.9	23.1	20.5	26.2	24.0	23.1	26.2	24.3	14.3	25.3	26.3	30.6	19.9	20.7	35.9	19.0	19.3	26.2	24.9	26.2	26.5	23.1	20.5	24.3	18.8	32.4	33.1	27.2	24.8	25.8	21.3	22.3	25.5	22.0	62.7	23.6	22.0	26.2	23.3	32.5	23.4	77.1	24.0	42.2	28.0	21.5	31.5	26.5	27.4	7.0	9.1	25.8	12.0	9.1	12.7	6.1	23.8	26.9	24.7	20.7	23.6	28.7	23.0	36.8	25.0	26.7	29.8	21.5	19.2	9.3	27.0	32.8	18.7	36.0	26.2	39.2	38.2	13.1	64.8	22.6	19.0	20.4	48.7	42.4	24.8	20.2	44.4	28.5	34.8	47.8	10.0	30.5	18.1	27.2	16.8	19.3	12.3	24.8	48.8	8.2	19.8	41.0	25.1	17.9	0.5	12.4	25.3	12.5	29.8	48.3	34.6	24.6	22.5	28.4	17.4	19.9	30.5	26.4	19.2	29.0	18.8	9.9	15.7	9.5	11.3	9.7	7.0	8.8	9.2	9.1	6.8	7.3	7.0	25.8	9.1	12.0	9.0	12.7	6.1	23.6	26.9	20.5	26.2	19.0	19.3	23.1	20.5	24.8	24.0
HERC1	"p532, p619"	ENSG00000103657	"HECT and RLD domain containing E3 ubiquitin protein ligase family member 1"	Q15751	15	63608618-63833942	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transport, Ubl conjugation pathway"	"Guanine-nucleotide releasing factor, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049749	Uncertain									"HPA049749: "	"unprognostic (9.72e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.43e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.35e-1)"	"prognostic favourable (4.87e-5)"	"unprognostic (1.53e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.89e-3)"	"prognostic favourable (3.66e-4)"	"unprognostic (1.24e-1)"	"prognostic favourable (1.36e-6)"	"unprognostic (2.87e-1)"	"unprognostic (3.36e-2)"	"unprognostic (9.04e-3)"	"unprognostic (3.94e-1)"	14.4	11.7	20.3	12.9	23.5	28.9	15.5	30.4	29.7	17.4	15.3	14.7	13.8	7.0	15.8	8.9	10.3	10.7	12.1	17.6	19.4	14.3	11.9	11.4	14.9	15.2	12.8	23.7	23.8	11.5	44.8	20.1	12.7	19.1	11.4	11.8	11.0	11.4	14.0	31.7	14.6	13.9	15.7	11.7	17.4	13.5	13.5	15.8	16.6	17.2	11.3	15.3	12.9	11.6	9.8	7.0	17.6	5.7	2.8	6.6	1.4	7.4	9.8	10.9	3.8	19.4	12.5	3.6	5.9	7.6	6.2	7.1	6.0	3.0	11.1	5.5	11.0	8.1	17.6	5.0	8.4	8.5	6.0	24.1	13.9	4.3	3.2	17.8	14.5	8.9	4.9	8.6	8.5	12.8	24.2	5.0	5.3	12.1	6.2	3.5	5.4	5.0	6.8	12.1	6.5	2.5	18.4	9.8	4.9	10.4	7.1	6.2	3.5	7.1	14.2	8.0	7.4	6.8	7.7	5.5	9.4	7.8	4.5	13.3	2.7	17.6	3.7	7.4	5.0	3.3	3.8	5.3	5.5	4.4	3.2	9.8	5.6	5.6	12.9	2.8	5.7	7.0	6.6	1.4	20.3	23.5	30.4	29.7	19.4	14.3	12.8	23.7	19.1	15.8
NSMCE2	"C8orf36, FLJ32440, MMS21, NSE2, ZMIZ7"	ENSG00000156831	"NSE2/MMS21 homolog, SMC5-SMC6 complex SUMO ligase"	Q96MF7	8	125091679-125367120	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair, Mitosis, Ubl conjugation pathway"	Transferase	"Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051614, HPA065734"	Supported		Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA051614: , HPA065734: "	"unprognostic (1.14e-3)"	"unprognostic (1.29e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.22e-3)"	"unprognostic (8.65e-2)"	"unprognostic (8.89e-3)"	"prognostic unfavourable (7.54e-4)"	"unprognostic (3.99e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.53e-2)"	"unprognostic (2.61e-2)"	"unprognostic (6.85e-2)"	22.4	22.3	17.6	16.4	20.2	26.2	23.8	21.0	22.6	18.2	19.9	17.1	17.6	12.3	28.3	19.5	18.6	14.3	16.5	22.9	13.7	12.7	18.5	17.2	16.3	19.4	20.2	17.3	21.3	14.9	11.2	32.0	19.1	16.1	15.0	17.8	16.7	19.3	17.4	36.5	18.1	13.4	21.9	18.3	16.6	18.9	19.1	20.6	18.5	18.2	16.8	24.9	18.8	21.2	12.6	12.6	35.3	12.6	11.1	18.8	12.5	16.1	14.0	16.7	10.5	13.2	20.0	8.1	13.0	24.5	23.1	26.9	8.9	15.5	20.3	15.3	12.3	12.1	13.0	10.9	23.6	22.7	12.7	28.6	8.5	12.9	19.1	8.5	8.7	14.7	15.3	13.3	17.0	20.8	16.5	13.4	20.1	27.9	21.9	7.9	3.7	18.8	12.3	11.6	18.3	13.9	12.3	11.1	11.8	15.5	46.8	21.6	19.9	9.8	12.9	8.9	25.3	11.0	18.4	17.9	31.9	25.5	13.9	16.6	13.8	5.1	12.6	35.3	12.2	10.9	13.5	12.6	13.0	13.7	12.6	11.5	13.4	14.6	6.1	11.1	10.9	7.4	18.8	12.5	17.6	20.2	21.0	22.6	13.7	12.7	20.2	17.3	16.1	20.6
PDZRN3	"KIAA1095, LNX3, SEMACAP3"	ENSG00000121440	"PDZ domain containing ring finger 3"	Q9UPQ7	3	73382433-73624940	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 15.1;ASC diff: 27.5;ASC TERT1: 14.5;BJ hTERT+: 19.6;HSkMC: 20.1;U-87 MG: 14.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	52	"plasmacytoid DC: 5.2"	"Lineage enriched"	"Detected in single"	52	"dendritic cells: 5.2"	"Group enriched"	"Detected in many"	5	"amygdala: 12.4;basal ganglia: 7.4;cerebral cortex: 17.9;hippocampal formation: 14.5"	"Low region specificity"	"Detected in many"			HPA038822	Approved									"HPA038822: AB_10675952"	"unprognostic (3.22e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.00e-2)"	"prognostic favourable (3.35e-5)"	"unprognostic (1.09e-1)"	"unprognostic (5.54e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.51e-2)"	"prognostic favourable (4.93e-4)"	"unprognostic (8.38e-2)"	"prognostic favourable (3.65e-7)"	"unprognostic (8.63e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.86e-3)"	13.0	17.4	11.5	4.8	12.9	0.0	10.3	1.7	26.8	18.7	32.6	4.5	4.6	4.3	29.0	12.4	13.6	11.6	13.1	19.8	9.1	2.5	5.3	0.9	6.3	1.9	3.6	11.2	35.1	2.9	0.3	2.2	8.1	6.8	15.4	6.9	9.7	9.7	14.9	38.3	7.5	10.2	26.3	3.8	1.0	19.3	3.4	2.9	0.2	1.6	5.1	1.1	21.3	18.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	27.5	14.5	0.0	7.8	19.6	2.4	1.5	7.4	0.0	0.0	0.0	10.5	0.0	0.0	0.0	2.3	0.0	1.0	0.0	0.0	0.0	4.6	0.0	0.0	20.1	0.0	6.5	0.0	0.0	0.0	0.0	2.3	0.9	0.0	0.1	2.1	0.0	0.0	4.0	0.0	0.0	0.0	1.7	5.0	0.0	3.6	5.6	2.1	0.0	0.0	9.9	0.7	11.1	1.0	0.3	0.0	0.1	14.5	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	11.5	12.9	1.7	26.8	9.1	2.5	3.6	11.2	6.8	2.9
RNF8	KIAA0646	ENSG00000112130	"Ring finger protein 8"	O76064	6	37353972-37394738	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Host-virus interaction, Mitosis, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA050731, HPA064925"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA050731: , HPA064925: "	"unprognostic (1.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.39e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.17e-2)"	"unprognostic (3.99e-2)"	"prognostic unfavourable (3.33e-5)"	"unprognostic (2.36e-2)"	"prognostic unfavourable (1.91e-4)"	"unprognostic (2.26e-3)"	"unprognostic (3.38e-1)"	"prognostic unfavourable (4.99e-5)"	"unprognostic (7.95e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.09e-1)"	8.0	11.7	13.1	8.2	17.8	8.9	11.5	25.7	18.7	9.2	9.5	10.6	6.8	6.9	13.5	5.7	18.3	12.0	8.8	17.6	13.4	14.8	11.8	7.5	10.8	8.3	12.0	16.0	13.2	6.5	11.9	16.4	10.2	13.7	8.6	8.2	8.0	10.2	11.9	15.2	9.9	8.4	10.7	9.6	7.7	7.6	19.8	13.8	6.6	8.0	9.4	13.3	12.9	15.2	8.8	8.3	2.6	8.1	7.6	10.8	5.5	6.5	3.9	9.5	11.3	7.7	11.1	2.7	6.8	8.4	12.9	14.2	5.8	3.7	8.1	4.2	6.6	6.2	13.2	8.6	13.6	8.5	12.8	14.0	6.9	8.7	4.4	7.4	10.3	5.5	8.3	7.7	9.0	12.4	9.4	2.8	7.4	4.3	9.0	9.2	6.6	5.2	7.1	8.8	5.6	6.6	4.6	18.8	6.3	5.1	5.8	9.4	5.2	7.3	5.6	8.5	7.6	8.0	10.0	8.4	11.1	40.0	4.2	10.6	9.8	1.0	4.6	2.6	10.8	6.0	10.0	8.8	8.1	10.2	8.3	6.0	7.1	9.4	0.6	7.6	8.1	3.6	9.3	5.5	13.1	17.8	25.7	18.7	13.4	14.8	12.0	16.0	13.7	13.8
UBE2D1	"E2(17)KB1, SFT, UBC4/5, UBCH5, UbcH5A"	ENSG00000072401	"Ubiquitin conjugating enzyme E2 D1"	P51668	10	58334975-58370753	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 74.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 41.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (1.12e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (5.58e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.17e-1)"	"prognostic unfavourable (8.04e-6)"	"unprognostic (9.71e-3)"	"unprognostic (4.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.66e-2)"	8.2	10.6	8.1	10.0	7.9	17.1	7.5	7.7	9.0	6.3	7.3	5.5	4.8	4.7	8.5	5.5	8.2	5.5	6.4	25.6	7.6	7.2	5.5	5.4	7.0	13.7	8.1	6.7	5.9	4.8	5.3	7.4	6.8	7.4	6.5	7.9	3.5	6.4	5.0	74.9	4.6	5.8	8.8	8.4	11.0	5.6	3.2	8.4	5.5	6.0	25.1	7.1	9.5	10.0	3.7	7.2	41.0	13.7	2.8	3.5	7.1	10.6	5.8	10.8	13.9	22.2	17.9	7.0	7.0	12.0	8.1	11.9	11.7	9.2	0.0	11.1	10.5	9.7	20.9	10.2	11.4	11.0	12.3	2.8	2.1	6.7	14.6	8.4	6.8	20.7	11.5	8.4	15.7	16.1	5.5	4.5	10.9	3.3	9.0	9.4	13.2	9.1	7.6	9.8	5.9	12.1	6.2	8.2	11.0	13.8	23.3	11.2	8.5	5.7	12.9	3.1	10.9	10.6	7.7	11.5	8.9	9.4	9.8	17.5	3.5	2.8	13.7	6.2	2.4	9.5	2.8	3.3	2.9	3.0	7.2	3.7	3.0	2.3	41.0	2.8	7.9	3.0	3.5	7.1	8.1	7.9	7.7	9.0	7.6	7.2	8.1	6.7	7.4	8.4
UHRF1	"FLJ21925, ICBP90, Np95, RNF106, TDRD22"	ENSG00000276043	"Ubiquitin like with PHD and ring finger domains 1"	Q96T88	19	4903080-4962154	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 75.6"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 62.6;REH: 142.1"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 8.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 8.2;T-cells: 4.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA049408, HPA055446"	Enhanced		Supported	Nucleoplasm				Nucleoplasm		"HPA049408: AB_2756317, HPA055446: AB_2732597"	"unprognostic (3.83e-2)"	"unprognostic (6.83e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.21e-2)"	"prognostic unfavourable (1.63e-4)"	"unprognostic (4.30e-2)"	"prognostic unfavourable (6.81e-4)"	"unprognostic (2.82e-1)"	"prognostic unfavourable (4.52e-5)"	"unprognostic (2.33e-3)"	"unprognostic (0.00e+0)"	"unprognostic (3.75e-3)"	"unprognostic (2.45e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.02e-1)"	0.7	0.0	0.7	8.2	3.7	16.5	0.7	0.3	4.2	0.3	1.5	1.6	0.0	2.1	0.3	0.2	2.0	0.0	1.0	0.9	1.2		0.1	0.1	0.3	10.0	4.3	0.7	0.3	0.6	0.0	0.0	1.0	1.4	0.0	1.4	0.0	0.0	0.0	0.3	1.9	2.2	0.8	0.7	2.2	1.9	3.1	4.0	75.6	0.0	4.0	6.6	1.1	0.0	0.4	8.2	1.5	0.4	0.9	4.2	0.9	15.6	11.3	17.2	12.2	0.5	2.0	2.7	12.7	6.1	13.3	12.9	13.5	7.9	8.9	3.1	5.6	7.8	11.8	6.9	9.4	14.4	13.4	7.7	10.6	14.4	0.2	18.9	11.7	0.9	0.5	7.2	1.8	3.9	11.0	10.3	7.9	12.2	62.6	11.6	7.7	12.3	142.1	38.3	6.5	3.6	11.5	12.7	10.1	10.0	5.5	1.7	9.9	18.1	4.9	14.1	11.5	18.2	15.3	4.4	4.5	26.2	8.1	18.4	17.9	0.6	0.4	0.2	1.1	0.1	0.1	0.3	1.5	1.9	2.2	0.4	0.4	1.5	1.5	0.9	0.3	8.2	4.2	0.9										
CUL3		ENSG00000036257	"Cullin 3"	Q13618	2	224470150-224585397	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Cilium biogenesis/degradation, ER-Golgi transport, Mitosis, Transport, Ubl conjugation pathway"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002678	Supported						12000			"CAB002678: "	"unprognostic (1.22e-2)"	"unprognostic (2.35e-1)"	"unprognostic (7.05e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.82e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.16e-2)"	"unprognostic (4.86e-3)"	"unprognostic (2.16e-2)"	"unprognostic (8.74e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.87e-2)"	15.1	18.9	18.5	17.1	19.1	20.5	16.1	20.2	19.1	16.1	16.3	12.9	15.6	13.7	16.5	17.0	27.2	12.9	12.9	23.5	16.0	14.1	19.3	20.9	13.2	19.5	15.8	18.7	16.0	14.9	26.8	14.2	17.3	16.6	14.2	15.6	12.7	19.1	12.7	56.8	21.7	18.1	13.2	12.1	18.8	15.1	80.2	15.4	31.0	18.0	16.8	27.9	16.4	22.6	8.0	4.8	9.5	5.1	11.8	9.7	2.2	22.7	23.1	33.9	27.8	28.5	25.0	32.0	28.0	28.3	28.2	26.5	27.2	22.9	24.9	17.3	28.6	20.3	38.0	32.2	43.9	24.6	20.8	35.6	24.2	37.3	34.7	34.9	26.9	24.8	26.7	26.2	28.9	28.3	32.9	25.7	37.1	38.6	32.2	33.8	34.8	14.5	28.3	42.5	18.5	41.6	53.1	31.0	22.8	19.3	28.3	31.7	22.4	29.5	25.0	30.2	22.9	20.1	27.6	26.8	19.9	43.7	23.4	21.8	31.9	9.5	3.8	9.4	5.1	4.6	6.5	7.3	5.5	7.6	4.0	8.0	6.9	7.6	9.0	11.8	5.1	4.8	9.7	2.2	18.5	19.1	20.2	19.1	16.0	14.1	15.8	18.7	16.6	15.4
CUL5	VACM-1	ENSG00000166266	"Cullin 5"	Q93034	11	108008733-108107776	"Cancer-related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002185, CAB017787"	Approved		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus, Cytosol"		"CAB017787: , HPA002185: AB_1078587"	"unprognostic (5.66e-2)"	"unprognostic (6.58e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.78e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.77e-2)"	"prognostic favourable (1.06e-5)"	"unprognostic (3.83e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.10e-1)"	11.6	13.2	10.8	9.0	14.8	25.0	13.4	17.1	19.3	13.1	10.8	12.7	11.0	9.0	13.6	10.7	11.2	10.9	8.7	14.8	11.3	10.6	16.7	15.3	9.7	10.2	12.5	12.3	13.2	11.2	17.8	14.6	12.6	19.5	12.9	9.5	11.2	11.4	10.9	41.6	11.5	11.2	11.8	13.1	12.5	10.3	6.5	12.7	23.1	14.6	15.1	10.0	10.8	13.6	6.4	5.9	4.1	6.7	4.0	6.2	3.6	9.7	4.6	13.8	10.6	9.1	14.6	6.9	10.3	11.4	9.5	10.7	14.6	11.5	13.7	19.3	12.9	12.5	12.8	8.6	13.9	8.8	7.8	12.9	4.4	10.8	15.6	14.5	10.5	11.5	11.8	9.9	13.2	13.0	16.5	5.1	14.9	5.4	13.9	12.6	7.2	8.1	10.1	10.3	14.9	12.0	14.8	10.0	14.2	14.0	14.9	8.4	21.7	12.0	13.5	17.6	8.2	12.4	11.0	5.2	4.0	17.9	6.9	16.6	11.1	1.9	6.7	4.1	5.4	5.2	4.9	4.4	5.6	5.3	5.9	6.4	6.1	6.2	1.2	4.0	6.0	5.9	4.0	3.6	10.8	14.8	17.1	19.3	11.3	10.6	12.5	12.3	19.5	12.7
DTX4	"KIAA0937, RNF155"	ENSG00000110042	"Deltex E3 ubiquitin ligase 4"	Q9Y2E6	11	59171430-59208587	"Enzymes, Predicted intracellular proteins"	"Notch signaling pathway, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.8"	"Cell line enhanced"	"Detected in many"		"AF22: 13.3;BEWO: 27.0;CACO-2: 14.6;CAPAN-2: 15.5;RT4: 40.5"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 63.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 6.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056760, HPA059294"	Approved		Approved	Vesicles				Vesicles		"HPA056760: , HPA059294: "	"unprognostic (3.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.10e-2)"	"unprognostic (4.98e-2)"	"unprognostic (4.97e-2)"	"unprognostic (5.03e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.04e-1)"	"prognostic unfavourable (8.94e-4)"	"unprognostic (5.51e-2)"	"unprognostic (2.51e-1)"	"prognostic favourable (5.81e-4)"	"unprognostic (2.57e-3)"	7.0	2.2	8.9	7.6	12.8	8.2	7.9	14.0	16.5	8.9	17.7	29.8	1.4	16.7	4.3	2.3	3.7	6.5	9.5	2.1	10.7	10.9	6.5	23.9	17.7	5.2	15.3	8.8	16.3	5.9	1.7	3.3	15.3	24.8	5.6	18.4	7.7	16.0	3.7	1.5	4.2	14.3	3.6	42.8	5.0	12.2	1.9	9.1	0.8	12.4	2.3	6.7	19.8	14.7	3.3	6.1	3.1	1.0	0.1	0.1	0.2	2.0	2.3	13.3	0.2	3.8	0.2	27.0	0.2	1.1	0.1	0.1	14.6	15.5	4.8	0.9	0.3	6.9	4.1	5.0	0.0	0.3	0.2	0.0	2.6	4.7	1.0	0.4	0.9	0.6	8.4	0.0	0.2	0.0	0.0	0.5	0.6	1.1	0.2	0.0	6.8	0.6	1.6	11.7	0.5	1.1	40.5	0.0	0.0	10.3	2.7	0.3	2.0	0.2	0.1	0.0	2.1	0.0	0.0	0.1	0.0	0.5	0.1	1.2	1.0	1.5	1.0	0.7	0.1	1.0	0.0	2.2	0.1	0.0	1.4	3.3	0.0	0.0	3.1	0.1	0.5	6.1	0.0	0.2	8.9	12.8	14.0	16.5	10.7	10.9	15.3	8.8	24.8	9.1
ERCC8	"CKN1, CSA"	ENSG00000049167	"ERCC excision repair 8, CSA ubiquitin ligase complex subunit"	Q13216	5	60873831-60945073	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"		"Cockayne syndrome, Deafness, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029328			Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA029328: "	"unprognostic (5.45e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.56e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.68e-2)"	"unprognostic (4.96e-2)"	"unprognostic (2.10e-3)"	"unprognostic (9.68e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.23e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.75e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.31e-3)"	"unprognostic (7.19e-2)"	13.6	10.4	11.5	7.1	12.4	4.2	13.9	10.2	16.5	9.8	9.9	11.8	8.6	8.5	9.8	10.0	10.0	8.4	8.0	11.6	10.3	10.6	13.2	10.6	8.0	9.2	11.4	8.9	9.1	8.5	6.6	18.7	12.6	14.7	7.7	12.2	10.6	8.4	10.3	8.7	7.2	7.7	12.9	12.5	11.5	7.6	14.1	11.7	14.0	10.2	8.9	11.6	11.2	7.8	4.3	12.1	1.4	6.5	3.6	6.3	3.9	6.0	8.9	12.3	13.4	7.6	10.2	7.0	9.0	10.4	12.8	15.0	10.2	9.5	8.2	13.3	10.5	6.1	9.9	13.4	16.3	13.5	5.9	5.7	3.6	12.7	10.5	6.3	5.4	9.2	12.0	10.9	6.1	11.8	7.8	4.7	12.4	9.3	9.0	6.9	6.6	5.5	15.0	13.5	8.1	6.5	7.8	8.5	11.3	9.6	5.7	9.5	10.1	7.6	7.1	5.1	7.9	8.5	14.4	6.3	12.4	10.0	7.4	12.5	13.7	0.0	6.5	1.4	5.1	5.9	5.6	4.3	4.3	6.2	12.1	2.4	5.9	5.9	0.2	3.6	1.7	5.5	6.3	3.9	11.5	12.4	10.2	16.5	10.3	10.6	11.4	8.9	14.7	11.7
GLMN	"FAP48, FKBPAP, GLML, GVM, VMGLOM"	ENSG00000174842	"Glomulin, FKBP associated protein"	Q92990	1	92246402-92298987	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031446, HPA031448"	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA031446: , HPA031448: "	"unprognostic (4.20e-2)"	"unprognostic (3.47e-2)"	"prognostic favourable (1.71e-4)"	"unprognostic (7.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.24e-2)"	"prognostic unfavourable (2.42e-5)"	"unprognostic (7.32e-2)"	"unprognostic (2.07e-3)"	"unprognostic (4.59e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.81e-2)"	"prognostic unfavourable (5.89e-8)"	"unprognostic (7.33e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.58e-1)"	4.9	6.6	12.5	8.1	14.8	9.0	10.3	21.3	19.5	7.4	6.8	6.6	5.1	5.1	11.5	8.6	10.1	6.3	5.7	7.2	9.4	6.9	6.4	5.2	5.3	10.6	6.8	13.2	8.3	4.7	8.5	13.6	7.9	8.6	7.6	7.3	13.9	4.9	6.9	7.5	13.5	6.6	6.9	8.0	7.6	5.8	11.2	5.7	13.3	9.0	4.8	12.1	7.9	6.9	2.5	2.0	1.4	1.4	9.0	5.5	1.9	12.1	4.7	15.7	8.6	5.6	8.8	14.5	8.5	7.0	10.6	9.5	9.6	4.8	12.3	13.7	5.0	9.3	8.2	7.7	15.3	8.7	11.6	16.4	9.3	9.5	5.5	20.7	8.6	6.8	4.5	12.4	5.6	11.4	13.6	7.6	13.9	2.8	12.7	15.8	23.9	8.5	11.0	21.6	8.5	12.0	11.8	14.5	7.5	14.7	14.0	8.8	6.7	20.0	7.1	7.7	7.5	13.2	12.7	6.7	9.1	15.5	2.9	21.0	4.5	0.0	0.7	1.4	3.2	1.4	5.5	2.5	3.5	3.9	2.0	1.5	3.1	3.6	0.2	9.0	0.8	1.4	2.7	1.9	12.5	14.8	21.3	19.5	9.4	6.9	6.8	13.2	8.6	5.7
HECTD4	"C12orf51, FLJ34154, KIAA0614"	ENSG00000173064	"HECT domain E3 ubiquitin protein ligase 4"		12	112160188-112382439	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in all"		"brain: 43.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041062, HPA045473"	Uncertain		Approved	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"HPA041062: , HPA045473: "	"unprognostic (9.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.38e-1)"	"prognostic favourable (2.97e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.58e-2)"	"unprognostic (4.51e-3)"	6.8	7.1	11.3	6.3	16.3	26.6	7.7	43.3	22.7	8.9	9.0	14.0	10.8	5.4	11.1	10.0	10.0	9.0	6.5	6.6	10.1	10.3	7.4	6.3	7.3	8.1	11.4	13.7	10.9	10.1	13.8	14.0	8.0	17.2	12.3	7.4	9.4	8.7	9.6	12.9	16.6	7.0	8.8	13.0	7.4	8.8	14.6	12.7	8.3	12.8	5.0	7.7	8.3	9.0	2.9	2.4	2.8	1.2	1.0	1.8	0.7	5.6	10.6	8.5	7.5	11.6	7.9	4.9	4.1	3.9	5.3	4.5	10.3	1.9	5.9	3.8	6.7	5.7	11.1	5.4	4.0	7.6	10.0	8.4	11.2	5.7	4.1	5.9	8.2	6.5	6.6	8.2	5.4	8.1	10.4	4.6	5.1	6.2	7.0	12.5	4.0	7.9	9.5	4.3	3.8	4.3	8.9	13.9	9.5	9.6	9.4	3.6	7.1	8.4	11.7	6.3	4.6	6.5	5.5	15.7	5.9	6.6	5.1	3.9	3.9	2.8	1.2	0.6	1.8	0.5	1.2	1.1	0.6	0.9	0.8	2.9	1.0	0.9	1.4	1.0	1.1	2.4	0.1	0.7	11.3	16.3	43.3	22.7	10.1	10.3	11.4	13.7	17.2	12.7
MUL1	"C1orf166, FLJ12875, GIDE, MAPL, MULAN, RNF218"	ENSG00000090432	"Mitochondrial E3 ubiquitin protein ligase 1"	Q969V5	1	20499448-20508161	"Enzymes, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026827			Approved	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Mitochondria, Cytosol"		"HPA026827: AB_10601137"	"unprognostic (1.39e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.85e-3)"	"unprognostic (6.05e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.86e-3)"	"unprognostic (4.05e-1)"	"unprognostic (9.10e-2)"	"prognostic favourable (6.15e-14)"	"unprognostic (1.59e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.37e-1)"	13.3	15.9	10.3	12.9	12.3	20.6	20.4	9.2	22.2	13.1	15.8	19.0	8.0	11.6	18.2	10.7	17.2	17.0	18.5	26.2	11.7	12.5	20.5	20.1	16.3	12.1	16.8	9.5	17.5	26.8	21.9	13.0	21.6	17.6	13.9	13.3	14.3	15.3	18.1	26.7	17.4	19.5	17.0	11.7	13.6	15.2	14.1	11.6	18.5	15.1	14.6	14.0	16.3	13.6	23.2	26.0	31.9	30.4	25.2	32.1	27.5	16.9	16.4	9.5	19.6	20.6	11.6	10.3	16.9	20.2	21.0	20.3	10.1	28.2	12.8	18.9	23.8	25.9	17.0	24.4	15.3	12.7	13.5	9.8	11.1	14.6	24.3	13.4	16.8	18.9	32.2	21.5	22.4	13.7	12.7	15.6	22.8	8.6	8.0	9.0	9.7	15.7	7.9	11.9	16.5	24.7	9.5	9.7	14.3	15.1	16.2	20.7	11.4	12.9	15.4	20.5	11.8	17.8	15.1	18.3	15.9	13.8	16.1	18.2	19.0	26.3	26.5	31.9	30.9	30.4	32.1	23.2	23.6	31.4	26.0	21.5	27.1	26.3	24.0	25.2	25.4	20.1	32.1	27.5	10.3	12.3	9.2	22.2	11.7	12.5	16.8	9.5	17.6	11.6
RNF139	"HRCA1, RCA1, TRC8"	ENSG00000170881	"Ring finger protein 139"	Q8WU17	8	124474738-124487914	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Ubl conjugation pathway"	"Receptor, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001202	Approved									"HPA001202: AB_1079824"	"unprognostic (3.28e-3)"	"unprognostic (2.92e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.32e-3)"	"unprognostic (2.71e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (3.54e-4)"	"unprognostic (9.85e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.45e-1)"	15.1	17.3	10.4	9.5	12.2	54.5	13.4	12.0	17.1	14.2	10.9	14.0	9.4	6.2	15.3	10.0	12.2	14.2	11.0	11.4	10.4	10.8	11.4	17.7	11.3	14.2	12.4	11.5	17.1	10.3	7.6	10.6	18.4	9.9	12.8	10.4	10.2	10.3	10.5	15.2	12.6	11.3	14.2	12.2	11.8	11.2	60.3	13.3	16.8	11.2	9.6	10.4	14.8	10.7	9.2	9.4	11.8	11.7	8.6	13.9	8.0	13.2	8.9	10.7	10.5	23.6	18.8	8.8	11.9	22.6	10.0	12.9	5.7	11.1	13.7	14.0	15.4	9.8	9.1	14.5	15.0	18.9	11.4	20.3	5.8	11.7	18.0	9.6	11.8	16.0	21.2	10.6	28.7	13.3	14.3	21.0	11.8	35.8	16.2	6.9	7.5	12.6	6.5	7.9	13.7	18.8	17.0	4.5	11.7	15.5	38.9	16.8	18.7	10.4	10.5	6.7	15.5	11.3	13.2	17.1	18.1	12.4	10.5	16.3	6.7	3.3	7.4	11.8	11.6	4.7	13.9	9.2	10.8	13.2	9.4	8.5	10.8	11.3	10.8	8.6	11.7	5.1	13.2	8.0	10.4	12.2	12.0	17.1	10.4	10.8	12.4	11.5	9.9	13.3
RNF19B	"FLJ90005, IBRDC3"	ENSG00000116514	"Ring finger protein 19B"	Q6ZMZ0	1	32936445-32964685	"Enzymes, Predicted membrane proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 54.7"	"Cell line enhanced"	"Detected in all"		"Daudi: 38.4;Karpas-707: 46.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 16.1"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 16.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049587	Approved		Approved	Cytosol				Cytosol		"HPA049587: "	"unprognostic (2.83e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.78e-2)"	"prognostic favourable (3.39e-4)"	"prognostic unfavourable (5.41e-6)"	"unprognostic (8.78e-2)"	"unprognostic (5.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.38e-1)"	"prognostic favourable (4.39e-5)"	"unprognostic (2.58e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.23e-2)"	8.6	11.3	8.0	13.1	10.5	36.4	12.0	14.1	14.1	9.9	13.2	10.1	4.8	14.1	10.8	6.9	23.3	7.9	10.1	8.5	6.0	7.2	12.0	6.5	13.8	12.9	9.6	9.3	7.1	7.0	6.4	5.7	9.4	10.2	7.4	15.3	9.0	10.8	5.7	10.2	13.6	15.5	10.6	8.0	9.0	7.4	54.7	8.3	6.8	8.2	11.1	16.7	11.3	12.8	1.3	1.3	16.1	2.0	0.8	1.6	0.7	6.6	5.1	4.4	4.0	2.7	3.8	29.3	3.0	3.8	5.6	6.0	5.9	19.9	38.4	5.3	4.0	9.5	5.4	7.3	5.1	14.1	3.5	3.3	4.0	5.9	8.6	5.0	7.0	3.1	13.7	12.2	15.1	11.7	4.1	46.2	5.4	2.1	3.3	6.3	7.0	5.8	4.5	6.3	3.9	4.3	9.6	7.0	3.5	9.8	3.4	21.9	2.8	7.4	12.7	3.0	4.2	7.7	5.3	11.1	5.6	13.6	4.4	5.2	4.5	5.3	2.0	3.5	1.6	1.8	1.2	1.2	1.4	0.8	1.3	1.3	0.4	0.6	16.1	0.8	1.5	0.6	1.5	0.7	8.0	10.5	14.1	14.1	6.0	7.2	9.6	9.3	10.2	8.3
RNF20	"BRE1, BRE1A, FLJ11189, FLJ20382, hBRE1, KAIA2779"	ENSG00000155827	"Ring finger protein 20"	Q5VTR2	9	101533851-101563344	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012478, HPA051773"	Supported		Enhanced	Nucleoplasm				Nucleoplasm		"CAB012478: , HPA051773: "	"unprognostic (7.02e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.04e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.01e-1)"	"unprognostic (5.47e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.60e-1)"	"prognostic favourable (1.64e-6)"	"unprognostic (2.72e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.54e-3)"	16.4	17.1	24.6	17.0	24.9	12.1	17.7	24.4	26.3	18.6	16.4	27.7	15.9	10.1	18.3	18.7	20.4	19.1	13.2	24.1	22.3	22.1	20.5	14.4	14.9	15.5	25.2	20.7	21.1	19.5	31.5	23.1	15.1	30.0	21.6	16.1	16.8	16.2	17.7	32.0	16.3	12.5	23.6	28.8	17.0	13.9	28.2	25.8	21.2	22.0	15.3	18.6	21.1	19.0	13.0	12.5	21.0	23.5	13.8	18.6	10.4	9.5	24.4	14.1	15.4	17.4	13.8	12.0	16.8	13.5	16.8	14.8	14.8	10.2	21.2	9.0	12.9	24.4	16.3	14.2	17.3	22.2	7.5	11.4	22.3	14.8	12.8	19.5	13.7	13.5	15.3	14.8	19.3	9.8	10.8	12.6	18.2	12.5	15.1	5.2	31.1	12.4	14.6	48.8	10.5	6.9	9.2	15.1	19.0	23.7	12.7	13.8	11.4	9.2	13.9	15.6	15.7	11.1	14.0	13.6	42.0	11.7	13.8	7.4	18.9	21.0	12.7	19.1	18.6	17.5	14.0	13.0	15.4	13.9	12.5	11.2	16.2	14.9	13.9	13.8	23.5	7.9	11.9	10.4	24.6	24.9	24.4	26.3	22.3	22.1	25.2	20.7	30.0	25.8
RNF40	"BRE1B, KIAA0661, RBP95, STARING"	ENSG00000103549	"Ring finger protein 40"	O75150	16	30761745-30776307	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041330, HPA054227"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA041330: AB_10793872, HPA054227: "	"unprognostic (1.61e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.06e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.01e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.16e-2)"	"unprognostic (1.91e-2)"	"prognostic favourable (8.11e-8)"	"unprognostic (9.96e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.55e-3)"	"unprognostic (6.60e-3)"	21.0	25.2	26.4	21.3	26.5	40.8	20.9	36.8	28.2	25.8	21.0	22.0	18.0	20.1	28.4	17.0	25.6	24.4	21.3	22.8	22.2	17.1	20.0	21.2	20.2	21.9	20.9	18.9	30.5	24.4	44.0	21.6	25.3	19.6	21.4	15.1	20.0	27.3	21.1	20.0	25.5	20.3	18.3	18.6	20.0	19.6	43.1	22.8	23.5	26.8	15.4	20.6	22.5	21.4	7.6	12.0	15.0	14.9	9.9	13.3	12.9	20.3	31.9	19.4	18.4	14.8	15.5	21.2	20.8	16.1	24.1	18.8	25.7	19.0	16.2	30.6	17.8	22.1	35.3	18.5	18.9	23.2	41.4	15.8	35.0	26.7	19.8	27.4	18.6	14.4	15.5	30.2	17.1	20.2	34.8	15.5	14.6	34.0	26.1	25.7	20.2	19.3	51.9	21.4	31.2	10.6	18.1	32.4	23.8	16.3	20.9	15.0	32.0	31.2	21.8	27.1	13.8	19.1	23.7	23.1	28.5	32.2	22.5	24.4	27.6	6.2	11.5	14.7	12.9	13.4	13.3	7.6	7.2	9.9	12.0	6.5	5.4	8.3	15.0	9.9	14.9	6.2	6.2	12.9	26.4	26.5	36.8	28.2	22.2	17.1	20.9	18.9	19.6	22.8
SEL1L	"IBD2, SEL1L1"	ENSG00000071537	"SEL1L ERAD E3 ligase adaptor subunit"	Q9UBV2	14	81471549-81533861	"Predicted intracellular proteins, Predicted membrane proteins"	"Notch signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 121.3"	"Cell line enhanced"	"Detected in all"		"U-266/70: 76.7;U-266/84: 64.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024267	Enhanced				"Intracellular and membrane"					"HPA024267: AB_1856659"	"unprognostic (4.94e-1)"	"unprognostic (8.69e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.76e-3)"	"unprognostic (4.86e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.25e-2)"	13.2	8.5	9.5	9.2	11.3	4.9	9.1	6.6	9.4	7.5	10.8	8.4	7.1	11.3	10.9	6.1	6.4	7.7	7.0	8.5	8.1	7.1	9.8	33.5	9.0	7.0	10.4	9.0	7.3	121.3	10.0	6.3	18.2	10.2	10.3	10.2	4.9	9.1	8.3	10.9	7.3	10.7	9.0	10.7	11.2	10.6	3.9	10.5	6.5	17.0	4.3	8.8	10.3	11.4	8.9	12.1	29.3	16.4	10.5	11.4	8.4	7.5	15.3	6.1	7.9	13.8	13.6	10.9	12.0	11.6	7.0	7.5	5.8	11.9	7.8	13.3	13.8	7.2	4.2	6.7	12.8	12.0	3.0	5.6	5.0	7.2	19.9	11.4	13.6	11.0	16.3	7.0	15.5	11.5	3.4	43.7	8.6	9.3	6.5	3.2	1.9	6.6	4.5	8.7	6.1	5.4	11.8	3.5	5.8	9.4	8.8	10.0	15.3	7.7	19.1	20.0	11.4	11.0	7.4	76.7	64.7	7.7	22.0	5.2	7.6	16.6	12.9	15.4	11.4	16.4	9.4	8.9	9.0	9.0	12.1	8.3	8.4	9.0	29.3	10.5	13.6	8.9	8.7	8.4	9.5	11.3	6.6	9.4	8.1	7.1	10.4	9.0	10.2	10.5
SHPRH	"bA545I5.2, FLJ90837, KIAA2023"	ENSG00000146414	"SNF2 histone linker PHD RING helicase"	Q149N8	6	145864245-145964423	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Helicase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034854, HPA034950"	Approved		Approved	Mitochondria				Mitochondria		"HPA034854: AB_10964488, HPA034950: "	"unprognostic (3.10e-2)"	"unprognostic (4.46e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.40e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.66e-3)"	"unprognostic (5.03e-1)"	"unprognostic (7.90e-2)"	"unprognostic (6.01e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.01e-1)"	10.9	7.3	8.3	11.0	10.0	5.5	10.4	38.0	11.5	10.6	8.0	4.5	10.8	6.0	14.1	9.2	8.5	9.8	6.7	7.2	7.2	4.2	8.4	6.5	7.1	9.0	7.6	5.9	18.8	8.7	11.4	19.7	6.6	8.5	8.3	7.4	7.3	10.2	13.7	11.4	13.9	8.2	11.0	10.3	8.8	8.5	10.7	8.7	8.4	12.5	7.2	8.0	10.7	11.5	6.7	4.8	4.4	2.4	3.4	4.3	1.2	2.9	2.3	11.4	6.7	5.3	5.7	5.5	3.5	2.9	4.4	5.7	5.2	2.1	10.4	4.4	2.7	5.1	7.0	5.0	5.8	4.7	8.0	10.5	5.2	4.4	4.0	22.0	6.5	3.9	5.8	4.1	6.0	4.7	14.6	5.9	3.7	2.6	14.1	8.2	7.7	4.0	10.2	17.8	3.5	6.0	2.9	9.4	6.6	6.3	5.8	3.9	3.1	10.6	5.2	2.8	5.3	5.5	4.1	4.8	6.8	12.4	2.9	9.5	4.3	1.6	2.3	4.4	4.3	2.4	3.7	3.9	3.6	2.9	2.7	6.7	4.1	3.3	0.1	3.4	2.4	4.8	3.3	1.2	8.3	10.0	38.0	11.5	7.2	4.2	7.6	5.9	8.5	8.7
SYVN1	"DER3, HRD1"	ENSG00000162298	"Synoviolin 1"	Q86TM6	11	65121780-65134533	"Enzymes, Predicted membrane proteins"	"Stress response, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 55.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005480, HPA024300, CAB037030"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane"				Nucleoplasm	"Endoplasmic reticulum, Plasma membrane"	"CAB037030: AB_1840939, HPA005480: AB_1079084, HPA024300: AB_1851073"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.85e-2)"	"prognostic favourable (6.88e-4)"	"unprognostic (7.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.89e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.16e-1)"	13.8	20.8	11.0	33.0	15.3	13.8	14.9	13.3	19.3	15.1	14.2	21.0	20.2	13.2	16.0	21.1	14.4	16.1	15.3	12.9	11.3	10.0	16.4	78.0	14.2	28.9	18.2	8.7	17.1	68.1	24.4	21.0	20.9	14.4	15.0	15.4	13.3	48.9	22.6	16.7	14.4	19.6	13.6	12.8	27.1	18.3	14.4	14.9	10.3	23.5	8.0	42.2	13.3	12.6	17.5	13.0	11.6	5.4	2.2	5.5	3.8	8.5	10.9	6.6	8.9	16.8	9.6	6.5	8.8	9.1	11.3	8.0	5.9	14.9	48.0	12.1	11.3	13.2	7.1	8.9	9.4	7.4	5.4	7.5	12.7	13.2	20.4	11.3	13.7	12.2	16.2	9.9	22.5	7.3	9.4	24.6	6.6	12.6	4.9	8.2	7.1	7.6	8.4	5.5	19.3	7.1	8.4	4.3	8.8	8.2	20.3	14.2	15.1	7.4	6.9	7.9	5.2	14.0	5.9	49.2	34.0	55.5	10.6	5.8	8.8	11.6	5.4	9.3	5.5	3.3	5.0	15.4	3.9	5.1	3.1	17.5	2.9	3.0	5.2	2.2	3.2	13.0	3.6	3.8	11.0	15.3	13.3	19.3	11.3	10.0	18.2	8.7	14.4	14.9
CBLL1	"FLJ23109, HAKAI, RNF188"	ENSG00000105879	"Cbl proto-oncogene like 1"	Q75N03	7	107743697-107761667	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021773, HPA026699"	Enhanced		Supported	"Nuclear speckles"				"Nuclear speckles"		"HPA021773: AB_1846103, HPA026699: AB_1846104"	"unprognostic (1.90e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.79e-2)"	"unprognostic (8.16e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.96e-3)"	"unprognostic (4.28e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.12e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.71e-2)"	15.8	12.0	11.7	13.6	20.0	38.8	16.8	18.7	19.4	15.3	17.2	19.2	11.6	10.8	22.9	9.7	14.4	14.2	10.2	11.5	11.9	10.7	11.6	12.5	12.9	16.5	12.6	14.3	18.2	15.5	14.5	17.2	13.5	16.5	18.7	13.0	14.7	12.8	19.6	32.6	16.6	14.4	16.2	15.1	15.8	14.7	21.1	13.3	29.0	15.8	11.8	19.3	17.6	12.7	17.9	16.7	32.2	15.7	23.4	40.3	20.1	13.5	15.5	12.0	15.3	11.0	9.6	8.2	10.2	10.6	11.5	11.4	10.4	13.8	19.6	14.8	11.5	9.6	16.6	12.4	15.8	13.9	10.5	16.0	11.4	8.7	12.8	23.5	15.7	10.0	11.5	15.5	17.0	11.8	25.1	16.7	11.0	23.1	32.1	16.0	17.2	10.6	14.9	13.0	20.3	8.7	12.5	12.8	20.0	15.2	22.4	11.1	7.5	12.0	11.5	17.9	12.9	16.9	15.6	27.2	29.5	31.8	11.0	14.7	15.1	32.2	14.2	23.3	19.0	14.7	28.0	17.9	30.1	21.8	16.7	17.4	20.9	19.6	21.9	23.4	15.7	9.0	40.3	20.1	11.7	20.0	18.7	19.4	11.9	10.7	12.6	14.3	16.5	13.3
MARCH6	"MARCH-VI, RNF176, TEB4"	ENSG00000145495	"Membrane associated ring-CH-type finger 6"	O60337	5	10353703-10440388	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040841, HPA063246"	Approved		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA040841: , HPA063246: "	"unprognostic (3.31e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.85e-2)"	"unprognostic (3.80e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.06e-2)"	"unprognostic (9.52e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-3)"	"unprognostic (3.94e-2)"	"unprognostic (5.58e-2)"	"unprognostic (5.08e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.57e-1)"	"unprognostic (8.50e-3)"	22.5	25.6	28.6	21.2	25.5	57.0	62.4	42.0	53.8	21.4	23.0	24.0	18.3	28.6	24.7	24.2	22.8	25.1	22.0	35.5	27.6	23.7	31.9	28.9	35.0	33.2	29.8	39.1	34.0	41.5	56.0	27.4	20.3	33.4	21.4	18.4	20.3	28.0	23.4	49.8	23.9	32.1	27.4	38.6	31.2	26.0	25.6	26.9	18.0	26.8	17.1	20.3	24.6	36.4	13.4	7.3	15.6	12.1	9.9	15.7	9.4	12.4	18.7	31.4	24.3	18.0	14.5	25.7	19.7	18.4	17.0	21.8	17.8	33.3	13.1	30.1	18.4	17.3	16.6	12.8	23.1	27.7	15.1	17.1	62.2	12.1	12.7	20.2	19.2	16.9	14.2	17.1	18.7	15.8	20.4	29.6	15.5	14.2	10.9	15.6	11.4	13.2	17.0	13.1	18.9	13.3	24.2	13.5	19.6	36.7	20.1	12.9	16.7	11.0	15.2	20.7	20.2	10.2	14.7	20.8	29.8	18.7	15.2	14.1	14.7	15.6	8.5	13.6	13.5	9.6	15.4	13.4	13.4	13.4	7.3	11.5	15.7	14.6	13.7	9.9	12.1	5.6	11.7	9.4	28.6	25.5	42.0	53.8	27.6	23.7	29.8	39.1	33.4	26.9
PIAS1	"DDXBP1, GBP, GU/RH-II, ZMIZ3"	ENSG00000033800	"Protein inhibitor of activated STAT 1"	O75925	15	68054179-68198603	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005743, CAB012304"	Supported		Approved	Microtubules				Microtubules		"CAB012304: AB_777265, HPA005743: "	"unprognostic (1.36e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.10e-3)"	"unprognostic (6.93e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.28e-2)"	19.5	19.5	15.5	19.9	20.1	26.4	17.4	27.5	20.5	24.3	19.8	12.6	40.3	15.1	25.5	21.5	25.5	22.7	16.6	18.8	15.5	10.5	14.5	13.6	23.2	21.4	13.8	14.4	30.6	16.3	17.6	25.0	16.5	17.3	22.8	14.8	17.6	19.8	44.7	25.1	23.1	19.9	23.0	16.5	21.0	20.9	28.9	14.7	33.4	26.6	12.4	21.8	30.8	23.8	10.7	15.7	37.0	15.5	9.4	12.5	11.9	8.0	11.1	18.0	8.7	10.9	11.2	5.4	12.4	12.7	13.7	15.5	9.2	12.2	15.3	8.5	10.4	22.6	26.5	6.8	14.9	8.7	9.9	18.4	11.2	10.1	7.1	17.8	14.9	10.1	19.8	8.9	8.1	9.6	12.6	11.8	10.5	6.6	14.6	9.1	10.1	6.4	13.1	17.4	14.9	8.9	10.3	15.1	6.3	8.3	7.7	8.5	6.9	16.8	8.5	12.0	12.7	6.8	9.1	8.8	11.6	16.6	7.4	18.9	8.8	15.2	15.5	20.6	10.3	12.3	10.7	10.7	10.4	10.8	15.7	10.3	12.5	10.8	37.0	9.4	12.4	8.7	10.8	11.9	15.5	20.1	27.5	20.5	15.5	10.5	13.8	14.4	17.3	14.7
RNF14	"ARA54, HFB30, TRIAD2"	ENSG00000013561	"Ring finger protein 14"	Q9UBS8	5	141958328-141990291	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008716	Approved		Supported	Cytosol				Cytosol		"HPA008716: AB_1856337"	"unprognostic (7.45e-3)"	"unprognostic (1.38e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.47e-2)"	"unprognostic (7.24e-3)"	"unprognostic (2.35e-1)"	"unprognostic (4.05e-2)"	"unprognostic (5.22e-2)"	"unprognostic (7.42e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.46e-1)"	"prognostic favourable (1.71e-4)"	"unprognostic (6.89e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavourable (2.21e-4)"	"unprognostic (1.06e-2)"	21.2	29.5	23.7	11.2	33.9	7.8	22.0	22.5	40.2	18.4	18.7	26.2	16.0	15.3	21.0	21.5	15.6	14.3	15.4	32.9	23.6	24.7	31.3	31.3	13.8	13.3	28.9	17.3	15.9	17.1	26.3	28.8	23.6	47.7	21.6	19.8	20.9	18.1	20.1	27.7	11.9	20.9	20.5	26.3	13.8	15.7	33.7	15.0	16.2	26.3	13.3	14.9	16.7	14.0	12.3	17.1	32.6	18.8	16.8	17.0	12.2	12.5	21.0	14.8	29.0	26.6	27.9	9.9	25.8	14.4	18.2	20.2	17.4	14.7	22.2	30.3	26.5	6.9	18.8	25.4	16.3	16.7	16.2	14.1	11.0	7.9	29.3	15.5	12.6	20.9	22.4	24.1	30.4	22.5	17.1	31.1	37.2	15.0	15.0	4.9	6.2	24.0	9.9	16.4	24.1	25.0	21.8	16.3	13.3	22.6	41.5	43.9	28.9	12.1	23.2	24.2	7.8	11.4	24.4	19.6	22.8	20.4	20.7	19.0	29.8	32.6	13.4	13.0	17.0	15.8	16.5	12.3	15.0	16.9	16.2	10.6	11.5	16.7	3.3	16.8	18.8	17.1	16.7	12.2	23.7	33.9	22.5	40.2	23.6	24.7	28.9	17.3	47.7	15.0
RNF144A	"hUIP4, KIAA0161, RNF144, UBCE7IP4"	ENSG00000151692	"Ring finger protein 144A"	P50876	2	6917392-7068286	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 50.4;SH-SY5Y: 15.3;SK-MEL-30: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.7"	"Group enriched"	"Detected in many"	7	"granulocytes: 8.7;T-cells: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049939	Approved		Approved	Vesicles				Vesicles		"HPA049939: "	"unprognostic (1.78e-1)"	"unprognostic (2.53e-3)"	"unprognostic (8.37e-2)"	"prognostic unfavourable (6.00e-4)"	"unprognostic (6.57e-2)"	"prognostic favourable (6.96e-4)"	"unprognostic (7.04e-6)"	"unprognostic (1.20e-1)"	"unprognostic (2.03e-2)"	"unprognostic (5.64e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (7.32e-5)"	"unprognostic (1.30e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.82e-3)"	12.9	28.8	13.3	4.2	21.2	12.1	11.1	45.5	20.7	17.3	5.2	28.7	9.0	3.0	26.0	8.3	4.7	8.4	7.5	8.0	15.6	11.6	7.5	1.8	5.7	7.9	26.5	12.2	20.0	29.7	21.5	12.5	6.2	13.2	8.7	5.7	5.9	4.0	7.4	8.7	5.7	4.1	12.2	21.8	21.1	2.8	5.0	27.1	3.4	3.2	1.2	5.8	5.8	6.5	0.1	0.2	8.7	0.1	0.8	4.1	0.6	0.3	2.2	11.7	2.4	2.6	5.5	9.0	0.0	0.0	0.4	1.1	0.0	0.2	1.1	1.3	0.1	0.2	3.8	0.0	0.0	0.6	1.0	14.9	0.1	4.4	0.1	0.2	50.4	8.7	0.0	0.8	0.0	0.0	6.4	0.2	0.0	1.8	7.6	0.6	4.3	5.3	5.9	8.5	0.9	0.3	3.9	3.9	15.3	0.2	1.5	15.1	0.6	0.9	0.0	1.5	4.0	4.1	1.7	4.1	1.3	0.0	5.8	3.3	5.5	1.5	0.1	8.7	2.1	0.0	3.0	0.1	2.1	1.5	0.2	0.1	4.1	2.8	0.4	0.8	0.0	0.0	0.8	0.6	13.3	21.2	45.5	20.3	15.6	11.6	26.5	12.2	13.2	27.1
TOPORS	"LUN, RP31, TP53BPL"	ENSG00000197579	"TOP1 binding arginine/serine rich protein"	Q9NS56	9	32540544-32552553	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, Ubl conjugation pathway"	Transferase	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 33.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 33.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060640, HPA065661"	Supported		Supported	Nucleoplasm				Nucleoplasm		"HPA060640: , HPA065661: "	"unprognostic (1.75e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.94e-2)"	"prognostic favourable (7.07e-4)"	"unprognostic (2.70e-1)"	"unprognostic (3.61e-1)"	"prognostic favourable (6.64e-6)"	"unprognostic (1.22e-1)"	"unprognostic (5.95e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.92e-1)"	16.0	12.5	12.7	8.5	16.0	22.9	13.7	18.6	15.1	14.0	12.2	9.6	9.5	8.8	12.9	11.4	13.1	10.5	11.7	9.3	15.9	9.6	14.6	17.4	10.6	10.0	20.1	5.2	17.5	13.2	19.6	19.5	17.9	14.8	13.1	10.3	9.2	11.0	10.8	10.9	10.2	16.8	12.3	17.8	12.4	10.7	18.9	15.0	15.5	15.6	9.8	10.5	16.3	16.0	5.2	4.9	33.4	5.9	7.1	7.4	3.4	8.0	7.5	10.3	9.0	12.6	11.4	6.5	10.3	9.7	8.6	10.0	4.6	4.1	13.1	5.9	10.2	5.4	12.1	11.7	12.1	10.9	6.6	44.2	13.0	5.8	7.8	12.5	12.2	9.2	13.1	12.4	8.8	10.4	7.6	6.8	13.9	4.3	11.2	23.1	13.7	7.6	11.6	9.2	5.9	11.4	8.5	5.1	8.2	10.3	5.6	6.7	5.7	7.2	10.9	9.4	9.6	4.9	7.6	4.8	7.7	14.2	8.7	7.2	4.2	14.6	4.9	10.0	5.0	4.6	5.4	4.6	5.4	5.8	4.9	5.2	7.4	7.2	33.4	7.1	5.9	4.0	6.3	3.4	12.7	16.0	18.6	15.1	15.9	9.6	20.1	5.2	14.8	15.0
ANAPC1	"APC1, MCPR, TSG24"	ENSG00000153107	"Anaphase promoting complex subunit 1"	Q9H1A4	2	111611639-111884690	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036329, HPA036330, HPA042998"	Approved		Approved	Vesicles				Vesicles		"HPA036329: AB_10670714, HPA036330: , HPA042998: "	"unprognostic (1.74e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.10e-2)"	"prognostic unfavourable (1.34e-4)"	"unprognostic (3.49e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.16e-4)"	"unprognostic (1.23e-1)"	"unprognostic (3.94e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.92e-1)"	4.9	4.4	3.2	6.1	4.4	4.3	5.8	6.0	4.6	4.9	6.0			5.6	5.6	2.5	6.5	5.2	3.4	4.5	3.5	3.2	3.8	4.0	4.1	7.5	3.0		6.7	5.3	8.7	4.1	4.8		4.1	7.3		4.7	3.7	7.5	5.2	5.5	4.8	2.9	6.0	4.5	6.5			3.9		8.4	5.4	4.9	6.3	5.6	0.7	3.0	6.4	8.7	4.5	18.1	12.9	14.5	10.1	6.1	8.1	14.3	11.0	7.9	13.6	11.9	25.8	11.7	30.9	9.0	9.8	15.6	21.9	12.0	17.3	13.8	12.4	33.1	12.4	13.9	6.3	35.9	11.9	5.6	5.7	20.0	18.8	12.3	31.0	13.6	9.2	7.6	20.8	9.1	22.0	11.1	21.8	16.9	17.6	7.4	17.4	11.9	6.9	11.2	9.9	9.5	6.4	12.3	8.6	11.3	12.8	9.6	11.4	10.5	21.0	28.3	9.5	15.2	9.6	0.0	2.7	0.7	5.9	3.0	8.7	6.3	5.3	5.0	5.6	4.2	8.6	7.3	0.5	6.4	2.4	2.2	2.3	4.5										
ANAPC5	APC5	ENSG00000089053	"Anaphase promoting complex subunit 5"	Q9UJX4	12	121308245-121399896	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039457, HPA039801"	Supported		Approved	Nucleoplasm				Nucleoplasm		"HPA039457: AB_10795676, HPA039801: "	"unprognostic (3.41e-1)"	"unprognostic (1.16e-3)"	"unprognostic (5.37e-2)"	"unprognostic (7.24e-3)"	"unprognostic (5.35e-3)"	"unprognostic (1.18e-2)"	"prognostic unfavourable (2.31e-5)"	"unprognostic (1.63e-1)"	"unprognostic (6.91e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.93e-3)"	"unprognostic (4.94e-2)"	"prognostic unfavourable (2.01e-9)"	"unprognostic (1.79e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.87e-2)"	"unprognostic (3.28e-1)"	28.9	26.9	23.2	24.1	37.3	29.3	31.3	34.1	38.1	28.2	26.3	57.0	21.8	22.3	33.7	28.4	26.0	34.2	20.8	24.8	25.4	21.6	23.6	33.5	22.2	31.6	53.8	25.1	30.0	40.1	27.4	34.1	22.3	34.3	22.9	29.6	24.9	47.3	24.7	48.6	29.2	23.9	26.1	36.5	30.0	27.6	18.2	45.5	36.5	27.5	32.1	37.7	26.3	25.9	30.7	36.4	27.0	32.1	34.9	38.7	42.0	27.6	39.2	17.6	12.6	31.1	34.4	31.1	26.9	30.7	31.4	28.2	31.2	14.3	37.7	27.8	39.2	23.8	40.8	26.5	25.1	32.4	45.5	34.4	25.5	35.7	34.1	49.7	34.3	34.4	25.3	32.1	25.7	39.6	43.3	22.9	25.2	39.7	42.9	48.8	27.9	43.1	38.3	25.8	48.7	22.8	28.8	22.4	22.5	40.0	16.7	27.3	40.1	47.6	24.8	21.3	15.3	14.4	22.0	29.6	29.8	44.3	27.9	37.5	26.1	18.6	30.7	27.0	26.6	32.1	32.4	30.7	30.3	32.5	36.4	23.9	30.6	29.0	7.5	34.9	27.3	24.2	38.7	42.0	23.2	37.3	34.1	38.1	25.4	21.6	53.8	25.1	34.3	45.5
ANAPC7	APC7	ENSG00000196510	"Anaphase promoting complex subunit 7"	Q9UJX3	12	110372900-110403730	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009567	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB009567: AB_2227137"	"unprognostic (2.49e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.69e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.35e-2)"	"prognostic unfavourable (1.54e-6)"	"unprognostic (3.20e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (4.36e-10)"	"unprognostic (1.45e-1)"	"unprognostic (9.92e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.58e-2)"	15.6	20.3	17.8	14.7	25.1	12.2	19.9	24.8	25.1	20.6	16.2	16.8	12.2	11.9	21.4	19.8	34.2	20.9	15.6	18.8	19.1	18.5	21.4	16.8	16.6	20.8	16.2	22.1	18.1	16.7	26.6	14.9	9.6	17.6	21.8	18.9	16.4	19.7	21.3	29.7	16.0	13.3	24.0	17.1	16.8	14.9	36.3	16.3	25.8	23.2	24.5	22.2	19.2	22.5	14.9	17.7	17.6	15.1	20.1	22.4	12.5	18.3	25.3	18.6	15.8	19.5	9.9	10.6	12.9	11.8	23.9	16.6	25.8	11.8	29.4	13.2	17.3	18.7	27.6	17.7	24.4	15.6	22.3	26.0	18.8	21.3	14.2	23.2	12.3	10.7	12.8	20.7	13.8	23.1	40.7	6.0	18.7	19.7	35.1	17.3	16.1	22.1	27.2	18.4	35.0	16.2	23.6	24.2	13.9	20.2	15.9	21.2	33.7	21.1	14.5	14.3	13.4	12.7	15.2	10.6	21.7	39.6	15.9	19.9	16.5	14.3	10.5	17.6	17.2	15.1	20.2	13.3	18.5	16.5	17.7	14.9	15.5	16.5	8.3	20.1	13.1	9.7	22.4	12.5	17.8	25.1	24.8	25.1	19.1	18.5	16.2	22.1	17.6	16.3
ASB2	ASB-2	ENSG00000100628	"Ankyrin repeat and SOCS box containing 2"	Q96Q27	14	93934153-93976791	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 96.9"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 8.6;RPMI-8226: 7.8;U-266/70: 23.4;U-266/84: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in many"	8	"eosinophil: 23.1"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 23.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA001546			Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA001546: AB_1078224"	"unprognostic (5.65e-4)"	"unprognostic (8.19e-2)"	"unprognostic (1.31e-1)"	"prognostic favourable (3.62e-6)"	"unprognostic (4.11e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.05e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.49e-7)"	"unprognostic (2.51e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.27e-1)"	3.1	0.5	0.2	7.9	0.8	0.4	0.5	0.2	1.7	7.4	14.0	0.0	4.6	2.2	11.9	5.7	7.2	6.5	7.7	17.2	0.2	0.2	0.3	0.3	0.8	2.3	0.3	0.6	2.3	0.3	0.3	0.2	0.3	0.5	8.5	1.5	1.5	1.6	5.8	96.9	0.5	4.4	24.4	0.3	1.5	5.0	0.3	0.0	0.0	0.7	25.7	4.7	14.3	4.5	0.9	2.6	23.1	3.0	0.0	1.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	7.8	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.0	1.7	0.0	0.0	0.0	0.1	0.0	23.4	5.2	0.8	0.2	2.4	0.5	0.0	0.0	23.1	0.8	1.0	0.1	0.9	0.8	1.7	2.6	0.2	0.1	0.2	0.0	0.0	3.0	0.1	1.1	0.5	0.2	0.8	0.2	1.7	0.2	0.2	0.3	0.6	0.5	0.0
CCNB1IP1	"C14orf18, HEI10"	ENSG00000100814	"Cyclin B1 interacting protein 1"	Q9NPC3	14	20311368-20333312	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Meiosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 86.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (4.79e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.37e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.79e-2)"	"unprognostic (8.43e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.77e-2)"	"prognostic favourable (5.18e-6)"	"unprognostic (2.12e-1)"	"unprognostic (1.54e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.52e-1)"	12.6	9.7	10.9	9.8	13.7	14.2	27.2	14.5	16.4	20.3	13.4	13.2	17.2	9.9	20.4	24.2	17.4	18.8	12.4	33.8	11.1	11.2	31.2	34.4	15.4	11.2	13.4	11.1	49.1	20.6	14.5	12.1	14.4	15.9	18.0	14.5	15.8	14.0	12.3	20.6	14.6	10.0	27.6	15.8	11.3	13.0	9.7	13.9	11.2	35.8	15.3	16.1	33.6	17.7	9.3	13.7	3.5	3.1	4.4	10.7	3.0	6.5	5.4	30.8	29.6	15.8	21.8	24.9	8.1	16.3	12.5	16.5	18.3	7.3	23.0	5.4	5.9	11.9	21.4	15.3	16.9	6.6	18.1	13.5	5.1	17.2	46.5	24.9	12.7	29.6	25.8	8.9	86.7	9.4	16.5	18.2	8.2	10.5	14.4	17.0	18.5	10.3	17.8	15.2	9.6	13.0	9.7	24.6	25.6	5.6	13.0	36.3	4.1	18.3	4.0	7.1	9.1	8.6	10.5	8.6	10.7	15.7	2.4	21.1	8.2	3.5	3.1	0.0	6.7	1.1	9.1	9.3	7.4	8.3	13.7	8.4	7.7	10.7	0.5	4.4	1.1	13.7	9.9	3.0	10.9	13.7	14.5	16.4	11.1	11.2	13.4	11.1	15.9	13.9
CHFR	"FLJ10796, RNF196"	ENSG00000072609	"Checkpoint with forkhead and ring finger domains"	Q96EP1	12	132822187-132956304	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045768, HPA073826"	Approved		Uncertain	"Nuclear bodies,Microtubules"				"Nuclear bodies, Microtubules"		"HPA045768: , HPA073826: "	"unprognostic (1.46e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.14e-3)"	"unprognostic (6.56e-4)"	"unprognostic (1.94e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.98e-3)"	"prognostic unfavourable (4.21e-9)"	"unprognostic (5.03e-1)"	"unprognostic (8.46e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.11e-2)"	13.7	11.4	14.1	19.0	15.0	25.8	12.5	20.0	16.9	12.1	15.2	16.5	13.4	19.0	15.6	16.7	21.6	12.6	14.3	13.7	12.5	9.8	12.8	13.4	17.0	21.7	15.1	12.6	9.6	16.8	9.6	20.6	22.9	13.0	14.3	12.8	15.5	13.9	14.7	21.0	16.7	18.7	17.8	15.1	24.9	16.8	19.2	14.2	22.3	13.5	12.7	18.4	18.6	14.2	6.6	12.1	19.7	17.0	12.3	12.5	10.1	4.4	10.8	9.1	0.8	8.0	10.7	17.0	9.1	7.6	9.7	10.1	8.5	3.8	0.1	8.8	10.6	7.1	1.1	9.2	5.6	0.6	9.6	14.4	7.4	8.6	17.5	0.6	25.0	14.4	8.4	8.8	6.6	11.8	6.1	0.0	6.7	14.8	10.4	11.2	10.9	8.6	1.4	1.3	4.4	6.4	20.9	8.9	11.4	7.5	7.7	7.0	13.8	14.9	13.2	0.6	2.2	5.0	3.3	15.9	0.0	2.1	0.0	3.0	8.7	17.6	14.2	19.7	10.8	16.9	10.0	6.6	8.7	11.6	12.1	4.5	8.3	9.1	18.9	12.3	17.0	6.6	12.5	10.1	14.1	15.0	20.0	16.9	12.5	9.8	15.1	12.6	13.0	14.2
DZIP3	"hRUL138, PPP1R66"	ENSG00000198919	"DAZ interacting zinc finger protein 3"	Q86Y13	3	108589682-108694846	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 57.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035066, HPA049232"	Approved		Approved	Vesicles				Vesicles		"HPA035066: AB_10601549, HPA049232: "	"unprognostic (1.14e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.33e-1)"	"unprognostic (5.16e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.59e-3)"	"unprognostic (5.38e-2)"	"prognostic favourable (3.65e-4)"	"unprognostic (6.06e-2)"	"unprognostic (2.78e-2)"	"unprognostic (5.51e-3)"	"unprognostic (3.81e-2)"	4.6	9.3	14.1	4.5	25.7	3.1	5.0	14.5	23.7	5.2	4.4	5.8	2.1	2.8	7.4	9.7	3.8	17.4	5.4	10.8	13.2	18.5	10.5	3.9	6.0	8.4	10.3	16.0	10.3	4.9	10.3	57.4	4.5	20.3	9.2	4.5	4.0	3.3	7.0	10.1	3.4	3.6	7.9	9.2	7.0	6.0	29.9	8.0	10.4	12.0	2.8	7.0	5.0	3.5	6.8	1.8	5.2	1.6	11.7	6.5	1.8	6.6	6.0	17.2	10.3	7.6	8.0	5.9	4.2	8.3	7.0	9.5	8.4	4.5	12.0	9.0	4.4	2.5	9.8	3.6	14.8	4.4	4.2	5.5	2.3	5.8	4.6	2.1	3.1	8.3	1.9	6.5	8.1	4.3	5.2	5.9	13.2	6.0	5.3	2.3	10.5	4.3	6.9	14.2	1.1	5.8	3.2	11.7	11.2	7.0	0.7	7.5	10.3	1.9	5.0	6.3	9.6	1.2	3.6	6.8	3.9	23.3	4.8	1.7	7.6	5.2	0.7	1.4	5.0	1.0	6.0	6.8	5.1	6.1	0.6	6.0	4.5	6.0	0.1	11.7	1.6	1.8	6.5	1.8	14.1	25.7	14.5	23.7	13.2	18.5	10.3	16.0	20.3	8.0
JADE2	"JADE-2, KIAA0239, PHF15"	ENSG00000043143	"Jade family PHD finger 2"	Q9NQC1	5	134524312-134583230	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025959, HPA055789"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA025959: AB_1855289, HPA055789: "	"unprognostic (8.98e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.69e-2)"	"unprognostic (5.56e-2)"	"unprognostic (8.25e-2)"	"prognostic unfavourable (4.42e-4)"	"unprognostic (1.58e-2)"	"unprognostic (3.49e-2)"	"prognostic favourable (5.36e-6)"	"unprognostic (3.73e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.87e-2)"	15.6	19.8	16.7	16.1	22.0	9.7	13.9	22.8	21.7	16.0	13.4	15.3	9.2	12.7	13.9	8.4	11.8	20.6	13.2	13.4	17.8	14.5	14.8	4.7	15.0	25.8	30.8	16.0	28.4	14.0	30.9	14.4	8.5	20.1	12.8	8.2	16.4	15.0	16.9	12.0	11.5	17.8	13.0	16.8	22.9	12.9	8.1	30.8	13.0	20.6	6.0	19.2	20.0	22.7	7.3	2.0	6.8	3.0	3.1	6.2	2.4	28.1	20.1	0.6	0.8	7.0	8.5	9.2	5.1	13.4	9.4	11.1	15.2	21.9	31.0	11.4	6.6	6.0	3.6	26.9	4.7	18.7	1.4	7.3	14.0	4.1	7.0	8.0	1.1	5.7	13.1	11.4	14.4	7.1	4.5	11.7	5.7	10.1	13.7	7.2	6.6	10.5	12.3	0.6	12.1	8.8	7.8	4.3	2.8	12.6	0.4	18.0	5.5	9.9	9.9	6.6	6.0	18.7	12.7	5.4	22.5	28.7	10.3	14.3	9.3	6.8	1.2	4.4	6.2	1.1	6.0	7.3	5.7	5.6	2.0	5.5	5.6	5.6	1.3	3.1	3.0	1.2	5.8	2.4	16.7	22.0	22.8	21.7	17.8	14.5	30.8	16.0	20.1	30.8
MYLIP	"IDOL, MIR"	ENSG00000007944	"Myosin regulatory light chain interacting protein"	Q8WY64	6	16129125-16148248	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 84.0"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"																		"unprognostic (1.54e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.79e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.11e-2)"	"prognostic favourable (6.44e-6)"	"unprognostic (2.75e-2)"	"unprognostic (2.67e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.03e-2)"	"prognostic favourable (3.67e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.35e-1)"	"prognostic favourable (4.11e-5)"	23.4	12.5	7.3	10.3	10.6	44.2	19.5	5.4	11.4	28.5	14.4	18.9	16.4	7.5	31.8	16.1	12.1	22.2	19.1	9.0	8.6	6.1	13.1	3.5	19.0	19.4	12.9	8.8	22.3	10.5	9.8	6.1	84.0	7.4	20.1	9.7	20.2	16.2	20.9	20.6	16.7	15.7	18.0	7.0	23.5	14.8	15.2	12.2	8.8	39.1	10.9	15.7	19.0	33.7	4.9	1.4	14.2	2.3	3.2	8.4	1.5	1.9	4.0	1.6	2.0	17.1	4.6	4.4	1.4	3.4	3.4	7.5	11.4	2.1	9.1	7.3	2.2	5.1	8.0	2.5	2.9	3.3	8.3	6.1	4.3	2.1	2.5	4.2	6.1	7.3	3.3	1.7	1.4	7.9	17.6	10.8	1.3	7.6	0.1	20.6	4.8	3.7	2.0	7.8	33.5	3.7	24.3	8.5	3.6	1.7	18.6	9.4	3.4	10.3	2.3	1.6	3.9	1.2	3.5	10.0	4.4	4.8	1.0	12.1	5.4	8.5	2.3	11.1	8.4	2.2	7.3	4.9	5.3	5.9	1.4	4.9	5.9	5.4	14.2	3.2	2.0	0.7	3.2	1.5	7.3	10.6	5.4	11.4	8.6	6.1	12.9	8.8	7.4	12.2
PJA2	"KIAA0438, Neurodap1, RNF131"	ENSG00000198961	"Praja ring finger ubiquitin ligase 2"	O43164	5	109334709-109409994	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040347, HPA057636"	Supported		Enhanced	"Intermediate filaments"				"Intermediate filaments"		"HPA040347: AB_10795631, HPA057636: "	"unprognostic (5.78e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.84e-2)"	"prognostic unfavourable (8.02e-4)"	"unprognostic (4.46e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.64e-3)"	"unprognostic (1.47e-3)"	"unprognostic (5.94e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.00e-2)"	21.6	27.0	40.1	15.9	49.9	29.0	22.1	41.6	63.0	29.0	23.8	19.7	16.8	12.5	29.2	25.0	20.7	20.3	18.6	24.4	44.3	46.2	24.1	29.2	19.4	14.3	36.8	44.0	35.4	14.8	42.8	30.3	21.8	53.2	31.7	20.6	12.5	17.3	37.7	17.1	13.6	15.9	39.2	37.6	19.5	15.8	17.0	27.4	16.7	35.9	9.7	16.3	35.5	21.4	10.3	11.7	29.9	15.5	10.7	12.2	10.6	11.8	8.2	33.1	25.4	32.9	36.1	18.0	19.4	29.4	15.4	25.3	7.6	16.1	15.2	27.0	37.3	6.9	19.3	24.0	28.3	12.9	7.3	17.5	16.8	10.2	23.3	13.1	26.2	24.8	20.1	20.6	29.6	24.5	12.0	28.7	24.8	7.2	15.7	12.1	6.6	5.5	10.2	29.1	25.3	24.0	10.6	6.3	16.3	20.0	7.3	23.4	16.5	19.4	28.2	21.9	10.7	20.2	9.1	19.4	16.5	18.0	23.2	18.3	14.4	17.3	11.6	17.3	9.5	12.2	9.4	10.3	9.4	8.7	11.7	7.4	12.1	8.9	29.9	10.7	15.5	4.9	12.2	10.6	40.1	49.9	41.6	63.0	44.3	46.2	36.8	44.0	53.2	27.4
RBBP6	"P2P-R, PACT, SNAMA"	ENSG00000122257	"RB binding protein 6, ubiquitin ligase"	Q7Z6E9	16	24537693-24572863	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA replication, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032866, HPA041725, HPA043544"	Approved		Enhanced	"Nuclear speckles"				"Nuclear speckles"		"CAB032866: AB_2177791, HPA041725: , HPA043544: "	"unprognostic (1.04e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.83e-2)"	15.1	17.6	17.2	14.0	16.4	81.4	17.9	33.0	15.7	17.8	18.8	16.3	19.8	10.2	23.2	18.7	15.3	21.2	17.6	14.7	15.0	13.2	13.1	15.8	15.7	18.1	18.7	12.2	27.2	14.4	20.7	23.1	73.9	15.4	18.2	14.4	18.4	13.7	14.7	19.2	19.2	16.4	18.4	19.2	18.6	16.4	25.1	18.7	24.3	18.6	11.8	15.5	17.9	17.9	3.8	6.9	8.5	3.7	6.5	4.2	1.0	17.6	9.2	21.8	22.6	16.7	17.4	23.6	14.3	13.2	13.1	14.2	10.2	14.3	24.5	10.8	12.1	17.0	23.3	12.5	21.7	13.4	18.1	21.1	26.5	29.0	13.0	28.0	12.6	15.1	17.4	17.0	20.1	18.7	26.5	22.4	15.1	18.1	22.6	25.3	25.0	8.8	31.1	22.1	21.6	12.6	15.8	17.5	15.3	20.1	18.1	25.3	14.1	24.9	16.2	16.3	12.0	14.0	15.3	20.0	19.8	30.9	13.1	18.6	13.4	8.5	2.3	3.7	4.0	3.7	4.2	3.8	4.1	2.8	1.6	3.8	3.5	4.0	5.0	6.5	2.1	6.9	3.1	1.0	17.2	16.4	33.0	15.7	15.0	13.2	18.7	12.2	15.4	18.7
RLIM	"MGC15161, NY-REN-43, RNF12"	ENSG00000131263	"Ring finger protein, LIM domain interacting"	Q9NVW2	X	74585217-74614617	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018895	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA018895: AB_1856323"	"unprognostic (1.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.98e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavourable (6.04e-4)"	"unprognostic (1.20e-1)"	11.8	14.3	17.5	10.6	25.6	37.4	12.4	12.6	20.5	12.2	7.4	8.3	5.6	6.4	10.6	8.0	10.2	9.5	10.7	10.5	17.1	16.6	11.6	9.7	13.8	9.2	12.4	13.7	12.4	9.7	19.5	18.5	10.5	28.6	11.9	7.6	5.2	8.9	8.7	11.2	10.2	7.1	10.1	13.9	9.8	8.4	6.9	12.4	9.7	13.0	6.2	10.1	10.5	9.3	3.5	4.8	16.3	7.4	5.2	4.6	3.0	13.5	13.8	13.4	11.2	13.5	14.3	13.2	13.1	15.2	11.7	14.5	10.7	14.2	7.3	15.3	16.4	11.8	26.9	15.7	18.0	6.6	14.2	12.8	24.3	6.5	12.0	19.3	22.9	13.8	9.9	16.7	28.7	13.6	11.1	13.3	15.4	10.3	14.3	10.9	20.6	13.3	13.7	28.4	12.3	10.9	16.2	9.9	11.5	24.5	11.9	15.2	6.7	15.2	18.0	14.2	13.8	14.5	11.4	7.1	13.6	11.7	15.5	19.6	13.8	16.3	5.9	5.6	3.2	7.4	3.3	3.0	4.1	4.0	4.8	3.5	4.5	4.1	11.4	5.2	5.4	2.6	4.6	3.0	17.5	25.6	12.6	20.5	17.1	16.6	12.4	13.7	28.6	12.4
RNF125	FLJ20456	ENSG00000101695	"Ring finger protein 125"	Q96EQ8	18	32018372-32073213	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	4	"HMC-1: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041514	Uncertain		Supported	"Nucleoli,Golgi apparatus"				"Golgi apparatus"	Nucleoli	"HPA041514: AB_10795596"	"unprognostic (2.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.88e-1)"	"unprognostic (3.93e-1)"	"unprognostic (5.03e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.30e-3)"	"unprognostic (6.15e-2)"	"unprognostic (4.21e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.35e-2)"	"prognostic unfavourable (4.06e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.82e-1)"	"unprognostic (7.07e-3)"	21.9	2.3	4.1	9.1	5.7	18.2	20.4	1.2	6.6	5.0	8.9	12.2	3.3	12.3	7.2	5.5	3.9	4.3	6.0	5.4	6.1	4.1	2.1	14.1	10.3	13.5	7.7	3.1	2.4	4.2	2.5	1.3	4.4	7.0	3.1	7.8	1.6	5.0	1.9	4.4	6.0	26.0	4.1	12.0	7.4	4.2	3.3	8.3	14.8	3.2	2.9	7.2	4.5	6.2	2.1	3.4	9.0	3.8	11.7	12.5	5.1	0.7	0.1	0.1	0.2	0.3	0.5	0.6	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.8	0.0	0.5	0.9	0.7	0.1	3.9	1.6	0.2	0.2	0.2	0.1	5.1	31.8	1.0	1.5	0.0	1.7	0.3	0.1	1.1	0.0	1.1	1.3	4.8	2.6	0.9	5.4	0.3	0.1	0.3	0.3	0.5	0.2	0.1	0.1	7.8	0.8	2.5	0.1	0.1	0.5	0.1	0.0	3.7	0.1	0.1	0.4	6.8	4.2	9.0	3.8	3.3	12.5	2.0	8.2	2.0	10.1	10.5	3.4	2.1	8.2	10.6	1.5	11.7	1.9	3.4	10.0	5.1	4.1	5.7	1.2	6.6	6.1	4.1	7.7	3.1	7.0	8.3
RNF165	"ARKL2, RNF111L2"	ENSG00000141622	"Ring finger protein 165"	Q6ZSG1	18	46326809-46463140	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 28.6"	"Cell line enhanced"	"Detected in some"		"AF22: 12.5;HaCaT: 6.8;HeLa: 6.7;RPMI-8226: 6.5;SCLC-21H: 12.9;SH-SY5Y: 14.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"MAIT T-cell: 1.1;NK-cell: 3.9;plasmacytoid DC: 1.5"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.5;NK-cells: 3.9;T-cells: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041615, HPA047798"	Uncertain		Approved	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"		"HPA041615: , HPA047798: "	"unprognostic (6.46e-3)"	"unprognostic (7.25e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.24e-5)"	"unprognostic (3.43e-1)"	"unprognostic (4.57e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.87e-5)"	"unprognostic (3.53e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.64e-1)"	1.9	1.7	9.9	1.0	9.5	0.9	2.1	28.6	13.8	1.0	0.8	1.7	1.7	0.4	1.0	8.4	2.7	3.0	1.0	2.5	6.1	4.4	2.3	8.3	1.0	0.9	2.2	7.2	0.5	1.0	13.1	4.8	0.8	2.0	3.6	0.6	2.7	1.4	3.9	3.6	3.5	1.0	0.7	1.7	5.3	0.7	1.3	1.0	1.7	8.8	1.2	1.3	1.2	1.0	0.0	1.5	0.5	0.0	3.9	1.1	0.0	1.5	0.1	12.5	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	6.8	0.5	1.0	0.0	0.0	1.0	0.1	6.7	0.0	0.0	2.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.3	1.0	1.7	1.2	2.4	0.5	6.5	0.8	2.1	12.9	14.7	2.3	0.0	0.0	0.3	0.5	0.0	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	4.0	0.4	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.9	0.0	1.5	0.0	0.0	9.9	9.5	28.6	13.8	6.1	4.4	2.2	7.2	2.0	1.0
RNF168	FLJ35794	ENSG00000163961	"Ring finger protein 168"	Q8IYW5	3	196468783-196503768	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA046109			Enhanced	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA046109: "	"unprognostic (6.15e-3)"	"prognostic favourable (8.21e-4)"	"unprognostic (3.11e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.22e-1)"	"unprognostic (5.04e-2)"	"prognostic unfavourable (2.29e-4)"	"unprognostic (6.81e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavourable (8.31e-4)"	"unprognostic (4.83e-3)"	"unprognostic (2.80e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.95e-2)"	"unprognostic (6.65e-2)"	20.8	9.3	8.9	10.7	11.1	31.6	18.7	21.1	13.0	13.6	11.2	10.7	12.3	11.1	13.9	8.5	14.3	10.1	10.9	12.0	10.2	10.2	7.5	18.8	14.3	12.0	13.8	11.0	14.6	9.2	12.0	8.1	9.9	15.3	10.1	10.8	9.1	11.0	13.6	20.8	20.1	10.1	12.9	10.5	11.7	10.7	18.4	13.4	17.6	9.6	13.9	15.2	14.7	17.1	6.2	5.8	21.8	10.0	7.7	11.6	5.7	12.3	4.9	8.9	11.6	8.3	6.1	12.7	7.6	4.8	5.1	8.1	9.6	6.1	13.1	17.6	6.3	12.6	12.4	9.0	7.9	6.2	6.1	24.9	12.5	11.9	4.3	7.6	6.2	6.0	3.5	8.0	7.1	7.4	7.4	13.8	5.1	20.9	25.1	4.5	10.5	6.5	11.3	10.3	10.6	4.3	17.1	7.4	7.5	8.6	10.6	6.5	16.0	6.8	7.3	8.9	7.0	9.4	10.0	11.8	11.1	19.9	8.7	9.2	7.0	21.8	6.6	7.5	11.6	7.1	10.4	5.7	9.8	8.3	5.8	6.2	8.7	9.1	7.3	7.7	10.0	5.5	6.2	5.7	8.9	11.1	21.1	13.0	10.2	10.2	13.8	11.0	15.3	13.4
RNF181	HSPC238	ENSG00000168894	"Ring finger protein 181"	Q9P0P0	2	85595725-85597613	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046112, HPA062121"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA046112: , HPA062121: "	"unprognostic (3.79e-1)"	"unprognostic (8.31e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.22e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.96e-2)"	"prognostic unfavourable (1.06e-6)"	"unprognostic (3.24e-1)"	"unprognostic (2.04e-1)"	"prognostic favourable (4.59e-5)"	"unprognostic (1.49e-2)"	32.9	41.5	42.2	26.4	36.2	32.8	40.4	19.0	38.7	34.4	40.5	33.0	36.0	34.5	28.1	44.5	40.2	33.3	34.8	52.4	34.5	32.9	57.8	85.1	36.0	33.1	41.2	29.3	31.6	85.1	21.8	20.2	50.7	36.0	34.2	35.4	32.1	42.1	45.7	47.0	30.4	46.5	33.2	42.2	37.2	35.7	36.3	31.3	31.0	43.7	39.2	42.6	43.8	29.4	53.2	80.2	78.6	94.7	39.3	54.4	83.3	32.2	32.7	25.5	27.6	26.1	32.3	41.2	27.3	53.8	58.3	55.4	49.9	34.3	30.8	53.7	40.5	30.3	22.0	43.7	62.7	35.0	27.1	23.4	16.9	59.9	45.8	25.9	32.1	33.7	58.1	38.8	65.0	48.4	27.4	32.1	78.6	51.7	24.4	60.3	17.8	49.4	26.1	53.6	43.7	54.4	30.1	15.2	20.1	23.1	33.6	44.8	33.3	34.3	41.8	28.6	20.4	57.2	38.9	44.8	37.3	38.6	44.7	39.1	25.1	40.4	94.7	71.6	40.7	69.3	37.7	53.2	42.6	39.1	71.0	44.3	36.7	36.8	78.6	39.3	51.8	80.2	54.4	83.3	42.2	36.2	19.0	38.7	34.5	32.9	41.2	29.3	36.0	31.3
RNF185	FLJ38628	ENSG00000138942	"Ring finger protein 185"	Q96GF1	22	31160183-31207019	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"														"unprognostic (1.50e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.76e-3)"	"unprognostic (2.60e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.97e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.61e-1)"	"unprognostic (9.41e-2)"	"prognostic favourable (4.82e-5)"	"unprognostic (3.04e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.10e-1)"	18.3	16.1	15.2	11.6	20.3	6.8	18.4	16.7	23.4	19.4	17.0	24.3	14.4	15.6	21.8	20.2	20.5	18.3	13.6	15.6	14.7	15.6	27.6	39.7	14.4	11.1	15.9	14.6	21.2	23.5	32.5	24.3	19.8	20.9	30.5	17.3	24.1	27.0	23.5	18.0	22.9	24.4	22.8	16.4	14.4	18.0	11.8	15.1	12.6	39.9	14.4	18.0	19.4	18.5	10.3	12.6	21.5	15.1	15.4	14.0	13.0	9.4	5.6	10.9	12.3	22.1	14.9	10.4	11.3	21.9	15.6	21.2	6.2	4.5	9.0	6.4	20.0	6.0	10.4	11.7	16.1	8.9	11.2	3.9	5.4	7.6	31.0	9.5	6.1	15.8	42.1	10.9	25.4	13.0	4.6	10.8	18.6	6.7	8.1	5.4	4.8	6.2	8.5	10.9	10.5	11.2	8.2	4.8	9.8	8.2	11.0	16.6	7.6	6.3	9.0	11.1	8.0	12.8	5.5	15.2	12.3	11.5	14.5	6.0	8.8	15.0	14.6	8.0	12.4	15.1	14.0	10.3	12.7	13.8	12.6	9.0	12.9	11.8	21.5	15.4	12.2	4.7	13.6	13.0	15.2	20.3	16.7	23.4	14.7	15.6	15.9	14.6	20.9	15.1
RNF2	"BAP-1, BAP1, DING, HIPI3, RING1B, RING2"	ENSG00000121481	"Ring finger protein 2"	Q99496	1	185045364-185102608	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026803	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA026803: AB_10602086"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (1.08e-5)"	"unprognostic (5.85e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.62e-2)"	"unprognostic (2.01e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavourable (1.94e-7)"	"unprognostic (2.08e-1)"	"unprognostic (5.51e-2)"	"unprognostic (9.89e-3)"	"unprognostic (2.52e-1)"	17.8	15.0	14.3	13.9	12.4	15.3	29.7	15.6	23.6	16.6	12.0	7.8	20.7	10.4	16.2	12.6	15.2	11.5	13.1	12.0	16.0	13.1	13.7	11.1	16.7	20.7	9.4	10.4	19.9	15.0	12.3	26.5	28.4	11.4	13.2	13.5	10.1	17.3	20.6	13.1	12.5	9.8	14.8	11.2	16.2	12.2	27.8	9.4	17.2	15.1	11.5	16.1	17.6	16.9	14.7	19.9	20.6	22.1	17.4	19.4	12.0	13.9	7.7	28.5	11.3	8.1	13.9	27.1	9.9	12.6	15.7	12.6	12.3	23.4	4.2	12.4	12.1	4.9	19.5	14.3	19.1	12.2	10.2	22.5	4.7	10.7	11.9	23.0	12.7	13.0	8.8	12.8	16.5	15.7	17.8	10.0	11.3	8.7	19.9	6.8	38.2	4.2	22.9	17.7	4.0	11.9	9.9	8.4	14.4	6.9	4.2	20.2	8.8	12.4	11.1	11.3	14.7	10.7	12.6	16.5	10.7	15.6	7.0	10.9	12.6	19.3	17.0	20.6	13.5	21.1	19.4	14.6	12.5	12.6	19.9	14.7	12.8	12.6	7.9	17.4	22.1	10.0	13.2	12.0	14.3	12.4	15.6	23.6	16.0	13.1	9.4	10.4	11.4	9.4
RNF216	"TRIAD3, UBCE7IP1, ZIN"	ENSG00000011275	"Ring finger protein 216"	Q9NWF9	7	5620047-5781739	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Ubl conjugation pathway"	Transferase	"Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018955, HPA021123"	Supported		Supported	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA018955: AB_1858500, HPA021123: AB_1858501"	"unprognostic (3.31e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.56e-1)"	"prognostic unfavourable (2.26e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.40e-2)"	"prognostic favourable (6.24e-5)"	"unprognostic (2.88e-2)"	"unprognostic (9.01e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.69e-3)"	16.9	14.9	22.0	18.8	24.8	22.2	18.4	33.5	27.8	17.8	26.9	22.0	13.4	11.5	26.9	13.3	18.7	19.6	14.2	29.1	20.5	17.4	12.7	11.8	14.9	23.8	23.8	14.8	25.6	21.3	23.2	24.9	14.6	20.4	17.7	11.8	18.9	16.2	21.5	22.5	15.1	20.1	25.0	18.7	23.3	18.3	34.3	26.3	18.5	19.8	9.6	24.1	17.7	30.7	8.8	6.7	24.5	8.4	10.0	9.7	6.5	14.4	15.6	12.8	21.8	15.3	13.3	8.8	15.5	16.3	16.1	14.9	11.3	8.3	12.7	8.0	17.3	10.4	13.3	10.9	13.2	7.9	11.6	9.8	9.5	11.4	18.4	16.0	16.8	13.7	14.0	12.3	15.1	12.7	19.6	8.9	17.8	22.2	6.0	25.5	17.6	13.0	15.3	18.1	7.1	9.6	12.2	9.8	15.6	9.8	24.6	8.8	9.7	16.4	13.8	16.3	29.4	16.6	13.9	7.2	5.4	10.3	12.2	14.9	25.9	1.3	7.7	24.5	9.0	8.4	9.0	7.3	7.9	6.7	6.7	8.8	9.7	9.1	13.1	10.0	7.7	5.4	7.0	6.5	22.0	24.8	33.5	27.8	20.5	17.4	23.8	14.8	20.4	26.3
RNF217	"C6orf172, dJ84N20.1, IBRDC1, MGC26996"	ENSG00000146373	"Ring finger protein 217"	Q8TC41	6	124962545-125092633	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 63.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.9;myeloid DC: 1.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029598	Uncertain									"HPA029598: AB_10602297"	"unprognostic (2.96e-2)"	"unprognostic (2.34e-3)"	"unprognostic (8.07e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.22e-3)"	"unprognostic (4.94e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavourable (4.60e-5)"	"unprognostic (8.29e-4)"	"unprognostic (2.16e-1)"	"unprognostic (7.52e-2)"	"prognostic unfavourable (1.92e-4)"	9.6	3.5	3.3	4.2	4.7	10.5	14.6	3.8	3.5	8.0	7.7	5.7	6.4	2.3	5.9	5.6	6.2	7.5	12.1	6.5	3.8	1.7	2.5	6.3	7.3	3.7	4.3	2.9	11.5	3.8	63.3	4.0	12.0	3.4	6.4	2.3	6.0	6.0	6.9	10.1	10.9	3.1	13.0	2.3	2.6	4.5	7.4	5.7	0.1	7.4	3.6	1.6	8.7	13.6	0.0	1.2	0.6	1.9	0.3	0.2	0.3	4.1	4.2	1.5	0.5	5.4	2.1	8.5	5.7	7.7	3.9	5.1	0.0	3.9	0.0	7.9	5.4	6.0	0.9	5.1	5.5	0.0	4.8	2.3	6.3	1.3	5.2	0.0	0.2	5.9	4.7	2.9	8.6	4.4	11.6	0.0	6.8	0.0	0.0	0.0	1.3	1.1	0.1	5.9	0.0	4.0	1.9	0.7	0.0	2.5	0.6	2.1	4.1	0.6	6.9	3.2	10.3	0.0	12.1	0.0	0.0	0.0	2.4	0.0	3.8	0.6	1.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.3	0.3	0.0	0.0	0.3	3.3	4.7	3.8	3.5	3.8	1.7	4.3	2.9	3.4	5.7
RNF31	"FLJ10111, FLJ23501, HOIP, Paul, ZIBRA"	ENSG00000092098	"Ring finger protein 31"	Q96EP0	14	24146683-24160661	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB009063, HPA048745"	Approved		Approved	Cytosol				Cytosol		"CAB009063: AB_2127706, HPA048745: "	"unprognostic (3.58e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.05e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.46e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.99e-1)"	14.4	18.5	11.7	21.5	17.4	20.0	15.1	20.0	26.4	17.7	17.3	18.4	19.9	13.4	22.4	22.3	15.4	17.4	17.2	14.5	10.7	9.8	17.2	14.8	15.3	19.3	11.0	18.0	20.6	23.6	20.0	19.2	18.7	13.4	16.4	14.1	16.9	19.6	23.1	39.5	29.1	16.1	19.7	9.1	27.3	16.5	21.8	11.0	33.6	17.4	13.1	24.9	16.3	13.5	2.4	4.6	3.8	3.7	2.5	4.8	1.3	4.4	10.3	9.7	12.0	6.6	6.9	19.7	7.8	11.5	15.3	12.2	9.4	11.2	8.8	4.9	11.0	7.6	5.5	11.0	9.1	9.3	4.2	8.2	10.6	20.6	10.8	13.8	14.7	12.5	9.5	6.9	10.9	9.7	4.8	11.7	6.8	13.8	13.0	8.1	5.2	11.3	8.8	7.2	5.6	7.8	18.4	8.6	10.8	7.1	18.9	9.4	6.6	10.2	9.5	10.8	8.2	7.8	7.3	15.6	13.8	8.6	4.1	5.5	10.0	0.0	2.1	1.5	1.9	3.7	4.8	2.4	1.9	2.1	1.8	1.1	2.3	1.3	3.8	2.5	2.1	4.6	3.0	1.3	11.7	17.4	20.0	26.4	10.7	9.8	11.0	18.0	13.4	11.0
RNF43	"DKFZp781H0392, FLJ20315, URCC"	ENSG00000108375	"Ring finger protein 43"	Q68DV7	17	58352500-58417595	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Developmental protein, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 14.9;Hep G2: 29.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 41.7"	"Region enriched"	"Detected in many"	7	"cerebellum: 30.6"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA008079	Uncertain									"HPA008079: AB_1856371"	"unprognostic (2.53e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.79e-1)"	"prognostic favourable (6.04e-9)"	"unprognostic (3.61e-3)"	"unprognostic (2.56e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.04e-2)"	0.4	9.4	2.2	6.2	3.5	1.9	4.5	30.6	4.3	3.4	26.4	0.9	21.3	18.5	1.7	9.1	10.0	3.9	8.1	3.3	1.9	1.3	8.0	7.0	6.1	2.7	0.8	1.1	1.6	13.2	3.0	13.3	8.7	4.1	8.0	16.3	3.8	13.7	19.0	0.5	8.9	29.0	0.9	0.8	0.9	4.9	3.1	0.7	3.0	1.8	5.7	6.6	4.0	4.4	0.9	1.1	1.7	1.8	5.6	3.6	1.2	0.7	10.4	1.9	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	14.9	5.0	4.2	5.3	0.0	2.9	0.4	4.0	0.0	8.8	7.3	3.4	0.5	29.2	0.0	4.2	3.0	0.0	8.2	0.0	1.3	0.0	0.3	3.6	0.0	0.1	2.2	3.9	0.3	0.7	6.9	0.0	2.2	3.7	5.6	1.2	0.3	0.9	0.4	0.3	1.3	1.2	0.0	0.1	1.2	0.0	0.0	3.8	1.7	3.3	0.4	0.4	2.4	1.7	0.2	1.6	3.1	0.8	3.2	0.9	2.5	3.6	0.4	0.9	2.3	3.0	0.8	5.6	1.8	1.1	1.2	1.2	2.2	3.5	30.6	4.3	1.9	1.3	0.8	1.1	4.1	0.7
TRIM71	"LIN-41, LIN41"	ENSG00000206557	"Tripartite motif containing 71"	Q2Q1W2	3	32818018-32897826	"Enzymes, Predicted intracellular proteins"	"RNA-mediated gene silencing, Ubl conjugation pathway"	"Developmental protein, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lung: 6.5;testis: 11.1"	"Cell line enhanced"	"Detected in some"		"AF22: 12.4;BEWO: 37.5;CACO-2: 8.8;Hep G2: 24.2;NTERA-2: 33.2"	"Cancer enriched"	"Detected in some"	28	"testis cancer: 28.6"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA038141, HPA038142"	Uncertain		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"				"Plasma membrane, Actin filaments, Focal adhesion sites"		"HPA038141: , HPA038142: AB_10697240"	"unprognostic (2.93e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.36e-6)"	"unprognostic (3.92e-2)"	"unprognostic (9.27e-2)"	"unprognostic (8.17e-2)"	"unprognostic (4.65e-2)"	0.1	0.0	0.7	0.1	1.9	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	2.7	0.7	2.2	0.0	6.5	0.0	0.2	0.0	0.1	0.0	0.0	0.5	1.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.1	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.5	0.3	0.0	0.1	0.0	0.0	0.0	12.4	0.0	0.0	0.0	37.5	0.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.6	0.0	24.2	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.2	2.6	33.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	1.9	0.0	0.5	2.7	0.7	0.2	0.0	1.9	0.0
VHLL	"VHLP, VLP"	ENSG00000189030	"VHL like"	Q6RSH7	1	156298624-156299299	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 2.6;pancreas: 1.6;skeletal muscle: 1.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.9;Daudi: 2.4;hTCEpi: 3.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																										"unprognostic (1.61e-1)"									"unprognostic (2.45e-1)"				0.1	0.1	0.1	0.0	0.3	0.0	0.0	2.6	0.2	0.0	0.1			0.0	0.3	0.0	1.2	0.1	0.8	0.1	0.2	0.2	0.0	0.4	0.1	0.1	0.0		0.2	1.6	0.0	0.1	0.1		0.2	0.1		0.0	0.0	1.5	0.3	0.0	0.2	0.1	0.2	0.1	0.6			0.1		0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.5	0.7	0.0	3.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ZNRF1	"DKFZp434E229, FLJ14846, nin283"	ENSG00000186187	"Zinc and ring finger 1"	Q8ND25	16	74999030-75110994	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 80.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 53.8;MOLT-4: 38.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 4.5;T-reg: 5.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 4.5;monocytes: 1.4;T-cells: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027470	Approved									"HPA027470: AB_10603108"	"unprognostic (2.78e-2)"	"prognostic favourable (9.90e-4)"	"unprognostic (4.45e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.69e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.44e-2)"	10.0	9.5	13.4	8.1	13.7	5.2	16.6	6.3	16.5	13.2	12.5	8.1	6.7	8.3	10.7	9.1	28.2	10.0	11.3	9.1	11.6	14.6	5.6	12.8	12.8	8.7	9.1	9.4	10.1	6.1	12.2	6.2	9.7	7.8	9.1	10.8	7.2	7.5	7.5	58.6	14.5	11.2	10.1	8.8	2.8	11.8	21.6	4.9	80.1	21.4	16.9	13.3	14.0	15.5	0.2	0.8	4.5	1.4	0.0	5.2	0.3	3.1	4.6	8.0	8.2	8.6	6.7	27.7	3.8	5.4	5.3	5.2	7.4	9.9	0.8	3.0	8.3	7.6	3.9	5.3	4.2	7.7	2.2	16.5	1.5	13.6	6.8	7.9	53.8	6.0	4.4	5.5	4.5	8.6	7.9	2.6	4.1	30.2	38.5	29.1	11.1	5.0	17.1	3.0	5.0	7.5	9.0	10.7	11.5	6.1	8.1	2.2	21.5	7.5	5.8	3.7	6.4	6.5	2.3	15.4	15.6	9.1	4.8	8.8	3.7	4.5	1.4	0.9	0.2	1.1	1.3	0.2	1.5	0.2	0.8	0.0	0.0	0.2	1.2	0.0	1.1	0.0	5.2	0.3	13.4	13.7	6.3	16.5	11.6	14.6	9.1	9.4	7.8	4.9
CBL	"c-Cbl, CBL2, RNF55"	ENSG00000110395	"Cbl proto-oncogene"	P22681	11	119206276-119313926	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 40.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 11.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004350, HPA027956"	Enhanced		Supported	Cytosol				Cytosol		"CAB004350: AB_2244054, HPA027956: AB_10601094"	"unprognostic (2.52e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.10e-3)"	"unprognostic (9.75e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.23e-2)"	"unprognostic (5.21e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.85e-2)"	9.9	5.5	9.1	17.0	11.1	11.1	8.8	10.7	12.0	6.2	7.5	8.7	3.0	5.7	9.9	5.3	7.5	7.4	6.3	5.9	8.0	9.6	5.5	4.0	10.3	16.3	8.1	6.9	6.3	5.6	16.6	4.1	9.1	9.3	5.3	7.5	6.4	5.4	7.1	3.9	7.4	8.6	10.6	8.9	13.3	7.3	32.3	5.1	40.9	6.0	5.5	15.6	7.6	7.7	1.8	3.3	11.8	3.7	0.6	1.9	1.0	6.3	4.8	16.8	10.5	5.0	6.0	9.9	6.8	7.1	6.6	6.6	10.2	7.8	15.0	6.2	8.6	9.3	11.5	5.8	14.5	8.5	2.7	15.4	3.6	3.1	6.2	17.9	17.6	5.2	6.5	16.9	18.2	16.3	12.4	6.3	11.9	6.8	9.5	10.0	8.7	5.3	10.3	8.4	2.8	5.9	5.1	2.3	7.0	12.7	5.5	4.5	5.8	15.1	13.6	10.3	7.3	7.2	8.9	2.1	3.1	12.2	4.2	15.5	7.3	0.8	3.2	2.4	1.3	3.7	1.1	1.8	1.6	1.3	3.3	1.8	1.8	1.9	11.8	0.6	3.1	1.8	1.4	1.0	9.1	11.1	10.7	12.0	8.0	9.6	8.1	6.9	9.3	5.1
CBLC	"CBL-3, CBL-SL, RNF57"	ENSG00000142273	"Cbl proto-oncogene C"	Q9ULV8	19	44777869-44800634	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 66.8"	"Cell line enhanced"	"Detected in some"		"A-431: 19.0;BEWO: 13.1;CACO-2: 12.8;CAPAN-2: 26.3;HaCaT: 18.4;HBEC3-KT: 16.0;hTCEpi: 12.2;RT4: 16.0;SK-BR-3: 14.6;T-47d: 10.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB008087, HPA035266"	Approved		Approved	Nucleoplasm				Nucleoplasm		"CAB008087: AB_2228531, HPA035266: "	"unprognostic (1.58e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.82e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.85e-1)"	"prognostic favourable (3.11e-6)"	"unprognostic (3.50e-1)"	"unprognostic (8.25e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.21e-3)"	0.1	0.0	0.5	8.5	0.2	0.0	4.8	0.1	0.4	4.4	39.5	0.1	3.2	29.5	1.7	1.7	22.0	1.4	18.8	0.1	0.6	0.0	4.9	15.1	1.3	0.1	0.1	0.3	0.8	18.1	0.9	0.7	4.1	0.2	6.9	6.9	0.5	11.4	5.2	0.1	20.8	66.8	0.4	0.1	0.1	10.2	1.6	0.1	0.5	1.9	13.2	15.7	7.6	8.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	19.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	12.8	26.3	0.0	0.0	0.0	18.4	0.0	16.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.0	0.1	0.0	0.0	14.6	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.4	0.6	0.0	0.1	0.3	0.2	0.1
CBLL2	"CT138, FLJ25735, HAKAIL, ZNF645"	ENSG00000175809	"Cbl proto-oncogene like 2"	Q8N7E2	X	22272943-22274461	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	52	"testis: 13.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5			0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0										
MARCH1	"FLJ20668, MARCH-I, RNF171"	ENSG00000145416	"Membrane associated ring-CH-type finger 1"	Q8TCQ1	4	163524298-164384050	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.4;lymphoid tissue: 32.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 9.4;U-266/70: 9.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	95	"classical monocyte: 16.8;eosinophil: 9.9;intermediate monocyte: 17.0;memory B-cell: 18.5;myeloid DC: 18.1;naive B-cell: 15.7;non-classical monocyte: 17.2;plasmacytoid DC: 6.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014600	Uncertain		Supported	Mitochondria				Mitochondria		"HPA014600: AB_1853573"	"unprognostic (7.29e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.79e-3)"	"unprognostic (9.00e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.91e-2)"	7.7	4.2	11.6	20.5	19.7	3.9	4.0	3.1	14.5	3.7	3.9	8.5	0.1	4.4	3.9	4.6	3.6	4.2	5.9	2.6	12.6	10.1	3.0	4.5	8.3	28.5	17.3	6.3	4.2	4.1	1.5	4.1	10.2	13.5	3.5	5.1	2.4	4.6	1.8	1.6	4.9	9.0	6.5	24.4	32.4	4.1	2.3	17.9	2.6	3.2	1.4	24.6	9.0	4.2	18.5	18.1	9.9	17.2	0.1	0.0	6.6	0.8	0.7	2.9	1.7	0.0	0.0	1.8	1.2	0.1	0.0	0.0	1.6	3.3	9.4	3.5	0.0	1.4	0.0	0.0	0.0	1.0	1.0	6.7	3.7	0.6	0.0	4.1	2.2	0.0	0.0	0.0	0.2	0.0	2.5	4.9	3.3	1.0	2.3	2.6	3.6	1.3	2.6	0.5	0.7	0.1	1.5	1.5	1.3	0.9	1.4	0.5	4.0	0.7	3.1	1.1	2.0	0.7	2.3	9.7	3.2	2.6	1.3	2.1	1.5	0.0	16.8	9.9	0.0	17.0	0.0	18.5	0.0	0.0	18.1	15.7	0.0	0.0	0.1	0.1	17.2	6.8	0.0	6.6	11.6	19.7	3.1	12.5	12.6	10.1	17.3	6.3	13.5	17.9
RNF111	"ARK, Arkadia, DKFZP761D081, FLJ38008"	ENSG00000157450	"Ring finger protein 111"	Q6ZNA4	15	58865175-59097419	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038576, HPA038577"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA038576: AB_10964492, HPA038577: AB_10960052"	"unprognostic (7.30e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.37e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.21e-1)"	"unprognostic (5.10e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.74e-2)"	12.8	11.2	15.3	15.6	19.3	21.2	12.7	24.1	21.9	15.1	9.8	18.8	10.9	11.4	16.4	9.8	16.2	12.6	13.0	11.0	13.0	13.0	12.9	14.8	13.3	13.9	15.7	15.5	16.8	14.8	20.8	19.2	16.7	17.8	12.7	10.3	12.9	14.9	12.5	15.0	14.1	10.9	11.7	14.2	14.3	12.0	15.7	16.9	14.9	16.4	6.5	17.8	15.8	14.8	7.9	5.2	26.7	9.9	3.3	6.1	2.0	9.7	22.7	14.5	12.4	12.6	14.2	12.4	12.8	15.0	12.8	16.5	9.9	6.5	12.0	14.5	17.8	19.2	3.9	9.5	16.0	12.4	8.1	14.9	9.2	7.6	13.7	8.6	16.8	11.1	10.4	13.8	15.3	14.2	13.7	12.1	15.7	4.7	11.4	5.6	11.9	8.8	11.5	20.7	9.8	9.8	17.5	11.9	17.4	11.5	11.4	11.1	8.9	10.7	16.3	20.5	17.2	10.7	12.2	8.7	11.9	14.3	12.5	14.0	15.4	6.4	9.9	9.3	4.8	7.0	4.8	7.4	4.9	4.3	5.2	7.9	5.5	4.2	26.7	3.3	7.6	4.9	6.1	2.0	15.3	19.3	24.1	21.9	13.0	13.0	15.7	15.5	17.8	16.9
RNF34	"FLJ21786, RIF, RIFF"	ENSG00000170633	"Ring finger protein 34"	Q969K3	12	121400041-121430623	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074151			Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA074151: "	"unprognostic (3.54e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.10e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.55e-2)"	"prognostic unfavourable (6.72e-8)"	"unprognostic (3.39e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.87e-3)"	"unprognostic (2.80e-2)"	"prognostic unfavourable (4.63e-4)"	"unprognostic (1.09e-1)"	"unprognostic (3.55e-1)"	"unprognostic (5.55e-3)"	"prognostic favourable (3.02e-4)"	11.9	10.6	18.2	19.6	23.4	10.4	12.3	25.2	26.9	11.2	17.3	21.5	10.0	17.0	15.0	12.7	14.4	11.7	15.5	16.0	17.6	17.7	10.8	11.1	11.6	27.2	19.3	19.4	14.0	12.2	11.1	17.1	10.2	19.3	10.2	14.2	12.7	12.4	12.9	45.7	13.8	16.0	15.0	21.3	19.4	16.3	20.8	17.2	21.7	12.7	9.1	22.5	16.4	11.5	31.8	16.9	36.5	20.3	29.9	42.8	25.8	18.4	22.4	14.6	15.3	11.6	10.7	18.4	19.7	17.7	19.7	15.1	27.7	7.1	26.6	15.2	21.2	13.4	22.0	12.4	17.6	38.7	13.0	30.8	15.5	25.4	14.0	26.5	21.7	9.5	16.8	17.1	14.9	20.6	23.2	12.5	19.3	14.6	23.3	38.9	18.8	20.4	22.3	19.2	15.6	13.6	22.1	21.7	14.1	24.8	9.3	15.0	16.1	20.2	16.5	17.0	12.3	14.7	15.5	22.2	36.7	29.0	12.1	18.7	17.0	26.9	17.9	36.5	32.4	19.9	33.0	31.8	37.8	34.1	16.9	25.5	32.8	32.6	27.4	29.9	20.3	14.3	42.8	25.8	18.2	23.4	25.2	26.9	17.6	17.7	19.3	19.4	19.3	17.2
RNF41	"NRDP1, SBBI03"	ENSG00000181852	"Ring finger protein 41"	Q9H4P4	12	56202175-56221933	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Autophagy, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016812	Approved		Approved	"Nucleoplasm,Nuclear bodies,Midbody ring"				"Nucleoplasm, Nuclear bodies"	"Midbody ring"	"HPA016812: AB_1856370"	"unprognostic (1.14e-2)"	"unprognostic (6.30e-2)"	"unprognostic (4.04e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.59e-2)"	"unprognostic (8.22e-2)"	"prognostic unfavourable (6.49e-4)"	"unprognostic (6.93e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.90e-2)"	"prognostic favourable (2.52e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"	22.2	17.6	18.6	11.8	30.2	12.0	14.3	30.9	47.1	16.2	15.0	16.9	12.3	8.5	16.4	9.7	16.5	17.7	18.0	22.6	17.3	22.4	14.1	10.5	16.5	14.8	15.3	18.2	17.0	16.0	17.9	16.7	14.6	25.3	25.2	13.6	14.6	10.5	15.6	21.2	10.1	10.8	20.3	11.8	13.5	12.2	10.1	12.1	11.3	20.5	10.1	17.0	16.2	11.5	24.6	13.1	41.1	11.5	13.4	12.5	12.3	7.5	11.6	12.6	20.0	26.5	19.3	9.4	25.3	25.1	22.8	18.5	14.2	9.9	14.6	13.5	21.4	8.7	17.0	12.2	16.6	15.2	9.3	19.6	8.3	8.1	55.6	21.4	21.4	24.6	28.7	19.0	33.6	22.1	13.8	15.0	12.6	12.2	12.2	9.6	15.2	13.6	13.3	9.1	8.8	12.1	11.1	23.1	14.0	22.1	12.7	20.0	17.8	25.2	13.3	11.5	12.3	14.8	9.7	10.8	12.4	13.3	13.7	12.9	13.7	21.0	11.5	41.1	12.5	11.4	11.2	22.7	10.6	10.9	13.1	24.6	11.0	11.2	15.8	13.4	11.2	10.2	12.1	12.3	18.6	30.2	30.9	47.1	17.3	22.4	15.3	18.2	25.3	12.1
ARIH2OS	C3orf71	ENSG00000221883	"Ariadne RBR E3 ubiquitin protein ligase 2 opposite strand"	Q8N7S6	3	48917788-48919385	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"																						"unprognostic (2.40e-5)"	"unprognostic (1.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.67e-3)"	"unprognostic (8.72e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.01e-3)"	"unprognostic (9.00e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.88e-1)"	"unprognostic (4.72e-5)"	"unprognostic (4.02e-2)"	"unprognostic (4.06e-4)"	"unprognostic (1.90e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.46e-1)"	2.1	2.7	3.0	2.1	5.6	5.5	2.2	2.1	2.4	2.1	2.1	2.1	2.1	1.9	2.2	2.9	2.1	3.2	2.1	2.5	3.2	3.0	2.2	2.1	2.1	3.1	3.6	2.1	5.5	2.7	1.3	3.6	2.1	2.1	2.6	1.5	2.1	4.3	2.2	2.1	2.7	2.5	2.1	3.8	2.5	2.0	5.4	2.1	2.1	3.2	2.1	2.1	2.1	2.1	5.0	7.6	9.1	3.2	4.7	7.9	2.2	1.2	0.0	0.9	2.0	5.1	1.7	3.8	1.3	1.6	2.4	1.1	0.5	2.8	1.6	1.1	0.9	0.6	0.8	0.7	1.0	2.1	1.4	2.3	1.8	2.0	3.5	0.7	1.2	4.9	2.5	2.1	1.6	1.3	1.1	7.3	0.7	0.9	3.5	1.6	1.4	1.2	1.0	0.8	5.1	1.9	1.0	1.2	3.4	3.0	1.6	3.9	2.4	1.9	0.8	1.0	1.9	1.1	0.8	4.5	5.8	4.1	1.1	1.9	2.6	4.5	3.2	7.4	3.9	2.9	3.4	4.9	3.9	4.8	3.7	5.0	7.9	5.7	9.1	4.7	2.1	7.6	4.8	2.2	3.0	5.6	2.1	2.1	3.2	3.0	3.6	2.1	2.1	2.1
CDKN2A	"ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf"	ENSG00000147889	"Cyclin dependent kinase inhibitor 2A"	"P42771, Q8N726"	9	21967753-21995301	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, rRNA processing, Transcription, Transcription regulation, Ubl conjugation pathway"	DNA-binding	"Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 22.6;pituitary gland: 39.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 50.0;HEK 293: 56.7;HeLa: 53.1;SK-MEL-30: 53.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 22.6"	"Group enriched"	"Detected in many"	8	"B-cells: 7.2;T-cells: 22.6"					"Low region specificity"	"Detected in many"			"CAB000093, CAB000445, CAB018232, HPA047838"	Enhanced		Supported	Nucleoli				Nucleoli		"CAB000093: AB_442119, CAB000445: , CAB018232: AB_785018, HPA047838: "	"unprognostic (3.41e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.00e-3)"	"prognostic unfavourable (1.82e-7)"	"unprognostic (5.22e-2)"	"prognostic favourable (5.19e-4)"	"prognostic unfavourable (2.17e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.56e-2)"	"prognostic unfavourable (5.76e-7)"	"unprognostic (9.41e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.55e-1)"	5.4	8.6	2.9	4.5	3.9	1.8	5.3	1.7	3.1	1.2	2.5	4.4	0.1	1.2	1.2	1.9	6.3	3.0	2.6	0.7	1.7	1.0	0.9	1.2	3.0	3.0	3.6	1.6	1.5	1.5	8.5	39.3	6.7	5.0	1.9	1.1	1.2	2.4	2.9	0.9	1.3	3.7	1.0	3.0	8.9	6.0	13.0	1.9	3.9	1.4	3.0	14.0	2.7	1.5	7.2	0.2	0.8	1.8	0.4	22.6	2.2	2.1	0.0	0.3	14.1	0.1	0.1	6.1	2.3	0.0	19.6	34.9	3.5	50.0	7.2	32.2	1.6	6.0	5.9	36.4	15.8	30.9	56.7	0.0	53.1	2.3	1.5	3.5	3.0	3.8	0.0	19.8	11.0	2.0	0.0	32.9	17.9	0.1	0.3	0.0	0.4	29.2	0.0	13.3	26.4	4.0	0.0	33.0	2.3	38.0	6.3	53.0	7.5	0.1	6.5	0.1	0.4	0.0	0.1	14.7	8.3	29.4	0.0	9.4	0.1	0.8	1.3	0.2	6.2	0.6	9.7	7.2	8.0	11.0	0.2	7.0	0.5	4.7	0.4	0.4	1.8	0.0	22.6	2.2	2.9	3.9	1.7	3.1	1.7	1.0	3.6	1.6	5.0	1.9
CUL7	"dJ20C7.5, KIAA0076"	ENSG00000044090	"Cullin 7"	Q14999	6	43037617-43053945	"Disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"		"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015449, HPA030095, HPA030096"	Approved									"CAB015449: AB_629341, HPA030095: AB_10600659, HPA030096: AB_10600997"	"unprognostic (2.32e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.01e-3)"	"unprognostic (6.06e-2)"	"unprognostic (5.41e-3)"	"unprognostic (4.95e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.81e-2)"	"unprognostic (2.13e-3)"	"unprognostic (4.81e-1)"	"prognostic unfavourable (2.19e-4)"	"unprognostic (8.92e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.35e-1)"	8.2	15.1	8.2	11.2	11.6	4.7	9.7	18.3	13.6	14.6	8.7	5.0	10.0	9.1	14.1	14.7	9.4	16.4	12.0	6.5	6.1	6.5	14.4	10.2	8.2	7.4	3.9	6.9	19.4	23.3	14.6	34.6	17.9	5.8	12.9	6.7	15.1	9.2	19.1	13.5	9.4	10.1	10.6	4.1	10.1	9.0	7.7	4.2	10.5	14.9	9.1	12.4	10.7	10.6	3.3	4.7	3.6	3.0	3.7	3.7	2.2	6.0	5.1	17.2	19.6	16.5	24.0	1.7	9.6	11.9	10.8	11.0	11.4	4.9	3.0	19.9	15.3	2.8	5.8	8.0	5.4	7.0	6.5	7.9	6.4	16.5	14.0	2.6	9.2	25.2	7.6	9.6	10.7	10.3	6.4	8.6	13.7	13.1	3.4	7.1	3.0	3.9	5.1	4.3	7.1	10.1	8.6	10.0	11.0	7.2	7.2	7.0	10.5	5.8	10.6	18.2	8.1	5.7	4.2	17.8	4.7	7.5	6.7	3.2	9.9	3.6	3.0	2.0	3.7	2.6	2.6	2.2	2.4	1.6	3.2	3.3	1.8	2.0	1.4	3.7	2.0	4.7	2.5	2.2	8.2	11.6	18.3	13.6	6.1	6.5	3.9	6.9	5.8	4.2
DCAF4	"DKFZp434K114, WDR21, WDR21A"	ENSG00000119599	"DDB1 and CUL4 associated factor 4"	Q8WV16	14	72926332-72959703	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA047276	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA047276: AB_10959615"	"unprognostic (6.01e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavourable (6.77e-4)"	"unprognostic (3.93e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.86e-1)"	"unprognostic (7.56e-2)"	"prognostic favourable (4.90e-4)"	"unprognostic (6.80e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.96e-3)"	"unprognostic (2.11e-2)"	9.0	10.4	6.7	10.2	11.4	7.3	10.8	6.1	19.2	8.4	10.5	12.0	7.5	6.7	14.5	9.8	10.0	8.9	9.9	6.6	7.4	9.2	12.3	9.6	6.3	9.4	9.4	10.9	15.0	17.9	9.4	6.5	14.5	15.4	9.3	10.6	9.0	13.4	8.6	18.2	18.5	8.8	9.6	6.6	9.2	10.7	14.5	6.6	7.9	17.7	7.5	12.1	9.9	9.6	12.0	3.5	1.0	4.5	9.0	7.1	3.1	12.5	6.1	1.5	6.6	6.4	8.5	11.9	7.2	7.3	9.4	10.9	6.7	5.5	16.1	5.5	13.7	9.5	10.3	11.1	16.6	8.0	5.7	6.8	2.6	8.8	9.3	4.5	11.0	15.0	11.2	10.1	19.0	3.3	9.7	10.5	7.6	20.7	7.9	11.5	3.7	12.6	5.5	7.9	9.2	14.1	7.4	7.7	3.1	4.3	22.9	9.0	7.7	6.1	4.9	5.1	12.1	14.0	3.6	14.6	14.0	10.7	7.2	3.8	3.1	0.3	1.7	0.3	4.5	2.7	6.7	12.0	5.5	5.1	3.5	10.3	6.4	6.7	1.0	9.0	4.5	2.7	7.1	3.1	6.7	11.4	6.1	19.2	7.4	9.2	9.4	10.9	15.4	6.6
DCAF8	"FLJ35857, H326, WDR42A"	ENSG00000132716	"DDB1 and CUL4 associated factor 8"	Q5TAQ9	1	160215715-160262531	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA027218, HPA027381"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA027218: AB_10602586, HPA027381: AB_1858808"	"unprognostic (3.47e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.39e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.13e-2)"	"unprognostic (9.34e-3)"	"prognostic favourable (4.71e-4)"	"unprognostic (5.42e-2)"	"prognostic unfavourable (3.74e-5)"	"unprognostic (3.30e-1)"	"unprognostic (7.42e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.56e-3)"	26.6	28.7	26.3	21.6	29.5	21.2	26.4	37.6	38.3	22.2	28.0	39.6	31.6	25.0	28.7	38.2	24.6	27.6	29.0	35.8	25.9	20.0	25.6	42.2	23.0	25.5	30.1	29.2	29.8	34.6	45.3	33.1	21.5	31.7	23.8	19.0	29.3	29.0	44.9	86.4	28.8	26.1	26.8	23.8	28.6	28.6	20.8	32.5	25.7	36.9	27.2	22.7	28.0	21.6	26.6	17.8	22.4	21.6	24.9	26.6	14.4	16.8	21.2	24.0	21.6	30.2	22.9	20.9	20.0	28.4	16.8	15.1	22.2	29.3	18.6	37.7	22.7	20.9	11.6	18.9	10.6	42.7	22.8	20.7	29.6	17.5	24.6	17.4	26.6	27.1	20.0	15.0	21.8	25.9	18.7	34.4	15.5	16.0	22.3	17.3	17.2	21.1	21.9	14.2	36.5	19.3	30.1	16.3	15.7	33.6	37.6	22.5	35.3	26.3	31.1	20.7	10.7	12.7	18.5	56.6	38.6	30.4	23.1	16.3	16.9	22.4	17.5	18.1	26.6	16.9	26.1	23.7	23.6	25.0	14.8	26.6	26.2	23.8	19.9	24.9	21.6	17.8	24.3	14.4	26.3	29.5	37.6	38.3	25.9	20.0	30.1	29.2	31.7	32.5
DDB2	"DDBB, FLJ34321, UV-DDB2, XPE"	ENSG00000134574	"Damage specific DNA binding protein 2"	Q92466	11	47214465-47239240	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	DNA-binding	"Cancer-related genes, Disease mutation, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025912, HPA058406"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"				"Nucleoplasm, Cell Junctions"		"CAB025912: , HPA058406: "	"prognostic favourable (7.29e-4)"	"prognostic favourable (1.58e-4)"	"unprognostic (1.49e-1)"	"prognostic favourable (1.20e-4)"	"unprognostic (4.29e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.58e-3)"	"unprognostic (3.53e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.21e-2)"	"unprognostic (4.25e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.07e-1)"	12.2	22.2	5.3	13.3	8.6	8.1	11.3	11.0	8.2	16.8	13.5	7.3	13.4	6.0	18.2	14.1	25.4	14.3	13.0	6.1	4.7	2.9	6.6	20.8	11.3	16.1	15.0	5.0	9.8	15.6	6.1	8.6	5.5	6.3	20.9	12.3	8.1	17.6	14.8	6.3	36.9	11.0	19.0	17.6	15.1	9.1	7.6	7.6	23.3	6.6	16.7	26.0	17.3	15.2	11.4	6.1	11.5	11.0	7.4	27.0	9.0	8.2	22.3	9.3	7.0	6.0	12.2	11.0	9.1	21.3	11.6	13.7	3.6	4.8	19.9	1.9	8.3	14.6	5.3	18.5	5.8	4.9	10.0	4.7	21.3	16.5	5.9	5.4	12.4	16.3	21.0	5.8	13.0	34.0	1.2	9.7	19.0	15.6	20.7	2.6	3.0	8.1	10.4	2.3	10.7	4.9	8.2	4.9	6.1	11.1	3.2	2.9	20.4	1.8	14.6	35.7	16.3	7.8	4.2	10.2	7.7	4.4	13.4	6.9	12.8	5.9	8.1	11.5	12.1	11.0	11.7	11.4	12.7	11.7	6.1	7.4	9.4	10.1	2.2	7.4	9.2	0.1	27.0	9.0	5.3	8.6	11.0	8.2	4.7	2.9	15.0	5.0	6.3	7.6
FANCL	"FAAP43, FLJ10335, PHF9, Pog"	ENSG00000115392	"Fanconi anemia complementation group L"	Q9NW38	2	58159243-58241372	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 62.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033842, HPA036685, HPA036686"	Supported		Approved	"Nuclear bodies,Vesicles"				"Nuclear bodies"	Vesicles	"CAB033842: AB_1122766, HPA036685: AB_10672474, HPA036686: AB_10670844"	"unprognostic (3.02e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.02e-3)"	"unprognostic (6.24e-2)"	"unprognostic (2.92e-2)"	"prognostic unfavourable (2.81e-7)"	"unprognostic (4.71e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.17e-2)"	"prognostic unfavourable (1.12e-7)"	"unprognostic (1.50e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.08e-3)"	"prognostic favourable (7.80e-5)"	6.3	29.2	16.0	11.2	22.9	10.6	16.2	7.1	18.1	11.6	9.6	30.7	7.9	9.2	16.6	15.7	8.6	11.7	9.8	10.2	17.0	23.5	7.1	16.7	7.7	10.9	25.0	15.2	21.3	10.8	16.8	62.5	10.0	33.5	11.6	12.4	13.7	14.8	9.1	6.5	14.4	10.1	11.3	23.4	12.0	10.5	14.7	28.2	8.6	14.2	6.9	12.0	10.1	12.7	10.8	7.1	5.6	6.9	8.8	5.5	2.7	18.4	13.5	27.6	13.5	4.9	6.5	14.7	13.6	8.5	13.5	17.6	11.9	23.3	12.8	17.7	4.4	10.8	15.3	10.3	22.6	30.0	24.2	21.0	19.0	16.1	5.3	20.2	11.6	4.8	4.9	9.8	3.9	10.5	19.5	11.7	9.1	9.4	7.1	25.1	29.8	2.8	13.5	20.9	10.0	11.8	18.3	31.3	15.7	19.4	8.0	12.7	7.3	13.6	6.2	12.1	18.2	8.8	14.9	12.1	7.6	7.5	25.7	13.7	18.3	2.7	3.7	5.6	4.9	6.9	3.8	10.8	4.1	5.4	7.1	10.0	1.4	3.1	1.1	8.8	4.9	6.5	5.5	2.7	16.0	22.9	7.1	18.1	17.0	23.5	25.0	15.2	33.5	28.2
FBXL4	"FBL4, FBL5"	ENSG00000112234	"F-box and leucine rich repeat protein 4"	Q9UKA2	6	98868538-98948006	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029140, CAB033362"	Approved		Supported	"Nuclear speckles"				"Nuclear speckles"		"CAB033362: AB_2103974, HPA029140: AB_10611967"	"unprognostic (1.24e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.62e-1)"	13.7	18.9	9.2	11.2	13.1	7.9	18.4	10.7	14.2	12.7	10.9	14.2	14.4	9.9	12.9	19.2	11.9	13.2	11.6	13.5	10.1	11.1	22.3	24.9	13.2	16.4	15.2	8.4	14.4	21.7	26.8	17.4	11.3	13.8	13.9	11.8	11.5	14.9	14.8	21.2	11.9	12.2	15.2	20.1	10.5	12.5	6.9	13.2	19.9	20.3	7.5	12.2	12.6	12.6	6.8	3.9	16.5	5.7	4.1	6.7	3.9	4.6	7.4	6.4	8.6	10.8	19.9	6.9	10.5	8.9	6.2	8.8	3.4	8.8	10.6	9.8	8.7	6.7	7.3	7.6	9.4	17.3	6.0	7.5	5.3	7.5	8.4	9.1	7.6	11.3	13.9	5.6	15.7	7.9	10.0	8.4	11.1	4.5	3.4	4.5	3.3	4.6	11.8	4.4	8.5	11.8	6.7	8.1	6.5	5.5	7.5	9.8	5.5	6.7	10.9	7.2	3.2	10.0	7.5	2.9	2.6	4.5	8.9	8.5	8.5	16.5	4.8	12.6	5.1	4.5	6.7	6.8	5.1	5.0	3.9	6.7	6.6	6.0	6.1	4.1	5.7	2.5	6.1	3.9	9.2	13.1	10.7	14.2	10.1	11.1	15.2	8.4	13.8	13.2
FBXW5	"DKFZP434B205, Fbw5, MGC20962"	ENSG00000159069	"F-box and WD repeat domain containing 5"	Q969U6	9	136940435-136944696	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046615	Approved		Approved	Mitochondria				Mitochondria		"HPA046615: AB_10965648"	"unprognostic (1.11e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.56e-2)"	"prognostic favourable (1.02e-4)"	"unprognostic (4.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.22e-2)"	"unprognostic (7.16e-3)"	"unprognostic (2.64e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.51e-3)"	"unprognostic (3.23e-2)"	"prognostic favourable (4.74e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.13e-1)"	17.6	13.9	13.3	12.4	14.4	14.7	11.8	11.2	24.3	9.8	17.0	9.6	12.7	23.7	11.1	11.8	19.5	8.5	15.9	30.7	15.3	9.6	13.4	31.0	9.0	10.8	11.8	10.9	8.4	25.9	8.8	10.5	12.8	12.0	13.7	7.5	9.3	25.7	16.1	68.2	11.5	23.4	18.2	6.5	12.7	16.4	67.8	9.6	16.2	12.8	17.3	16.0	14.4	11.6	16.3	38.7	33.0	28.4	20.1	41.2	26.0	15.1	26.3	6.0	14.7	14.7	9.6	35.7	15.8	10.9	11.1	6.1	17.5	19.8	10.4	18.4	16.2	20.0	5.4	13.8	1.8	13.9	18.3	9.0	35.9	18.0	16.3	13.0	23.2	11.0	12.4	10.1	8.4	11.3	17.5	17.2	8.3	40.0	10.2	15.6	11.1	28.7	11.5	9.2	18.9	9.6	15.4	12.7	12.8	19.6	21.2	21.0	24.4	20.7	21.9	16.6	15.0	30.8	13.7	14.3	17.1	6.9	22.6	11.7	12.5	19.6	24.8	33.0	41.2	28.4	31.3	16.3	31.3	34.5	23.3	12.9	14.0	23.2	13.1	20.1	21.9	38.7	36.3	26.0	13.3	14.4	11.2	24.3	15.3	9.6	11.8	10.9	12.0	9.6
LNX1	"LNX, MPDZ, PDZRN2"	ENSG00000072201	"Ligand of numb-protein X 1"	Q8TBB1	4	53459301-53701405	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002235, HPA071091"	Approved		Supported	"Cell Junctions,Cytosol"	"Intracellular and membrane"			"Cell Junctions"	Cytosol	"HPA002235: AB_1079261, HPA071091: "	"unprognostic (4.95e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.31e-1)"	"unprognostic (5.62e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.18e-2)"	"unprognostic (8.56e-2)"	"prognostic favourable (3.08e-7)"	"unprognostic (2.67e-1)"	"unprognostic (5.49e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.05e-2)"	16.9	2.5	11.8	1.7	24.6	0.8	13.2	4.4	33.3	5.9	7.2	1.5	11.2	8.3	4.5	3.2	21.7	5.6	4.8	6.9	6.1	5.5	10.0	3.7	2.5	1.8	3.8	11.6	2.1	12.9	10.8	5.0	21.6	4.8	5.1	5.6	2.0	22.1	10.0	5.1	10.0	8.2	2.8	1.3	0.9	8.0	4.1	2.0	0.7	15.0	5.7	7.8	5.8	7.7	1.4	1.1	1.5	1.9	3.8	1.6	0.6	1.6	0.6	1.9	1.0	3.5	7.3	9.2	1.5	0.7	0.0	0.0	2.7	8.4	2.1	1.2	4.2	1.6	0.0	0.3	0.0	0.5	4.6	2.9	1.7	1.6	1.4	2.7	0.8	5.4	0.3	0.5	0.0	2.8	1.7	1.0	6.6	4.7	2.4	1.8	4.8	1.0	1.5	0.7	0.9	6.3	8.8	2.3	2.6	0.7	9.7	1.0	5.2	1.4	8.0	10.5	3.1	3.4	1.8	3.9	0.6	1.4	9.6	2.4	1.9	1.5	0.5	0.3	1.0	0.5	1.5	1.4	1.5	1.5	0.8	0.9	1.6	1.2	0.4	3.8	1.9	1.1	1.3	0.6	11.8	24.6	4.4	33.3	6.1	5.5	3.8	11.6	4.8	2.0
MARCH3	"MARCH-III, MGC48332, RNF173"	ENSG00000173926	"Membrane associated ring-CH-type finger 3"	Q86UD3	5	126867714-127030808	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 24.6;HUVEC TERT2: 16.4;TIME: 19.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 8.8;naive B-cell: 13.1"	"Lineage enriched"	"Detected in many"	5	"B-cells: 13.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043406	Uncertain		Supported	Vesicles				Vesicles		"HPA043406: AB_10793947"	"unprognostic (5.96e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.21e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.75e-3)"	"unprognostic (9.41e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.60e-6)"	"unprognostic (7.74e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.64e-1)"	11.3	6.0	5.6	11.0	9.4	6.6	6.2	5.3	4.8	2.0	10.8	8.2	0.5	2.4	3.7	3.6	3.4	3.2	10.4	15.2	7.8	6.8	2.0	1.9	5.2	5.2	9.5	2.3	4.0	5.0	1.7	10.8	4.0	12.3	2.9	11.8	9.7	11.2	1.1	11.9	11.5	5.2	6.5	16.0	3.7	5.5	14.2	7.6	2.1	3.6	3.4	5.8	6.5	6.7	13.1	0.7	2.5	0.4	1.9	2.6	0.7	0.3	1.2	2.3	1.2	2.1	2.0	0.7	8.4	3.5	6.8	10.0	1.1	0.5	2.2	0.8	1.3	0.7	2.9	1.5	9.6	0.5	2.7	7.0	1.9	1.1	3.4	2.8	1.8	1.4	0.5	24.6	2.9	16.4	2.9	0.4	5.5	0.8	0.3	1.2	2.0	2.8	0.9	9.4	0.6	0.5	1.2	0.7	0.5	1.9	0.3	1.0	1.7	2.9	19.9	1.3	1.0	7.7	0.9	1.1	1.3	1.3	5.0	2.3	1.1	0.0	0.2	2.5	0.5	0.4	0.1	8.8	0.6	0.3	0.1	13.1	2.4	0.5	0.8	1.9	0.3	0.7	2.6	0.7	5.6	9.4	5.3	4.8	7.8	6.8	9.5	2.3	12.3	7.6
MEX3C	"FLJ38871, RKHD2, RNF194"	ENSG00000176624	"Mex-3 RNA binding family member C"	Q5U5Q3	18	51174550-51218304	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040603	Uncertain		Approved	Vesicles	"Intracellular and membrane"			Vesicles		"HPA040603: AB_10805714"	"unprognostic (1.09e-1)"	"unprognostic (2.90e-2)"	"unprognostic (8.88e-2)"	"unprognostic (8.88e-3)"	"unprognostic (2.04e-1)"	"unprognostic (7.30e-2)"	"prognostic unfavourable (8.49e-5)"	"unprognostic (4.34e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.01e-2)"	"unprognostic (3.17e-1)"	12.6	12.2	13.8	14.5	13.5	27.5	19.4	21.7	13.7	14.7	11.3	10.7	8.8	8.7	13.4	9.5	11.7	11.1	13.0	11.3	15.1	9.1	9.3	10.3	12.0	19.8	16.3	8.3	14.5	10.1	16.6	9.5	11.7	12.3	10.3	9.8	7.6	12.4	10.1	9.0	10.2	12.7	13.6	12.6	16.3	10.5	43.7	12.7	40.0	13.6	9.3	18.4	13.0	17.5	2.8	2.0	10.3	1.3	5.8	3.8	1.5	7.5	4.5	21.8	8.1	12.1	15.0	17.0	10.8	14.1	6.3	7.7	7.2	5.8	15.4	3.8	14.3	13.8	9.4	15.4	12.1	11.3	4.2	3.3	4.5	9.4	19.6	20.9	6.3	12.6	21.7	8.8	27.6	16.2	3.5	27.0	16.2	5.5	15.6	10.4	10.5	4.5	15.8	11.4	15.8	14.5	2.5	9.7	13.3	8.1	4.4	42.5	4.4	11.7	12.1	15.2	10.1	4.6	9.2	19.6	2.9	24.6	10.4	10.6	34.3	10.3	1.3	1.5	3.6	1.3	3.1	2.8	3.8	3.7	2.0	2.1	1.6	3.8	0.7	5.8	0.9	2.0	3.1	1.5	13.8	13.5	21.7	13.7	15.1	9.1	16.3	8.3	12.3	12.7
MGRN1	"KIAA0544, RNF156"	ENSG00000102858	"Mahogunin ring finger 1"	O60291	16	4616493-4690974	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 16.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 16.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007653, HPA008033"	Approved		Approved	Vesicles				Vesicles		"HPA007653: AB_1846304, HPA008033: "	"unprognostic (2.27e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.26e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.03e-2)"	"unprognostic (9.47e-2)"	"unprognostic (6.41e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.04e-2)"	18.7	23.1	22.9	24.0	24.3	29.7	19.9	43.1	37.6	16.3	16.6	28.7	16.8	28.9	23.7	13.8	14.7	20.9	20.2	20.7	24.3	18.6	15.9	30.4	21.6	22.2	27.9	21.5	21.3	34.9	19.7	21.5	18.8	18.6	19.0	11.6	20.7	23.8	22.9	29.9	13.5	28.6	20.0	17.2	26.2	25.2	11.5	24.5	12.9	19.7	10.4	11.0	18.7	14.2	1.7	4.1	16.6	3.9	1.4	3.3	2.9	5.2	25.1	13.0	13.3	7.8	7.6	17.8	11.3	8.0	9.6	8.1	16.6	12.6	15.6	14.7	13.7	8.5	10.4	9.3	2.8	21.6	11.5	8.5	17.6	22.8	14.3	12.3	21.2	14.1	6.1	13.3	5.7	9.1	12.4	11.4	6.5	23.1	12.8	16.5	19.2	11.0	23.5	6.8	20.9	8.4	15.4	20.9	17.4	18.8	20.3	11.3	12.3	12.2	16.1	17.8	9.9	50.1	9.7	18.2	14.1	10.5	7.6	12.4	12.8	4.5	3.5	3.4	2.7	3.9	2.5	1.4	1.5	2.3	2.3	1.7	3.3	2.0	16.6	1.4	2.4	4.1	1.7	2.9	22.9	24.3	43.1	37.6	24.3	18.6	27.9	21.5	18.6	24.5
MKRN2	"HSPC070, RNF62"	ENSG00000075975	"Makorin ring finger protein 2"	Q9H000	3	12557014-12583713	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037559, HPA037560"	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA037559: AB_10672460, HPA037560: AB_10696936"	"unprognostic (4.17e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (1.58e-4)"	"unprognostic (4.38e-1)"	"unprognostic (8.49e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.56e-3)"	"prognostic favourable (6.04e-4)"	"unprognostic (3.26e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.32e-2)"	13.7	10.4	15.1	11.1	18.3	16.4	11.6	29.3	19.5	13.7	12.7	12.4	16.1	12.5	15.2	12.3	16.2	13.1	10.9	26.3	14.0	15.1	13.7	12.5	12.1	12.6	15.2	14.8	20.8	26.6	17.3	11.9	14.4	16.0	11.3	11.5	13.2	12.8	13.1	24.5	12.8	10.9	15.9	16.2	10.1	11.7	46.1	14.7	15.4	18.2	17.0	13.7	13.0	12.6	21.3	19.0	30.0	20.3	25.3	26.2	18.7	10.7	12.4	14.8	11.1	23.2	22.6	28.7	16.6	17.8	21.2	17.8	12.0	10.7	15.2	9.5	18.3	6.6	19.3	16.3	18.9	17.2	16.2	21.7	14.2	16.0	26.7	21.3	9.9	25.1	15.2	24.6	15.6	17.4	20.2	21.6	18.2	15.1	26.1	11.1	9.9	21.8	25.2	14.3	17.1	14.9	14.2	8.7	14.7	14.4	7.4	14.8	16.7	18.9	17.5	14.5	14.3	17.2	22.5	16.4	33.6	32.7	15.7	25.5	21.8	18.9	17.2	30.0	21.5	15.6	26.2	21.3	22.1	22.0	19.0	16.4	23.9	22.3	15.0	25.3	20.3	15.1	23.4	18.7	15.1	18.3	29.3	19.2	14.0	15.1	15.2	14.8	16.0	14.7
MKRN3	"D15S9, MGC88288, RNF63, ZFP127, ZNF127"	ENSG00000179455	"Makorin ring finger protein 3"	Q13064	15	23565678-23630075	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.4"	"Cell line enhanced"	"Detected in many"		"K-562: 17.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 5.7"	"Lineage enriched"	"Detected in many"	4	"T-cells: 5.7"	"Low region specificity"	"Detected in many"							HPA029494	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA029494: AB_10603873"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.15e-2)"	"unprognostic (6.27e-4)"	"unprognostic (1.51e-1)"	"unprognostic (8.52e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.97e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.05e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.91e-2)"	"unprognostic (9.78e-2)"	1.0	0.7	5.1	1.2	10.4	4.0	1.2	1.0	11.1	0.5	1.1	8.4	0.0	1.3	1.3	3.2	5.6	0.9	0.8	0.8	6.4	3.4	1.1	0.7	1.0	1.9	14.4	3.0	1.2	1.7	0.5	3.8	8.5	5.1	1.2	0.8	3.1	5.2	1.0	1.4	1.2	1.9	0.8	8.2	1.5	0.9	5.7	13.3	5.0	0.9	1.1	1.7	0.7	0.6	1.0	0.9	1.3	0.5	0.4	5.7	0.7	4.7	3.4	3.0	3.1	0.0	0.0	7.1	0.3	0.0	2.9	2.0	8.5	0.0	0.2	0.1	0.0	8.2	1.3	0.0	0.7	0.0	0.3	6.8	9.1	0.3	0.2	8.0	6.1	0.1	0.0	6.0	0.0	0.0	17.5	7.5	0.8	0.0	8.4	3.5	0.0	10.4	6.0	1.1	4.2	0.0	0.1	0.7	2.4	0.0	3.4	0.0	2.7	2.4	0.1	8.0	6.7	0.4	5.6	9.4	11.5	5.6	4.7	0.1	0.1	1.3	0.5	0.4	1.8	0.2	1.0	1.0	0.6	1.4	0.2	0.9	2.0	5.7	1.3	0.4	0.3	0.9	0.4	0.7	5.1	10.4	1.0	6.8	6.4	3.4	14.4	3.0	5.1	13.3
NEURL4	KIAA1787	ENSG00000215041	"Neuralized E3 ubiquitin protein ligase 4"	Q96JN8	17	7315628-7329393	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 1.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043678, HPA055314"	Uncertain									"HPA043678: AB_10963092, HPA055314: "	"unprognostic (4.38e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.70e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.63e-1)"	"unprognostic (4.22e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.85e-2)"	"unprognostic (8.96e-3)"	"prognostic favourable (2.34e-5)"	"unprognostic (4.96e-2)"	"unprognostic (3.72e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.12e-2)"	6.7	7.6	13.4	8.3	13.6	7.1	7.0	22.2	20.7	7.6	9.3	11.2	13.3	10.6	10.8	5.1	7.9	9.4	7.8	10.5	11.7	7.7	7.6	5.2	6.4	9.5	9.5	13.2	13.2	11.1	15.7	11.5	8.2	9.7	9.1	5.1	8.1	11.8	9.9	20.6	12.7	8.7	7.5	5.8	10.2	7.5	10.1	9.8	5.3	11.5	6.3	7.8	8.7	7.5	0.4	0.2	1.8	0.6	0.0	1.0	0.1	4.6	16.6	10.8	17.2	6.6	4.4	12.9	7.3	4.7	8.9	7.3	11.5	4.0	14.4	7.6	4.3	13.6	11.4	6.8	3.9	7.8	18.0	7.2	17.1	6.6	4.7	6.9	10.2	4.1	7.1	9.1	5.2	5.5	10.1	3.0	3.8	6.0	10.5	13.2	7.5	8.3	18.1	8.7	5.8	5.4	4.9	10.1	8.4	7.5	7.7	2.9	6.4	5.1	7.0	8.2	6.3	6.8	7.9	6.3	4.0	6.2	5.2	6.6	8.1	1.8	0.6	0.7	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.4	1.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	13.4	13.6	22.2	20.7	11.7	7.7	9.5	13.2	9.7	9.8
PIAS3	"FLJ14651, ZMIZ5"	ENSG00000131788	"Protein inhibitor of activated STAT 3"	Q9Y6X2	1	145848522-145859836	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006389, HPA067383"	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA006389: , HPA067383: "	"unprognostic (1.23e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavourable (6.12e-4)"	"unprognostic (2.30e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.77e-3)"	"unprognostic (5.06e-1)"	"prognostic unfavourable (1.21e-7)"	"unprognostic (5.14e-2)"	"unprognostic (4.98e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.11e-2)"	15.2	9.8	10.7	12.8	12.7	4.5	17.4	19.1	16.3	29.1	16.2	17.9	16.5	7.5	25.5	15.0	26.4	36.7	20.2	14.1	11.5	9.7	13.9	6.4	13.6	8.2	11.6	11.9	21.2	11.7	14.7	13.8	10.5	11.9	20.3	8.4	28.8	20.9	26.8	17.4	28.6	10.3	23.1	10.7	10.2	15.9	10.0	12.1	7.3	11.4	19.2	22.7	22.6	24.2	6.1	8.6	10.7	11.9	15.1	12.6	6.8	13.2	9.2	9.5	8.4	14.7	27.8	5.8	12.5	17.3	14.3	15.9	7.5	8.7	6.8	13.5	21.3	13.7	4.9	19.8	12.1	7.4	7.2	3.1	6.3	3.9	14.7	5.6	15.6	22.6	12.9	13.2	7.5	20.6	5.0	9.5	29.6	22.1	6.0	2.9	14.7	15.0	9.4	6.5	4.4	11.3	8.0	3.2	15.2	12.0	6.7	6.1	31.0	8.5	31.6	19.1	14.2	12.6	8.0	13.1	5.9	4.5	18.5	4.2	9.4	8.5	9.5	10.7	11.7	8.8	12.5	6.1	7.7	12.6	7.0	4.3	7.1	6.7	2.2	15.1	11.9	8.6	8.2	6.8	10.7	12.7	19.1	16.3	11.5	9.7	11.6	11.9	11.9	12.1
PIAS4	"FLJ12419, Piasg, PIASY, ZMIZ6"	ENSG00000105229	"Protein inhibitor of activated STAT 4"	Q8N2W9	19	4007646-4039386	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway, Wnt signaling pathway"	"DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010598	Enhanced		Approved	Nucleoplasm				Nucleoplasm		"HPA010598: AB_1079616"	"unprognostic (1.23e-1)"	"unprognostic (8.94e-3)"	"unprognostic (3.50e-2)"	"prognostic favourable (1.18e-5)"	"unprognostic (2.45e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.01e-3)"	"unprognostic (9.79e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.22e-2)"	"prognostic favourable (7.04e-4)"	"unprognostic (1.33e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.52e-3)"	"unprognostic (5.76e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.67e-3)"	11.0	9.2	12.4	11.1	16.8	8.6	7.6	22.5	15.7	8.8	11.9	16.7	8.1	13.0	9.5	9.2	9.1	8.4	9.7	6.9	9.7	7.1	7.3	12.4	7.8	10.2	18.2	9.3	11.2	16.0	7.1	9.3	12.9	12.6	9.9	5.4	6.5	14.7	8.7	15.2	12.2	11.2	8.0	12.3	12.0	13.9	38.1	15.9	11.0	6.6	6.3	8.3	8.8	9.8	17.9	11.8	20.2	19.1	16.3	17.3	11.3	10.5	7.6	7.1	6.8	3.5	3.2	11.3	6.4	3.6	6.8	6.2	11.8	4.9	8.0	5.9	3.4	11.1	7.3	5.1	2.9	12.9	11.4	5.7	5.4	9.1	7.2	8.3	10.1	3.7	5.7	6.1	3.8	8.0	10.7	11.1	3.3	10.8	15.1	9.8	15.7	7.0	13.5	7.3	10.4	4.4	5.9	13.0	14.5	9.2	9.0	7.0	8.3	7.7	5.9	6.8	9.8	14.1	10.0	20.8	15.5	10.2	5.7	10.3	8.3	10.5	14.9	20.2	17.3	16.0	12.2	17.9	12.6	15.9	11.8	15.9	11.1	12.5	16.6	16.3	19.1	11.8	13.4	11.3	12.4	16.8	22.5	15.7	9.7	7.1	18.2	9.3	12.6	15.9
RNF103	"hkf-1, KF1, ZFP103"	ENSG00000239305	"Ring finger protein 103"	O00237	2	86603393-86623866	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 9.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057922	Approved									"HPA057922: "	"unprognostic (4.41e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.37e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.67e-2)"	"prognostic favourable (6.77e-5)"	13.2	13.5	18.0	9.8	20.6	9.8	18.5	38.3	24.6	15.8	28.1	16.9	9.6	15.6	18.8	39.7	11.7	12.7	23.3	29.5	16.7	15.9	13.1	43.8	8.6	8.5	17.8	10.6	13.2	20.2	23.8	12.2	16.2	14.7	20.5	14.2	14.5	13.8	16.1	17.7	10.4	27.2	17.9	21.8	8.1	18.7	13.7	16.5	11.9	9.0	8.8	8.3	13.4	11.5	1.4	1.6	9.9	0.9	3.0	3.4	0.9	5.6	7.7	3.9	6.0	18.0	11.7	6.4	8.1	12.5	4.2	5.7	4.4	9.7	9.4	9.9	12.2	6.9	5.2	6.4	6.4	7.8	7.1	5.3	3.5	9.8	17.1	1.7	8.0	16.9	13.5	6.2	7.8	12.6	1.9	5.7	11.5	6.9	4.0	4.7	1.8	5.5	2.5	16.9	5.5	15.4	8.9	6.2	6.4	9.6	21.5	8.0	8.2	4.4	14.2	8.2	3.9	8.2	4.8	19.9	6.6	6.3	6.5	3.0	3.9	6.5	0.7	9.9	1.1	0.9	1.5	1.4	1.6	2.4	1.6	1.4	1.9	1.3	1.5	3.0	0.6	1.0	3.4	0.9	18.0	20.6	38.3	24.6	16.7	15.9	17.8	10.6	14.7	16.5
RNF123	"FLJ12565, KPC1"	ENSG00000164068	"Ring finger protein 123"	Q5XPI4	3	49689499-49721529	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065983, HPA071879"	Approved		Approved	Cytosol				Cytosol		"HPA065983: , HPA071879: "	"unprognostic (2.68e-1)"	"unprognostic (3.34e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.51e-2)"	"unprognostic (5.03e-3)"	"prognostic favourable (1.33e-8)"	"unprognostic (5.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.83e-1)"	5.3	8.0	7.7	8.0	10.4	17.5	5.0	13.8	13.6	5.2	6.8	6.2	7.8	12.7	6.4	8.0	7.5	6.4	7.0	12.9	8.5	6.8	8.4	21.8	5.7	6.1	7.3	6.6	5.1	7.7	8.9	8.4	7.3	6.6	7.3	4.8	7.6	6.9	6.7	81.2	7.7	12.5	6.2	6.7	7.6	6.9	8.8	7.8	8.3	6.2	12.0	9.1	6.6	4.8	11.3	12.7	11.8	10.9	7.7	11.4	5.3	6.7	9.5	11.4	11.7	17.3	10.7	12.3	8.8	11.7	11.2	12.5	10.1	11.7	16.4	8.0	12.5	8.5	8.6	13.3	7.9	10.9	11.7	13.4	18.8	22.2	17.3	12.9	14.5	13.5	13.1	10.5	12.3	11.6	14.0	14.3	9.5	10.1	13.6	21.0	6.2	15.4	6.4	6.9	17.0	15.4	11.4	7.8	15.6	12.1	10.8	13.4	11.1	23.3	11.9	9.9	12.1	8.9	10.8	19.4	19.0	6.6	14.0	16.4	14.8	11.8	10.9	7.9	11.4	9.5	6.8	9.8	7.2	6.8	8.6	11.3	8.7	8.2	6.3	7.7	9.7	12.7	5.5	5.3	7.7	10.4	13.8	13.6	8.5	6.8	7.3	6.6	6.6	7.8
RNF144B	"bA528A10.3, IBRDC2, P53RFP"	ENSG00000137393	"Ring finger protein 144B"	Q7Z419	6	18387350-18468874	"Enzymes, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 54.7;hTCEpi: 17.4;HUVEC TERT2: 16.1;TIME: 16.1;U-698: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 28.8"	"Group enriched"	"Detected in many"	9	"dendritic cells: 7.9;granulocytes: 15.6;monocytes: 28.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046013, HPA054127, HPA072469"	Uncertain		Approved	Nucleoli,Mitochondria				Nucleoli	Mitochondria	"CAB046013: AB_11126028, HPA054127: , HPA072469: "	"unprognostic (2.24e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.48e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.87e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.21e-1)"	16.3	2.0	4.6	11.1	6.8	15.7	21.1	5.1	7.5	8.0	4.2	2.8	4.6	1.5	6.8	7.5	9.4	9.0	6.8	8.7	5.3	4.3	13.8	11.4	39.0	11.1	8.3	2.3	4.2	3.7	3.0	2.3	11.1	8.8	12.8	2.3	8.3	16.9	6.2	36.8	19.2	3.7	4.9	9.2	37.1	4.3	3.3	6.9	5.8	32.9	11.4	12.2	7.3	6.6	2.0	7.9	15.6	28.8	0.2	0.7	2.6	1.3	0.2	0.1	0.0	0.0	0.6	2.9	1.5	1.6	3.2	3.5	0.0	0.1	54.7	15.0	0.6	4.7	0.0	4.6	4.6	0.2	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.8	17.4	1.2	3.9	16.1	0.0	0.0	0.8	0.5	0.4	0.0	0.4	0.3	0.2	0.5	3.3	9.8	3.0	0.5	0.0	0.3	7.0	5.2	8.2	0.1	16.1	2.5	0.5	0.2	0.3	0.0	0.0	46.0	0.3	0.1	0.2	0.1	9.1	5.1	0.2	16.4	0.7	2.0	0.3	0.3	5.6	1.6	0.7	0.4	15.6	0.2	28.8	7.9	0.2	2.6	4.6	6.8	5.1	7.5	5.3	4.3	8.3	2.3	8.8	6.9
RNF167	DKFZP566H073	ENSG00000108523	"Ring finger protein 167"	Q9H6Y7	17	4940008-4945222	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA049810	Approved									"HPA049810: "	"unprognostic (1.13e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.77e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.07e-2)"	"prognostic favourable (2.03e-6)"	"unprognostic (2.16e-1)"	"prognostic favourable (4.47e-4)"	"unprognostic (7.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.12e-1)"	30.5	45.9	45.8	32.1	47.0	40.7	38.3	37.9	67.9	44.3	43.5	54.6	49.2	42.7	43.1	55.8	51.6	44.0	47.4	40.1	43.1	39.9	44.1	84.1	35.6	38.7	43.7	43.6	42.6	52.4	52.8	40.7	49.0	41.2	43.6	46.7	38.5	49.1	51.7	56.5	51.6	51.1	42.4	46.4	47.1	42.7	42.0	33.1	53.9	55.1	47.3	47.6	48.1	40.7	25.6	18.2	54.4	26.7	27.6	53.0	37.9	23.7	34.5	15.0	18.4	37.0	18.5	22.4	14.7	20.5	31.1	24.6	24.0	10.9	17.6	28.6	24.2	36.5	26.1	28.5	23.2	16.9	41.9	30.0	43.5	23.6	28.0	14.1	63.2	21.7	45.1	32.3	30.8	20.0	11.7	60.0	24.8	17.0	22.3	17.6	17.9	22.2	15.3	14.9	21.8	35.8	19.9	11.8	14.7	13.5	23.2	19.5	22.2	14.4	12.2	18.6	12.3	16.6	27.9	19.9	20.2	5.8	25.6	20.3	19.4	22.4	21.4	54.4	53.0	22.6	41.1	25.6	40.6	52.7	18.2	24.0	28.5	42.3	52.1	27.6	26.7	18.0	37.7	37.9	45.8	47.0	37.9	67.9	43.1	39.9	43.7	43.6	41.2	33.1
RNF170	"ADSA, DKFZP564A022, SNAX1"	ENSG00000120925	"Ring finger protein 170"	Q96K19	8	42849637-42897290	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA050931, HPA054621"	Uncertain									"HPA050931: , HPA054621: "	"unprognostic (3.06e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.54e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.23e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.61e-3)"	"unprognostic (4.13e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.13e-1)"	8.9	13.6	14.3	8.7	17.0	2.2	13.0	15.3	18.8	8.6	10.9	17.5	15.0	10.2	9.8	15.6	14.5	9.7	9.5	8.1	13.7	14.3	17.0	19.4	9.3	8.4	15.7	18.2	13.4	10.8	15.5	16.6	19.0	19.7	11.5	11.7	12.5	12.0	11.5	10.5	14.9	11.3	7.9	21.8	8.8	10.6	7.8	14.2	5.5	29.4	8.0	9.6	10.4	10.6	8.5	11.1	2.6	7.2	5.6	8.0	5.9	6.8	11.2	11.5	5.8	18.8	19.4	6.9	8.3	11.5	7.8	8.5	5.3	22.5	8.4	10.1	7.8	5.9	6.1	8.3	6.7	5.7	6.5	9.7	5.0	5.6	10.5	1.2	7.0	16.8	12.9	5.9	12.4	8.4	8.7	10.0	12.5	2.0	10.2	5.7	5.4	4.0	5.4	15.3	4.7	12.6	6.7	3.0	9.0	7.8	5.6	13.9	14.6	5.6	12.1	8.5	3.7	11.2	2.6	16.2	15.4	9.4	11.5	4.1	8.5	1.7	7.2	2.6	4.0	7.1	5.6	8.5	6.3	6.9	10.7	5.1	7.7	5.5	0.7	5.6	6.5	11.1	8.0	5.9	14.3	17.0	15.3	18.8	13.7	14.3	15.7	18.2	19.7	14.2
SEL1L2	"C20orf50, DKFZp434C1826"	ENSG00000101251	"SEL1L2 ERAD E3 ligase adaptor subunit"	Q5TEA6	20	13849247-13996443	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	33	"testis: 13.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA059121	Approved									"HPA059121: "	"unprognostic (6.70e-2)"	"unprognostic (1.64e-2)"		"unprognostic (2.72e-3)"	"unprognostic (2.19e-1)"				"unprognostic (8.51e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.12e-2)"	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SIAH3	FLJ39203	ENSG00000215475	"Siah E3 ubiquitin protein ligase family member 3"	Q8IW03	13	45777243-45851736	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 10.2;fallopian tube: 11.8"	"Cell line enriched"	"Detected in single"	8	"EFO-21: 4.9"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 0.7"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060576	Uncertain									"HPA060576: "	"unprognostic (1.07e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.00e-2)"		"unprognostic (1.05e-1)"		"unprognostic (7.53e-2)"	"unprognostic (3.24e-4)"	"unprognostic (1.11e-1)"	"unprognostic (4.77e-3)"	"unprognostic (3.24e-3)"	"unprognostic (9.03e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.18e-1)"	0.6	1.3	5.1	0.9	8.3	0.9	0.6	5.6	10.2	4.1	0.6	0.0	0.1	0.8	1.7	2.0	0.6	11.8	0.7	0.6	4.0	2.8	1.7	0.6	0.8	0.8	3.4	6.6	0.7	0.6	0.5	0.4	0.5	8.9	0.6	0.7	2.8	1.7	3.6	0.6	0.8	0.8	0.8	1.3	0.8	0.7	0.8	0.7	0.4	0.6	0.0	0.9	0.7	0.4	0.1	0.1	0.5	0.1	0.2	1.5	0.0	0.1	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.0	4.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	1.5	0.7	0.5	0.2	0.0	0.1	0.0	0.0	5.1	8.3	5.6	10.2	4.0	2.8	3.4	6.6	8.9	0.7
TMEM129	D4S2561E	ENSG00000168936	"Transmembrane protein 129"	A0AVI4	4	1715952-1721358	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway, Unfolded protein response"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (6.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.22e-3)"	"unprognostic (7.35e-3)"	"unprognostic (4.82e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.51e-3)"	"unprognostic (2.81e-1)"	"prognostic favourable (9.64e-8)"	"unprognostic (1.47e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.36e-3)"	18.2	19.8	17.6	11.3	21.7	6.0	11.0	19.3	25.6	16.4	17.9	22.1	21.5	23.7	16.1	14.6	18.7	18.0	16.5	29.0	18.3	16.2	22.4	26.3	14.5	12.8	20.1	14.0	17.3	32.6	25.9	24.9	15.8	16.9	17.5	9.6	20.4	34.0	22.8	20.9	15.7	17.6	12.7	14.9	14.6	16.0	15.0	20.0	11.5	32.4	11.0	12.3	14.6	10.5	2.1	7.7	0.7	3.3	2.0	3.6	2.1	9.0	10.5	8.9	13.1	16.3	9.6	10.3	7.3	12.0	7.7	8.3	7.8	22.6	11.9	8.9	7.9	9.1	4.5	9.4	1.3	8.2	13.4	6.5	7.5	9.8	13.4	9.2	11.8	15.9	20.2	4.2	3.9	11.9	7.3	8.8	7.2	7.1	12.6	15.0	13.8	13.1	8.1	4.6	14.7	19.2	10.1	20.6	12.7	6.3	11.2	9.6	23.1	4.3	8.1	9.0	6.9	7.8	7.1	22.4	6.7	5.7	10.4	12.7	9.5	0.3	3.3	0.1	3.6	2.2	3.1	1.6	3.2	2.6	3.4	2.1	2.2	1.5	0.7	2.0	2.4	7.7	1.5	2.1	17.6	21.7	19.3	25.6	18.3	16.2	20.1	14.0	16.9	20.0
TRIM25	"EFP, RNF147, ZNF147"	ENSG00000121060	"Tripartite motif containing 25"	Q14258	17	56887909-56914038	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	"Ligase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 20.0"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 20.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA005909	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"			35000	"Nucleoplasm, Cytosol"	"Nuclear bodies"	"HPA005909: AB_1078722"	"unprognostic (8.73e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.06e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.78e-2)"	"prognostic unfavourable (9.37e-4)"	"unprognostic (1.53e-1)"	"unprognostic (4.23e-1)"	"unprognostic (1.15e-1)"	"prognostic favourable (3.36e-4)"	"unprognostic (3.23e-1)"	"unprognostic (3.11e-2)"	"prognostic favourable (9.35e-4)"	"unprognostic (5.21e-2)"	"unprognostic (5.13e-2)"	"unprognostic (7.39e-2)"	20.0	19.7	7.5	23.6	8.9	32.6	19.3	11.6	7.8	15.3	22.5	5.0	8.0	15.3	13.4	12.6	17.7	15.3	18.4	8.3	5.8	6.3	10.1	27.0	20.8	15.9	6.7	5.5	13.3	15.3	13.6	11.5	55.0	7.4	12.2	14.3	12.5	14.5	11.5	11.7	23.1	20.7	10.1	5.2	35.8	14.1	12.8	6.5	26.2	11.8	15.1	18.5	10.6	35.9	1.7	2.4	20.0	2.3	0.8	1.5	0.7	28.8	14.3	3.5	11.9	26.7	22.6	0.0	11.4	23.1	27.3	23.6	13.9	15.9	28.2	23.7	10.9	17.2	17.2	15.3	15.3	24.0	13.6	18.2	11.1	15.4	23.0	21.7	13.1	10.1	25.8	14.2	30.3	18.1	4.4	17.3	13.8	19.3	24.2	15.7	2.2	27.8	17.4	11.9	17.7	15.9	22.8	6.9	6.4	9.0	14.5	26.5	19.6	17.7	12.0	12.8	9.2	19.6	11.8	9.8	18.7	4.7	12.4	15.0	5.0	3.0	2.3	0.9	0.9	1.9	1.1	1.7	0.8	0.8	2.4	1.4	0.6	0.8	20.0	0.8	1.4	1.7	1.5	0.7	7.5	8.9	11.6	7.8	5.8	6.3	6.7	5.5	7.4	6.5
TRIM37	"KIAA0898, MUL, POB1, TEF3"	ENSG00000108395	"Tripartite motif containing 37"	O94972	17	58982638-59106921	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Ubl conjugation pathway"	"Repressor, Transferase"	"Dwarfism, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 46.1"	"Cell line enriched"	"Detected in all"	4	"MCF7: 75.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 20.0"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021911	Uncertain									"HPA021911: AB_10964487"	"unprognostic (4.07e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavourable (4.99e-6)"	"unprognostic (7.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.10e-3)"	"unprognostic (4.79e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.46e-1)"	"unprognostic (4.27e-2)"	"unprognostic (3.04e-2)"	6.7	10.3	17.4	7.1	24.4	5.1	7.1	33.4	33.9	7.2	5.9	7.9	4.9	5.2	7.4	9.2	7.1	8.2	7.5	9.1	19.0	19.5	6.5	6.5	7.4	6.8	17.7	18.1	5.5	6.5	6.1	8.9	7.7	32.4	8.1	6.2	5.8	4.4	8.1	7.9	6.1	4.6	8.9	8.7	6.4	5.3	46.1	7.4	6.8	11.1	2.1	6.7	6.8	4.4	3.8	3.4	20.0	3.1	2.9	6.5	2.5	6.8	10.0	6.9	9.1	6.8	6.2	11.1	7.5	11.7	8.2	13.5	6.1	4.7	6.4	11.5	7.8	5.9	10.0	5.6	13.1	12.7	9.7	9.9	9.5	8.4	12.0	5.1	5.3	5.0	5.4	10.2	13.3	10.5	7.7	9.5	8.1	75.3	10.3	3.0	10.1	6.7	4.6	18.2	4.5	7.8	8.8	16.8	9.9	7.8	3.3	7.3	9.7	2.4	8.1	12.9	15.4	11.7	8.5	9.6	14.1	5.7	8.8	5.5	6.0	20.0	3.1	3.6	6.3	2.4	5.9	3.2	4.1	4.1	3.4	3.8	3.7	4.7	4.5	2.9	2.3	2.6	6.5	2.5	17.4	24.4	33.4	33.9	19.0	19.5	17.7	18.1	32.4	7.4
TRIM63	"IRF, MURF-1, RNF28, SMRZ"	ENSG00000158022	"Tripartite motif containing 63"	Q969Q1	1	26051304-26068436	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Muscle protein, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skeletal muscle: 271.4"	"Group enriched"	"Detected in some"	38	"ASC diff: 10.5;SK-MEL-30: 33.5"	"Cancer enriched"	"Detected in some"	10	"melanoma: 31.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (1.10e-1)"	"unprognostic (4.80e-4)"	"unprognostic (1.45e-2)"	"unprognostic (7.52e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.58e-2)"	3.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	1.2	1.7	0.0	0.6	38.2	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.1	0.5	0.0	3.6	1.0	0.0	271.4	0.6	0.1	0.9	0.1	0.0	0.1	0.1	0.0	0.0	1.7	12.7	0.8	1.2	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
TTC3	"DCRR1, RNF105, TPRD, TPRDI, TPRDII, TPRDIII"	ENSG00000182670	"Tetratricopeptide repeat domain 3"	P53804	21	37073226-37203112	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016810, HPA023964, HPA036304"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				"Nucleoplasm, Nucleoli"	Cytosol	"HPA016810: AB_1858434, HPA023964: AB_1858435, HPA036304: "	"unprognostic (3.90e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.52e-2)"	"unprognostic (9.29e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.99e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.74e-2)"	22.9	22.1	34.0	18.7	36.5	12.0	23.4	39.2	40.0	34.9	20.6	15.9	26.7	13.0	21.6	33.3	15.3	19.5	19.0	21.5	29.1	16.5	21.4	17.0	15.4	14.3	17.7	27.5	34.5	25.8	27.4	50.4	15.2	34.7	28.9	19.9	16.1	24.5	25.4	21.6	16.1	16.8	21.6	21.7	13.6	21.3	19.5	19.9	19.7	35.4	11.1	15.1	23.3	18.9	10.6	12.8	4.8	5.7	9.1	18.6	3.8	21.4	7.6	35.7	6.7	34.5	50.2	12.4	23.6	29.4	10.7	14.5	10.1	10.8	18.5	8.2	39.5	7.0	10.7	14.5	15.1	19.6	7.7	37.4	11.5	13.1	12.6	20.8	12.1	25.9	9.0	10.8	9.7	15.8	22.5	21.8	20.0	16.6	20.2	5.4	10.1	13.0	27.1	17.1	9.7	12.4	16.6	27.3	20.8	29.3	16.8	15.2	19.0	8.2	20.5	15.3	6.1	18.7	8.8	21.9	15.7	18.5	25.2	20.9	11.5	2.9	4.4	4.8	9.1	4.8	13.6	9.5	10.6	12.3	7.9	10.6	18.6	11.3	0.7	9.1	5.7	12.8	7.2	3.8	34.0	36.5	39.2	40.0	29.1	16.5	17.7	27.5	34.7	19.9
UBA6	"FLJ10808, UBE1L2"	ENSG00000033178	"Ubiquitin like modifier activating enzyme 6"	A0AVT1	4	67612652-67701179	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037001	Approved		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA037001: AB_10672787"	"unprognostic (2.52e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.97e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.67e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.55e-3)"	"unprognostic (6.06e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.30e-2)"	"prognostic unfavourable (7.01e-5)"	"unprognostic (2.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.05e-3)"	16.8	12.6	14.1	14.1	16.6	22.7	13.0	18.0	16.0	17.0	10.5	14.6	7.0	12.2	16.7	10.0	20.5	9.9	12.4	9.5	12.0	12.0	10.2	16.4	14.5	17.3	18.7	11.2	14.3	10.9	17.4	44.8	18.5	17.7	12.7	13.2	7.5	13.7	10.4	10.1	12.6	15.3	13.4	20.7	16.9	13.9	14.6	18.6	27.1	12.3	13.3	19.9	15.7	19.5	5.6	5.1	9.3	4.0	9.7	5.8	1.9	14.8	8.3	13.8	10.8	6.8	8.1	9.3	30.8	12.1	14.1	16.5	8.7	20.1	18.8	11.0	12.6	8.8	14.2	15.3	21.3	21.6	4.0	12.0	14.7	8.1	5.8	21.1	9.2	5.7	4.9	18.2	11.1	12.4	28.6	11.2	16.6	5.6	21.9	4.8	8.1	10.1	13.0	28.3	6.9	11.5	16.9	6.7	8.5	17.4	12.4	5.8	8.2	5.7	17.9	13.1	14.7	10.6	13.4	8.1	6.3	19.0	23.3	5.9	12.5	9.3	3.0	4.6	4.4	3.9	4.8	5.6	5.1	5.8	3.7	5.2	3.9	4.5	2.2	9.7	4.0	5.1	4.2	1.9	14.1	16.6	18.0	16.0	12.0	12.0	18.7	11.2	17.7	18.6
UFL1	"KIAA0776, Maxer, NLBP, RCAD"	ENSG00000014123	"UFM1 specific ligase 1"	O94874	6	96521595-96555276	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030558, HPA030559, HPA030560"	Enhanced		Supported	"Endoplasmic reticulum"			6900	"Endoplasmic reticulum"		"HPA030558: AB_10600663, HPA030559: AB_10600537, HPA030560: AB_10602000"	"unprognostic (5.40e-2)"	"unprognostic (7.48e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.04e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.46e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.92e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.46e-1)"	20.2	26.3	19.8	21.9	24.0	14.6	20.9	16.4	23.6	22.1	17.9	19.4	32.1	21.5	20.5	28.5	23.6	18.6	20.2	22.1	21.6	17.8	21.6	32.7	15.8	21.5	31.1	20.0	24.8	35.7	28.8	32.4	25.6	28.0	24.6	19.2	14.2	23.9	30.7	33.0	19.3	28.4	18.5	33.0	18.8	20.6	13.4	27.3	29.2	27.6	23.1	20.1	24.0	18.8	11.2	12.6	10.1	11.7	14.7	14.7	7.9	8.7	4.7	9.9	16.6	14.4	22.1	14.8	12.4	12.7	8.0	7.5	5.8	10.3	21.4	15.9	12.4	17.2	8.1	11.7	11.7	11.4	7.3	9.3	7.4	10.6	19.2	17.5	14.0	15.7	11.0	9.5	26.4	13.0	12.4	23.7	15.0	8.5	6.4	10.9	3.6	5.3	8.1	11.7	16.8	14.4	16.1	7.0	6.8	10.2	12.1	11.5	29.4	15.1	12.7	11.2	6.1	11.3	13.0	14.0	7.2	16.4	17.2	11.8	10.2	7.8	9.2	10.1	10.9	11.7	12.5	11.2	11.5	11.6	11.8	11.0	14.7	11.5	2.0	14.7	11.2	12.6	12.7	7.9	19.8	24.0	16.4	23.6	21.6	17.8	31.1	20.0	28.0	27.3
ASB9	"DKFZP564L0862, FLJ20636, MGC4954"	ENSG00000102048	"Ankyrin repeat and SOCS box containing 9"	Q96DX5	X	15235288-15270467	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 21.0"	"Cell line enhanced"	"Detected in many"		"A549: 14.9;EFO-21: 11.8;PC-3: 31.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 4.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA003014, HPA003060, CAB004997"	Enhanced									"CAB004997: AB_426132, HPA003014: AB_1078226, HPA003060: AB_1078225"	"unprognostic (8.26e-3)"	"unprognostic (1.70e-1)"	"unprognostic (8.82e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.39e-1)"	"unprognostic (9.23e-2)"	"unprognostic (9.30e-2)"	"prognostic unfavourable (4.36e-4)"	"unprognostic (2.88e-1)"	"unprognostic (2.27e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.57e-1)"	1.6	0.9	0.6	1.6	0.4	1.1	2.1	0.5	0.8	2.4	0.9	0.4	1.3	0.7	4.1	6.4	2.1	1.3	4.0	1.5	0.6	0.3	11.6	11.6	3.6	1.6	1.7	0.3	1.1	6.8	0.1	0.6	1.9	0.9	1.6	1.4	1.3	3.0	2.5	1.9	1.0	1.3	1.3	0.5	8.9	2.4	21.0	0.3	4.0	1.3	2.0	3.2	1.0	0.9	0.5	4.3	1.2	1.8	0.5	3.6	1.0	0.8	14.9	0.1	1.4	0.1	0.7	0.4	0.3	1.6	1.7	0.6	3.3	0.1	0.2	11.8	0.5	4.3	0.0	0.7	1.1	3.0	0.3	3.5	7.4	6.8	0.0	0.0	0.0	3.9	0.1	0.1	0.0	5.5	0.0	3.4	1.0	1.2	2.9	0.1	7.0	31.0	0.0	6.6	3.2	4.6	2.5	1.8	1.5	0.5	0.8	5.1	0.0	0.4	4.7	0.0	1.1	0.7	2.2	0.2	2.9	0.1	0.4	0.0	8.2	1.2	1.8	0.1	0.2	0.0	2.0	0.2	0.6	0.2	4.3	0.5	3.6	1.0	0.7	0.5	0.1	0.2	0.1	1.0	0.6	0.4	0.5	0.8	0.6	0.3	1.7	0.3	0.9	0.3
BRCC3	"BRCC36, C6.1A, CXorf53"	ENSG00000185515	"BRCA1/BRCA2-containing complex subunit 3"	P46736	X	155071420-155123074	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Metalloprotease, Protease"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA048737			Supported	Nucleoplasm				Nucleoplasm		"HPA048737: "	"unprognostic (1.16e-2)"	"unprognostic (2.40e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.47e-3)"	"unprognostic (1.33e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.72e-2)"	"unprognostic (3.71e-3)"	"unprognostic (7.14e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.90e-1)"	12.9	14.8	11.3	11.2	16.5	14.0	12.9	20.0	18.6	11.8	19.5	9.1	15.2	16.7	9.4	11.8	20.4	12.1	8.3	10.3	10.3	12.1	18.3	12.3	9.4	12.5	10.4	10.5	10.7	12.2	14.3	11.8	14.2	15.3	12.2	19.5	8.7	15.5	12.6	21.3	10.0	19.2	13.1	8.9	11.1	13.7	3.9	12.9	10.2	13.9	13.7	12.7	11.4	11.6	13.4	16.2	25.0	17.8	21.0	19.0	12.3	31.4	19.5	8.2	6.4	6.2	5.1	13.6	12.9	8.2	7.9	17.5	17.6	13.8	30.3	23.6	8.2	12.2	21.1	11.5	11.5	17.6	16.9	6.1	30.7	14.6	5.5	21.4	9.5	6.3	5.2	12.9	11.0	10.8	9.9	9.0	6.4	13.3	8.2	7.6	7.3	13.9	12.9	14.1	12.6	9.5	14.9	13.5	5.8	8.5	13.6	7.7	9.4	7.3	12.1	7.1	10.9	10.4	19.4	11.5	18.7	39.4	10.3	20.1	8.2	22.6	14.7	25.0	16.2	17.8	19.0	13.4	16.0	14.8	16.2	11.8	12.5	14.0	8.0	21.0	16.9	10.4	18.6	12.3	11.3	16.5	20.0	18.6	10.3	12.1	10.4	10.5	15.3	12.9
DCAF11	"GL014, PRO2389, WDR23"	ENSG00000100897	"DDB1 and CUL4 associated factor 11"	Q8TEB1	14	24114195-24125242	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA003583, HPA031157"	Approved		Enhanced	Nucleoplasm				Nucleoplasm		"HPA003583: , HPA031157: AB_10603002"	"unprognostic (1.50e-1)"	"unprognostic (4.72e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.48e-3)"	"unprognostic (3.23e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.01e-1)"	"prognostic favourable (3.50e-13)"	"unprognostic (2.58e-1)"	"unprognostic (3.48e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.68e-1)"	7.6	20.8	14.4	12.1	15.4	21.7	10.3	14.2	23.0	8.1	14.0	11.5	18.7	23.7	8.8	14.1	13.5	10.5	13.6	13.9	14.1	10.9	15.3	56.2	9.8	13.1	12.3	15.5	11.8	42.5	21.1	12.6	8.6	10.4	11.6	11.3	12.3	18.3	19.4	26.8	8.9	25.2	9.5	9.7	14.2	14.4	13.4	9.4	13.1	17.1	13.2	10.5	10.6	7.3	12.8	18.0	20.9	16.5	23.9	17.2	14.8	6.2	10.5	5.1	4.8	5.9	4.7	9.3	5.1	7.8	9.4	8.9	6.5	10.4	11.0	4.9	6.5	9.1	8.7	7.3	6.3	11.1	5.2	10.5	11.1	33.4	8.0	13.0	14.5	5.1	8.6	4.9	9.6	6.9	6.8	11.2	5.4	19.6	12.8	11.2	3.1	9.4	12.1	9.5	13.0	6.8	15.9	10.9	7.3	4.3	15.2	7.7	8.8	11.0	3.9	7.0	5.9	5.7	6.0	17.2	16.2	13.3	5.3	10.4	7.8	15.1	15.3	20.9	15.8	16.5	13.7	12.8	14.2	14.4	18.0	12.5	14.7	13.7	13.2	23.9	13.1	9.3	17.2	14.8	14.4	15.4	14.2	23.0	14.1	10.9	12.3	15.5	10.4	9.4
DCAF12	"CT102, DKFZP434O125, KIAA1892, MGC1058, TCC52, WDR40A"	ENSG00000198876	"DDB1 and CUL4 associated factor 12"	Q5T6F0	9	34086387-34127399	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062279	Uncertain									"HPA062279: "	"unprognostic (9.56e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.22e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.34e-3)"	"unprognostic (6.57e-2)"	"unprognostic (2.86e-3)"	"prognostic favourable (2.81e-5)"	"unprognostic (1.77e-1)"	"unprognostic (4.37e-1)"	"unprognostic (2.21e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.03e-1)"	14.4	32.9	9.7	22.3	9.3	17.3	25.9	9.6	22.9	13.6	16.4	11.5	11.3	10.3	12.8	15.9	28.6	11.6	14.4	13.5	8.7	8.6	11.9	16.0	22.0	22.4	8.6	6.6	15.3	21.0	13.5	11.1	30.6	9.3	11.7	16.3	11.7	15.7	17.9	28.2	13.4	10.8	10.8	11.0	15.5	10.9	49.7	10.1	29.2	13.5	13.1	24.9	13.4	16.3	0.8	15.5	19.3	17.1	9.7	13.7	11.5	15.6	10.5	21.1	9.4	9.2	8.1	12.0	8.8	11.5	16.0	13.8	9.0	7.7	31.1	7.6	9.9	7.0	23.3	10.2	14.0	14.0	12.5	24.5	22.6	12.5	13.6	29.9	15.3	8.0	20.0	10.3	19.6	12.8	24.1	10.9	10.3	6.4	18.9	29.8	10.8	10.2	18.1	11.5	13.6	16.7	11.6	20.8	17.9	17.7	15.2	7.1	8.5	47.2	9.0	7.6	9.4	6.5	11.7	7.2	13.2	24.1	7.3	23.0	18.4	19.3	17.1	16.7	8.1	14.7	11.9	0.8	8.1	9.1	15.5	0.3	6.6	7.6	17.2	9.7	12.0	12.6	13.7	11.5	9.7	9.3	9.6	22.9	8.7	8.6	8.6	6.6	9.3	10.1
FBXL7	"FBL6, FBL7, KIAA0840"	ENSG00000183580	"F-box and leucine rich repeat protein 7"	Q9UJT9	5	15500196-15939795	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA055464	Uncertain									"HPA055464: "	"unprognostic (3.03e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.18e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.93e-2)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (4.54e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.41e-2)"	"unprognostic (4.29e-3)"	"unprognostic (3.42e-3)"	"unprognostic (1.32e-1)"	"prognostic unfavourable (6.69e-4)"	"unprognostic (1.94e-3)"	13.8	23.3	11.5	6.2	13.6	0.8	10.6	4.0	11.9	16.5	12.1	24.2	9.4	3.0	28.1	12.9	11.9	11.8	10.2	18.4	13.2	4.7	4.5	3.1	7.3	3.3	14.1	9.3	26.8	2.0	1.8	4.1	8.1	11.1	11.9	6.8	12.3	4.4	24.0	3.1	3.9	5.0	28.9	10.1	5.5	8.8	5.7	16.8	0.0	6.6	5.7	3.1	12.2	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	10.1	14.6	8.4	6.4	0.0	8.6	10.5	6.2	6.5	0.0	0.0	0.0	0.0	13.2	0.0	5.0	3.2	6.2	0.0	0.7	0.0	0.0	0.0	3.3	0.0	0.0	7.6	0.0	5.0	0.4	14.3	0.0	3.8	4.6	0.0	0.0	0.0	3.4	1.6	0.0	7.1	0.0	0.0	0.0	2.9	10.0	0.0	3.0	9.1	0.0	0.0	14.0	13.0	2.6	7.3	3.8	0.0	0.0	0.0	7.2	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	13.6	4.0	11.9	13.2	4.7	14.1	9.3	11.1	16.8
MARCH11	"MARCH-XI, RNF226"	ENSG00000183654	"Membrane associated ring-CH-type finger 11"	A6NNE9	5	16067139-16180762	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 42.1"	"Cell line enriched"	"Detected in some"	14	"SH-SY5Y: 43.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (9.91e-3)"				"unprognostic (1.08e-1)"					"unprognostic (2.98e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.54e-1)"			"unprognostic (1.52e-1)"	"unprognostic (3.55e-2)"		0.4	1.1	1.8	0.3	3.4	0.3	0.4	3.7	3.7	0.3	0.4	0.0	0.0	0.3	0.4	0.3	0.3	0.3	0.3	2.2	2.0	3.2	0.5	0.5	0.4	0.3	1.5	2.0	0.5	1.0	0.3	6.8	0.4	2.1	0.6	0.4	0.6	1.4	0.3	0.3	0.3	0.4	0.3	0.5	0.3	0.4	42.1	0.0	0.0	0.3	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.0	43.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	3.4	3.7	3.7	2.0	3.2	1.5	2.0	2.1	0.0
MARCH2	"HSPC240, MARCH-II, RNF172"	ENSG00000099785	"Membrane associated ring-CH-type finger 2"	Q9P0N8	19	8413270-8439017	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Endocytosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014063	Approved		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum"	Cytosol	"HPA014063: AB_1853576"	"unprognostic (1.15e-2)"	"unprognostic (4.01e-3)"	"prognostic unfavourable (6.48e-4)"	"prognostic favourable (1.05e-5)"	"unprognostic (3.00e-1)"	"prognostic favourable (8.29e-4)"	"unprognostic (3.43e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.32e-1)"	"prognostic favourable (6.21e-4)"	"unprognostic (2.01e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.80e-2)"	37.7	12.4	30.7	13.5	28.3	17.5	23.9	8.6	39.1	9.8	29.8	20.7	9.7	11.2	12.5	39.0	19.3	10.0	11.4	38.9	23.5	21.9	11.0	17.9	18.2	15.0	30.8	19.8	8.2	10.0	10.5	11.3	13.9	20.2	16.0	10.3	12.7	13.4	21.8	46.9	12.7	11.7	28.5	27.8	18.9	13.3	8.6	13.3	8.4	21.3	14.1	10.0	20.4	9.7	3.6	26.5	20.4	14.6	3.7	7.3	10.1	5.4	7.0	3.2	14.7	19.5	6.4	5.4	6.0	7.3	4.8	5.0	3.4	2.6	2.2	17.6	12.8	3.9	4.1	8.4	3.7	10.9	9.7	16.7	3.3	7.6	10.5	2.4	25.1	7.6	9.7	4.6	4.1	18.7	2.3	12.3	3.7	10.5	3.3	7.9	6.6	17.0	5.3	1.0	5.5	11.0	6.5	1.6	8.9	0.4	6.4	11.3	4.9	5.2	18.8	6.7	4.1	22.3	5.0	11.0	13.0	2.5	10.9	5.0	5.1	20.4	10.0	15.4	5.7	14.6	5.9	3.6	5.9	4.6	6.7	3.5	4.0	5.4	12.5	3.7	12.8	26.5	7.3	10.1	30.7	28.3	8.6	39.1	23.5	21.9	30.8	19.8	20.2	13.3
MARCH4	"KIAA1399, MARCH-IV, RNF174"	ENSG00000144583	"Membrane associated ring-CH-type finger 4"	Q9P2E8	2	216257865-216372027	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 16.6;pituitary gland: 13.1"	"Cell line enhanced"	"Detected in many"		"BJ: 33.3;fHDF/TERT166: 21.2;TIME: 15.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014348	Approved									"HPA014348: AB_1853578"	"unprognostic (4.84e-2)"	"unprognostic (1.02e-4)"	"unprognostic (1.63e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.49e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.07e-1)"	"unprognostic (6.81e-5)"	"unprognostic (4.82e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.09e-3)"	0.7	2.9	7.0	0.7	11.9	0.7	0.6	1.0	16.6	0.6	1.1	0.3	0.0	1.5	0.7	0.7	0.6	2.5	0.6	0.6	5.8	5.6	0.6	0.6	0.8	0.6	2.0	4.8	0.6	1.5	0.6	13.1	3.1	3.4	0.7	1.2	0.1	0.6	0.6	0.6	0.7	1.4	0.6	1.6	0.6	5.1	0.7	1.1	0.0	0.6	0.0	0.6	0.6	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.0	5.5	1.2	0.0	0.0	0.1	0.8	0.0	33.3	11.4	7.2	2.5	0.0	0.5	0.0	5.2	21.2	0.0	0.0	13.1	7.1	0.0	0.0	2.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	6.5	9.9	9.3	0.0	0.0	11.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.9	0.0	0.0	0.0	0.0	0.0	15.6	11.2	11.6	0.0	8.9	0.0	0.0	0.0	2.5	0.0	7.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.0	11.9	1.0	16.6	5.8	5.6	2.0	4.8	3.4	1.1
MARCH7	"AXOT, MARCH-VII, RNF177"	ENSG00000136536	"Membrane associated ring-CH-type finger 7"	Q9H992	2	159712457-159771027	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014275, HPA022152"	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA014275: AB_10599820, HPA022152: AB_10601107"	"unprognostic (2.42e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (2.41e-4)"	"unprognostic (2.46e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.44e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavourable (1.84e-4)"	"unprognostic (1.41e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.61e-1)"	31.6	21.1	18.3	27.4	29.0	22.6	28.9	33.1	23.0	33.4	25.3	17.0	22.0	17.1	32.3	24.1	47.6	22.7	22.4	28.1	16.9	14.4	21.8	30.9	29.5	32.9	21.6	17.8	31.6	15.4	25.3	31.5	41.3	21.5	28.8	22.3	24.8	25.7	22.6	48.0	24.2	25.2	33.8	20.4	28.9	20.0	34.1	21.8	60.4	28.5	25.5	32.9	30.0	35.1	10.0	10.1	46.1	14.5	14.0	14.6	10.5	18.5	12.8	34.5	15.5	25.0	33.1	33.4	31.2	31.6	32.1	29.5	26.4	22.3	26.4	14.2	32.5	23.5	21.2	28.8	41.2	27.0	15.6	35.8	18.6	19.9	24.3	29.3	28.0	29.4	32.9	39.2	34.0	38.5	27.2	25.5	32.4	15.2	18.7	28.1	32.5	18.4	27.9	25.5	21.9	29.5	38.7	20.5	19.3	25.5	18.8	25.0	21.8	35.6	34.7	34.4	20.8	21.1	17.6	20.4	21.4	36.0	21.3	17.8	32.0	24.8	10.3	20.6	11.1	10.6	13.3	10.0	12.1	12.6	10.1	9.7	14.6	14.1	46.1	14.0	14.5	7.9	12.5	10.5	18.3	29.0	33.1	23.0	16.9	14.4	21.6	17.8	21.5	21.8
MARCH8	"c-MIR, CMIR, MARCH-VIII, MIR, RNF178"	ENSG00000165406	"Membrane associated ring-CH-type finger 8"	Q5T0T0	10	45454585-45594906	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA014597	Approved									"HPA014597: AB_1853580"	"unprognostic (1.38e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.04e-1)"	"prognostic favourable (2.71e-4)"	"unprognostic (1.28e-1)"	"prognostic favourable (6.64e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.12e-2)"	10.0	17.6	13.5	11.4	16.0	28.8	12.1	37.5	12.2	10.3	14.6	24.5	8.5	9.7	14.3	8.2	7.5	11.1	9.9	14.1	12.7	11.8	11.0	16.7	10.3	13.5	19.0	9.3	14.2	18.2	15.1	18.1	13.2	14.5	8.8	12.9	12.9	11.5	11.4	9.0	8.9	18.8	12.4	18.2	14.3	9.7	43.2	14.9	10.5	11.5	8.5	13.6	11.0	8.0	5.3	1.7	13.6	1.8	7.3	4.7	2.4	9.1	9.2	7.9	7.0	11.5	14.4	5.9	4.2	19.8	7.8	8.6	2.3	9.5	13.2	7.3	12.3	1.7	8.6	7.2	7.3	20.0	9.5	5.1	4.2	5.5	8.0	6.1	22.7	11.7	9.3	4.0	10.5	12.8	14.3	13.0	6.0	3.2	6.2	3.9	2.6	3.0	7.0	7.9	3.8	5.9	5.3	7.0	9.8	8.3	2.0	7.9	12.2	2.9	8.7	6.2	8.0	9.0	6.6	23.0	18.4	5.8	12.2	8.6	1.6	9.7	1.1	10.0	3.1	1.8	4.7	3.5	3.4	3.3	1.6	5.3	2.7	3.3	13.6	7.3	0.9	1.7	3.1	2.4	13.5	16.0	37.5	12.2	12.7	11.8	19.0	9.3	14.5	14.9
MARCH9	"FLJ36578, RNF179"	ENSG00000139266	"Membrane associated ring-CH-type finger 9"	Q86YJ5	12	57755098-57760407	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	12	"RH-30: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.96e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.90e-3)"	"prognostic favourable (3.07e-4)"	"unprognostic (2.16e-1)"	"unprognostic (6.85e-2)"	"unprognostic (8.15e-3)"	"prognostic favourable (1.54e-5)"	"unprognostic (7.76e-2)"	"prognostic favourable (1.59e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.06e-1)"	"prognostic favourable (2.98e-5)"	"unprognostic (2.44e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.34e-1)"	5.9	11.8	11.0	10.7	14.1	6.1	8.8	25.0	16.6	9.5	9.3	7.8	17.5	10.1	6.8	11.9	8.3	9.6	14.3	12.2	10.8	9.9	16.9	5.6	16.5	16.6	7.7	11.0	6.4	14.4	26.3	24.6	10.3	7.4	11.0	9.0	16.8	12.3	17.6	10.5	13.4	12.7	7.0	6.1	19.4	11.6	5.2	6.8	37.6	20.2	6.2	17.8	9.2	7.7	6.8	11.0	2.2	0.7	3.0	6.1	1.3	3.0	1.5	2.4	2.6	0.2	0.0	3.1	0.4	3.2	1.8	1.8	1.9	2.4	7.5	2.5	0.0	2.7	3.9	3.3	1.2	4.4	4.3	0.9	1.1	1.0	2.3	0.9	1.5	0.3	3.5	0.5	1.9	0.8	1.3	7.7	0.4	2.8	4.7	1.1	1.5	3.3	3.9	107.7	8.0	3.6	2.7	5.4	3.6	0.2	0.2	2.0	5.4	1.8	0.0	2.4	1.9	1.3	1.5	8.7	3.9	4.5	2.6	0.2	2.4	2.2	0.5	0.1	4.0	0.7	5.9	5.3	6.0	5.2	1.5	6.8	6.1	4.6	0.2	3.0	0.2	11.0	3.6	1.3	11.0	14.1	25.0	16.6	10.8	9.9	7.7	11.0	7.4	6.8
RNF5	"G16, NG2, RING5, RMA1"	ENSG00000204308	"Ring finger protein 5"	Q99942	6	32178354-32180793	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034107, HPA065032"	Uncertain		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"CAB034107: AB_2238618, HPA065032: "	"unprognostic (1.94e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.07e-1)"	"prognostic favourable (2.44e-4)"	"unprognostic (1.95e-1)"	"unprognostic (8.93e-3)"	"unprognostic (2.91e-3)"	"unprognostic (8.84e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.99e-2)"	9.8	20.6	19.3	9.0	20.6	10.3	14.0	13.6	16.8	11.3	25.7	17.4	14.7	18.1	12.3	14.6	15.9	16.9	13.9	19.2	16.9	12.0	32.7	38.1	14.7	11.6	16.3	14.2	19.0	19.3	7.2	5.8	23.4	12.3	13.1	19.1	12.2	25.3	15.3	24.5	13.4	36.7	13.7	19.7	10.2	14.2	9.6	9.6	10.8	18.0	14.2	12.5	13.2	9.9	6.7	26.9	7.2	6.4	7.5	7.0	6.5	5.2	6.8	4.6	17.8	5.1	3.5	3.6	2.1	2.7	4.6	5.3	9.1	4.4	6.8	7.7	5.1	4.3	8.6	4.8	4.9	4.2	11.7	5.4	7.7	18.7	6.0	0.0	11.1	3.5	6.5	7.8	5.9	9.3	13.9	7.4	6.7	7.4	6.6	15.6	0.0	2.9	4.5	5.3	9.5	13.1	3.3	4.8	10.0	4.1	4.5	4.6	9.3	19.1	4.2	5.2	5.0	0.0	8.1	4.0	6.1	8.0	3.6	12.1	3.0	5.1	4.6	7.2	7.0	6.4	6.1	6.7	5.7	6.2	6.6	6.0	6.4	6.3	2.4	7.5	4.5	26.9	5.7	6.5	19.3	20.6	13.6	16.8	16.9	12.0	16.3	14.2	12.3	9.6
TRIM31	"C6orf13, HCG1, HCGI, RNF"	ENSG00000204616	"Tripartite motif containing 31"	Q9BZY9	6	30102897-30113106	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 16.3;lymphoid tissue: 7.4;urinary bladder: 12.2"	"Cell line enriched"	"Detected in single"	490	"RT4: 79.5"	"Group enriched"	"Detected in many"	5	"cervical cancer: 6.7;colorectal cancer: 25.8;pancreatic cancer: 11.4;stomach cancer: 19.8;urothelial cancer: 12.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046400	Uncertain									"HPA046400: "	"unprognostic (1.37e-1)"	"unprognostic (7.78e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.75e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.84e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.50e-3)"	0.1	0.0	0.1	7.4	0.1	0.0	0.1	0.1	0.1	0.2	16.3	0.1	0.1	1.2	0.1	0.1	0.1	0.1	3.3	0.1	0.1	0.0	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	2.1	0.4	0.1	0.1	0.1	0.1	0.1	13.7	0.7	0.1	0.1	4.8	2.0	0.1	0.1	0.1	0.1	0.1	12.2	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TRIM68	"FLJ10369, RNF137, SS-56"	ENSG00000167333	"Tripartite motif containing 68"	Q6AZZ1	11	4598672-4608259	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023455	Uncertain		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA023455: AB_1858319"	"unprognostic (4.77e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.63e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.75e-2)"	"unprognostic (7.78e-2)"	"prognostic favourable (4.14e-6)"	"unprognostic (4.23e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.37e-1)"	7.7	11.3	11.1	8.0	11.1	3.1	10.6	15.2	12.8	16.3	10.9	12.6	18.2	10.3	10.6	12.2	8.0	12.6	10.3	9.4	9.6	7.9	14.9	12.7	11.7	7.6	13.1	10.5	17.3	9.9	12.6	10.5	9.8	10.0	16.8	10.1	9.9	12.0	17.5	8.7	7.6	9.8	9.8	11.9	10.7	12.4	13.2	9.5	10.0	17.8	6.7	8.9	11.7	8.4	9.1	5.9	8.9	5.2	5.5	12.8	7.6	8.3	9.3	3.9	6.3	6.3	10.3	0.0	9.2	6.7	8.3	7.6	1.2	8.6	5.7	5.6	4.6	9.8	3.8	6.4	7.2	14.1	7.4	6.9	2.4	0.0	7.3	11.1	9.8	7.9	9.4	4.9	7.4	10.5	6.4	3.0	7.4	2.0	9.1	3.0	4.5	7.7	7.3	5.5	0.2	5.4	3.7	2.0	3.7	0.0	9.3	5.8	4.0	5.6	8.4	11.2	7.7	11.2	4.0	11.7	12.6	8.3	7.7	4.9	10.5	6.4	2.7	8.9	9.0	5.1	10.1	9.1	9.9	10.0	5.9	7.9	12.8	10.1	0.3	5.5	5.2	4.0	8.7	7.6	11.1	11.1	15.2	12.8	9.6	7.9	13.1	10.5	10.0	9.5
TRIM8	"GERP, RNF27"	ENSG00000171206	"Tripartite motif containing 8"	Q9BZR9	10	102642310-102660680	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023560, HPA023561"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA023560: AB_10600414, HPA023561: AB_10601861"	"unprognostic (4.32e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.03e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.15e-3)"	"unprognostic (4.62e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.36e-2)"	31.7	18.4	26.1	23.9	25.2	17.0	18.0	26.1	31.6	31.8	19.5	22.9	15.4	15.8	18.0	14.3	17.8	21.6	19.8	25.0	23.2	18.0	27.2	21.9	23.0	25.4	20.1	20.0	19.3	35.9	24.7	14.7	17.5	16.3	17.4	8.1	19.4	28.5	18.5	34.8	14.6	23.7	13.6	15.7	22.5	21.2	11.7	21.9	48.3	26.6	14.5	30.3	21.4	15.9	9.0	11.9	17.8	5.3	5.5	7.2	3.9	27.6	6.5	6.4	10.5	7.1	14.4	6.0	9.9	20.2	10.8	8.7	11.7	33.4	8.9	26.7	22.0	10.2	4.3	13.3	8.9	9.0	8.4	22.5	5.4	26.7	18.1	5.0	9.0	16.5	7.4	23.7	14.0	14.3	4.2	13.4	8.4	18.0	9.5	16.9	3.5	13.2	4.8	14.4	4.4	12.8	19.5	3.9	7.6	5.5	6.8	13.1	19.2	10.0	26.6	14.5	6.5	8.1	22.2	12.3	8.0	5.2	22.1	12.6	3.6	10.7	4.8	2.6	6.8	4.4	6.7	9.0	7.2	5.3	4.1	7.0	6.4	5.5	17.8	5.5	5.3	11.9	6.9	3.9	26.1	25.2	26.1	31.6	23.2	18.0	20.1	20.0	16.3	21.9
TRIML1	"FLJ36180, RNF209"	ENSG00000184108	"Tripartite motif family like 1"	Q8N9V2	4	188139419-188147743	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	21	"testis: 14.1"	"Cell line enriched"	"Detected in single"	9	"BEWO: 5.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																			"unprognostic (6.99e-2)"									"unprognostic (5.21e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UHRF2	"MGC33463, NIRF, RNF107, TDRD23, URF2"	ENSG00000147854	"Ubiquitin like with PHD and ring finger domains 2"	Q96PU4	9	6413151-6507054	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026633, HPA026697"			Enhanced	Nucleoplasm				Nucleoplasm		"HPA026633: AB_1858610, HPA026697: AB_1858611"	"unprognostic (1.08e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.14e-2)"	"unprognostic (6.21e-2)"	"unprognostic (8.77e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.50e-1)"	14.1	12.9	10.6	25.4	12.2	49.1	19.0	24.8	11.8	18.6	15.6	12.7	17.6	7.9	17.5	15.1	13.3	12.0	11.9	11.3	10.2	10.6	10.1	9.8	13.5	19.3	12.3	10.5	18.9	14.5	12.7	12.7	14.6	11.4	19.3	12.0	10.7	13.0	16.4	15.7	11.0	12.0	17.1	12.2	14.1	11.6	10.6	14.8	40.3	15.2	10.2	19.8	18.7	18.2	5.1	2.5	7.5	1.4	1.2	3.6	1.2	6.6	7.5	10.9	4.6	9.0	12.9	8.0	15.3	9.4	9.6	16.9	4.8	4.8	10.2	3.3	7.6	4.3	10.0	8.9	14.8	18.3	4.7	17.7	14.7	7.6	7.4	8.2	6.0	5.8	5.8	7.5	18.4	37.5	1.7	9.9	22.7	2.3	13.8	32.1	4.2	5.6	15.8	5.0	3.6	7.2	4.6	9.9	3.8	6.6	4.4	9.6	5.5	16.6	31.7	10.3	3.8	4.3	12.8	2.6	7.9	11.9	5.0	7.2	4.1	7.5	1.1	4.3	2.3	0.9	1.7	3.5	3.6	1.8	0.7	5.1	2.3	3.0	1.3	1.2	1.4	2.5	3.5	1.2	10.6	12.2	24.8	11.8	10.2	10.6	12.3	10.5	11.4	14.8
USP20	KIAA1003	ENSG00000136878	"Ubiquitin specific peptidase 20"	Q9Y2K6	9	129834698-129881838	"Enzymes, Predicted intracellular proteins"	"Endocytosis, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 30.4;MOLT-4: 27.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006287, HPA007008"	Uncertain	Supported	Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"		"HPA006287: AB_1080510, HPA007008: "	"unprognostic (2.64e-2)"	"prognostic favourable (8.01e-4)"	"prognostic unfavourable (2.48e-4)"	"prognostic favourable (4.01e-4)"	"unprognostic (4.69e-1)"	"unprognostic (1.89e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.89e-2)"	"prognostic favourable (1.54e-7)"	"unprognostic (2.09e-1)"	"prognostic favourable (5.65e-5)"	"unprognostic (1.76e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.24e-2)"	7.8	13.2	10.5	15.2	14.6	24.4	8.5	23.0	19.6	13.2	12.1	12.7	10.2	9.7	13.3	6.2	9.3	11.6	12.5	8.8	10.5	13.7	8.0	7.3	9.1	19.6	9.6	16.1	16.8	12.9	11.5	19.0	8.0	11.9	14.9	6.1	10.8	13.7	17.2	10.2	14.0	11.8	20.0	8.8	14.6	10.2	14.0	8.8	51.5	19.3	4.2	15.3	15.6	10.0	3.8	2.4	4.8	1.7	9.0	10.7	5.4	3.0	2.9	5.2	7.0	6.8	5.8	7.4	4.9	4.1	3.7	2.6	2.4	3.3	4.1	4.2	4.7	7.6	3.1	3.5	1.5	22.2	4.1	7.6	8.0	1.6	4.8	7.1	5.7	5.1	5.1	4.9	3.7	4.0	30.4	5.1	2.2	8.0	27.8	16.9	4.1	7.0	4.7	5.8	7.0	2.9	3.3	1.1	5.8	5.7	7.2	4.6	7.5	10.0	5.9	4.1	1.9	5.5	3.2	5.1	7.4	2.9	8.2	9.4	3.8	1.0	1.7	4.8	8.6	1.4	9.3	3.7	8.8	8.3	2.4	3.8	10.4	8.9	2.8	9.0	1.3	2.1	10.7	5.4	10.5	14.6	23.0	19.6	10.5	13.7	9.6	16.1	11.9	8.8
XIAP	"API3, BIRC4, hILP"	ENSG00000101966	"X-linked inhibitor of apoptosis"	P98170	X	123859724-123913979	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway, Wnt signaling pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB009203, HPA042428"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009203: AB_2257167, HPA042428: "	"prognostic unfavourable (9.21e-4)"	"unprognostic (8.43e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.40e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.95e-2)"	"unprognostic (8.51e-2)"	"unprognostic (9.17e-2)"	"unprognostic (3.90e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.15e-3)"	"unprognostic (8.21e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.65e-2)"	17.4	14.4	20.0	18.1	20.2	12.0	15.9	21.3	18.9	17.2	19.4	14.5	22.9	16.1	17.4	17.0	18.9	12.6	14.7	15.7	18.9	22.1	19.8	19.4	16.5	15.5	18.8	14.6	13.9	19.7	36.6	26.1	18.2	15.9	15.6	16.8	16.9	14.6	22.9	21.5	14.2	23.4	17.0	19.0	15.8	16.2	7.0	12.3	13.9	24.3	11.4	14.0	15.4	20.5	5.7	4.3	11.1	3.9	3.3	5.5	1.9	11.5	9.9	7.8	6.7	9.2	11.9	10.2	12.6	9.4	6.9	5.9	4.4	13.6	10.8	18.7	10.7	4.3	11.5	7.9	12.7	11.2	6.3	7.3	8.3	6.7	11.7	13.2	15.2	8.2	12.3	11.4	14.7	9.5	11.5	12.5	13.3	12.0	7.3	6.4	6.4	7.8	7.9	9.1	11.4	10.4	16.8	5.3	7.7	17.2	10.0	10.1	6.1	6.5	11.7	0.3	4.7	20.6	14.0	10.5	10.5	12.0	14.2	9.4	8.7	11.1	2.6	3.5	5.0	2.3	4.7	4.6	3.8	5.5	1.4	5.7	4.4	3.0	8.2	3.3	3.9	4.3	2.5	1.9	20.0	20.2	21.3	18.9	18.9	22.1	18.8	14.6	15.9	12.3
CACYBP	"S100A6BP, SIP"	ENSG00000116161	"Calcyclin binding protein"	Q9HB71	1	174999163-175011715	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 117.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025753, HPA057038"	Approved		Enhanced	Nucleoplasm,Cytosol			360000	Cytosol	Nucleoplasm	"HPA025753: AB_1845878, HPA057038: "	"unprognostic (4.70e-3)"	"unprognostic (9.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.96e-3)"	"prognostic unfavourable (1.12e-6)"	"unprognostic (1.50e-2)"	"unprognostic (2.03e-2)"	"prognostic favourable (1.39e-5)"	"unprognostic (4.55e-2)"	"unprognostic (1.87e-2)"	"prognostic unfavourable (1.25e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.79e-2)"	15.1	15.9	38.3	20.3	39.7	24.6	36.2	36.1	46.5	16.0	16.7	10.7	12.5	13.3	14.0	22.5	13.9	15.6	12.7	13.0	36.9	39.1	23.4	18.5	13.3	25.2	33.8	22.8	26.5	10.1	21.4	17.2	19.1	33.1	17.0	18.6	7.9	11.8	17.2	29.8	12.6	14.0	14.4	29.0	13.3	11.7	23.3	27.5	16.2	19.1	12.6	23.9	16.6	117.2	26.7	20.1	17.3	30.2	25.3	29.0	25.8	30.4	21.1	31.1	13.3	10.4	11.7	20.0	23.4	13.9	30.4	22.2	21.7	19.1	32.2	24.5	16.6	16.7	38.7	17.1	31.5	17.0	23.6	24.1	20.8	23.3	7.9	32.4	15.1	7.8	10.6	24.9	15.1	21.3	48.3	18.1	21.8	11.3	49.8	29.6	29.5	9.8	22.5	22.1	37.1	21.6	24.4	21.4	20.6	15.9	27.9	24.1	21.6	28.4	11.0	17.3	18.5	24.1	37.5	17.5	50.2	71.4	14.5	28.5	20.1	17.3	16.1	15.9	19.0	24.4	22.1	26.7	27.5	23.0	20.1	20.4	29.0	25.7	8.7	25.3	30.2	16.6	28.5	25.8	38.3	39.7	36.1	46.5	36.9	39.1	33.8	22.8	33.1	27.5
COPS4	CSN4	ENSG00000138663	"COP9 signalosome subunit 4"	Q9BT78	4	83034447-83075818	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036894, HPA042828"	Uncertain		Supported	"Nuclear speckles"			84000	"Nuclear speckles"		"HPA036894: AB_10670929, HPA042828: "	"unprognostic (1.82e-3)"	"unprognostic (1.01e-2)"	"prognostic favourable (4.14e-4)"	"unprognostic (7.97e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.96e-2)"	"unprognostic (3.26e-1)"	"unprognostic (3.10e-2)"	"unprognostic (9.21e-2)"	"prognostic favourable (5.21e-6)"	"unprognostic (5.84e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.80e-1)"	16.3	24.1	22.5	12.5	35.8	21.1	19.4	20.8	33.0	20.5	15.6	13.4	11.5	13.8	19.2	18.0	20.6	16.1	13.5	34.9	22.0	28.9	23.3	18.3	13.1	16.0	24.2	25.4	20.2	14.5	22.3	32.0	21.7	35.7	18.8	15.4	11.6	14.1	19.4	55.1	16.3	12.9	20.1	15.6	17.0	14.3	27.6	14.6	24.8	23.2	23.9	18.6	20.8	14.9	20.3	22.4	34.2	27.7	25.4	28.5	24.1	16.9	10.1	22.1	20.1	19.8	25.5	12.0	22.5	29.3	25.8	23.0	14.5	17.7	29.0	19.9	47.4	12.9	27.3	23.2	35.0	18.2	19.3	16.8	16.6	13.9	16.4	28.3	47.8	19.2	16.2	19.3	16.5	34.2	21.0	16.4	31.2	14.1	33.7	20.9	12.1	13.8	24.2	16.7	15.9	20.7	15.7	23.3	13.6	15.0	23.8	14.3	17.9	15.6	22.3	18.1	19.3	13.6	16.0	17.2	10.4	31.9	17.4	18.4	17.8	34.2	18.4	26.0	22.9	24.9	28.5	20.3	25.4	26.2	22.4	18.6	24.3	26.0	4.2	25.4	27.7	14.6	23.1	24.1	22.5	35.8	20.8	33.0	22.0	28.9	24.2	25.4	35.7	14.6
COPS5	"CSN5, JAB1, MOV-34, SGN5"	ENSG00000121022	"COP9 signalosome subunit 5"	Q92905	8	67043079-67083783	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004242, HPA004845, HPA051531"	Supported		Enhanced	Nucleoplasm			27000	Nucleoplasm		"CAB004242: AB_627835, HPA004845: AB_1078557, HPA051531: "	"unprognostic (1.90e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.85e-3)"	"unprognostic (2.53e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.48e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.18e-2)"	20.2	26.3	29.4	19.6	28.6	16.2	28.1	28.5	40.3	18.0	21.7	15.6	20.2	22.0	17.6	21.7	24.0	17.7	15.5	46.8	27.6	27.5	27.4	33.7	16.8	17.5	31.8	29.9	17.0	20.7	23.3	21.7	24.3	33.7	18.3	25.5	9.9	19.6	18.9	64.0	16.8	22.5	23.3	39.2	16.1	20.7	27.4	31.3	19.6	18.5	29.2	22.4	18.3	16.5	20.7	35.1	33.7	30.0	26.5	28.1	22.3	30.2	28.7	24.4	22.3	25.7	27.4	19.4	26.7	21.9	37.1	33.4	18.6	37.3	28.1	12.3	27.5	25.3	32.7	29.4	40.9	26.9	28.2	39.9	28.9	24.9	24.9	25.2	24.3	24.9	37.7	30.2	39.0	36.1	47.2	19.5	33.2	28.1	44.3	44.2	32.4	33.1	28.5	17.5	22.1	39.2	27.0	14.8	20.4	15.3	29.7	25.8	48.8	26.0	26.7	18.8	23.3	22.7	20.8	24.6	31.3	37.4	27.5	28.7	25.6	26.0	28.6	33.7	20.8	30.0	21.7	20.7	20.1	23.1	35.1	17.5	21.6	19.1	21.2	26.5	28.3	18.4	28.1	22.3	29.4	28.6	28.5	40.3	27.6	27.5	31.8	29.9	33.7	31.3
COPS6	"CSN6, MOV34-34KD"	ENSG00000168090	"COP9 signalosome subunit 6"	Q7L5N1	7	100088954-100092200	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044315	Approved		Supported	Nucleoplasm	"Intracellular and membrane"		58000	Nucleoplasm		"HPA044315: AB_10959750"	"unprognostic (1.48e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.84e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.45e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (6.72e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.58e-2)"	"unprognostic (8.57e-2)"	"unprognostic (8.77e-2)"	25.4	30.0	37.7	20.2	50.6	19.7	25.6	31.5	43.3	32.5	30.4	26.5	15.1	19.3	31.0	39.8	33.4	33.7	32.4	47.2	31.5	32.1	31.7	41.2	20.1	30.4	33.3	32.6	30.8	42.8	38.1	28.2	29.1	34.1	27.4	26.6	25.0	28.3	35.7	53.1	23.4	19.2	45.2	30.1	22.7	26.9	25.5	30.8	29.4	27.6	21.6	25.8	26.7	24.8	53.4	67.6	58.9	64.0	48.2	69.4	45.3	31.8	45.4	27.3	32.3	24.0	28.7	17.3	29.0	44.6	48.6	35.7	37.1	30.2	22.1	37.5	47.4	24.4	30.8	49.0	49.2	21.9	48.3	18.8	45.1	28.6	50.3	21.3	19.5	28.3	32.5	52.2	55.9	66.3	26.9	31.9	57.1	79.3	47.1	31.7	24.6	54.6	22.5	45.4	52.6	38.5	30.0	42.8	31.8	29.9	59.2	21.9	24.4	21.1	34.8	46.8	42.7	56.0	50.9	23.6	26.1	45.2	35.4	29.0	69.0	58.9	61.9	51.7	61.1	64.0	61.2	53.4	61.3	57.8	67.6	49.8	48.3	53.9	24.1	48.2	57.4	50.2	69.4	45.3	37.7	50.6	31.5	43.3	31.5	32.1	33.3	32.6	34.1	30.8
COPS8	"COP9, CSN8, MGC1297, SGN8"	ENSG00000198612	"COP9 signalosome subunit 8"	Q99627	2	237085312-237100466	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 77.7;U-138 MG: 92.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036485	Uncertain		Supported	Nucleoplasm,Cytosol			110000	Nucleoplasm	Cytosol	"HPA036485: AB_10670720"	"unprognostic (8.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.74e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavourable (4.70e-5)"	"unprognostic (1.34e-2)"	"unprognostic (8.03e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.85e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.36e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.82e-2)"	20.1	23.1	25.2	15.6	37.0	15.7	17.9	15.2	33.8	20.6	14.0	16.7	8.6	7.7	20.9	18.3	12.5	18.0	19.9	37.8	31.7	27.9	24.2	15.6	12.3	13.5	23.6	25.8	23.7	10.8	18.2	15.0	19.8	28.1	16.6	11.7	18.6	12.7	18.1	64.5	12.3	9.7	25.4	21.3	10.4	13.5	20.8	15.4	14.8	17.5	20.3	14.5	18.0	13.2	32.4	26.9	26.1	25.9	32.2	36.2	31.7	9.4	8.0	17.6	8.7	50.5	40.0	11.7	16.7	16.6	17.2	19.1	5.2	9.6	6.5	6.4	18.1	7.2	17.2	22.7	24.0	15.3	11.1	9.5	10.3	18.5	34.9	12.3	5.6	65.8	26.3	17.2	77.7	20.0	13.1	6.3	54.2	9.0	15.1	12.6	15.5	11.8	11.6	20.9	13.0	21.2	7.7	8.6	14.9	10.0	8.6	24.8	9.9	10.1	21.0	92.0	15.5	18.0	18.0	12.1	10.0	20.9	28.7	7.5	23.2	21.9	22.8	26.1	29.7	25.0	36.2	32.4	31.7	33.8	26.9	26.9	30.8	32.1	7.0	32.2	25.9	19.4	33.1	31.7	25.2	37.0	15.2	32.3	31.7	27.9	23.6	25.8	28.1	15.4
DCAF17	"C2orf37, FLJ13096"	ENSG00000115827	"DDB1 and CUL4 associated factor 17"	Q5H9S7	2	171434217-171485052	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"		Hypotrichosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053339, HPA055040"	Uncertain		Supported	Nucleoplasm				Nucleoplasm		"HPA053339: , HPA055040: "	"unprognostic (1.60e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.98e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.27e-1)"	"prognostic unfavourable (7.10e-4)"	"unprognostic (2.79e-2)"	7.9	9.8	12.3	9.7	19.0	5.7	12.2	14.5	12.1	11.2	10.4	14.5	8.7	8.4	16.2	12.5	9.2	9.2	9.0	7.1	13.6	9.4	11.2	8.3	7.3	12.6	19.2	8.0	14.1	13.1	13.8	10.9	10.0	10.9	10.2	9.2	9.4	9.0	10.2	7.4	13.5	9.5	14.6	17.2	11.5	8.1	10.5	17.3	15.4	19.6	5.0	11.0	10.7	11.1	3.9	2.0	2.3	2.9	2.0	7.1	3.0	6.7	5.6	7.3	8.6	9.3	10.0	11.3	6.0	6.1	6.0	5.7	6.6	4.5	19.6	4.4	7.3	6.7	7.4	7.3	8.4	9.0	5.0	9.0	4.5	11.9	9.5	12.7	6.5	7.8	9.7	7.7	17.2	6.5	14.0	6.8	8.3	4.1	13.9	11.8	10.9	3.5	10.6	9.7	10.6	5.2	6.1	6.5	9.4	5.6	4.8	5.9	3.7	6.7	7.8	7.0	6.3	3.9	5.1	10.3	14.0	16.5	7.4	6.6	7.2	2.3	2.6	1.0	5.0	2.9	7.1	2.8	4.0	3.5	2.0	3.9	4.4	5.4	0.1	2.0	2.5	1.5	3.5	3.0	12.3	19.0	14.5	12.1	13.6	9.4	19.2	8.0	10.9	17.3
DCST1	FLJ32785	ENSG00000163357	"DC-STAMP domain containing 1"	Q5T197	1	155033824-155050930	"Enzymes, Predicted membrane proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"retina: 18.2;skin 1: 6.8;testis: 10.7"	"Cell line enhanced"	"Detected in some"		"HaCaT: 4.8;HeLa: 4.0;RPMI-8226: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060314	Uncertain									"HPA060314: "	"unprognostic (1.44e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.05e-4)"	"unprognostic (3.58e-2)"	"unprognostic (8.75e-4)"	"unprognostic (1.46e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.22e-1)"	"unprognostic (6.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.33e-15)"	"unprognostic (7.77e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.23e-1)"	0.2	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.2	0.1	0.1	0.1	1.7	0.1	0.1	0.4	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.0	18.2	0.7	0.1	0.1	6.8	1.6	0.1	0.1	0.2	0.4	10.7	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.8	0.8	0.9	1.2	0.0	1.0	0.1	1.5	0.7	2.7	1.5	0.1	0.0	1.0	0.5	0.0	0.0	0.0	0.7	3.2	1.5	0.5	0.0	4.8	0.0	0.0	0.0	1.2	0.4	0.4	4.0	0.3	0.0	1.1	0.6	0.0	0.2	0.0	0.0	0.0	1.1	2.3	0.0	1.0	0.0	0.3	0.2	2.2	0.0	1.1	5.4	0.0	0.8	0.9	1.8	0.6	1.8	0.2	3.4	0.1	0.0	0.3	0.2	0.8	0.4	0.9	0.8	0.3	0.7	1.6	0.0	0.0	0.2	0.9	0.1	0.0	0.0	0.8	0.4	0.2	0.3	0.0	1.0	0.2	0.2	0.0	1.2	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
EGR2	KROX20	ENSG00000122877	"Early growth response 2"	P11161	10	62811996-62919900	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Transferase"	"Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 57.1"	"Cell line enriched"	"Detected in some"	6	"U-87 MG: 22.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 5.5;non-classical monocyte: 5.3"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"amygdala: 2.5;basal ganglia: 3.8;cerebral cortex: 4.9;hippocampal formation: 4.1;olfactory region: 3.0"	"Group enriched"	"Detected in many"	4	"basal ganglia: 3.7;cerebral cortex: 6.6;hippocampal formation: 5.1;midbrain: 3.0;olfactory region: 9.8"	HPA031165			Supported	Nucleoplasm				Nucleoplasm		"HPA031165: "	"prognostic favourable (7.30e-5)"	"unprognostic (1.86e-3)"	"unprognostic (1.45e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.47e-3)"	"unprognostic (6.54e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.11e-3)"	9.4	4.7	1.8	8.3	9.2	2.7	7.8	1.2	9.9	8.5	2.9	18.7	0.5	0.7	5.8	25.5	3.5	6.1	13.1	16.1	3.3	1.6	3.0	5.2	15.7	5.3	6.0	1.2	7.6	2.2	3.9	10.6	4.9	7.5	7.6	1.5	7.8	3.1	1.3	1.2	15.9	3.1	6.7	3.1	3.6	3.0	4.3	0.7	22.7	57.1	5.0	11.5	8.2	2.4	1.2	1.1	1.5	5.5	0.5	0.4	0.6	0.0	0.2	2.4	1.0	1.8	2.4	0.4	0.5	0.2	0.5	0.8	0.0	0.3	0.6	0.0	0.6	0.3	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.6	3.8	0.3	0.6	1.3	0.2	0.1	0.2	0.8	0.1	1.2	0.0	1.7	0.2	1.3	0.1	0.2	0.4	0.0	0.2	0.1	0.3	0.2	0.8	3.9	0.0	0.5	0.1	0.6	0.4	0.2	0.3	1.4	0.6	0.3	22.4	0.4	0.4	0.0	1.1	0.4	0.4	5.5	0.0	1.0	0.0	0.2	1.1	1.2	0.0	0.4	1.5	0.5	5.3	0.0	0.0	0.6	1.8	9.2	1.2	9.9	3.3	1.6	6.0	1.2	7.5	0.7
KCTD17	FLJ12242	ENSG00000100379	"Potassium channel tetramerization domain containing 17"	Q8N5Z5	22	37051736-37063390	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Ubl conjugation pathway"		"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 59.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018459	Uncertain									"HPA018459: AB_1852169"	"unprognostic (1.09e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.61e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.09e-3)"	"prognostic unfavourable (3.59e-5)"	"unprognostic (1.89e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.19e-1)"	"prognostic favourable (4.22e-5)"	"unprognostic (8.62e-2)"	"prognostic unfavourable (5.13e-12)"	"unprognostic (2.32e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.94e-2)"	6.1	11.8	21.7	9.6	59.0	2.5	4.2	7.0	36.3	6.2	8.3	9.2	2.7	3.8	9.6	2.6	7.7	5.9	8.9	17.1	23.1	12.9	2.3	2.1	7.1	9.6	12.6	14.7	10.8	3.0	4.0	14.5	9.5	10.5	5.1	5.8	2.3	1.8	10.3	1.9	16.9	4.3	10.0	6.8	6.8	4.4	18.7	16.0	4.1	2.8	2.3	7.1	8.7	7.9	2.9	2.7	0.0	2.9	3.8	2.8	1.0	8.2	10.9	17.3	12.8	8.3	8.3	0.7	8.7	8.4	14.2	12.3	2.3	2.5	6.4	6.0	11.0	2.2	5.4	10.1	6.0	12.4	14.4	2.7	2.9	2.6	12.4	0.0	3.3	9.7	5.0	14.5	3.2	18.1	0.6	7.1	8.9	6.7	5.6	0.1	11.0	9.4	10.3	4.5	1.9	3.6	2.1	14.5	18.0	8.0	7.7	3.9	2.0	2.2	10.4	18.5	17.3	8.7	6.3	9.7	2.8	1.0	16.3	3.8	10.0	0.0	2.3	0.0	2.7	2.9	2.6	2.9	2.0	2.8	2.7	1.5	2.5	2.0	0.0	3.8	1.3	0.6	2.8	1.0	21.7	59.0	7.0	25.4	23.1	12.9	12.6	14.7	10.5	16.0
KIAA1586		ENSG00000168116	KIAA1586	Q9HCI6	6	57046532-57055239	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA036370	Approved		Approved	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"		"HPA036370: AB_10672219"	"unprognostic (7.17e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.96e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.36e-3)"	"unprognostic (5.64e-2)"	"unprognostic (8.25e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.07e-1)"	7.2	8.7	11.9	5.7	19.7	11.7	9.0	33.8	15.7	9.1	6.8	2.9	6.5	3.6	10.4	6.5	5.7	6.1	7.8	6.0	10.4	8.7	6.1	8.0	5.9	6.9	10.9	9.3	13.3	5.4	9.8	19.7	15.3	12.4	9.1	4.5	2.6	5.0	6.5	4.1	4.3	5.3	7.5	8.4	7.4	4.7	12.5	10.4	6.2	9.6	3.6	6.4	9.0	6.6	5.5	6.3	3.1	4.2	8.2	7.1	3.2	4.8	2.1	12.9	14.7	5.2	8.5	7.2	8.2	6.8	7.2	8.6	3.4	1.6	1.9	6.8	6.0	2.4	9.9	4.8	9.8	6.1	7.5	20.3	4.7	7.7	6.8	16.2	7.6	6.1	3.5	6.3	7.0	6.7	27.9	1.6	8.3	3.9	7.8	9.9	8.3	3.0	7.2	9.5	4.7	4.8	10.2	11.0	10.1	5.3	1.8	6.1	4.2	14.8	5.4	11.1	4.6	10.6	5.8	6.5	8.5	9.5	6.8	12.0	4.5	0.3	4.2	3.1	3.9	3.0	4.3	5.5	5.7	4.9	5.9	4.4	7.1	6.0	0.3	8.2	2.8	6.3	6.5	3.2	11.9	19.7	33.8	15.7	10.4	8.7	10.9	9.3	12.4	10.4
KLHL13	"BKLHD2, FLJ10262, KIAA1309"	ENSG00000003096	"Kelch like family member 13"	Q9P2N7	X	117897813-118117340	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 35.6"	"Cell line enhanced"	"Detected in many"		"HeLa: 22.2;RH-30: 13.9;RPTEC TERT1: 39.9;SH-SY5Y: 35.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 3.2;eosinophil: 9.3;plasmacytoid DC: 5.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.6;granulocytes: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046039, HPA059901"	Approved		Approved	Cytosol				Cytosol		"HPA046039: , HPA059901: "	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.07e-2)"	"unprognostic (9.54e-2)"	"unprognostic (7.22e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.54e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.31e-1)"	2.4	5.5	3.4	3.9	11.9	0.2	19.0	2.5	3.7	24.9	5.3	3.1	6.6	2.2	35.6	5.6	5.4	8.1	10.1	9.0	2.3	4.0	15.4	3.3	1.4	0.4	4.7	2.1	7.7	3.3	3.5	5.0	1.7	6.6	7.3	3.0	5.6	2.6	9.7	2.3	1.5	4.9	22.2	3.5	1.1	3.5	2.8	4.9	3.6	1.4	3.1	1.2	8.2	5.0	0.0	5.6	9.3	0.1	1.4	0.9	0.4	0.4	0.1	2.6	5.4	0.0	0.0	0.1	0.2	0.0	0.1	0.0	3.3	0.0	0.0	6.2	0.0	6.2	12.5	2.0	0.0	0.0	4.8	0.1	22.2	0.0	0.3	0.4	0.8	0.6	0.9	0.0	0.2	9.5	0.0	0.0	0.0	0.5	2.1	0.5	5.0	3.5	0.0	13.9	0.0	39.9	1.4	0.0	35.6	0.1	0.4	0.3	7.7	0.0	0.2	0.9	1.1	0.7	3.1	0.1	0.0	0.0	3.8	0.0	1.5	3.2	0.1	9.3	0.0	0.0	0.0	0.0	0.1	0.1	1.3	0.0	0.9	0.8	0.0	1.4	0.0	5.6	0.4	0.4	3.4	11.9	2.5	3.5	2.3	4.0	4.7	2.1	6.6	4.9
KLHL3	KIAA1129	ENSG00000146021	"Kelch like family member 3"	Q9UH77	5	137617500-137736090	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Actin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 64.2"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 6.3;RT4: 6.6;TIME: 14.6;U-266/70: 8.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 64.2"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051291	Approved									"HPA051291: "	"unprognostic (4.31e-2)"	"unprognostic (5.31e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.39e-3)"	"unprognostic (3.28e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.20e-3)"	"unprognostic (1.50e-4)"	4.1	5.8	9.1	3.2	11.9	1.2	2.7	64.2	12.0	5.3	2.1	0.8	1.7	2.6	5.0	2.7	2.2	5.1	5.8	14.7	6.2	4.2	10.2	1.8	2.8	5.2	4.7	9.3	9.0	2.2	1.3	5.9	3.3	5.0	2.3	2.4	10.4	1.6	2.2	2.2	3.1	1.9	3.6	4.2	3.5	5.1	5.5	1.7	3.7	12.1	1.3	4.0	3.0	3.4	0.1	1.2	1.6	0.0	2.2	3.2	0.6	0.4	0.3	1.5	0.0	0.9	1.2	1.0	0.3	0.4	0.2	0.2	0.5	5.8	1.4	3.1	0.0	0.2	0.3	2.6	0.2	1.4	0.7	0.6	1.0	0.0	0.3	0.0	1.1	1.1	0.2	0.7	0.0	6.3	0.3	1.2	0.2	0.0	3.1	0.9	2.7	0.9	2.5	0.0	0.0	1.0	6.6	1.8	1.0	0.4	0.0	0.5	0.0	0.5	14.6	0.4	0.4	0.0	0.4	8.8	4.9	0.0	5.6	0.1	0.7	0.0	0.0	1.6	0.7	0.0	0.8	0.0	3.0	1.1	0.1	0.1	3.2	1.8	0.0	2.2	0.0	1.2	1.3	0.6	9.1	11.9	64.2	12.0	6.2	4.2	4.7	9.3	5.0	1.7
KLHL9	"FLJ13568, KIAA1354"	ENSG00000198642	"Kelch like family member 9"	Q9P2J3	9	21329671-21335380	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046039, HPA059901"	Approved		Approved	Cytosol				Cytosol		"HPA046039: , HPA059901: "	"unprognostic (7.82e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.89e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.52e-2)"	"unprognostic (9.06e-2)"	"prognostic favourable (9.43e-10)"	"unprognostic (2.87e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.91e-1)"	"unprognostic (3.33e-3)"	17.8	15.1	16.4	12.4	15.6	9.3	20.8	18.0	19.5	19.7	14.4	19.4	12.7	8.7	19.5	18.7	14.8	16.8	12.6	13.6	15.8	19.9	17.8	15.1	13.6	13.2	16.9	11.9	25.3	20.4	18.1	16.9	22.6	15.7	20.0	15.1	15.3	16.2	14.8	9.3	10.1	15.6	17.6	16.9	17.3	16.1	9.9	13.2	23.0	19.9	11.6	13.5	15.7	16.5	3.4	5.0	16.7	7.2	6.0	8.3	4.5	5.9	7.3	16.6	9.0	21.6	21.5	3.6	11.3	11.5	8.6	9.7	2.7	4.8	2.7	7.3	16.4	3.3	9.7	11.0	10.7	14.9	7.0	0.0	13.8	7.1	15.0	4.7	3.3	21.0	11.9	6.7	10.9	13.0	0.0	3.6	19.5	3.8	9.8	16.5	6.8	6.3	0.0	7.3	3.2	10.6	7.5	5.3	10.1	6.5	5.9	6.9	10.6	0.0	15.5	0.0	6.1	4.8	6.5	3.9	5.3	2.8	0.0	5.0	5.8	7.5	6.2	16.7	5.5	6.9	6.2	3.4	6.7	5.0	5.0	2.6	8.3	5.6	2.0	6.0	7.2	3.7	4.6	4.5	16.4	15.6	18.0	19.5	15.8	19.9	16.9	11.9	15.7	13.2
LRSAM1	"CMT2P, FLJ31641"	ENSG00000148356	"Leucine rich repeat and sterile alpha motif containing 1"	Q6UWE0	9	127451486-127503501	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	Transferase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021403, HPA021844, CAB037304"	Supported		Approved	Cytosol				Cytosol		"CAB037304: AB_2138198, HPA021403: AB_1853366, HPA021844: AB_1853368"	"unprognostic (8.83e-2)"	"unprognostic (3.13e-1)"	"unprognostic (7.48e-3)"	"unprognostic (4.15e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.72e-2)"	"prognostic favourable (6.78e-6)"	"unprognostic (1.27e-1)"	"prognostic favourable (5.72e-4)"	"unprognostic (1.94e-2)"	"unprognostic (3.26e-1)"	"unprognostic (9.07e-2)"	"unprognostic (3.33e-2)"	9.5	13.6	15.6	10.1	17.2	15.3	9.2	24.2	22.6	10.7	18.0	15.3	10.9	10.8	12.6	17.6	12.3	11.0	11.9	18.7	13.3	17.3	11.2	15.6	11.7	11.5	13.5	22.7	16.0	9.6	17.6	11.8	9.2	17.9	13.6	8.6	10.2	11.9	13.7	20.4	28.3	11.1	16.0	18.7	12.6	12.2	6.1	13.9	5.5	11.6	9.6	11.5	17.2	12.9	4.1	5.4	17.4	6.6	1.3	4.8	3.2	5.7	8.7	5.3	10.1	8.9	8.8	8.3	5.4	6.7	8.3	6.2	10.0	5.6	9.8	5.5	7.5	18.9	6.4	11.3	3.3	10.4	4.9	5.3	11.3	8.7	7.1	5.8	11.2	5.1	9.3	5.7	10.9	8.9	4.7	10.2	3.6	14.4	4.1	5.1	5.0	8.8	6.7	4.7	15.3	9.0	5.0	9.7	8.0	3.5	12.0	7.0	24.6	3.1	10.4	5.6	5.7	7.0	3.6	11.3	8.4	1.6	9.2	5.4	2.9	14.6	4.9	17.4	4.4	6.6	4.8	4.1	3.0	3.7	5.4	3.1	1.5	2.0	5.7	1.3	5.5	4.6	2.4	3.2	15.6	17.2	24.2	22.6	13.3	17.3	13.5	22.7	17.9	13.9
MARCH5	"FLJ20445, MARCH-V, MITOL, RNF153"	ENSG00000198060	"Membrane associated ring-CH-type finger 5"	Q9NX47	10	92291163-92353964	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056596			Supported	Mitochondria				Mitochondria		"HPA056596: "	"unprognostic (4.00e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.10e-2)"	"unprognostic (5.47e-3)"	"unprognostic (2.33e-3)"	"unprognostic (4.43e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.24e-2)"	"unprognostic (9.77e-2)"	"unprognostic (5.50e-3)"	"unprognostic (4.02e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.53e-1)"	"unprognostic (2.85e-2)"	18.2	21.7	17.5	17.7	18.3	20.7	27.1	16.8	25.7	15.5	15.4	12.7	20.7	15.8	19.3	18.8	28.0	14.8	15.4	18.4	15.8	15.1	21.7	27.6	16.5	16.6	16.3	17.9	20.9	16.7	16.3	12.3	16.3	14.8	22.2	14.8	14.5	19.4	19.3	42.6	13.7	16.0	18.1	14.0	12.1	14.4	20.1	13.5	25.0	24.5	21.5	17.3	14.7	21.0	7.3	9.4	16.8	10.2	6.5	8.7	6.6	16.4	8.9	17.6	20.2	12.1	12.6	9.1	14.7	16.2	18.4	18.9	5.9	11.8	9.6	10.2	14.4	13.6	12.3	12.3	26.5	7.2	14.5	7.7	8.4	13.9	14.6	12.3	7.7	12.8	16.7	12.1	25.5	16.1	8.4	12.0	14.7	10.4	10.8	14.1	4.1	13.5	11.8	18.1	5.7	18.8	10.7	8.2	15.2	12.8	9.5	15.6	16.5	9.6	15.6	8.6	9.5	9.4	20.1	12.2	9.3	8.5	7.9	17.0	5.7	5.2	8.3	9.0	7.6	10.2	7.6	7.3	8.4	8.0	9.4	6.7	8.7	8.3	16.8	6.5	8.5	6.2	7.8	6.6	17.5	18.3	16.8	25.7	15.8	15.1	16.3	17.9	14.8	13.5
MID1	"FXY, OS, RNF59, TRIM18"	ENSG00000101871	"Midline 1"	O15344	X	10445310-10833654	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 56.8;AF22: 43.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002878, HPA003715"	Approved		Approved	"Centriolar satellite"				"Centriolar satellite"		"HPA002878: , HPA003715: AB_1079384"	"unprognostic (1.99e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.66e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavourable (3.06e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.61e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.25e-3)"	"unprognostic (9.89e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.12e-3)"	"unprognostic (5.88e-2)"	13.4	3.6	6.5	10.4	8.4	0.3	8.6	16.3	7.1	17.5	21.5	3.8	11.7	7.7	17.9	11.3	12.2	7.7	13.1	13.2	6.2	4.2	7.9	4.9	10.4	4.2	4.5	3.7	12.0	4.8	2.7	6.6	7.8	4.9	14.6	12.8	15.9	7.1	19.1	2.8	3.9	8.7	30.6	2.6	1.3	5.3	6.5	4.1	0.8	6.2	7.1	5.8	17.1	20.5	1.0	0.7	3.3	0.0	0.0	0.1	0.1	12.2	56.8	43.0	6.6	2.5	3.6	5.3	7.7	6.4	7.9	8.1	10.4	3.7	4.1	2.5	7.0	8.4	3.5	5.3	5.9	0.2	5.1	0.9	8.1	0.2	1.1	0.0	0.2	4.1	2.8	5.2	5.5	7.6	0.6	0.7	3.1	1.9	1.6	0.1	13.7	4.1	1.2	11.0	0.0	5.8	11.3	3.0	1.1	3.3	9.7	3.6	6.7	0.0	4.8	2.6	0.3	13.3	6.7	0.6	0.3	0.1	5.6	0.0	12.8	0.1	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.1	6.5	8.4	16.3	5.2	6.2	4.2	4.5	3.7	4.9	4.1
MSL2	"FLJ10546, KIAA1585, msl-2, MSL2L1, RNF184"	ENSG00000174579	"MSL complex subunit 2"	Q9HCI7	3	136148922-136197241	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003339, HPA003413"	Uncertain		Approved	Nucleoplasm,Midbody				Nucleoplasm	Midbody	"HPA003339: , HPA003413: AB_1848659"	"unprognostic (9.86e-2)"	"prognostic favourable (4.80e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.41e-2)"	"unprognostic (8.11e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.62e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.79e-3)"	"unprognostic (4.54e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.76e-3)"	13.1	10.1	13.3	16.2	15.6	40.2	13.5	31.0	15.8	13.7	11.3	14.8	9.9	11.1	15.5	8.2	12.2	14.1	10.0	9.8	12.4	9.0	10.0	14.1	13.4	23.7	12.6	11.2	18.3	12.7	19.9	19.8	15.9	12.0	13.0	10.1	10.6	13.2	9.8	14.9	14.1	18.2	9.6	14.2	24.2	12.3	13.6	15.6	59.3	13.8	7.4	23.9	13.4	12.9	7.6	3.8	8.7	3.9	6.6	13.3	5.4	12.5	4.2	8.6	9.8	6.0	6.7	15.7	7.6	6.4	6.1	6.1	8.3	6.6	23.5	10.5	5.6	9.0	9.9	6.6	9.6	12.4	7.6	25.6	8.3	4.7	6.2	21.0	13.4	5.2	7.2	5.0	14.1	6.1	9.1	20.4	5.1	7.7	37.9	12.3	11.5	7.3	17.7	14.7	14.9	3.0	8.9	11.2	8.0	17.3	7.1	11.5	6.3	13.8	9.5	8.3	7.2	7.6	7.0	24.2	12.6	35.1	7.0	9.0	5.5	5.2	3.7	5.0	7.0	3.9	8.8	4.5	6.6	8.2	3.8	7.6	13.3	8.9	8.7	6.6	2.8	2.5	5.0	5.4	13.3	15.6	31.0	15.8	12.4	9.0	12.6	11.2	12.0	15.6
OTUB1	"FLJ20113, FLJ40710"	ENSG00000167770	"OTU deubiquitinase, ubiquitin aldehyde binding 1"	Q96FW1	11	63985853-64001811	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, DNA damage, DNA repair, Immunity, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039176, CAB072836"	Approved	Supported	Approved	Nucleoplasm,Cytosol			630000	"Nucleoplasm, Cytosol"		"CAB072836: , HPA039176: AB_10674980"	"unprognostic (2.50e-1)"	"unprognostic (5.70e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavourable (3.05e-4)"	"unprognostic (1.85e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.33e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.82e-1)"	19.8	24.7	41.9	24.1	61.6	32.6	20.8	41.8	101.9	24.3	25.0	31.9	22.3	24.7	21.9	23.6	37.8	34.5	21.6	31.6	46.9	37.8	27.2	27.6	23.0	31.9	33.1	45.4	23.4	23.0	26.0	21.6	30.7	60.4	23.8	24.1	24.2	30.4	27.7	26.7	36.9	26.0	23.1	26.7	25.7	23.9	22.1	21.2	27.8	29.9	24.5	32.8	27.1	22.9	46.0	60.8	56.1	71.3	44.8	64.5	78.2	30.5	55.2	30.5	26.9	20.6	22.8	23.4	18.4	27.4	41.0	30.3	37.0	29.3	16.3	35.0	29.5	38.2	39.3	45.8	25.5	18.8	30.5	27.1	33.1	46.8	28.9	26.9	29.8	24.2	29.8	31.3	20.0	38.6	18.9	18.5	27.5	62.8	29.3	35.6	35.7	26.3	24.1	11.9	27.8	42.6	44.7	23.1	33.3	20.8	32.0	33.6	49.6	23.8	27.9	21.9	21.3	29.3	24.1	21.8	13.7	23.3	28.3	17.5	20.9	55.1	56.3	54.3	53.1	71.3	41.4	46.0	49.1	48.6	60.8	41.9	38.4	42.6	56.1	44.8	60.9	42.1	64.5	78.2	41.9	61.6	41.8	101.9	46.9	37.8	33.1	45.4	60.4	21.2
RAG1	"MGC43321, RNF74"	ENSG00000166349	"Recombination activating 1"	P15918	11	36510709-36593156	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA recombination, Ubl conjugation pathway"	"Chromatin regulator, DNA-binding, Endonuclease, Hydrolase, Multifunctional enzyme, Nuclease, Transferase"	"Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	62	"lymphoid tissue: 462.4"	"Group enriched"	"Detected in some"	110	"MOLT-4: 65.8;REH: 62.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043939			Supported	Nucleoplasm				Nucleoplasm		"HPA043939: "	"unprognostic (7.35e-2)"	"unprognostic (1.57e-3)"	"unprognostic (8.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.98e-3)"	"unprognostic (1.28e-1)"	"unprognostic (1.16e-9)"	"unprognostic (2.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.53e-4)"	"unprognostic (1.53e-1)"	0.7	2.3	0.5	0.5	0.5	7.4	0.7	0.5	0.5	0.5	0.6	0.5	0.5	1.2	0.5	1.3	0.5	0.6	0.5	0.6	0.5	0.2	2.4	1.2	0.8	0.5	0.5	0.5	0.6	1.1	1.9	0.5	0.8	0.5	0.5	0.4	0.5	1.5	0.5	0.5	0.2	1.5	0.5	0.5	4.4	0.8	0.9	0.5	462.4	4.5	0.5	0.8	0.7	0.5	0.2	0.3	0.0	0.0	0.2	1.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	65.8	0.0	0.5	0.0	62.9	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.8	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.5	0.5	0.5	0.5	0.5	0.2	0.5	0.5	0.5	0.5
RING1	RNF1	ENSG00000204227	"Ring finger protein 1"	Q06587	6	33208495-33212722	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008701	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA008701: AB_1079814"	"unprognostic (2.12e-3)"	"unprognostic (7.98e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.88e-2)"	26.7	22.6	17.8	15.9	21.3	12.0	14.6	27.6	24.2	22.2	17.6	22.0	21.0	18.2	31.9	17.3	14.5	18.8	21.4	14.4	17.3	18.2	19.3	21.6	16.8	14.5	24.0	15.4	25.0	18.3	24.0	34.0	14.9	17.0	21.8	7.6	20.0	19.0	20.5	18.0	21.7	19.5	22.9	18.5	23.2	24.1	16.9	20.8	25.5	29.3	13.1	14.3	13.9	17.1	1.2	2.2	0.8	1.5	0.2	2.2	0.2	4.2	3.5	4.2	4.0	4.2	1.4	9.7	11.1	6.8	4.5	4.6	3.8	3.1	6.9	4.6	4.4	7.6	3.6	3.3	3.2	8.5	2.9	8.3	5.8	7.1	9.6	4.7	6.8	0.0	3.4	4.0	7.5	1.6	11.9	5.3	4.7	0.0	0.3	3.7	1.9	4.6	4.5	6.9	7.6	5.0	3.7	8.3	5.2	4.0	4.3	11.5	4.9	8.3	2.3	5.0	3.8	0.0	9.1	6.0	6.2	6.6	3.7	4.3	3.1	0.0	1.5	0.8	2.2	0.4	0.4	1.1	0.7	1.0	0.7	1.2	1.7	0.9	0.3	0.2	0.5	2.2	0.4	0.2	17.8	21.3	27.6	24.2	17.3	18.2	24.0	15.4	17.0	20.8
RNF114	"PSORS12, ZNF313"	ENSG00000124226	"Ring finger protein 114"	Q9Y508	20	49936336-49953892	"Enzymes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 108.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA021184	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA021184: AB_1859185"	"unprognostic (8.38e-2)"	"unprognostic (3.56e-2)"	"unprognostic (5.62e-2)"	"prognostic unfavourable (8.10e-6)"	"unprognostic (1.56e-1)"	"unprognostic (2.96e-1)"	"prognostic unfavourable (3.11e-4)"	"unprognostic (2.50e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.99e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.54e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.76e-1)"	"prognostic favourable (3.01e-4)"	"unprognostic (1.36e-2)"	23.2	21.3	24.4	18.3	25.7	31.2	20.6	26.7	23.1	24.0	29.7	32.6	21.1	29.5	20.3	23.4	20.2	23.6	20.1	21.9	23.0	25.3	30.3	31.6	24.4	24.0	28.3	19.4	28.4	36.8	16.1	21.6	40.6	23.7	24.5	21.3	27.1	27.8	24.1	43.8	15.2	33.9	17.6	29.3	36.3	24.2	101.9	24.1	28.3	37.9	20.0	24.1	22.6	25.0	28.5	32.5	43.4	44.6	23.7	29.4	34.9	15.6	15.4	7.9	8.3	16.3	11.3	23.3	14.0	15.9	29.0	12.3	45.7	12.9	7.6	28.0	7.4	12.6	11.8	14.1	10.0	13.7	8.6	9.6	10.3	32.1	14.3	17.4	11.6	9.8	13.0	11.1	7.6	6.9	18.0	8.9	8.5	52.6	14.6	18.1	8.2	22.1	16.0	8.3	13.7	15.3	12.8	12.1	8.7	17.1	108.1	21.6	28.8	16.2	9.1	26.3	12.2	13.8	16.1	18.3	19.1	14.4	14.9	11.4	14.5	38.5	42.5	35.7	22.0	39.2	24.6	28.2	24.6	22.4	32.5	28.5	29.4	23.7	43.4	23.7	44.6	26.7	28.8	34.9	24.4	25.7	26.7	23.1	23.0	25.3	28.3	19.4	23.7	24.1
RNF115	"CL469780, ZNF364"	ENSG00000265491	"Ring finger protein 115"	Q9Y4L5	1	145738868-145824077	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019130	Approved		Approved	Nucleoli,Mitochondria				"Nucleoli, Mitochondria"		"HPA019130: AB_1859220"	"unprognostic (3.44e-2)"	"unprognostic (2.47e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.90e-1)"	"prognostic unfavourable (2.95e-4)"	"unprognostic (2.29e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.64e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.23e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.08e-1)"	7.2	5.2	6.8	4.8	6.8	6.4	7.7	16.2	7.0	6.3	3.4	4.6	5.7	3.5	8.9	5.0	5.8	4.3	4.8	23.5	5.8		5.6	5.1	3.9	5.6	4.7	6.2	4.7	4.5	5.8	5.9	3.5	5.2	6.5	3.8	7.3	3.6	5.6	27.6	3.8	3.1	10.9	4.5	4.2	3.8	3.4	4.5	6.0	5.0	5.4	4.5	4.1	6.3	2.7	2.4	9.0	2.2	3.2	3.2	1.4	11.1	4.6	5.7	4.2	10.4	13.7	4.6	8.4	15.7	6.2	7.6	5.0	4.1	7.8	9.6	12.0	7.8	6.3	5.8	6.8	7.8	4.1	6.2	5.9	4.6	6.6	9.7	14.5	7.9	5.1	6.3	7.6	8.0	6.1	12.8	11.3	8.4	7.1	6.2	7.2	9.8	6.8	5.7	6.5	12.2	3.8	5.7	7.9	6.8	8.5	6.2	9.3	9.3	9.8	9.1	7.1	5.4	8.9	10.8	10.2	8.3	4.6	6.6	5.7	9.0	2.2	3.2	3.2	1.5	2.7	2.7	2.2	3.2	1.8	2.4	2.3	3.1	1.7	3.2	1.6	2.4	2.0	1.4										
RNF126	FLJ20552	ENSG00000070423	"Ring finger protein 126"	Q9BV68	19	647526-663277	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043050	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA043050: AB_10794768"	"unprognostic (2.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.48e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.68e-2)"	"unprognostic (9.96e-3)"	"unprognostic (7.04e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.67e-2)"	14.2	14.2	13.4	17.0	13.7	18.7	14.5	12.2	24.7	9.8	16.0	14.8	7.4	24.3	10.4	9.2	19.8	9.5	13.1	14.2	13.1	10.2	11.6	27.9	10.4	19.9	11.4	11.6	12.1	22.4	5.9	10.0	14.1	12.3	10.0	6.3	10.1	13.2	9.3	50.3	21.9	20.3	9.9	10.0	18.6	21.0	33.6	9.3	16.1	8.6	19.5	18.6	13.1	11.2	15.9	13.6	7.5	13.8	17.1	17.3	9.2	25.9	8.6	7.3	10.4	1.7	2.4	12.5	13.7	5.2	7.9	7.5	17.4	9.1	21.5	8.9	5.7	17.5	4.4	10.2	2.2	14.2	31.8	10.9	9.0	14.4	6.6	21.7	16.1	4.1	8.1	6.5	5.1	7.2	21.9	21.7	4.1	20.9	22.1	10.2	19.5	17.0	16.1	6.3	33.9	6.0	14.5	17.5	13.6	10.3	13.6	14.0	8.7	17.1	9.4	14.4	10.4	21.1	23.3	38.4	19.0	25.2	18.3	12.7	14.8	0.6	9.8	7.5	17.3	11.5	14.2	15.9	15.7	16.7	12.4	15.6	12.2	11.4	2.2	17.1	13.8	13.6	16.8	9.2	13.4	13.7	12.2	24.7	13.1	10.2	11.4	11.6	12.3	9.3
RNF13	RZF	ENSG00000082996	"Ring finger protein 13"	O43567	3	149812708-149962139	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 72.4"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064784	Approved		Supported	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles"	Cytosol	"HPA064784: "	"unprognostic (1.27e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.64e-2)"	"unprognostic (8.49e-2)"	"unprognostic (4.36e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.13e-1)"	"prognostic favourable (2.00e-8)"	"unprognostic (2.95e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.79e-1)"	24.0	21.3	30.6	19.0	39.4	9.8	28.5	19.9	30.4	19.0	17.7	39.9	16.2	14.3	16.8	33.7	16.8	15.9	20.4	16.4	40.5	29.7	35.8	39.2	31.7	19.6	60.9	26.8	18.1	19.6	23.5	14.9	32.4	40.7	25.5	20.3	19.5	36.1	20.9	18.0	18.4	16.3	20.4	102.2	25.5	17.0	12.5	51.2	13.3	32.1	18.8	15.9	21.4	16.5	8.8	15.7	72.4	31.5	7.8	8.5	14.6	19.4	12.1	8.2	9.3	32.3	19.8	13.7	10.8	27.8	10.4	15.5	10.6	28.0	8.1	15.8	13.2	18.5	11.0	13.8	14.7	9.9	8.0	9.7	5.6	10.3	21.5	10.4	13.9	20.9	26.3	8.8	23.9	11.5	3.0	16.5	9.3	10.9	7.5	6.9	5.5	9.5	5.4	8.8	34.3	20.2	9.1	4.3	12.5	8.9	13.4	34.7	25.5	11.1	12.0	14.2	5.7	15.0	6.9	28.0	18.4	16.7	11.9	9.8	7.6	12.9	20.3	16.6	6.8	25.2	8.5	8.8	7.6	7.6	15.7	8.3	7.3	7.5	72.4	7.8	31.5	11.2	8.3	14.6	30.6	39.4	19.9	29.2	40.5	29.7	60.9	26.8	40.7	51.2
RNF138	"NARF, STRIN"	ENSG00000134758	"Ring finger protein 138"	Q8WVD3	18	32091855-32131561	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway, Wnt signaling pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 43.8;bone marrow: 40.4;lymphoid tissue: 28.3;testis: 73.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041101			Approved	Mitochondria				Mitochondria		"HPA041101: AB_10805837"	"unprognostic (2.37e-2)"	"unprognostic (4.63e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.90e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.27e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.52e-3)"	"unprognostic (2.77e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.90e-1)"	8.2	5.0	6.5	11.0	7.4	40.4	7.7	9.9	7.1	6.5	11.0	9.0	5.8	8.0	7.5	6.3	7.4	9.7	7.1	5.0	6.8	6.4	5.9	10.1	7.6	17.9	10.6	6.3	9.0	7.8	5.6	8.7	7.2	6.7	6.5	10.0	4.5	6.9	4.9	5.1	5.6	11.2	5.6	9.1	14.3	6.6	73.4	8.1	28.3	7.0	5.7	9.9	6.1	6.8	14.4	24.3	25.7	24.9	16.4	43.8	24.2	8.9	5.3	22.0	10.9	2.8	6.0	12.5	9.2	5.2	11.5	13.4	6.2	6.3	21.6	11.5	6.0	9.4	11.5	10.4	15.7	12.0	19.2	17.0	6.9	7.6	11.3	46.8	15.1	5.8	10.4	12.7	18.1	11.7	23.4	8.9	7.4	8.5	31.6	21.0	24.6	7.4	32.7	13.8	12.4	10.5	6.7	25.0	12.5	12.3	7.1	9.5	4.6	19.8	9.0	13.9	10.2	3.4	10.2	14.8	19.5	37.5	7.6	26.2	13.6	8.0	24.9	24.0	10.5	18.6	13.4	14.0	22.9	14.8	24.3	14.4	43.8	27.9	25.7	16.4	15.3	10.5	16.7	24.2	6.5	7.4	9.9	7.1	6.8	6.4	10.6	6.3	6.7	8.1
RNF146	"dactylidin, dJ351K20.1, DKFZp434O1427"	ENSG00000118518	"Ring finger protein 146"	Q9NTX7	6	127266610-127288567	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027158, HPA027209"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	Nucleoplasm	"HPA027158: AB_10600772, HPA027209: AB_10602312"	"unprognostic (8.22e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.74e-2)"	"prognostic favourable (5.26e-5)"	"unprognostic (2.65e-2)"	"prognostic favourable (7.32e-4)"	"unprognostic (4.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.15e-2)"	27.3	20.9	28.5	16.6	29.1	5.1	23.9	63.7	34.5	22.7	18.6	29.2	10.5	11.8	32.0	35.2	14.2	17.9	21.3	25.2	26.3	21.7	20.9	16.8	21.0	17.3	30.0	27.7	28.5	12.6	26.5	27.4	27.8	31.3	18.6	17.6	17.5	16.7	20.3	55.9	16.0	15.2	26.1	28.7	24.6	15.5	16.3	27.7	9.2	26.7	15.5	17.6	19.2	18.7	11.7	14.2	22.8	22.8	11.5	10.3	9.1	5.5	7.0	26.7	23.5	24.7	24.8	9.7	18.9	30.2	10.1	14.5	9.1	8.4	10.0	13.4	15.4	7.1	7.9	8.8	14.8	11.5	6.9	12.7	8.4	12.7	24.5	7.5	9.0	21.6	18.7	11.4	22.8	17.7	13.6	9.8	22.2	10.6	7.3	13.6	9.7	7.3	9.4	6.9	5.0	14.4	6.1	16.0	16.1	7.3	10.4	11.6	7.1	26.0	20.8	17.8	5.9	18.4	13.3	14.2	8.8	6.6	13.6	13.2	16.8	16.8	18.9	16.1	9.3	20.0	9.7	11.1	8.0	10.3	14.2	11.7	7.3	10.2	22.8	11.5	22.8	7.1	8.6	9.1	28.5	29.1	63.7	34.5	26.3	21.7	30.0	27.7	31.3	27.7
RNF149	FLJ90504	ENSG00000163162	"Ring finger protein 149"	Q8NC42	2	101271219-101308701	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 123.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"neutrophil: 123.7"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 123.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011424	Approved		Approved	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"		"HPA011424: AB_1079825"	"unprognostic (2.56e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.17e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.16e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.61e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.69e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (2.04e-8)"	"unprognostic (1.39e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.70e-1)"	"prognostic favourable (2.91e-4)"	20.3	13.4	7.9	29.0	10.9	32.9	13.5	7.9	10.8	12.5	16.6	10.8	11.4	12.3	11.3	12.8	28.9	14.3	14.5	12.1	9.5	9.4	15.1	19.6	24.5	47.4	13.7	6.2	14.3	21.1	14.3	10.6	19.4	11.2	11.1	12.0	12.8	15.8	8.1	8.8	20.2	16.8	9.6	13.9	65.0	13.8	15.2	9.7	17.0	12.7	13.1	24.4	14.9	17.2	2.1	9.3	123.7	21.3	2.3	9.0	9.9	9.6	5.7	4.3	5.5	16.3	16.4	25.5	12.0	15.8	16.2	18.3	14.4	25.6	2.8	14.5	11.8	19.7	6.1	12.2	15.1	8.4	8.4	6.0	5.1	24.3	21.8	6.4	9.7	15.0	20.1	19.2	12.7	29.5	5.2	9.0	16.2	8.2	8.6	6.5	3.0	10.4	5.6	7.2	11.1	19.1	23.7	5.7	4.2	7.2	17.9	17.3	4.8	8.7	19.5	8.2	4.7	12.2	2.6	18.3	10.7	0.1	2.6	9.0	6.0	5.8	13.0	14.8	8.2	20.4	7.4	2.1	7.3	8.1	4.8	1.5	5.1	5.3	123.7	2.3	21.3	9.3	9.0	9.9	7.9	10.9	7.9	10.8	9.5	9.4	13.7	6.2	11.2	9.7
RNF152	FLJ39176	ENSG00000176641	"Ring finger protein 152"	Q8N8N0	18	61808063-61894247	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"kidney: 53.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 16.0;SH-SY5Y: 9.9;TIME: 9.9;U-138 MG: 16.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (3.30e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.55e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.96e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.14e-2)"	"unprognostic (6.73e-2)"	"prognostic favourable (1.13e-8)"	"prognostic unfavourable (2.85e-5)"	"unprognostic (3.26e-2)"	"unprognostic (2.82e-2)"	"unprognostic (4.83e-2)"	8.3	3.9	2.4	2.3	6.8	1.5	8.8	19.1	3.8	8.5	7.4	4.0	6.2	2.2	8.6	10.4	4.5	3.9	8.0	6.5	2.5	3.1	53.7	28.3	7.8	1.2	4.1	1.4	3.8	3.1	4.7	2.6	6.6	7.7	4.7	6.7	3.4	11.8	6.8	4.6	9.6	9.8	4.6	4.2	1.3	5.7	3.9	4.5	0.0	5.1	4.9	2.0	5.0	11.6	0.5	0.4	1.7	0.4	0.6	0.4	0.2	0.0	0.0	3.5	0.8	3.3	0.4	0.0	2.2	7.0	0.5	0.4	0.0	0.1	0.1	0.7	3.5	16.0	4.3	8.5	0.9	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.1	0.5	5.9	2.7	1.7	6.4	0.0	0.0	1.0	0.6	0.6	0.0	0.2	0.0	0.2	2.3	0.0	0.3	2.6	2.9	9.9	0.0	6.3	1.1	3.8	0.0	9.9	16.2	1.7	0.0	0.3	0.0	0.0	0.0	0.5	0.0	5.3	1.7	0.3	0.4	0.2	0.3	0.3	0.3	0.3	0.3	0.2	0.5	0.4	0.4	1.5	0.6	0.4	0.4	0.3	0.2	2.4	6.8	19.1	3.8	2.5	3.1	4.1	1.4	7.7	4.5
RNF180		ENSG00000164197	"Ring finger protein 180"	Q86T96	5	64165844-64372869	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 54.0"	"Cell line enriched"	"Detected in some"	7	"RPMI-8226: 24.9"	"Cancer enhanced"	"Detected in many"		"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006897	Approved		Approved	Cytosol				Cytosol		"HPA006897: AB_1856348"	"unprognostic (7.46e-2)"	"unprognostic (3.90e-3)"	"unprognostic (3.19e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.72e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.37e-3)"	"unprognostic (3.68e-2)"	"prognostic favourable (6.81e-5)"	"unprognostic (2.01e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.81e-2)"	"unprognostic (9.81e-3)"	8.1	8.1	9.9	3.1	12.8	1.6	6.3	6.0	13.0	10.1	7.1	5.5	20.1	3.4	12.7	11.8	6.9	8.1	7.3	10.4	7.4	10.6	12.4	7.2	6.1	3.4	9.4	9.3	12.0	6.6	54.0	16.1	2.0	10.7	11.5	3.0	11.3	7.3	16.4	4.4	6.6	3.2	15.0	11.0	5.1	5.0	8.1	7.1	0.0	20.6	2.5	2.4	10.9	7.9	2.4	1.0	4.2	1.8	2.0	4.2	0.3	0.0	0.1	1.3	0.0	0.0	0.0	0.3	1.1	0.5	1.1	0.6	0.0	0.1	0.0	0.1	0.8	0.2	0.0	0.5	0.2	0.0	0.1	0.3	0.0	0.0	0.4	0.0	0.2	0.1	2.6	0.0	0.1	0.0	0.0	0.0	2.1	0.4	0.0	0.0	0.5	1.3	0.1	3.3	24.9	1.8	0.3	0.3	0.1	0.0	0.3	0.0	1.3	0.1	0.1	0.0	3.2	0.1	2.8	0.0	0.0	0.0	0.5	0.0	3.5	3.0	1.8	4.2	1.9	0.6	2.5	1.4	3.0	3.2	0.6	2.4	4.2	3.9	2.6	2.0	0.8	1.0	1.8	0.3	9.9	12.8	6.0	11.7	7.4	10.6	9.4	9.3	10.7	7.1
RNF183	MGC4734	ENSG00000165188	"Ring finger protein 183"	Q96D59	9	113297093-113303376	"Enzymes, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"epididymis: 19.0;kidney: 9.5"	"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 20.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 7.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA057675	Uncertain									"HPA057675: "	"unprognostic (1.23e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.11e-1)"	"prognostic favourable (7.95e-6)"	"unprognostic (2.56e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.65e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.98e-1)"	"prognostic favourable (3.51e-4)"	"unprognostic (5.50e-2)"	"unprognostic (8.84e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.53e-3)"	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	1.9	0.2			0.2	1.2	19.0	5.1	1.2	6.2	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0		0.1	0.1	0.0	1.9	0.0		0.8	0.3		6.9	0.2	0.0	0.1	0.1	0.0	0.0	0.0	3.7	4.3			0.1		0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
RNF220	"C1orf164, FLJ10597"	ENSG00000187147	"Ring finger protein 220"	Q5VTB9	1	44405194-44651724	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 57.4"	"Cell line enhanced"	"Detected in all"		"U-937: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA027577, HPA027578"	Uncertain		Approved	Nucleoplasm	"Intracellular and membrane"			Nucleoplasm		"HPA027577: , HPA027578: AB_10601482"	"unprognostic (3.12e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.94e-2)"	"unprognostic (6.96e-3)"	"prognostic unfavourable (2.35e-6)"	"unprognostic (1.55e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.14e-3)"	"unprognostic (2.96e-2)"	"prognostic unfavourable (5.12e-4)"	"unprognostic (1.51e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.37e-3)"	"unprognostic (6.46e-2)"	9.8	7.4	20.9	9.6	38.5	12.7	6.7	12.6	40.1	5.4	9.2	40.7	2.7	10.7	8.0	8.8	6.0	9.3	4.5	9.2	33.4	20.9	7.4	5.1	7.4	7.6	49.8	19.8	9.5	8.1	7.0	5.7	8.7	25.8	7.7	5.9	4.2	9.3	7.1	28.4	8.7	8.8	8.0	57.4	7.9	7.6	7.0	49.6	5.0	7.3	4.6	8.0	7.9	5.6	3.6	6.6	2.8	2.3	1.9	4.3	1.4	5.9	2.8	12.3	4.2	4.8	4.4	9.3	7.1	6.5	5.5	8.1	4.9	5.9	11.6	6.3	5.6	3.9	13.8	5.8	7.5	14.4	12.2	16.0	8.9	8.3	7.8	11.3	8.2	4.8	13.3	6.1	9.8	3.1	11.7	5.8	3.4	4.1	11.1	8.6	13.4	6.5	9.4	7.3	8.3	3.5	3.7	5.6	6.9	6.0	4.2	8.6	3.1	20.0	4.8	5.8	6.2	5.4	13.1	13.2	12.7	8.4	4.8	36.5	3.5	2.4	2.3	2.8	3.2	1.8	2.4	2.4	1.0	4.3	3.4	3.6	1.9	1.7	1.5	1.9	1.3	6.6	3.2	1.4	20.9	38.5	12.6	30.8	33.4	20.9	49.8	19.8	25.8	49.6
RNF25	"AO7, FLJ13906"	ENSG00000163481	"Ring finger protein 25"	Q96BH1	2	218663864-218672411	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036420, HPA036421"	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA036420: , HPA036421: AB_10669604"	"unprognostic (3.22e-2)"	"unprognostic (7.85e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavourable (6.58e-4)"	"unprognostic (3.58e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.04e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.50e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.69e-2)"	13.4	12.7	13.9	11.1	16.1	6.2	13.7	13.4	27.6	17.3	13.3	17.1	9.8	4.3	16.6	16.2	12.2	16.8	11.8	17.2	13.1	16.5	13.7	15.6	11.9	12.1	12.1	11.6	17.8	13.0	19.3	14.8	17.7	15.4	14.7	9.0	15.3	13.6	17.9	16.9	15.7	10.3	16.0	10.0	12.9	11.8	18.4	9.1	15.3	16.8	12.7	16.8	14.0	11.8	13.3	8.2	23.3	11.2	14.8	15.0	13.9	5.9	7.6	6.9	8.0	10.5	6.4	7.4	6.7	17.0	23.2	21.7	12.6	4.0	3.9	5.4	14.2	5.4	7.9	13.2	10.1	4.3	10.9	5.4	5.6	11.9	12.9	4.7	5.9	14.2	12.4	21.1	14.2	12.7	9.0	6.2	14.9	16.9	5.3	5.8	10.9	8.7	7.5	4.3	5.8	14.2	6.3	7.0	7.9	5.2	5.8	10.0	6.9	8.8	7.3	13.2	6.3	5.1	9.6	5.3	4.2	6.6	11.1	5.9	8.0	23.3	10.6	14.9	13.9	10.3	12.6	11.9	13.7	13.6	8.2	13.3	15.0	11.7	8.9	14.8	11.2	7.4	11.5	13.9	13.9	16.1	13.4	27.6	13.1	16.5	12.1	11.6	15.4	9.1
RNF26	MGC2642	ENSG00000173456	"Ring finger protein 26"	Q9BY78	11	119334527-119337313	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA027620	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol				Nucleoplasm	"Vesicles, Cytosol"	"HPA027620: AB_1856356"	"unprognostic (9.23e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.68e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.07e-2)"	"prognostic unfavourable (3.19e-4)"	"unprognostic (2.14e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.24e-3)"	"unprognostic (6.22e-2)"	"prognostic favourable (3.45e-6)"	"unprognostic (9.61e-2)"	"unprognostic (3.50e-2)"	"unprognostic (4.41e-2)"	"prognostic unfavourable (7.73e-4)"	19.0	21.5	13.6	15.4	21.6	25.6	16.9	18.4	38.9	19.8	22.0	17.6	14.5	20.3	31.2	15.6	26.0	24.4	19.8	15.1	17.1	13.8	22.3	28.7	17.3	17.5	15.0	16.6	25.6	18.5	31.4	14.3	27.5	27.2	19.2	18.2	20.2	20.0	28.5	17.6	19.8	21.4	27.0	14.3	19.8	24.3	27.6	13.0	26.7	20.6	14.0	21.1	25.8	18.1	13.8	14.2	7.1	15.5	9.8	16.7	16.2	15.6	17.3	16.2	19.1	16.0	12.7	17.3	17.0	18.4	19.9	15.8	29.2	32.8	13.8	23.6	20.2	28.5	23.0	25.6	12.5	16.5	12.6	36.4	8.1	24.1	12.3	15.2	15.2	13.1	13.2	24.8	22.4	15.1	17.6	21.7	13.6	34.1	13.9	15.8	16.2	22.2	14.5	16.7	11.0	12.2	11.3	11.6	11.2	13.7	17.5	4.5	39.5	12.8	9.9	24.1	16.1	12.6	15.5	5.2	8.5	0.1	8.0	25.8	18.7	7.1	15.5	3.9	16.7	14.5	11.0	9.0	12.7	14.5	14.2	13.8	14.5	12.4	1.1	9.8	14.1	8.1	6.6	16.2	13.6	21.6	18.4	38.9	17.1	13.8	15.0	16.6	27.2	13.0
RNF38		ENSG00000137075	"Ring finger protein 38"	Q9H0F5	9	36336396-36487548	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015853	Approved		Supported	Nucleoplasm				Nucleoplasm		"HPA015853: AB_1856365"	"unprognostic (2.26e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.53e-1)"	"unprognostic (8.16e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.65e-3)"	"unprognostic (3.30e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.15e-2)"	"prognostic favourable (2.90e-6)"	"unprognostic (3.88e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.39e-2)"	11.9	8.0	13.1	7.7	14.5	20.3	11.1	18.8	17.0	13.6	14.1	12.2	8.1	6.4	16.3	12.9	10.1	11.7	9.6	9.5	10.0	11.1	12.3	6.8	11.7	14.5	9.2	12.3	24.4	12.8	12.2	5.7	21.2	14.0	15.3	10.1	14.4	10.3	12.8	9.6	8.9	10.2	16.9	8.5	11.4	8.7	46.3	10.0	13.1	14.4	4.3	11.1	16.5	13.5	6.2	4.1	12.2	4.3	8.4	8.7	4.2	9.3	5.3	20.6	12.2	9.5	8.8	20.2	5.8	7.4	7.2	9.5	9.0	5.2	14.1	6.2	11.3	3.7	13.1	6.9	11.2	12.5	5.6	17.0	7.5	8.8	7.4	12.5	15.6	9.0	7.4	9.1	8.8	18.3	3.5	13.6	11.6	3.2	12.8	6.6	13.8	3.8	11.8	9.3	7.8	12.3	10.8	8.6	9.3	6.6	6.7	6.6	6.4	12.8	18.0	6.9	10.5	4.0	6.9	9.0	18.7	10.0	6.3	10.6	8.8	12.2	4.3	7.2	7.2	4.1	6.0	5.8	6.5	7.6	4.1	6.2	7.0	7.0	8.0	8.4	4.1	3.3	8.7	4.2	13.1	14.5	18.8	17.0	10.0	11.1	9.2	12.3	14.0	10.0
RNF4	"RES4-26, SLX5, SNURF"	ENSG00000063978	"Ring finger protein 4"	P78317	4	2462220-2625320	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022047, HPA049356"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Microtubule ends"				"Nucleoplasm, Nuclear bodies"	"Microtubule ends"	"HPA022047: , HPA049356: "	"unprognostic (8.38e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.31e-3)"	"unprognostic (9.03e-3)"	"prognostic unfavourable (6.38e-4)"	"unprognostic (1.34e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.40e-2)"	"unprognostic (4.70e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.54e-1)"	28.6	29.1	25.4	32.2	39.4	36.4	28.6	35.9	50.3	28.2	25.1	34.8	28.4	27.0	32.2	28.0	30.3	27.8	27.1	24.6	22.7	22.8	32.3	25.6	27.4	41.9	23.5	23.4	32.1	31.0	31.2	30.0	29.4	36.7	28.5	26.7	29.2	36.1	28.5	26.0	28.5	29.3	31.8	23.1	41.9	28.9	36.8	23.7	50.4	29.3	19.1	51.5	27.7	26.3	36.9	35.3	41.8	39.9	39.7	43.7	45.8	19.8	18.9	19.8	13.8	17.2	18.0	22.1	24.3	27.4	25.9	23.5	21.4	18.8	25.2	14.5	24.5	13.0	20.9	19.0	24.7	11.8	12.6	30.5	19.5	20.4	25.9	21.4	26.7	20.8	23.1	24.0	20.1	23.9	16.1	34.9	26.4	13.6	34.3	29.9	30.4	23.7	25.0	18.8	13.0	17.6	25.4	18.4	17.4	17.0	13.3	16.9	21.0	16.2	19.9	22.6	11.1	21.3	37.2	45.2	60.1	27.9	22.0	23.4	23.4	14.6	29.6	41.8	43.7	39.3	43.7	36.9	37.5	43.0	35.3	27.2	36.2	36.3	32.9	39.7	39.9	23.6	39.9	45.8	25.4	39.4	35.9	50.3	22.7	22.8	23.5	23.4	36.7	23.7
RNF6	DKFZp686P0776	ENSG00000127870	"Ring finger protein 6"	Q9Y252	13	26132115-26222493	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039343, HPA040048"	Approved		Supported	"Nuclear membrane"				"Nuclear membrane"		"HPA039343: AB_2676456, HPA040048: AB_10672969"	"unprognostic (3.22e-1)"	"prognostic unfavourable (3.07e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.07e-2)"	"unprognostic (7.63e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.21e-2)"	"unprognostic (2.70e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.84e-1)"	"unprognostic (7.70e-2)"	"unprognostic (8.47e-2)"	16.4	19.8	22.3	15.9	27.5	25.1	24.2	26.6	28.9	13.1	16.4	8.1	20.3	15.5	13.0	13.0	20.9	13.4	12.5	17.9	20.4	17.3	16.9	17.5	14.5	18.4	15.8	22.6	10.9	14.2	17.9	26.3	23.3	16.8	15.2	17.2	8.1	16.1	13.5	24.8	15.5	21.0	14.3	16.7	16.6	15.1	28.7	14.5	23.6	16.1	14.4	20.7	14.1	19.5	13.5	12.5	24.6	15.0	13.3	13.2	9.2	12.6	11.1	4.2	6.2	14.7	11.6	9.5	21.7	17.8	14.1	10.0	13.9	16.3	22.7	10.9	20.6	17.0	11.8	17.6	23.5	21.7	7.4	24.7	9.4	11.9	23.1	25.8	26.1	10.9	34.4	15.8	33.9	14.1	9.5	0.0	21.8	11.3	14.4	15.1	3.4	7.8	11.5	16.4	8.9	17.4	16.7	7.7	4.7	11.6	21.3	20.6	8.1	25.4	18.4	12.2	7.4	16.3	15.5	5.8	5.4	13.6	11.1	14.8	15.9	24.6	10.1	23.7	11.9	13.1	12.8	13.5	13.0	13.2	12.5	9.4	13.2	11.2	7.1	13.3	15.0	6.5	13.1	9.2	22.3	27.5	26.6	28.9	20.4	17.3	15.8	22.6	16.8	14.5
SH3RF1	"KIAA1494, POSH, RNF142, SH3MD2"	ENSG00000154447	"SH3 domain containing ring finger 1"	Q7Z6J0	4	169094256-169271105	"Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 5.9;myeloid DC: 3.4;non-classical monocyte: 8.5"	"Group enriched"	"Detected in many"	13	"dendritic cells: 3.4;monocytes: 8.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA074783	Approved		Supported	"Vesicles,Intermediate filaments"				Vesicles	"Intermediate filaments"	"HPA074783: "	"unprognostic (4.14e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.65e-1)"	"unprognostic (8.44e-2)"	"unprognostic (9.58e-2)"	"unprognostic (4.77e-3)"	"unprognostic (7.88e-2)"	"prognostic favourable (5.51e-8)"	"unprognostic (4.43e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.77e-1)"	15.2	4.8	13.8	7.2	11.8	3.7	11.1	2.5	12.7	7.5	17.2	15.9	10.8	15.7	6.8	7.2	7.1	6.9	19.7	7.8	17.8	9.3	14.6	9.6	11.3	3.7	13.0	10.9	11.9	12.0	5.2	7.8	8.6	10.3	17.2	16.0	10.7	20.9	10.7	16.2	6.8	17.2	8.8	11.7	4.5	27.6	7.0	11.3	0.9	23.1	7.6	5.5	9.4	6.3	0.4	3.4	0.0	8.5	0.3	0.0	0.7	7.3	6.2	5.6	16.2	6.1	7.6	7.3	20.6	10.0	15.4	7.1	6.1	8.9	0.0	1.0	21.4	4.9	4.5	8.1	17.0	0.0	2.6	4.3	14.1	3.2	13.8	1.5	0.1	4.5	4.5	13.1	10.4	9.4	0.0	0.0	14.2	3.0	1.5	1.4	2.8	5.3	2.3	1.8	0.3	7.0	5.8	4.2	5.1	5.2	8.0	2.0	2.6	0.6	8.5	7.3	5.7	12.1	7.2	0.5	0.0	0.0	8.2	1.5	8.7	0.0	1.4	0.0	0.0	5.9	0.0	0.4	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.3	8.5	0.2	0.0	0.7	13.8	11.8	2.5	12.7	17.8	9.3	13.0	10.9	10.3	11.3
SIM2	"bHLHe15, MGC119447, SIM"	ENSG00000159263	"Single-minded family bHLH transcription factor 2"	Q14190	21	36699133-36749917	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 31.3;kidney: 16.1;lymphoid tissue: 28.7;skeletal muscle: 15.7"	"Cell line enhanced"	"Detected in some"		"PC-3: 22.9;RPTEC TERT1: 28.8;RT4: 17.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 11.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 0.5"	"Group enriched"	"Detected in some"	4	"hypothalamus: 2.1;midbrain: 0.8"	HPA029295	Approved		Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA029295: AB_10610425"	"unprognostic (1.17e-3)"	"unprognostic (6.46e-2)"	"unprognostic (5.03e-2)"	"prognostic unfavourable (2.10e-4)"	"unprognostic (8.62e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.30e-2)"	"unprognostic (5.46e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.16e-3)"	"unprognostic (9.18e-2)"	"unprognostic (9.18e-7)"	"unprognostic (2.98e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.07e-2)"	"prognostic favourable (2.88e-4)"	0.5	0.3	0.8	0.1	2.3	0.0	0.1	2.4	2.3	2.8	0.2	0.2	0.0	0.1	0.3	1.5	31.3	0.3	0.2	0.1	2.5	1.1	16.1	0.1	0.1	0.1	1.4	0.7	0.1	0.1	1.2	1.7	0.1	0.3	6.8	0.0	0.2	0.4	0.0	15.7	0.3	0.1	0.0	0.4	0.1	5.5	0.2	1.3	0.0	0.2	11.0	28.7	1.5	0.4	0.3	0.7	0.0	0.0	0.0	0.8	0.0	3.2	5.0	0.2	0.2	0.0	0.0	5.0	0.1	0.0	0.4	0.0	2.6	7.6	0.1	4.6	0.1	1.7	2.5	0.0	0.2	3.9	7.9	0.1	7.2	0.2	0.0	0.0	0.0	0.8	0.7	0.0	1.4	0.0	0.1	0.0	8.3	1.9	0.0	0.0	0.2	22.9	0.0	0.1	0.1	28.8	17.3	0.2	0.3	8.2	0.0	0.7	2.1	0.2	0.3	0.0	1.4	0.5	0.2	0.1	0.0	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	2.3	2.4	2.3	2.5	1.1	1.4	0.7	0.3	1.3
SMAD7	"MADH7, MADH8"	ENSG00000101665	"SMAD family member 7"	O15105	18	48919853-48950711	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 23.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026212, HPA028897"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"CAB026212: , HPA028897: AB_10600811"	"unprognostic (1.63e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavourable (5.61e-4)"	"unprognostic (8.15e-2)"	"unprognostic (5.35e-1)"	"unprognostic (2.76e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.44e-1)"	9.5	3.3	3.1	7.4	4.3	8.6	11.6	8.0	7.7	11.4	11.5	4.2	5.1	5.5	6.5	3.0	2.8	4.2	5.7	27.0	5.8	3.1	7.4	6.5	13.7	2.8	6.1	4.4	4.5	5.6	14.6	3.9	11.2	6.0	9.3	7.0	7.1	5.3	11.5	4.9	4.4	15.0	5.0	6.3	2.9	7.2	3.2	2.8	3.6	10.0	5.7	3.4	6.8	19.4	0.1	0.3	8.3	0.8	2.6	1.9	0.4	2.3	1.9	1.6	5.4	9.5	4.0	13.7	10.9	4.6	4.3	1.9	0.6	3.3	0.2	20.6	7.9	12.4	3.9	3.6	2.3	23.6	6.2	0.1	5.8	5.1	1.7	4.7	11.8	3.4	3.3	4.8	5.2	0.8	3.9	15.5	6.4	0.8	0.0	1.4	11.4	0.8	1.4	1.7	5.2	6.6	2.5	3.0	6.5	4.9	2.3	4.7	1.9	3.7	10.4	11.5	6.3	3.2	10.6	8.4	4.1	1.3	5.0	3.0	1.7	5.8	0.2	8.3	1.4	0.8	1.2	0.1	1.4	1.3	0.3	0.0	0.4	0.9	0.0	2.6	0.2	0.0	1.9	0.4	3.1	4.3	8.0	7.7	5.8	3.1	6.1	4.4	6.0	2.8
TNFRSF1B	"CD120b, p75, TNF-R-II, TNF-R75, TNFBR, TNFR2, TNFR80"	ENSG00000028137	"TNF receptor superfamily member 1B"	P20333	1	12167003-12209228	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	Apoptosis	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 70.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 17.1;K-562: 20.9;THP-1: 24.5;U-87 MG: 16.8;U-937: 17.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 70.1"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA004796	Approved				"Secreted to blood"	3226667	2500000			"HPA004796: AB_1078436"	"unprognostic (4.45e-2)"	"unprognostic (2.27e-3)"	"unprognostic (7.62e-2)"	"unprognostic (3.82e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.47e-3)"	"unprognostic (5.28e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.73e-2)"	"unprognostic (7.26e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavourable (8.35e-5)"	"unprognostic (2.02e-1)"	"prognostic unfavourable (8.68e-4)"	"unprognostic (3.26e-2)"	"unprognostic (1.10e-1)"	43.4	4.7	4.6	44.3	13.8	29.2	42.3	2.1	6.1	13.3	13.1	6.6	1.9	11.9	9.7	10.2	6.5	11.3	11.6	21.8	8.5	6.2	6.2	22.2	24.5	60.6	9.1	2.2	9.4	4.2	2.3	4.4	24.9	15.0	7.3	8.2	8.3	5.7	3.7	11.5	6.2	17.3	11.5	22.6	48.3	10.5	6.0	6.1	10.9	6.2	5.6	16.2	18.3	8.4	2.7	13.2	25.7	70.1	2.5	12.7	19.9	0.0	0.1	2.0	0.0	5.5	7.5	4.3	0.5	1.0	2.0	2.2	0.8	17.1	0.1	0.3	1.8	0.0	0.4	0.0	1.1	6.8	0.0	0.0	0.1	0.0	12.9	0.1	1.8	7.4	0.0	6.8	0.0	10.4	20.9	3.1	0.9	0.0	0.0	3.9	0.1	0.6	0.5	0.2	12.0	0.0	0.4	0.0	0.0	0.3	0.1	0.6	0.0	24.5	3.6	3.0	0.1	13.0	0.0	0.9	0.0	0.0	16.8	17.7	0.7	0.0	20.7	3.0	9.4	49.3	5.4	2.7	6.6	7.7	13.2	1.7	2.0	3.0	25.7	2.5	70.1	2.8	12.7	19.9	4.6	13.8	2.1	6.1	8.5	6.2	9.1	2.2	15.0	6.1
TRAF7	"DKFZp586I021, MGC7807, RFWD1, RNF119"	ENSG00000131653	"TNF receptor associated factor 7"	Q6Q0C0	16	2155698-2178129	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041229	Approved		Supported	"Vesicles,Plasma membrane"				Vesicles	"Plasma membrane"	"HPA041229: AB_10794194"	"unprognostic (1.94e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.77e-3)"	"unprognostic (7.08e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.23e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.43e-1)"	"unprognostic (8.48e-2)"	16.0	18.2	18.3	22.3	20.6	28.5	39.1	28.7	25.6	22.1	29.4	9.1	21.1	37.3	20.4	18.3	32.9	21.9	36.9	21.0	18.3	14.8	21.3	47.3	18.3	40.9	13.4	14.7	19.3	41.6	17.7	20.3	19.5	12.8	16.2	16.9	13.0	24.4	23.1	25.5	32.2	37.8	28.8	14.1	21.4	25.1	13.2	10.6	26.1	20.3	30.9	21.9	21.9	28.9	6.7	12.3	7.7	13.9	3.0	7.1	5.2	20.8	26.7	15.3	27.3	15.8	30.0	18.0	16.1	20.3	19.0	17.1	32.4	27.0	13.4	19.1	20.5	24.5	14.3	28.6	7.2	21.1	18.3	19.1	35.6	24.8	21.0	20.3	27.7	29.6	23.9	18.3	24.0	36.7	20.3	18.1	18.0	47.7	20.8	23.6	30.0	13.1	38.9	25.4	26.8	15.3	11.2	30.8	25.6	13.5	25.9	17.6	29.4	25.0	27.6	23.1	32.5	21.5	17.5	26.2	19.4	17.7	13.2	13.2	17.9	3.7	10.0	7.7	5.4	13.9	5.0	6.7	5.3	5.7	12.3	4.9	3.8	4.5	6.9	3.0	9.4	6.0	7.1	5.2	18.3	20.6	28.7	25.6	18.3	14.8	13.4	14.7	12.8	10.6
TRAIP	"RNF206, TRIP"	ENSG00000183763	"TRAF interacting protein"	Q9BWF2	3	49828599-49856574	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 25.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036261, HPA036262"	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA036261: AB_10673348, HPA036262: AB_2675029"	"unprognostic (5.30e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.50e-3)"	"unprognostic (1.88e-1)"	"unprognostic (7.68e-3)"	"prognostic unfavourable (8.77e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.24e-2)"	"unprognostic (7.97e-2)"	"unprognostic (9.01e-5)"	"unprognostic (5.84e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-1)"	4.8	1.6	3.4	6.0	10.7	9.5	3.0	7.4	3.0	3.5	3.7	2.0	3.2	2.3	3.8	2.4	4.5	3.0	2.9	1.5	2.7	2.7	1.6	1.2	1.3	8.1	2.0	2.8	3.4	1.6	1.6	2.0	2.5	3.0	2.9	4.8	2.7	3.1	1.7	2.8	6.7	3.4	3.4	5.1	3.7	1.9	25.0	3.4	11.5	2.2	3.1	6.8	1.9	3.0	5.1	1.6	0.6	3.0	2.7	4.9	1.6	6.4	7.9	11.3	11.3	1.0	1.6	9.3	7.8	3.7	16.5	15.8	9.5	7.4	15.9	5.5	4.5	8.5	11.8	8.9	12.4	9.1	7.8	11.9	9.6	8.5	0.4	9.7	10.0	1.1	1.3	13.2	7.0	4.3	8.6	11.5	7.3	9.3	16.1	12.4	9.0	13.0	8.9	7.6	9.2	3.0	9.0	5.5	9.4	8.6	7.3	5.5	6.6	13.9	3.3	10.6	12.6	14.5	15.2	8.5	20.2	17.0	5.3	13.2	9.4	0.0	1.5	0.6	2.3	0.8	2.0	5.1	1.3	4.9	1.3	3.8	1.7	2.6	0.3	2.7	3.0	1.6	0.8	1.6	3.4	10.7	7.4	3.0	2.7	2.7	2.0	2.8	3.0	3.4
TRIM11	"BIA1, RNF92"	ENSG00000154370	"Tripartite motif containing 11"	Q96F44	1	228393673-228406840	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028541, HPA043879"	Approved		Enhanced	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA028541: AB_10600833, HPA043879: "	"unprognostic (1.73e-1)"	"unprognostic (9.73e-3)"	"unprognostic (5.48e-3)"	"unprognostic (7.73e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.33e-1)"	"prognostic unfavourable (7.42e-5)"	"unprognostic (1.08e-1)"	"unprognostic (9.74e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.15e-1)"	"prognostic unfavourable (1.62e-4)"	"unprognostic (3.40e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-2)"	8.8	9.2	8.9	13.8	16.5	33.2	23.8	45.2	11.5	8.7	11.2	6.4	15.1	10.1	8.7	10.6	13.3	9.4	13.9	6.9	9.2	8.5	7.7	7.1	27.5	18.6	9.0	8.0	9.0	11.9	8.5	7.2	9.4	7.1	10.5	9.7	6.0	14.4	18.2	5.0	12.5	11.8	8.6	6.0	16.5	12.6	9.5	7.8	20.0	9.0	9.7	13.1	9.5	24.3	6.4	6.9	10.0	11.4	9.4	11.8	5.4	13.8	13.2	7.1	9.7	5.3	4.4	33.5	9.1	6.1	10.6	8.5	16.0	12.1	10.4	10.2	6.1	22.6	8.5	8.7	4.5	11.6	20.5	8.6	12.2	8.6	14.5	10.9	13.2	5.9	14.0	10.9	5.5	5.2	19.7	13.5	5.4	9.0	13.1	17.2	18.1	11.7	12.9	6.4	12.6	6.9	17.0	11.8	21.7	7.6	21.6	12.0	15.2	18.2	5.8	6.7	9.5	15.7	18.8	13.9	9.2	9.2	8.4	8.7	10.6	6.1	6.9	8.3	9.6	8.2	10.2	5.8	10.7	11.8	6.9	6.4	6.3	8.4	10.0	9.4	11.4	5.5	9.8	5.4	8.9	16.5	45.2	11.5	9.2	8.5	9.0	8.0	7.1	7.8
TRIM13	"DLEU5, Leu5, RFP2, RNF77"	ENSG00000204977	"Tripartite motif containing 13"	O60858	13	49995888-50020481	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000367	Enhanced									"HPA000367: AB_1856196"	"unprognostic (1.14e-1)"	"unprognostic (8.22e-2)"	"unprognostic (6.14e-2)"	"unprognostic (2.23e-3)"	"unprognostic (4.75e-3)"	"unprognostic (5.01e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.07e-1)"	"unprognostic (7.28e-3)"	"unprognostic (4.66e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.55e-2)"	13.2	9.8	9.9	11.9	11.4	37.5	19.6	18.5	13.5	13.1	11.7	12.3	15.2	8.6	13.9	10.7	18.8	12.2	8.7	12.4	10.1	9.2	16.6	9.9	14.7	12.4	12.2	8.0	13.8	14.0	10.8	14.4	10.0	11.5	14.5	14.0	9.6	16.2	15.6	16.3	18.2	13.0	10.4	10.8	15.3	10.6	49.0	12.1	25.1	17.3	13.9	15.5	13.0	12.9	28.4	20.6	21.6	13.0	15.4	17.2	8.4	5.1	6.0	20.9	16.1	11.8	18.5	9.5	8.5	12.3	6.9	4.8	8.3	11.8	19.1	2.6	9.2	8.1	9.2	11.2	8.5	7.3	8.1	18.9	4.6	9.2	13.2	18.1	11.1	13.5	16.5	6.3	10.5	15.2	10.0	6.1	13.5	4.6	15.0	28.4	18.9	4.5	18.3	0.9	5.7	14.6	8.5	8.4	13.8	7.7	8.0	11.8	9.0	23.0	14.1	7.1	6.6	5.8	4.7	4.4	3.6	14.0	3.2	8.3	9.6	12.1	10.8	16.1	12.2	9.3	15.3	28.2	16.5	15.9	13.5	28.4	14.6	13.6	21.6	15.4	13.0	20.6	17.2	8.4	9.9	11.4	18.5	13.5	10.1	9.2	12.2	8.0	11.5	12.1
TRIM21	"RNF81, Ro/SSA, RO52, SSA1"	ENSG00000132109	"Tripartite motif containing 21"	P19474	11	4384897-4393696	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	"DNA-binding, Ribonucleoprotein, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 72.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004566, HPA005673"	Approved		Approved	Nucleoplasm				Nucleoplasm		"CAB004566: AB_628286, HPA005673: AB_1080090"	"prognostic favourable (4.83e-5)"	"unprognostic (4.55e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavourable (1.87e-4)"	"unprognostic (1.20e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.27e-2)"	"unprognostic (4.69e-2)"	"prognostic favourable (2.26e-6)"	"unprognostic (9.12e-3)"	18.2	12.1	4.9	13.7	6.5	15.0	9.8	2.5	6.4	15.0	11.7	6.4	6.0	12.5	11.6	10.3	14.6	10.4	10.8	8.5	5.0	5.3	12.9	14.9	14.6	21.4	6.8	4.0	17.4	10.7	4.3	9.9	19.9	8.6	18.0	12.0	8.5	11.9	8.6	4.5	6.9	21.8	12.0	4.7	28.3	13.5	6.0	4.7	21.5	19.1	6.8	17.0	11.6	13.5	10.9	22.0	72.4	27.5	14.5	19.5	28.6	5.9	7.0	3.5	3.3	7.3	11.0	4.9	7.6	14.4	30.2	33.5	3.2	17.2	9.1	3.5	11.2	8.5	6.2	11.6	9.4	15.2	6.9	14.0	4.0	2.8	16.2	16.5	13.9	10.7	7.0	6.1	4.2	18.4	4.4	10.0	10.0	5.2	8.6	12.1	3.0	3.6	6.1	4.6	5.0	11.9	5.5	0.0	1.5	6.2	7.0	8.4	2.4	11.3	16.5	7.4	5.8	3.8	2.8	5.3	4.1	5.8	6.6	13.1	5.2	18.8	26.9	60.1	19.3	27.5	16.8	10.5	16.6	17.1	22.0	10.9	14.9	15.7	72.4	14.5	24.4	7.4	19.5	28.6	4.9	6.5	2.5	6.4	5.0	5.3	6.8	4.0	8.6	4.7
TRIM32	"BBS11, HT2A, LGMD2H, TATIP"	ENSG00000119401	"Tripartite motif containing 32"	Q13049	9	116687302-116701300	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Bardet-Biedl syndrome, Ciliopathy, Disease mutation, Limb-girdle muscular dystrophy, Mental retardation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050060	Approved		Approved	"Intermediate filaments"				"Intermediate filaments"		"HPA050060: "	"unprognostic (2.47e-2)"	"unprognostic (7.06e-3)"	"unprognostic (5.50e-2)"	"unprognostic (3.63e-1)"	"unprognostic (5.08e-2)"	"prognostic unfavourable (4.53e-4)"	"prognostic unfavourable (4.72e-4)"	"unprognostic (2.41e-3)"	"unprognostic (2.92e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.79e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.03e-2)"	"unprognostic (7.06e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.64e-3)"	"unprognostic (9.77e-2)"	9.5	9.1	6.6	5.8	11.5	0.8	8.0	23.2	17.1	12.8	7.9	7.2	6.2	6.7	17.0	8.0	8.8	15.9	8.2	8.9	5.7	7.3	6.2	5.0	6.3	8.4	5.7	9.8	12.6	12.5	12.2	7.7	7.0	9.1	10.3	7.4	10.4	10.9	9.2	23.9	6.6	8.9	12.9	5.3	6.9	6.8	6.5	2.2	9.4	8.4	6.2	8.3	11.1	8.8	6.1	3.5	0.2	2.6	5.6	16.0	4.7	6.4	14.9	8.8	9.7	17.9	12.9	6.7	12.1	13.3	13.8	11.6	9.9	7.1	6.7	5.4	18.5	13.9	10.7	13.6	12.6	5.9	5.2	3.6	9.6	6.0	9.3	2.4	11.9	11.0	12.3	13.0	7.7	8.9	5.0	5.7	16.1	8.3	6.4	0.0	8.0	9.0	7.6	23.7	4.4	5.6	15.2	8.8	4.5	9.5	6.6	6.9	18.4	2.4	11.0	12.8	10.3	9.4	9.1	9.4	2.5	10.5	10.7	1.6	12.5	0.0	1.3	0.0	9.3	2.6	7.2	6.1	8.2	7.4	1.8	4.4	8.3	8.4	0.2	5.6	2.1	3.5	16.0	4.7	6.6	11.5	23.2	17.1	5.7	7.3	5.7	9.8	9.1	2.2
TRIM58	BIA2	ENSG00000162722	"Tripartite motif containing 58"	Q8NG06	1	247857199-247878205	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 24.8;placenta: 22.4;thyroid gland: 15.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 7.9;HEL: 21.0;K-562: 11.6;PC-3: 20.2;U-2 OS: 16.5;WM-115: 21.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA023637	Uncertain						310000			"HPA023637: AB_1858309"	"unprognostic (3.85e-1)"	"unprognostic (5.24e-3)"	"unprognostic (7.00e-2)"	"unprognostic (6.52e-4)"	"unprognostic (1.46e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.14e-5)"	"unprognostic (3.59e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.57e-2)"	0.7	0.8	1.3	1.0	4.4	24.8	0.7	0.3	3.7	0.6	1.3	0.2	0.0	0.3	0.5	0.4	0.5	1.4	0.5	0.8	1.5	3.2	0.5	0.6	3.4	0.4	2.4	1.2	1.1	0.4	0.3	0.7	22.4	6.9	1.7	1.0	1.1	0.5	0.4	0.5	1.2	0.6	0.8	1.3	5.8	0.7	4.9	0.1	0.0	15.2	0.0	0.4	1.9	0.7	3.1	0.6	3.7	0.7	1.7	0.3	1.9	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.0	7.9	0.0	0.0	0.0	0.8	21.0	0.0	0.0	0.0	2.8	1.6	0.0	0.0	0.0	0.0	0.0	11.6	0.1	0.0	0.0	0.0	0.1	1.3	20.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	2.1	0.0	0.0	16.5	0.0	0.0	3.5	0.0	0.0	0.0	5.9	21.3	2.8	0.7	1.8	0.3	0.5	0.2	3.1	0.2	0.2	0.6	1.0	0.3	0.2	3.7	1.7	0.6	0.6	0.2	1.9	1.3	4.4	0.3	3.7	1.5	3.2	2.4	1.2	6.9	0.1
UBE2W	"FLJ11011, UBC-16"	ENSG00000104343	"Ubiquitin conjugating enzyme E2 W"	Q96B02	8	73780097-73878910	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045161, HPA073181"	Uncertain		Approved	Nucleoli				Nucleoli		"HPA045161: AB_10960706, HPA073181: "	"unprognostic (5.36e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.17e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.47e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.01e-2)"	"unprognostic (4.38e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.18e-1)"	15.2	14.2	13.5	13.3	21.8	17.5	13.4	18.9	24.4	12.0	9.8	11.3	11.0	7.9	13.4	10.5	16.6	9.4	15.2	14.8	19.0	12.3	21.9	23.4	13.6	11.6	11.6	13.0	11.8	12.7	18.4	20.9	13.6	18.4	12.0	11.5	9.5	12.2	10.6	16.4	10.6	8.5	12.8	12.6	13.6	10.0	16.4	12.3	14.7	17.1	4.8	12.9	16.8	12.8	5.0	8.1	23.0	9.4	4.7	4.3	4.8	8.5	5.6	6.9	7.5	12.1	12.4	6.0	9.4	10.4	9.1	9.5	4.6	9.6	4.0	7.8	9.8	8.7	10.2	9.6	15.2	6.4	6.2	8.1	5.8	7.1	8.2	4.4	11.5	9.7	10.8	10.6	19.0	11.0	4.0	8.6	13.8	6.8	9.6	4.8	5.3	11.1	2.9	7.1	3.4	16.9	9.4	5.1	5.6	7.5	24.5	11.3	11.5	7.9	9.8	11.0	8.4	8.3	6.9	7.3	7.5	2.9	9.6	7.1	9.4	12.9	9.4	11.5	3.5	8.8	4.3	5.0	3.6	2.6	6.3	4.3	3.2	3.8	23.0	4.7	9.4	8.1	4.0	4.8	13.5	21.8	18.9	24.4	19.0	12.3	11.6	13.0	18.4	12.3
VHL	VHL1	ENSG00000134086	"Von Hippel-Lindau tumor suppressor"	P40337	3	10141008-10152220	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes, Congenital erythrocytosis, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 53.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB005430, HPA031631, HPA031632"	Uncertain		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB005430: AB_2241850, HPA031631: , HPA031632: "	"prognostic unfavourable (9.02e-5)"	"unprognostic (1.10e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (1.32e-5)"	"unprognostic (3.55e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.51e-1)"	"prognostic favourable (7.84e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.28e-3)"	13.8	17.4	18.1	29.2	18.4	24.3	15.4	25.8	21.4	13.3	19.8	19.3	14.5	15.9	15.1	13.6	16.4	14.3	18.9	10.5	17.1	18.5	13.7	16.3	14.6	27.9	13.5	12.3	15.2	22.5	13.8	14.6	18.8	12.8	15.1	16.6	12.5	21.8	13.7	14.8	14.0	22.3	13.4	17.0	22.6	16.2	17.9	11.2	39.2	16.9	11.5	29.3	15.4	19.1	5.4	3.9	8.0	4.1	4.4	4.3	1.7	6.7	6.5	14.3	8.8	13.3	10.3	53.6	5.9	8.5	7.6	9.0	7.6	8.4	23.8	8.1	8.0	5.8	13.2	8.3	9.4	11.4	12.0	18.5	10.5	10.5	12.6	16.3	14.8	10.3	9.5	10.1	12.8	8.7	16.4	18.1	7.5	12.2	15.5	12.0	9.6	8.3	19.7	12.6	11.9	9.3	17.4	5.4	17.9	12.5	6.7	7.2	13.2	20.7	7.5	7.6	10.1	7.0	9.3	12.9	26.4	38.0	8.4	19.5	6.9	2.6	4.1	3.3	3.8	2.5	3.6	4.1	2.9	4.3	3.9	5.4	2.5	2.7	8.0	4.4	3.2	2.4	3.1	1.7	18.1	18.4	25.8	21.4	17.1	18.5	13.5	12.3	12.8	11.2
ZC3HC1	NIPA	ENSG00000091732	"Zinc finger C3HC-type containing 1"	Q86WB0	7	130018286-130051451	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019089, HPA024023"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"				"Nucleoplasm, Nuclear membrane"		"HPA019089: AB_1858976, HPA024023: AB_1858977"	"unprognostic (7.14e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavourable (3.36e-4)"	"unprognostic (1.89e-1)"	"unprognostic (3.39e-2)"	"prognostic unfavourable (1.02e-6)"	"unprognostic (2.11e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.11e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.53e-1)"	11.0	13.8	8.1	10.0	10.3	4.9	14.2	9.5	12.6	9.5	9.2	9.9	5.9	6.0	14.5	11.0	7.9	9.4	7.5	16.3	8.2	8.9	13.2	14.8	6.9	13.6	7.3	8.4	10.7	10.6	10.5	9.6	10.0	10.5	9.0	8.4	9.6	10.5	8.4	33.0	7.1	7.8	12.9	5.5	13.7	9.0	24.6	6.6	15.4	8.3	11.9	11.5	8.5	9.6	23.1	20.2	17.4	17.7	17.4	23.8	15.8	7.0	12.0	14.9	16.8	8.5	7.8	10.3	9.2	11.0	17.4	18.1	14.1	12.1	16.3	6.7	11.7	6.5	19.5	13.9	17.2	10.6	16.7	11.3	10.9	13.7	13.7	13.0	11.6	9.4	10.5	18.1	11.8	19.0	33.9	5.7	17.6	12.4	15.3	25.1	30.4	13.7	14.5	11.5	14.2	17.6	4.8	9.6	17.2	13.3	19.3	14.7	8.4	13.8	8.7	11.9	5.8	10.4	15.4	11.1	16.7	21.2	18.8	16.7	20.2	17.4	16.2	14.5	17.0	17.7	19.5	23.1	18.2	18.2	20.2	20.6	23.8	18.8	1.3	17.4	16.3	11.9	18.5	15.8	8.1	10.3	9.5	12.6	8.2	8.9	7.3	8.4	10.5	6.6
ZER1	"C9orf60, Hzyg, ZYG, ZYG11BL"	ENSG00000160445	"Zyg-11 related cell cycle regulator"	Q7Z7L7	9	128729786-128772414	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048464			Approved	Cytosol				Cytosol		"HPA048464: AB_2756306"	"unprognostic (1.37e-1)"	"prognostic favourable (1.18e-6)"	"unprognostic (9.11e-3)"	"unprognostic (2.36e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.35e-2)"	"unprognostic (2.18e-1)"	"unprognostic (4.81e-3)"	"unprognostic (3.65e-1)"	"unprognostic (4.90e-3)"	"unprognostic (6.65e-3)"	"unprognostic (1.69e-1)"	"prognostic favourable (5.15e-11)"	"unprognostic (5.77e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.14e-1)"	15.4	17.1	36.0	9.7	32.0	12.0	12.5	28.0	45.3	15.9	18.2	19.7	11.3	27.4	16.7	12.3	23.8	21.9	14.4	29.9	27.0	28.5	15.7	11.1	16.5	10.4	19.9	34.2	22.1	22.0	24.1	18.2	13.1	29.1	20.6	11.0	14.7	21.9	22.2	40.3	17.4	25.3	14.0	13.5	12.5	14.1	25.8	18.8	16.9	19.0	8.5	9.3	17.9	12.6	5.0	5.7	15.8	5.8	5.5	7.7	4.9	8.7	9.6	6.4	8.7	19.2	13.3	17.6	8.4	14.5	11.7	9.6	8.6	9.9	5.4	9.5	14.7	19.1	7.0	12.5	4.9	10.7	9.3	3.7	17.0	6.3	15.0	5.4	10.4	16.4	18.9	11.8	8.4	9.9	6.6	11.8	7.9	33.1	10.2	6.1	6.4	12.4	9.3	8.5	20.4	8.7	11.8	12.4	9.4	14.1	18.2	9.6	26.5	6.5	11.1	9.7	4.3	12.3	5.0	14.9	13.9	4.2	14.2	3.3	7.0	10.9	3.7	10.0	5.6	5.6	7.7	3.8	5.8	7.2	3.9	5.0	6.5	5.9	15.8	5.5	5.8	5.7	5.3	4.9	36.0	32.0	28.0	45.3	27.0	28.5	19.9	34.2	29.1	18.8
ZNF451	"COASTER, dJ417I1.1, KIAA0576, KIAA1702"	ENSG00000112200	"Zinc finger protein 451"	Q9Y4E5	6	57086844-57170307	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028838			Approved	Nucleoplasm				Nucleoplasm		"HPA028838: AB_10603330"	"unprognostic (5.95e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.00e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.27e-3)"	"unprognostic (9.09e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.13e-3)"	"unprognostic (6.17e-2)"	13.2	17.8	14.2	10.8	30.9	61.8	14.4	23.3	21.2	13.8	12.8	15.5	11.6	8.8	14.9	16.1	11.7	12.0	11.2	11.2	15.4	13.0	11.9	13.3	13.5	15.2	20.5	13.9	14.3	11.9	14.5	27.6	18.0	20.3	14.9	10.8	8.8	11.3	11.8	11.2	12.3	12.0	18.9	21.1	15.5	12.9	27.5	21.0	16.5	16.6	7.8	14.1	14.9	12.9	14.2	14.2	19.3	10.0	7.7	12.3	6.8	9.2	5.0	12.7	7.8	12.2	15.7	12.2	10.2	12.9	12.5	13.6	11.5	4.6	10.1	6.8	11.3	8.8	12.5	11.4	20.3	8.2	8.8	26.3	9.2	10.7	9.3	14.6	11.4	11.1	11.7	13.8	17.4	12.2	35.1	9.8	10.7	6.7	18.2	12.7	6.9	5.6	12.5	16.2	9.5	8.3	15.8	15.1	10.1	11.2	7.4	12.1	8.9	14.1	8.0	12.6	13.0	16.2	12.0	9.6	16.0	20.7	11.0	18.1	6.2	19.3	10.0	9.7	10.8	8.3	10.6	9.6	9.3	6.4	10.6	14.2	12.3	9.4	5.0	7.7	8.5	14.2	7.2	6.8	14.2	30.9	23.3	21.2	15.4	13.0	20.5	13.9	20.3	21.0
ZNRF2	RNF202	ENSG00000180233	"Zinc and ring finger 2"	Q8NHG8	7	30284307-30367692	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 5.8"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072244	Approved									"HPA072244: "	"unprognostic (9.44e-2)"	"unprognostic (2.38e-2)"	"unprognostic (8.64e-2)"	"prognostic unfavourable (7.68e-4)"	"unprognostic (4.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.06e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.93e-2)"	"prognostic favourable (2.29e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.71e-1)"	"prognostic favourable (8.71e-4)"	"unprognostic (8.67e-2)"	7.8	8.0	10.0	9.3	10.6	9.7	16.2	12.8	10.0	5.8	16.1	10.5	7.6	11.3	7.7	9.7	14.2	5.2	8.7	8.4	9.6	6.1	19.3	24.0	7.9	12.0	10.0	7.4	5.8	14.0	8.0	9.9	9.6	11.0	7.0	14.3	5.8	10.5	13.7	17.5	11.5	12.7	8.3	10.5	9.2	12.4	20.6	9.1	7.9	13.3	9.8	10.9	9.4	11.8	1.3	5.8	1.4	1.1	0.7	2.4	0.5	6.6	2.4	2.0	1.7	2.3	1.6	10.5	2.5	2.6	2.8	3.9	1.2	11.2	7.0	6.7	2.0	6.5	6.6	4.3	3.1	6.8	6.0	4.3	5.2	3.2	1.2	3.3	8.3	2.5	7.4	1.9	4.8	2.3	5.3	14.0	3.0	2.5	6.8	8.9	4.6	3.0	5.9	4.3	11.9	8.6	14.4	6.9	6.5	5.1	21.7	4.3	5.8	13.6	2.6	2.8	4.8	2.6	5.3	24.0	20.5	9.1	3.0	7.3	4.0	0.5	0.9	1.1	1.0	0.9	1.5	1.3	1.2	1.4	0.8	0.8	0.7	1.1	1.4	0.7	1.1	5.8	2.4	0.5	10.0	10.6	12.8	10.0	9.6	6.1	10.0	7.4	11.0	9.1
ZNRF3	"BK747E2.3, FLJ22057, KIAA1133, RNF203"	ENSG00000183579	"Zinc and ring finger 3"	Q9ULT6	22	28883592-29057487	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 28.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036702, HPA036703"	Uncertain		Uncertain	"Golgi apparatus"				"Golgi apparatus"		"HPA036702: , HPA036703: AB_10672227"	"unprognostic (1.07e-1)"	"unprognostic (2.13e-3)"	"unprognostic (7.48e-3)"	"unprognostic (5.72e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.68e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.94e-1)"	"unprognostic (9.55e-5)"	"unprognostic (6.49e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.55e-2)"	4.6	11.8	16.8	2.5	14.7	1.0	4.5	12.2	18.1	7.8	5.7	7.7	21.8	5.1	8.3	22.2	5.9	8.1	3.8	4.3	22.0	5.0	13.6	7.5	8.7	1.2	6.1	17.7	10.0	5.4	16.3	4.2	8.0	8.1	12.0	5.9	4.9	12.1	13.4	5.6	7.6	4.7	7.8	8.9	2.2	6.4	6.7	10.5	0.0	6.9	1.9	1.5	5.7	4.9	0.2	0.4	1.5	1.0	2.0	0.5	0.1	3.6	8.7	8.1	2.3	1.5	1.8	15.5	2.2	1.1	1.8	1.7	13.1	2.0	0.0	3.5	1.1	6.2	5.6	3.5	2.2	4.8	5.7	1.4	1.5	28.6	1.3	4.3	1.5	1.8	3.3	2.8	2.8	1.5	3.1	2.1	2.5	3.5	0.1	2.2	3.0	3.5	4.3	5.3	3.3	7.5	5.4	13.5	5.0	4.0	3.9	2.3	2.6	1.9	1.4	6.8	5.8	5.3	3.6	2.8	3.8	5.1	2.9	2.4	3.5	1.0	0.2	1.3	0.2	1.0	0.4	0.1	0.2	0.1	0.4	0.2	0.1	0.5	1.5	2.0	0.2	0.3	0.1	0.1	16.8	14.7	12.2	18.1	22.0	5.0	6.1	17.7	8.1	10.5
ZSWIM2	"MEX, MGC33890, ZZZ2"	ENSG00000163012	"Zinc finger SWIM-type containing 2"	Q8NEG5	2	186827835-186849208	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	12	"testis: 17.4"	"Cell line enhanced"	"Detected in some"		"HSkMC: 1.1;U-138 MG: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"																		"unprognostic (2.00e-1)"													0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.3	0.2	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.1	0.4	0.0	0.0	0.3	0.0
FBXL19	"CXXC11, DKFZp434K0410, Fbl19, JHDM1C"	ENSG00000099364	"F-box and leucine rich repeat protein 19"	Q6PCT2	16	30923055-30948783	"Predicted intracellular proteins"	"Ubl conjugation pathway"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035317			Approved	"Intermediate filaments"				"Intermediate filaments"		"HPA035317: "	"unprognostic (1.37e-1)"	"prognostic unfavourable (3.27e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.20e-1)"	"prognostic unfavourable (3.54e-4)"	"unprognostic (3.61e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.37e-3)"	"unprognostic (6.02e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.45e-2)"	"unprognostic (2.38e-2)"	5.5	6.7	17.4	9.8	15.3	8.3	3.8	13.2	23.5	6.8	9.6	3.4	9.5	11.2	7.5	4.4	10.5	6.0	9.4	4.9	17.6	10.5	6.1	3.1	5.8	9.8	9.6	11.6	6.9	6.6	11.0	8.3	11.2	9.5	6.9	4.1	5.2	8.4	7.1	4.5	12.7	9.8	6.2	4.8	9.9	9.3	19.6	8.4	7.3	5.8	4.7	6.7	9.7	7.0	2.1	2.8	1.9	1.7	3.6	1.5	0.4	6.2	17.4	16.5	13.9	3.0	3.1	15.1	8.8	4.7	7.1	6.7	9.1	9.5	10.0	10.5	5.1	9.2	13.2	9.4	5.2	27.2	41.1	10.7	27.1	13.0	3.7	11.8	27.0	3.1	7.5	8.4	6.0	11.0	29.0	9.7	3.8	17.0	12.9	16.3	17.0	5.7	26.9	5.2	9.8	6.5	8.6	11.7	21.9	3.2	20.1	4.9	12.3	12.6	10.8	8.3	10.1	5.0	6.2	8.6	6.9	5.9	9.6	18.1	11.6	0.0	1.7	1.9	1.5	0.8	1.2	2.1	0.4	0.6	0.9	0.8	0.2	1.2	1.8	3.6	0.2	2.8	0.7	0.4	17.4	15.3	13.2	23.5	17.6	10.5	9.6	11.6	9.5	8.4
RNF212	"FLJ38841, LOC285498"	ENSG00000178222	"Ring finger protein 212"	Q495C1	4	1056250-1113562	"Predicted intracellular proteins"	"Meiosis, Ubl conjugation pathway"	Transferase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pituitary gland: 18.1"	"Group enriched"	"Detected in some"	4	"A-431: 8.6;HeLa: 26.3;SiHa: 15.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA057527	Uncertain									"HPA057527: "	"unprognostic (2.75e-2)"	"prognostic favourable (1.39e-4)"	"unprognostic (1.55e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.45e-2)"	"unprognostic (7.65e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.05e-1)"	2.9	1.9	3.1	1.7	8.4	4.5	3.9	11.4	4.7	4.6	2.4	4.3	2.0	1.2	2.7	4.3	2.4	4.0	2.1	1.3	2.4	1.6	4.7	0.6	2.9	2.7	3.4	1.1	8.8	13.0	0.8	18.1	1.0	5.3	3.3	1.8	3.6	4.2	1.4	1.9	4.4	1.8	2.2	4.1	1.9	2.6	12.1	2.1	0.5	8.2	1.0	1.9	1.4	3.0	2.1	1.2	0.1	0.7	0.4	3.8	0.9	8.6	0.5	0.0	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.3	0.0	3.8	0.1	0.0	2.2	0.0	2.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.0	2.9	0.0	15.7	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	2.2	0.7	1.8	0.6	3.8	1.0	1.2	2.1	3.8	1.2	0.0	0.4	0.0	0.4	1.1	0.9	3.1	8.4	11.4	4.7	2.4	1.6	3.4	1.1	5.3	2.1
UBE2D2	"UBC4, UbcH5B"	ENSG00000131508	"Ubiquitin conjugating enzyme E2 D2"	P62837	5	139526431-139628433	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (1.14e-1)"	"unprognostic (2.75e-3)"	"prognostic favourable (5.09e-5)"	"prognostic favourable (5.90e-4)"	"unprognostic (2.33e-1)"	"unprognostic (8.19e-3)"	"prognostic unfavourable (9.63e-7)"	"unprognostic (7.41e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.41e-3)"	"prognostic unfavourable (2.09e-5)"	"unprognostic (8.00e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.20e-1)"	"unprognostic (1.07e-1)"	35.6	25.0	41.2	31.5	39.9	44.2	35.9	31.9	49.6	43.9	50.4	35.5	31.5	22.2	35.5	52.2	44.8	47.6	27.1	34.8	39.5	40.5	37.2	39.5	34.8	55.6	40.5	36.1	35.3	41.7	23.8	35.3	33.6	35.9	30.8	46.4	30.7	30.5	37.9	80.6	33.2	37.4	39.3	41.9	41.3	29.1	68.0	29.3	71.0	34.4	31.2	64.5	42.2	36.1	34.3	39.3	40.8	23.0	22.5	41.7	19.5	36.5	24.4	42.8	29.9	28.9	37.1	27.4	38.7	36.2	45.6	53.4	62.8	34.8	52.3	51.0	39.9	23.2	42.0	65.2	61.1	33.7	24.5	29.6	27.0	36.0	56.6	28.9	26.4	29.1	33.7	45.2	67.7	48.6	25.6	44.8	42.2	36.7	44.6	41.2	23.5	26.6	34.0	44.5	37.8	47.9	43.3	39.0	25.8	33.8	43.5	61.4	27.2	25.7	31.8	34.8	19.4	28.9	47.2	32.2	52.3	73.3	24.9	47.7	27.7	14.8	20.9	40.8	22.6	18.8	24.7	34.1	32.7	31.7	23.4	34.3	41.7	35.2	34.5	22.5	23.0	39.3	40.0	19.5	41.2	39.9	31.9	49.6	39.5	40.5	40.5	36.1	35.9	29.3
UBE2D3	UbcH5C	ENSG00000109332	"Ubiquitin conjugating enzyme E2 D3"	P61077	4	102794383-102868896	"Enzymes, Predicted intracellular proteins"	"Apoptosis, DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003920	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (7.43e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.78e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.31e-2)"	"prognostic favourable (4.51e-4)"	"unprognostic (5.08e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.34e-2)"	67.2	70.6	39.1	52.7	44.6	132.7	70.4	36.9	50.9	45.5	51.8	37.5	38.4	49.3	46.3	39.1	63.2	45.7	47.5	72.5	37.3	39.5	63.0	91.9	67.5	68.1	43.4	36.9	60.6	53.4	42.8	49.1	66.5	45.2	49.6	48.5	38.4	46.7	43.3	91.1	53.2	58.9	48.4	44.4	68.2	49.5	40.0	42.2	88.8	66.3	55.4	61.4	74.6	81.4	24.7	31.2	118.0	36.2	29.7	33.2	50.9	52.5	30.1	50.3	40.6	53.7	77.6	43.3	53.6	71.4	47.8	45.2	45.2	75.1	56.4	35.1	54.3	30.2	53.6	71.9	65.9	52.3	27.0	51.3	31.0	36.8	56.4	72.1	44.2	58.9	45.6	52.7	73.9	62.0	64.4	57.6	63.6	42.5	105.7	41.1	36.4	30.2	55.8	49.4	40.7	48.2	50.3	50.8	42.8	32.9	84.5	60.4	35.1	42.7	56.9	50.1	42.9	32.8	48.6	51.1	65.8	86.2	53.4	40.2	53.7	71.1	35.9	54.6	25.1	36.1	33.2	24.7	31.8	29.6	31.2	20.1	32.6	29.7	118.0	29.7	36.2	21.5	32.6	50.9	39.1	44.6	36.9	50.9	37.3	39.5	43.4	36.9	45.2	42.2
AC098582.1		ENSG00000285385			4	88523810-88649847	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"pituitary gland: 8.8"	"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 4.4;RPTEC TERT1: 3.4"									"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.8"	"Low lineage specificity"	"Detected in single"																																							1.4	0.1	2.4	2.5	3.3	2.8	2.4	2.8	6.3	0.9	0.4	3.3	1.3	0.1	1.1	3.2	0.7	2.2	0.3	0.7	1.4		1.3	0.5	1.3	0.6	0.8	3.5	1.3	0.1	0.1	8.8	1.0	4.8	1.3	2.0	2.2	2.4	1.5	3.1	0.8	0.9	1.1	3.0	2.0	0.1	1.8	1.7	0.0	3.6	0.1	0.7	0.7	0.5	0.9	0.0	0.0	0.2	0.6	2.8	0.7	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.7	0.7	0.0	1.8	0.0	1.0	0.0	0.5	1.4	0.4	0.0	0.0	0.0	0.9	0.0	1.4	0.0	0.6	0.9	0.0	0.0	0.9	1.3	0.0	4.4	1.3	1.2	0.9	0.0	0.0	0.9	0.3	0.0	0.6	1.1	0.4	0.4	3.4	0.0	0.0	1.6	0.0	0.4	0.1	0.5	0.0	0.0	0.5	0.7	0.0	1.9	2.2	0.0	0.0	2.1	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.4	0.3	1.4	0.3	0.0	0.9	2.8	1.5	0.0	0.6	0.2	0.0	0.7	0.7										
CBX4	"hPC2, NBP16, PC2"	ENSG00000141582	"Chromobox 4"	O00257	17	79833156-79839429	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 109.1"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 38.4;SK-MEL-30: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008228, HPA012021"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	"Nuclear bodies"	"HPA008228: AB_1078413, HPA012021: "	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.97e-2)"	"unprognostic (8.80e-2)"	"unprognostic (5.39e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.40e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavourable (8.72e-8)"	"unprognostic (7.49e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.07e-1)"	7.1	9.9	11.6	11.3	14.8	109.1	7.0	9.0	22.5	5.9	6.2	20.4	6.3	8.3	5.9	6.3	14.8	6.7	10.3	12.0	12.9	12.9	6.5	15.3	9.0	13.9	15.4	10.8	9.3	16.8	16.2	14.8	17.0	13.9	8.9	4.8	14.5	12.9	6.9	3.8	20.6	8.5	5.2	12.6	16.3	10.8	5.5	13.1	29.2	8.3	6.7	19.2	8.6	7.1	3.6	4.2	5.2	1.7	1.0	3.8	1.3	10.6	9.6	2.9	12.5	1.8	1.7	8.2	4.8	2.9	1.8	1.9	6.9	6.0	4.1	6.9	1.9	5.5	3.2	3.2	1.3	4.4	6.1	2.3	9.1	12.8	9.0	12.2	18.3	2.3	19.0	1.6	2.9	1.5	7.1	23.3	1.9	7.6	16.7	12.5	1.6	9.7	17.4	2.9	18.5	2.5	5.1	3.0	5.8	7.3	38.4	42.7	9.1	19.6	3.8	10.4	9.2	6.4	6.2	20.2	10.3	11.6	6.5	10.6	13.8	3.9	1.4	4.1	2.4	1.5	1.8	3.3	3.1	3.3	0.9	3.6	3.8	3.5	5.2	1.0	1.7	4.2	0.5	1.3	11.6	14.8	9.0	22.5	12.9	12.9	15.4	10.8	13.9	13.1
CCM2	"C7orf22, MGC4607, OSM"	ENSG00000136280	"CCM2 scaffolding protein"	Q9BSQ5	7	44999475-45076469	"Disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020273, HPA021669, HPA065815"	Supported		Enhanced	Mitochondria				Mitochondria		"HPA020273: AB_1846185, HPA021669: AB_1846186, HPA065815: "	"unprognostic (4.30e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (1.79e-4)"	"unprognostic (3.17e-1)"	"prognostic unfavourable (2.45e-4)"	"unprognostic (4.85e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.37e-3)"	"unprognostic (3.92e-1)"	"unprognostic (2.65e-1)"	"prognostic favourable (1.16e-4)"	"unprognostic (3.03e-1)"	"prognostic unfavourable (5.06e-7)"	"unprognostic (2.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.48e-1)"	16.7	18.3	31.6	20.7	52.0	11.2	8.6	21.3	36.1	9.7	12.5	13.9	8.6	10.5	7.2	7.0	10.6	8.4	9.1	13.7	29.8	23.1	7.9	31.6	12.4	30.7	29.0	14.2	8.2	17.9	16.5	11.2	11.5	17.8	7.7	8.8	6.9	13.6	12.6	27.0	13.4	10.6	13.3	14.7	20.8	11.2	10.5	11.5	37.5	7.4	8.2	23.4	15.4	12.6	14.8	7.3	32.4	13.8	17.6	50.6	11.1	14.0	15.5	9.3	18.5	17.6	15.5	6.9	17.0	14.0	12.2	16.5	11.2	14.6	19.8	13.2	21.5	18.3	5.7	22.0	8.1	22.0	11.1	8.8	12.4	7.9	15.6	3.6	23.7	17.5	14.5	21.4	9.2	22.2	10.0	16.1	24.4	21.1	17.3	48.0	10.7	17.3	9.3	5.3	16.1	12.5	13.6	18.0	14.0	13.9	11.0	7.5	12.6	16.5	16.8	16.7	14.1	16.6	16.3	28.9	22.6	40.0	16.3	13.1	20.0	27.1	10.5	31.2	17.3	12.1	11.6	13.6	20.5	18.7	7.2	14.8	19.9	14.7	32.4	17.6	13.8	7.3	50.6	11.1	31.6	52.0	21.3	36.1	29.8	23.1	29.0	14.2	17.8	11.5
CDKN1B	"KIP1, P27KIP1"	ENSG00000111276	"Cyclin dependent kinase inhibitor 1B"	P46527	12	12715058-12722371	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle"	"Protein kinase inhibitor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003691, CAB021888, HPA059086"	Approved		Supported	Nucleoplasm,Vesicles				Nucleoplasm	Vesicles	"CAB003691: AB_425362, CAB021888: , HPA059086: "	"unprognostic (5.67e-2)"	"unprognostic (9.76e-2)"	"prognostic favourable (5.15e-4)"	"unprognostic (6.90e-3)"	"unprognostic (5.84e-3)"	"unprognostic (1.03e-2)"	"prognostic unfavourable (3.25e-4)"	"unprognostic (4.04e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.85e-3)"	"unprognostic (9.23e-3)"	"unprognostic (2.96e-1)"	"prognostic unfavourable (8.39e-4)"	"unprognostic (1.23e-1)"	"unprognostic (8.68e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.15e-1)"	29.8	30.9	30.2	25.0	30.0	40.2	45.3	64.5	50.6	31.6	34.4	35.6	19.9	29.2	33.1	19.8	26.0	24.3	24.3	21.2	33.0	29.5	20.8	23.3	29.2	38.5	42.9	25.1	46.2	15.1	22.2	15.9	26.8	26.3	25.1	22.2	31.4	23.5	24.2	48.8	26.1	26.4	19.4	46.0	34.3	19.4	19.2	39.0	43.0	29.4	21.4	25.5	34.1	29.1	6.2	3.3	19.2	4.5	6.2	10.6	2.9	12.8	6.4	34.3	5.9	11.8	6.7	16.8	12.1	19.2	16.7	20.6	18.3	14.6	0.1	4.6	6.9	12.3	16.0	5.9	15.0	21.8	11.3	10.0	17.6	18.4	15.8	8.5	7.1	7.4	12.8	5.5	16.1	9.9	10.7	36.7	5.9	16.5	11.9	12.2	13.7	6.0	8.8	11.2	21.5	8.0	13.9	13.0	21.4	17.3	12.5	22.6	6.6	19.1	6.7	8.3	13.2	7.5	11.7	31.8	21.0	11.6	10.3	12.8	8.0	4.5	3.1	6.8	5.4	3.1	5.6	6.2	6.9	6.5	3.2	4.8	7.4	5.2	19.2	6.2	4.5	3.3	10.6	2.9	30.2	30.0	64.5	50.6	33.0	29.5	42.9	25.1	26.3	39.0
CNOT4	"CLONE243, NOT4, NOT4H"	ENSG00000080802	"CCR4-NOT transcription complex subunit 4"	O95628	7	135361795-135510127	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Ubl conjugation pathway"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005737	Approved									"HPA005737: AB_1078544"	"unprognostic (9.11e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.64e-2)"	"prognostic unfavourable (1.19e-4)"	"unprognostic (2.82e-2)"	"unprognostic (4.18e-2)"	"prognostic favourable (1.61e-4)"	"unprognostic (9.08e-2)"	"unprognostic (1.00e-2)"	"prognostic favourable (7.67e-6)"	"unprognostic (1.01e-1)"	"unprognostic (6.31e-2)"	"unprognostic (2.23e-1)"	"unprognostic (9.33e-2)"	19.4	14.3	19.8	12.0	23.3	11.1	13.8	31.6	24.6	18.7	15.0	21.9	7.0	11.3	21.1	15.2	15.8	16.7	13.8	18.7	19.2	18.0	16.0	16.0	13.6	14.4	18.5	15.1	24.7	14.1	22.6	28.6	16.1	21.1	15.3	13.4	16.4	16.8	15.6	35.0	15.6	12.3	17.1	22.6	13.7	12.3	25.8	18.5	18.5	21.1	12.3	18.1	16.2	15.7	12.0	10.0	21.5	12.7	16.7	15.5	9.1	13.5	12.9	13.2	17.6	22.0	17.5	9.6	15.3	16.7	13.1	16.3	11.1	14.0	13.6	13.3	13.9	13.0	16.7	11.6	18.8	15.3	12.8	11.2	11.1	9.8	12.3	12.5	13.4	13.4	14.8	16.7	10.5	13.4	19.5	10.9	19.1	17.0	17.2	20.5	17.3	10.9	11.2	13.0	14.7	15.4	12.6	14.0	16.5	17.8	20.1	11.1	12.4	14.3	18.0	15.9	9.5	14.7	16.5	16.8	15.7	19.4	16.0	14.8	21.1	21.5	11.5	14.9	14.1	11.5	15.5	11.0	12.0	11.7	10.0	12.0	13.1	12.1	10.7	16.7	12.7	8.0	10.1	9.1	19.8	23.3	31.6	24.6	19.2	18.0	18.5	15.1	21.1	18.5
CORO7	FLJ22021	ENSG00000262246	"Coronin 7"	P57737	16	4354542-4425705	"Predicted intracellular proteins"	"Protein transport, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 53.9"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 19.5;RPMI-8226: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA041657, HPA053586"	Uncertain						17000			"HPA041657: AB_10796351, HPA053586: "	"unprognostic (4.75e-3)"	"prognostic favourable (8.68e-4)"	"unprognostic (2.18e-1)"	"prognostic favourable (4.25e-4)"	"unprognostic (3.80e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.54e-4)"	"unprognostic (3.32e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.05e-3)"	"unprognostic (1.20e-2)"	"unprognostic (6.76e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.55e-2)"	"unprognostic (4.06e-3)"	9.7	8.4	14.8	15.7	19.2	53.9	6.8	7.0	16.1	5.9	9.3	25.2	4.0	14.7	7.7	7.9	5.6	8.9	9.5	5.8	13.5	7.4	8.7	4.8	14.1	27.9	27.3	9.7	4.3	8.4	6.5	7.3	9.6	11.9	9.0	6.4	5.0	7.1	7.8	4.0	5.8	15.8	7.1	12.2	30.9	10.7	13.2	24.9	13.1	7.6	5.3	11.8	7.8	5.9	5.6	9.3	17.3	16.3	4.1	9.4	9.7	2.4	3.7	2.1	2.3	0.5	0.8	4.4	1.7	1.4	2.4	2.5	2.0	5.1	5.8	2.0	1.8	3.7	1.5	2.8	1.0	5.4	10.3	2.0	5.4	3.1	2.0	5.8	11.9	2.1	0.7	1.6	0.4	3.9	5.6	19.5	1.0	7.6	4.0	14.7	2.4	1.4	13.1	7.8	36.3	1.3	4.0	4.2	5.1	1.6	1.7	4.1	1.2	8.1	4.9	1.8	3.0	4.9	2.1	10.5	5.3	12.8	1.4	7.8	1.8	8.9	12.4	17.3	8.7	16.3	9.4	5.6	7.3	9.2	9.3	2.7	3.8	5.4	12.4	4.1	13.2	3.7	8.4	9.7	14.8	19.2	7.0	16.1	13.5	7.4	27.3	9.7	11.9	24.9
CRBN	"MRT2, MRT2A"	ENSG00000113851	Cereblon	Q96SW2	3	3144628-3179727	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045910	Approved									"HPA045910: AB_10960409"	"unprognostic (1.26e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.40e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.17e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.47e-2)"	22.9	17.3	30.9	12.4	29.0	28.1	26.2	41.8	36.6	19.1	19.1	15.3	15.8	15.9	19.7	18.5	15.4	16.8	15.5	22.0	27.6	27.1	23.1	25.6	18.3	18.8	31.4	25.2	25.0	17.3	20.4	23.4	21.4	38.6	20.7	17.7	9.5	27.4	18.9	31.8	17.9	20.3	24.7	37.1	21.2	16.6	33.5	33.1	18.3	24.0	12.9	15.3	20.2	17.9	13.0	10.9	65.3	14.3	26.2	25.5	26.1	7.2	6.0	19.0	8.2	23.0	22.9	8.0	8.2	13.9	10.8	14.6	8.8	10.7	7.8	12.1	10.1	7.0	11.5	13.6	11.8	13.7	18.3	20.1	12.0	11.0	15.6	18.0	13.1	17.5	18.2	11.7	8.9	14.5	11.7	17.0	9.4	10.5	15.8	18.0	15.8	14.9	14.4	11.4	18.5	12.7	11.4	8.4	13.9	9.0	12.5	19.5	16.7	13.4	9.2	11.0	5.8	15.7	10.5	19.5	31.6	19.7	17.2	16.6	13.4	65.3	12.6	25.9	18.1	14.2	19.2	13.0	24.4	19.3	10.9	10.1	25.5	21.0	7.2	26.2	14.3	5.7	16.7	26.1	30.9	29.0	41.8	36.6	27.6	27.1	31.4	25.2	38.6	33.1
DBT		ENSG00000137992	"Dihydrolipoamide branched chain transacylase E2"	P11182	1	100186919-100249834	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Acyltransferase, Transferase"	"Disease mutation, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026481, HPA026485, HPA026533"	Enhanced		Supported	Mitochondria				Mitochondria		"HPA026481: AB_1847504, HPA026485: AB_1847505, HPA026533: AB_1847506"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.67e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.90e-1)"	"prognostic favourable (8.79e-12)"	"unprognostic (1.63e-1)"	"unprognostic (3.77e-1)"	"unprognostic (9.67e-2)"	"unprognostic (9.92e-2)"	8.6	14.1	8.3	5.0	13.6	3.9	8.7	8.0	11.8	8.5	7.8	7.9	13.6	6.6	9.8	6.6	13.6	8.6	5.2	18.1	8.6	7.3	22.2	29.1	8.0	5.3	10.2	8.2	9.1	13.7	10.2	12.3	7.3	9.4	12.0	7.6	5.2	11.3	8.3	15.7	8.1	5.8	11.2	8.6	6.0	12.6	5.7	8.2	9.6	13.0	8.7	6.3	12.8	7.7	4.4	2.6	3.3	3.1	4.0	5.0	2.1	11.5	5.7	5.2	10.6	11.6	10.1	12.2	7.9	6.4	7.1	8.6	11.8	4.4	10.5	11.6	4.7	10.4	11.6	8.4	8.9	11.1	6.7	7.6	10.9	5.8	9.9	10.0	3.6	9.8	9.3	5.8	9.1	6.6	12.2	11.5	5.6	2.6	8.3	3.2	11.0	11.4	8.1	19.2	7.9	7.8	10.5	9.2	5.7	17.5	15.6	13.2	12.3	6.2	7.6	7.0	4.7	8.9	7.1	8.1	8.2	5.4	8.3	6.2	3.1	3.3	2.2	1.8	4.9	3.1	5.0	4.4	4.4	4.2	2.2	4.1	4.5	4.2	2.1	4.0	2.7	2.6	3.4	2.1	8.3	13.6	8.0	11.8	8.6	7.3	10.2	8.2	9.4	8.2
DCAF1	"KIAA0800, MGC102804, VPRBP"	ENSG00000145041	"DDB1 and CUL4 associated factor 1"	Q9Y4B6	3	51395867-51500002	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036142, HPA052445, HPA053203"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"				"Nucleoplasm, Nucleoli fibrillar center"		"HPA036142: AB_10669666, HPA052445: , HPA053203: "	"unprognostic (7.51e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.15e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.75e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.21e-2)"	"prognostic favourable (7.45e-5)"	"unprognostic (5.49e-2)"	"unprognostic (5.00e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.64e-1)"	13.3	12.5	11.5	16.3	12.3	12.9	12.2	17.9	12.5	9.6	10.3	11.0	12.5	7.6	13.1	10.1	11.3	9.2	8.4	8.8	9.6	6.8	11.0	11.1	10.9	13.0	11.1	9.1	11.9	11.1	24.8	12.9	15.4	10.3	10.1	10.9	8.6	12.5	11.8	28.1	14.1	11.8	10.4	9.1	11.9	10.7	50.7	10.9	18.5	14.2	7.6	16.7	12.5	16.5	7.3	6.4	3.3	6.0	7.3	10.7	6.2	10.7	13.2	12.9	11.6	11.6	9.3	12.2	12.1	9.1	13.1	12.9	14.4	10.5	26.2	6.7	9.5	9.5	24.2	10.8	17.0	18.2	12.0	22.4	18.1	12.4	8.5	29.2	16.3	6.1	12.6	16.9	12.4	10.1	13.1	17.1	10.2	10.9	22.3	11.9	13.5	14.6	9.5	13.8	17.3	10.2	16.8	6.7	11.9	13.3	12.4	7.3	8.4	12.4	12.6	10.8	14.5	17.7	18.5	11.6	15.7	27.0	12.5	20.1	8.8	3.2	4.0	3.3	9.4	4.5	10.7	7.1	8.1	8.0	6.4	7.3	8.9	7.3	1.0	7.3	6.0	5.2	8.7	6.2	11.5	12.3	17.9	12.5	9.6	6.8	11.1	9.1	10.3	10.9
DCAF10	"FLJ23201, MGC10765, WDR32"	ENSG00000122741	"DDB1 and CUL4 associated factor 10"	Q5QP82	9	37800502-37867666	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024160	Uncertain		Approved	"Nucleoli fibrillar center"				"Nucleoli fibrillar center"		"HPA024160: AB_1858802"	"unprognostic (2.16e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.50e-3)"	"unprognostic (2.54e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.17e-1)"	"prognostic favourable (1.02e-6)"	"unprognostic (1.01e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.05e-2)"	12.4	21.1	8.8	8.1	12.0	9.9	12.1	14.8	14.9	14.2	13.3	8.8	13.0	10.0	14.2	12.1	16.9	11.7	10.4	15.3	7.9	7.9	14.5	19.1	10.6	9.3	8.4	9.9	15.6	14.8	25.8	13.7	10.5	10.3	16.0	10.9	10.9	12.9	15.7	16.9	12.6	15.2	13.3	7.6	9.4	11.7	29.7	8.6	19.0	16.2	8.0	8.6	17.3	20.4	3.4	1.2	4.2	3.7	3.0	3.5	0.6	12.1	5.6	6.1	5.8	10.2	14.0	8.1	9.8	9.1	5.5	7.9	2.0	4.4	12.3	4.5	11.3	4.6	6.2	6.9	6.8	10.5	6.1	5.5	9.2	3.7	18.5	7.2	4.2	12.5	13.8	6.6	23.3	8.9	19.4	5.6	8.7	4.4	6.7	3.3	6.7	4.9	6.7	3.2	6.3	8.9	5.6	7.1	9.8	9.1	10.1	7.9	8.1	13.4	11.2	6.2	4.8	8.7	6.8	5.5	9.3	7.0	9.9	7.2	8.7	0.9	1.4	4.2	2.3	1.2	1.5	2.6	1.9	2.6	1.2	3.4	3.5	2.0	3.9	3.0	3.7	1.1	1.1	0.6	8.8	12.0	14.8	14.9	7.9	7.9	8.4	9.9	10.3	8.6
DCAF13	"DKFZP564O0463, Gm83, HSPC064, Sof1, WDSOF1"	ENSG00000164934	"DDB1 and CUL4 associated factor 13"	Q9NV06	8	103414714-103443453	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Ubl conjugation pathway"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044504	Uncertain		Supported	"Nucleoplasm,Nucleoli,Cell Junctions,Centrosome,Cytosol"				"Nucleoplasm, Nucleoli"	"Cell Junctions, Centrosome, Cytosol"	"HPA044504: "	"prognostic unfavourable (4.06e-4)"	"unprognostic (4.39e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.46e-3)"	"unprognostic (3.57e-2)"	"unprognostic (7.86e-3)"	"prognostic unfavourable (8.05e-6)"	"unprognostic (5.92e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.27e-2)"	"unprognostic (5.54e-3)"	"unprognostic (2.31e-2)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.42e-2)"	"unprognostic (8.63e-2)"	18.4	20.5	13.8	18.1	15.7	10.6	20.2	11.3	14.3	16.0	16.7	13.0	12.9	13.1	18.1	16.7	24.0	15.3	10.7	15.9	12.4	11.8	35.2	26.5	12.4	18.4	16.5	12.1	20.9	28.9	15.7	34.6	21.2	16.2	16.4	18.5	7.4	15.9	11.3	21.1	13.7	16.8	15.3	13.9	20.4	14.7	25.3	15.0	26.4	17.1	22.6	24.3	16.9	15.5	28.6	26.4	10.3	22.1	24.0	27.2	20.2	27.5	24.8	23.2	23.6	16.9	19.6	17.4	20.6	15.8	19.6	20.1	24.4	27.0	38.4	35.3	21.5	20.8	31.4	26.3	38.0	36.6	22.3	53.1	14.9	27.7	19.3	21.7	22.9	15.9	18.2	28.8	48.0	27.2	35.6	16.9	29.8	22.5	41.1	22.8	35.5	38.8	26.8	28.2	39.6	28.5	23.1	29.6	28.1	12.9	20.2	23.3	31.1	14.9	17.8	20.0	32.1	25.7	27.5	18.7	32.5	54.3	26.9	47.5	25.5	8.6	18.6	10.3	18.4	22.1	25.2	28.6	19.8	19.7	26.4	22.1	19.8	20.2	2.0	24.0	16.0	13.7	27.2	20.2	13.8	15.7	11.3	14.3	12.4	11.8	16.5	12.1	16.2	15.0
DCAF15	"C19orf72, MGC99481"	ENSG00000132017	"DDB1 and CUL4 associated factor 15"	Q66K64	19	13952492-13961449	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068351			Approved	Vesicles,Mitochondria				Mitochondria	Vesicles	"HPA068351: "	"unprognostic (6.91e-2)"	"unprognostic (6.55e-3)"	"unprognostic (3.03e-2)"	"unprognostic (5.18e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.83e-3)"	"unprognostic (9.72e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.21e-1)"	"prognostic favourable (7.97e-4)"	"unprognostic (1.98e-2)"	"prognostic unfavourable (1.34e-5)"	"unprognostic (7.97e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.59e-1)"	10.3	6.5	10.4	15.1	8.5	27.5	11.1	20.1	13.3	13.9	12.7	8.7	8.9	10.7	11.4	8.4	14.7	11.3	10.0	11.0	12.1	7.0	11.1	13.1	14.8	19.4	9.0	8.5	10.3	8.4	11.0	10.7	18.6	8.8	10.4	8.4	9.8	10.0	9.1	13.3	21.0	13.8	8.2	7.4	21.4	9.9	41.0	6.5	29.2	10.7	16.5	23.4	9.9	12.8	2.2	2.8	5.1	2.2	0.8	3.6	1.3	15.4	9.6	25.3	13.9	2.7	4.0	11.6	10.7	7.5	22.5	22.5	17.0	6.6	14.3	12.4	10.2	14.1	16.1	10.1	8.0	17.2	28.6	17.6	16.1	17.6	5.7	14.5	26.0	5.2	9.5	16.6	7.5	11.2	18.5	21.2	9.8	23.6	25.9	27.1	30.1	15.1	24.0	8.9	9.8	12.0	12.0	16.2	16.7	9.6	7.0	8.7	8.9	18.8	7.7	15.4	11.4	24.3	19.9	15.0	16.4	14.9	9.9	21.3	13.2	1.2	2.0	5.1	2.1	2.2	1.6	2.1	1.7	2.4	1.2	2.2	0.9	2.4	4.1	0.8	1.4	2.8	3.6	1.3	10.4	8.5	20.1	13.3	12.1	7.0	9.0	8.5	8.8	6.5
DCAF16	"C4orf30, FLJ20280"	ENSG00000163257	"DDB1 and CUL4 associated factor 16"	Q9NXF7	4	17800655-17810758	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA042487	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA042487: AB_10795505"	"unprognostic (2.23e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.97e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavourable (6.40e-4)"	"prognostic favourable (5.78e-4)"	"unprognostic (5.31e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.23e-3)"	"prognostic favourable (7.67e-4)"	13.0	13.1	12.7	12.1	20.5	23.3	19.8	19.4	19.7	18.5	13.1	22.5	9.9	12.0	26.9	16.5	11.5	16.1	11.3	11.8	13.9	15.7	11.3	6.8	12.6	16.7	14.4	16.2	29.6	16.0	17.8	25.8	14.8	19.0	16.9	14.8	17.1	15.2	13.0	16.2	22.4	14.0	17.2	16.0	13.3	13.6	19.2	16.3	30.6	15.7	7.0	18.3	16.3	14.6	4.8	3.0	9.7	2.8	3.6	6.3	2.2	12.1	2.6	14.2	14.8	4.1	7.2	7.8	8.0	9.4	9.5	11.3	7.4	9.9	13.7	6.4	7.3	6.2	8.3	8.4	14.2	4.6	7.6	19.2	8.7	12.1	9.8	16.8	7.9	9.3	7.0	12.0	12.0	6.5	20.6	22.9	5.5	4.5	18.5	16.2	11.7	7.7	19.6	16.2	8.8	4.1	9.6	21.2	17.0	8.4	2.3	9.1	8.3	4.6	8.2	11.1	8.7	12.2	10.0	10.2	4.0	17.2	9.1	11.7	7.4	9.7	2.4	3.4	4.5	2.8	5.9	3.7	5.0	4.9	1.5	4.8	6.3	5.9	1.8	3.6	1.9	3.0	3.4	2.2	12.7	20.5	19.4	19.7	13.9	15.7	14.4	16.2	19.0	16.3
DCAF5	"BCRG2, BCRP2, D14S1461E, KIAA1824, WDR22"	ENSG00000139990	"DDB1 and CUL4 associated factor 5"	Q96JK2	14	69050881-69153150	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041575, HPA048098"	Uncertain		Approved	Mitochondria				Mitochondria		"HPA041575: , HPA048098: "	"unprognostic (8.12e-2)"	"unprognostic (3.28e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.27e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.63e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.06e-1)"	23.5	18.1	18.5	18.1	21.7	19.0	21.7	23.5	24.0	23.1	24.4	21.4	20.2	15.6	26.9	17.2	24.5	22.0	19.9	22.2	17.9	11.7	19.3	23.8	23.8	18.4	13.6	13.5	24.5	17.8	32.6	30.1	20.6	15.5	23.7	16.0	23.4	20.6	24.9	47.7	23.4	20.5	24.5	20.1	22.3	20.6	41.8	17.5	38.7	25.0	14.0	27.9	24.2	24.6	5.3	3.5	9.6	2.5	17.5	19.4	7.2	25.9	8.3	19.6	18.2	21.8	19.1	12.8	12.3	17.9	14.1	17.9	10.6	16.6	14.4	11.3	19.1	12.8	13.8	18.4	13.3	19.4	7.6	15.4	8.4	7.6	16.6	5.8	18.9	21.6	19.2	12.6	17.7	21.0	11.9	12.1	14.0	15.5	18.5	10.3	8.7	13.2	12.3	18.6	5.7	18.7	20.4	14.0	15.8	16.4	17.2	10.9	21.0	12.0	19.0	24.2	22.8	11.0	7.2	16.1	5.2	13.2	16.1	7.1	7.2	9.6	2.5	9.0	19.4	2.4	16.4	5.0	10.5	14.2	3.3	5.3	10.1	12.5	3.2	17.5	1.6	3.5	4.7	7.2	18.5	21.7	23.5	24.0	17.9	11.7	13.6	13.5	15.5	17.5
DCAF6	"IQWD1, PC326"	ENSG00000143164	"DDB1 and CUL4 associated factor 6"	Q58WW2	1	167935783-168075843	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 155.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054305			Supported	"Nucleoplasm,Focal adhesion sites"				"Nucleoplasm, Focal adhesion sites"		"HPA054305: "	"unprognostic (1.54e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.20e-2)"	"unprognostic (9.21e-2)"	"unprognostic (7.06e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	10.6	17.0	10.9	7.8	12.2	6.2	8.8	10.5	17.8	10.2	11.5	3.9	8.4	6.2	9.5	11.4	9.3	7.7	8.2	43.8	7.6	5.5	9.5	26.2	7.3	4.8	5.2	11.5	8.3	6.1	10.8	11.3	7.8	6.5	10.5	8.7	5.7	10.3	11.9	155.9	6.4	7.8	10.2	4.8	5.9	9.8	21.5	4.8	7.8	8.2	27.3	7.3	9.1	7.3	6.2	7.7	12.5	13.9	4.4	7.2	5.0	22.9	11.0	6.1	9.9	20.2	28.8	21.5	23.5	35.3	16.7	24.9	18.2	19.4	19.0	13.7	30.3	17.3	9.5	17.6	23.7	10.7	10.2	20.2	16.7	13.1	16.3	9.0	9.7	20.4	17.8	15.8	13.2	18.2	22.8	15.7	24.5	5.3	10.0	8.3	3.9	12.2	7.8	12.6	14.7	41.7	11.2	9.0	7.1	18.8	17.3	12.9	29.6	11.1	25.6	16.7	10.4	16.1	9.7	16.9	13.7	14.8	22.3	7.8	6.8	6.0	7.0	12.5	6.7	9.6	7.2	6.2	5.4	5.8	7.7	4.5	5.0	6.4	7.2	4.4	13.9	4.6	6.1	5.0	10.9	12.2	10.5	17.8	7.6	5.5	5.2	11.5	6.5	4.8
DCAF7	"HAN11, SWAN-1, WDR68"	ENSG00000136485	"DDB1 and CUL4 associated factor 7"	P61962	17	63550461-63594266	"Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022948, HPA022962"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA022948: AB_1858820, HPA022962: AB_1858821"	"unprognostic (7.75e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.78e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.24e-2)"	"prognostic unfavourable (2.42e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.28e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.79e-2)"	"unprognostic (3.38e-2)"	"prognostic favourable (3.49e-4)"	"unprognostic (2.40e-2)"	"unprognostic (1.97e-1)"	"unprognostic (9.95e-2)"	"unprognostic (4.18e-2)"	17.0	18.4	27.6	25.8	24.8	7.9	15.6	20.8	27.3	21.1	22.9	27.1	22.5	24.9	19.4	19.4	20.5	19.6	20.1	17.1	24.9	22.3	26.7	20.9	23.5	25.5	22.2	16.5	17.1	20.0	39.2	19.0	25.7	19.4	22.4	25.7	21.1	18.0	24.5	11.5	15.8	26.7	18.8	24.4	28.8	19.8	32.5	22.2	47.1	21.9	13.0	30.3	20.7	16.2	10.2	12.1	13.6	17.3	10.0	13.6	8.4	11.1	15.9	27.9	17.8	9.7	8.0	7.4	11.2	9.9	12.4	10.6	11.6	12.1	20.7	9.1	11.1	12.0	23.2	15.7	16.0	7.9	14.8	26.9	10.2	13.6	10.0	29.9	15.7	6.7	10.4	7.2	16.6	19.3	28.3	9.7	15.7	13.7	32.3	14.4	9.0	21.5	25.9	33.2	11.7	18.2	17.0	26.9	49.8	10.1	19.6	13.2	14.5	24.4	20.3	20.6	9.5	10.3	18.4	10.1	13.0	11.1	11.7	19.5	12.2	11.5	12.6	13.6	13.6	15.0	11.0	9.4	9.5	10.5	12.1	10.2	8.7	9.2	5.5	10.0	17.3	9.0	6.6	8.4	27.6	24.8	20.8	27.3	24.9	22.3	22.2	16.5	19.4	22.2
DDA1	"C19orf58, MGC2594, PCIA1"	ENSG00000130311	"DET1 and DDB1 associated 1"	Q9BW61	19	17309518-17323301	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042134, HPA055272"	Approved		Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"		"HPA042134: AB_10794169, HPA055272: "	"unprognostic (1.30e-1)"	"unprognostic (6.35e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.49e-3)"	"unprognostic (5.38e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.15e-3)"	11.6	15.5	24.5	12.7	26.6	16.1	9.9	14.6	36.2	10.8	14.6	13.5	9.6	15.4	11.6	9.9	13.4	13.5	11.8	16.4	18.9	19.8	12.9	17.9	14.6	14.7	19.0	24.4	12.9	13.4	10.9	10.9	26.4	23.0	12.9	13.1	10.8	13.6	15.9	17.8	20.8	16.9	11.5	13.2	13.4	17.4	29.6	12.0	15.9	10.5	10.9	13.7	12.4	9.9	7.1	12.7	11.5	8.0	6.5	8.8	5.7	12.4	11.1	8.4	6.7	8.8	6.3	13.1	8.5	10.8	13.0	12.0	9.8	11.0	4.9	11.8	8.7	10.6	6.2	12.3	6.3	8.1	16.4	6.0	8.8	9.2	10.7	6.8	11.8	9.7	14.2	7.8	7.2	7.5	7.1	8.6	6.8	6.2	13.6	10.1	9.6	19.0	8.7	6.6	8.2	10.2	9.3	8.6	12.9	6.2	14.3	7.4	7.2	9.1	11.3	8.7	7.3	22.4	11.7	10.7	14.4	6.9	19.2	11.7	8.6	5.0	7.3	11.5	8.6	8.0	7.4	7.1	7.2	8.5	5.9	6.6	8.3	8.0	8.2	6.5	6.9	12.7	8.8	5.7	24.5	26.6	14.6	36.2	18.9	19.8	19.0	24.4	23.0	12.0
KCMF1	"DEBT91, DKFZP434L1021, PCMF, ZZZ1"	ENSG00000176407	"Potassium channel modulatory factor 1"	Q9P0J7	2	84971093-85059472	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030383, HPA030384"	Enhanced		Enhanced	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA030383: AB_10599977, HPA030384: AB_10601230"	"unprognostic (8.01e-2)"	"unprognostic (1.98e-2)"	"unprognostic (9.95e-2)"	"unprognostic (7.42e-3)"	"unprognostic (1.24e-2)"	"unprognostic (8.54e-2)"	"prognostic unfavourable (2.33e-7)"	"unprognostic (5.68e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.81e-2)"	"prognostic unfavourable (6.10e-5)"	"unprognostic (4.98e-2)"	"prognostic unfavourable (4.18e-6)"	"unprognostic (6.11e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.42e-1)"	"unprognostic (1.01e-1)"	19.2	13.3	17.9	20.2	16.0	23.6	26.1	13.4	18.6	15.0	20.2	10.7	20.3	15.4	16.3	18.8	28.5	12.8	17.9	30.4	16.5	12.0	14.8	20.7	16.4	18.8	13.7	11.1	17.2	48.6	14.7	18.7	20.5	14.4	17.5	21.4	14.0	19.4	15.7	67.2	17.6	20.6	25.7	10.3	16.7	16.8	29.0	11.5	19.7	18.7	21.8	22.5	23.9	34.0	4.0	4.2	8.1	3.4	2.8	8.8	1.5	27.1	21.4	19.1	14.7	20.2	19.5	32.5	29.1	27.1	28.0	18.7	26.1	29.4	29.6	29.3	39.4	18.1	14.8	28.2	36.9	22.1	10.4	18.9	16.1	26.6	39.5	20.7	18.1	20.1	44.6	27.4	76.0	21.0	18.7	23.6	27.9	25.1	20.0	11.5	20.8	18.0	14.4	26.8	18.5	25.3	23.9	18.4	13.8	16.9	21.6	28.2	10.0	13.2	17.9	28.6	27.9	26.6	30.2	26.9	33.2	30.0	21.5	15.3	21.4	5.0	2.6	8.1	4.5	2.2	3.6	3.5	3.2	3.4	2.2	4.0	2.8	3.1	7.5	2.8	3.4	4.2	8.8	1.5	17.9	16.0	13.4	18.6	16.5	12.0	13.7	11.1	14.4	11.5
MAP3K1	"MAPKKK1, MEKK, MEKK1"	ENSG00000095015	"Mitogen-activated protein kinase kinase kinase 1"	Q13233	5	56815574-56896152	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 27.0;THP-1: 25.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in many"	6	"olfactory region: 22.5"	"Low region specificity"	"Detected in all"			"CAB004500, HPA046509"	Approved		Approved	Cytosol				Cytosol		"CAB004500: AB_627926, HPA046509: "	"unprognostic (1.77e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.09e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.48e-2)"	"unprognostic (5.39e-3)"	"unprognostic (5.20e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.92e-3)"	"unprognostic (1.11e-1)"	6.7	4.9	5.4	14.6	4.8	15.2	14.9	8.0	4.5	7.6	6.7	5.4	7.3	4.3	7.1	9.4	12.7	7.2	5.9	4.3	3.7	3.2	9.5	4.4	8.8	21.4	6.4	3.1	8.4	9.2	6.3	7.9	8.1	4.5	8.3	4.5	12.6	15.4	9.7	3.5	21.8	11.2	4.0	3.8	21.3	5.5	8.5	5.1	11.7	19.2	6.6	18.2	6.0	11.7	6.6	2.8	6.7	7.2	2.7	5.8	2.3	6.4	3.9	6.2	4.1	1.0	0.8	10.4	1.2	1.7	3.9	5.5	18.4	4.9	5.8	0.4	1.5	3.4	5.1	2.3	5.4	2.0	2.2	3.2	1.7	8.6	2.5	5.1	9.0	1.0	2.5	1.2	1.9	1.7	2.8	10.5	1.0	2.8	3.5	6.9	2.8	0.5	5.6	4.4	19.9	6.8	6.8	2.6	27.0	3.8	4.8	11.0	13.2	25.2	4.9	0.3	3.3	1.4	2.3	7.7	3.9	11.1	0.6	3.0	6.6	6.7	4.5	1.0	1.2	6.8	1.2	6.6	3.8	1.8	2.8	5.1	2.5	0.9	2.6	2.7	7.2	1.5	5.8	2.3	5.4	4.8	8.0	4.5	3.7	3.2	6.4	3.1	4.5	5.1
MID2	"FXY2, MRX101, RNF60, TRIM1"	ENSG00000080561	"Midline 2"	Q9UJV3	X	107825755-107927193	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 23.8;Karpas-707: 20.8;MCF7: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 4.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (8.28e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.69e-4)"	"unprognostic (6.40e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.50e-2)"	"unprognostic (3.87e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.19e-2)"	"prognostic unfavourable (3.73e-4)"	"unprognostic (2.07e-1)"	"unprognostic (3.77e-1)"	"unprognostic (5.97e-3)"	12.7	11.3	3.6	4.8	11.4	0.4	13.0	9.3	8.0	10.8	9.0	5.1	9.4	2.0	12.6	9.7	15.1	10.0	8.6	4.4	4.0	5.2	6.6	6.2	9.0	6.2	4.3	5.8	11.5	10.2	16.0	11.1	4.7	7.1	12.9	4.0	12.4	12.7	10.9	16.6	14.5	4.6	17.2	5.4	5.8	7.7	4.7	4.7	0.5	14.5	8.3	6.6	16.7	11.9	0.7	0.0	0.0	0.0	0.0	4.2	1.1	4.7	4.1	0.1	6.6	5.3	7.5	0.1	3.4	8.6	2.9	2.2	0.3	0.8	0.0	4.5	6.5	3.0	2.4	6.9	0.7	0.0	3.2	0.0	2.5	0.0	7.9	0.0	0.0	4.7	7.9	0.1	8.7	23.8	0.0	20.8	3.2	15.1	0.0	0.0	0.7	7.6	0.0	1.9	0.0	3.6	4.3	0.4	0.0	7.2	0.3	10.9	2.7	0.2	4.9	0.0	1.2	5.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	3.3	0.1	1.8	3.5	0.0	0.7	4.2	2.3	0.0	0.0	0.0	0.0	0.3	1.1	3.6	11.4	9.3	8.0	4.0	5.2	4.3	5.8	7.1	4.7
MKNK2	"GPRK7, MNK2"	ENSG00000099875	"MAP kinase interacting serine/threonine kinase 2"	Q9HBH9	19	2037465-2051244	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Translation regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 207.5"	"Cell line enhanced"	"Detected in all"		"HHSteC: 78.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021875, CAB037253, HPA070499"	Supported		Supported	"Nuclear bodies"				"Nuclear bodies"		"CAB037253: AB_1079401, HPA021875: AB_1854050, HPA070499: "	"unprognostic (8.76e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.64e-1)"	"prognostic favourable (4.86e-5)"	"unprognostic (3.08e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.42e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.32e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.07e-2)"	"prognostic favourable (4.01e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.59e-1)"	30.3	15.6	7.6	24.2	8.5	31.9	31.1	16.6	9.7	12.5	22.7	6.5	21.4	13.1	9.3	18.4	42.1	11.0	21.7	33.3	7.5	5.7	10.3	22.0	24.5	16.9	10.3	3.3	13.8	53.1	8.3	13.4	16.7	9.2	18.8	8.4	14.2	35.2	32.5	207.5	19.3	15.1	13.0	7.0	27.8	16.7	9.1	9.1	16.0	32.3	47.1	32.8	21.2	63.6	10.7	5.9	26.9	8.0	6.1	7.5	2.2	13.1	14.8	6.3	13.8	46.9	17.0	14.2	7.8	5.6	5.6	5.7	9.5	23.1	18.6	10.8	15.7	16.3	7.9	22.8	2.5	25.3	7.4	7.5	12.5	10.1	78.8	14.7	13.6	18.1	55.5	10.6	22.6	13.2	12.9	33.3	3.8	7.7	8.8	12.3	16.5	16.2	16.9	1.8	23.5	9.9	8.6	8.7	10.4	18.3	27.1	33.4	11.2	18.3	19.8	2.0	8.0	8.2	9.3	54.3	21.0	18.2	16.5	11.1	3.7	2.7	6.1	5.7	5.6	6.3	5.1	10.7	5.8	6.2	4.8	10.2	3.7	4.5	26.9	6.1	8.0	5.9	7.5	2.2	7.6	8.5	16.6	9.7	7.5	5.7	10.3	3.3	9.2	9.1
OSTM1	"GL, HSPC019"	ENSG00000081087	"Osteopetrosis associated transmembrane protein 1"	Q86WC4	6	108041409-108165854	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			Osteopetrosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010851	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol			130000	Cytosol	"Nucleoplasm, Vesicles"	"HPA010851: AB_1079533"	"prognostic unfavourable (4.36e-4)"	"unprognostic (4.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.72e-3)"	"prognostic unfavourable (4.26e-4)"	"unprognostic (9.40e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavourable (1.34e-6)"	"prognostic unfavourable (1.20e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.77e-1)"	26.3	21.9	9.0	18.1	13.5	5.5	16.7	13.7	17.2	14.4	17.8	12.8	9.9	8.4	21.8	10.3	14.1	15.0	13.5	23.2	10.4	16.5	22.0	15.9	17.0	17.2	11.0	10.5	15.6	9.7	11.8	26.0	24.7	20.0	15.4	12.4	29.7	10.8	19.0	18.0	10.4	12.9	24.7	13.1	21.7	14.3	11.1	10.7	13.6	12.4	8.1	13.9	21.0	19.4	10.8	12.4	20.9	28.1	14.5	16.4	16.9	2.2	6.5	7.8	11.3	23.3	7.6	11.0	16.2	16.3	11.9	19.8	3.9	3.7	5.1	13.4	11.3	4.2	7.6	5.5	18.4	11.7	6.0	10.7	4.2	4.8	18.1	11.8	25.1	11.1	13.8	14.6	11.7	6.0	8.5	18.7	19.2	3.1	2.5	2.7	3.1	5.0	4.2	11.2	2.7	8.5	5.9	0.8	4.6	13.1	3.3	29.0	3.8	17.1	7.3	10.4	3.8	23.0	22.9	7.2	12.3	4.4	30.8	8.0	23.0	16.8	13.9	15.2	15.0	19.9	16.0	10.8	12.8	16.4	12.4	6.2	12.0	15.0	20.9	14.5	28.1	8.9	15.4	16.9	9.0	13.5	13.7	17.2	10.4	16.5	11.0	10.5	20.0	10.7
PLRG1	"Cwc1, PRL1, Prp46, PRPF46, TANGO4"	ENSG00000171566	"Pleiotropic regulator 1"	O43660	4	154535006-154550435	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035931, HPA035932, HPA061486"	Supported		Enhanced	"Nuclear membrane,Nuclear speckles"				"Nuclear speckles"	"Nuclear membrane"	"HPA035931: AB_2674868, HPA035932: AB_10673224, HPA061486: "	"unprognostic (6.51e-2)"	"unprognostic (5.66e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.74e-2)"	"prognostic favourable (8.20e-5)"	"unprognostic (2.92e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.97e-1)"	20.2	18.1	23.3	14.9	30.9	17.5	25.2	29.3	28.6	22.7	19.5	24.7	16.7	15.6	24.4	19.3	24.4	22.8	16.0	16.2	22.9	22.2	26.0	34.9	17.1	20.4	28.9	24.3	23.9	14.2	28.2	21.9	17.8	29.4	18.4	22.7	13.3	19.4	23.3	23.0	16.5	22.1	29.2	32.5	19.1	16.8	13.3	25.9	22.0	24.8	22.3	31.5	18.3	16.5	25.2	25.2	23.2	30.9	34.0	28.8	23.7	23.4	19.2	24.9	26.5	29.4	25.6	21.0	30.2	37.0	41.3	33.8	22.6	20.8	25.6	15.5	35.8	17.3	32.4	40.4	45.9	25.8	16.2	30.7	15.3	21.9	30.2	30.6	25.8	27.5	37.5	48.8	38.4	35.3	31.3	32.9	35.9	16.8	23.5	14.6	18.8	20.9	23.3	12.9	15.5	28.6	15.1	14.5	16.4	18.4	19.9	28.8	19.1	21.5	22.7	24.7	28.0	21.7	26.8	17.2	22.3	32.2	23.2	14.8	32.8	23.2	19.4	15.2	23.7	22.5	28.2	25.2	24.8	25.6	25.2	19.2	26.6	24.8	5.2	34.0	30.9	24.8	28.8	23.7	23.3	30.9	29.3	28.6	22.9	22.2	28.9	24.3	29.4	25.9
RANBP2	"ADANE, ANE1, NUP358"	ENSG00000153201	"RAN binding protein 2"	P49792	2	108719481-108785811	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway"	"RNA-binding, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA018437, HPA023960, CAB034063, HPA049497, HPA051675, HPA067564"	Supported		Enhanced	"Nuclear membrane,Vesicles"				"Nuclear membrane, Vesicles"		"CAB034063: AB_2176784, HPA018437: AB_2620151, HPA023960: , HPA049497: , HPA051675: , HPA067564: "	"unprognostic (2.51e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.30e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.23e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.62e-2)"	"unprognostic (8.74e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.53e-1)"	20.5	24.3	14.4	17.0	18.6	35.5	24.4	23.1	22.2	19.8	17.1	12.8	25.5	13.3	19.9	21.5	17.0	19.1	14.8	20.2	12.9	12.5	18.9	19.5	17.7	19.2	15.1	17.0	32.4	24.1	48.5	37.5	18.8	16.5	21.8	15.8	14.3	20.0	31.6	37.5	17.3	17.4	23.2	17.8	16.3	20.9	20.6	15.9	26.6	28.7	18.0	17.5	20.5	19.7	5.6	5.1	8.3	6.3	4.2	8.7	2.3	18.2	11.2	16.1	14.6	18.8	16.9	15.6	16.5	13.1	13.6	12.0	27.8	8.8	28.8	12.8	17.1	15.4	27.5	17.1	19.9	17.5	13.3	30.0	13.9	19.6	11.0	35.0	10.1	14.1	13.1	21.3	16.6	20.8	32.1	16.0	18.0	10.1	15.5	14.3	20.3	13.4	14.6	24.8	13.9	12.1	22.9	23.5	10.8	14.6	12.6	16.0	8.0	16.1	24.8	14.3	18.9	10.0	18.4	13.3	19.6	26.2	11.1	15.8	11.0	8.3	5.3	5.1	7.6	3.4	8.7	5.5	6.3	6.9	4.2	5.6	6.2	6.7	8.3	4.2	6.3	5.1	5.1	2.3	14.4	18.6	23.1	22.2	12.9	12.5	15.1	17.0	16.5	15.9
RASD2	"MGC:4834, Rhes, TEM2"	ENSG00000100302	"RASD family member 2"	Q96D21	22	35540868-35554001	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.0;seminal vesicle: 25.2"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 4.0;SK-BR-3: 9.2;U-2 OS: 5.3;U-87 MG: 6.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 71.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	8	"basal ganglia: 527.8"	"Region enriched"	"Detected in all"	8	"basal ganglia: 265.8"	HPA005839	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA005839: AB_1079745"	"unprognostic (1.76e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.07e-3)"	"unprognostic (9.76e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.00e-3)"	"prognostic unfavourable (2.22e-5)"	"unprognostic (3.75e-2)"	"unprognostic (1.61e-1)"	"unprognostic (8.42e-3)"	"unprognostic (6.22e-2)"	1.6	7.9	8.6	2.5	71.0	3.4	1.3	1.8	23.5	1.1	8.3	2.2	3.2	2.5	3.5	16.4	5.2	6.2	2.5	2.8	4.1	5.0	0.8	0.5	1.5	0.6	3.4	8.0	0.8	1.0	0.9	1.0	0.4	2.1	9.6	4.4	3.5	4.0	25.2	13.6	0.8	3.4	7.5	2.2	0.4	1.8	0.6	15.3	0.0	1.4	0.1	1.4	3.8	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	3.5	0.0	0.6	0.0	0.0	0.1	0.9	0.3	1.4	1.1	0.2	0.7	0.0	0.2	3.0	0.2	0.2	0.0	1.3	0.0	0.9	0.0	0.2	0.0	1.7	0.0	0.1	0.2	4.0	2.7	0.4	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.2	0.4	1.5	0.0	1.1	0.0	0.0	2.4	0.4	2.6	9.2	0.0	0.7	0.3	0.1	2.2	5.3	0.2	1.0	2.3	0.7	0.0	6.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	8.6	71.0	1.8	23.5	4.1	5.0	3.4	8.0	2.1	15.3
RFWD3	"FANCW, FLJ10520, RNF201"	ENSG00000168411	"Ring finger and WD repeat domain 3"	Q6PCD5	16	74621394-74666881	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048258, HPA075649"	Approved		Enhanced	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA048258: , HPA075649: "	"unprognostic (4.79e-2)"	"unprognostic (6.45e-3)"	"unprognostic (6.35e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.03e-3)"	"unprognostic (2.53e-3)"	"unprognostic (1.73e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.31e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.29e-1)"	7.3	5.2	4.2	12.2	6.1	33.9	7.8	7.8	5.6	7.4	6.7	8.4	8.4	5.5	9.7	10.0	12.8	6.3	5.5	5.4	3.9	3.7	6.5	5.6	6.5	12.0	6.1	4.8	7.7	9.6	8.5	7.5	11.5	5.3	6.5	8.1	7.2	8.0	8.4	4.5	11.6	7.8	5.6	4.8	9.7	6.2	35.1	7.2	40.5	7.0	7.5	18.0	7.2	8.6	9.3	7.1	13.8	10.9	9.1	11.7	6.5	13.9	17.9	13.5	9.8	2.8	3.9	15.3	12.6	9.7	20.2	17.6	23.3	14.7	19.5	10.3	9.8	16.8	22.1	13.1	24.8	6.1	13.2	17.2	14.6	13.1	2.5	17.3	18.0	2.8	4.2	25.4	15.7	8.5	26.0	8.8	15.1	22.2	25.2	15.9	26.6	8.7	39.3	9.2	17.2	7.2	14.8	10.1	10.7	20.3	7.2	9.0	13.2	14.8	8.3	14.8	14.2	8.3	15.8	11.9	22.1	58.4	10.6	13.4	17.9	13.8	6.8	9.9	9.3	6.3	10.2	7.8	7.7	8.6	7.1	9.3	11.7	8.1	7.7	9.1	10.9	5.5	10.9	6.5	4.2	6.1	7.8	5.6	3.9	3.7	6.1	4.8	5.3	7.2
RHOBTB2	"DBC2, KIAA0717"	ENSG00000008853	"Rho related BTB domain containing 2"	Q9BYZ6	8	22987417-23020199	"Predicted intracellular proteins"			"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 31.1;hTCEpi: 27.7;RT4: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060938	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA060938: "	"unprognostic (2.67e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.94e-2)"	"unprognostic (7.83e-3)"	"unprognostic (2.13e-2)"	"unprognostic (8.13e-2)"	"unprognostic (8.17e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.93e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.46e-2)"	"prognostic favourable (2.98e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.89e-3)"	"unprognostic (2.43e-1)"	5.9	7.4	14.8	6.4	33.2	2.0	5.3	5.1	36.9	4.4	8.1	7.2	24.4	7.7	6.3	5.2	4.6	6.6	6.0	17.6	14.0	9.1	6.0	1.9	31.0	12.2	9.8	14.4	15.9	7.2	5.8	9.0	10.0	8.0	5.7	2.5	11.2	5.6	22.6	10.9	3.5	19.7	6.1	4.0	10.4	6.9	7.0	6.5	5.5	14.9	2.8	14.5	13.7	3.4	7.8	2.9	4.5	1.6	4.4	2.8	1.1	2.4	4.8	3.9	6.2	4.8	3.3	5.3	3.4	4.5	5.3	4.1	12.4	2.4	31.1	5.2	4.9	4.9	1.9	19.0	2.6	2.6	1.1	3.3	6.6	3.5	2.3	1.9	7.0	4.3	27.7	5.6	2.8	3.8	0.8	3.0	3.5	7.1	1.2	3.1	4.1	3.4	1.6	6.3	2.1	3.8	46.6	2.5	4.7	2.6	7.9	5.2	1.5	5.1	4.7	6.7	4.9	12.0	3.8	7.8	7.5	11.2	6.5	2.9	5.2	4.5	1.0	1.3	2.8	1.6	1.9	7.8	0.8	1.3	1.0	7.1	1.1	1.1	0.2	4.4	1.6	2.9	1.4	1.1	14.8	33.2	5.1	36.9	14.0	9.1	9.8	14.4	8.0	6.5
RNF130	"G1RZFP, GOLIATH, GP"	ENSG00000113269	"Ring finger protein 130"	Q86XS8	5	179911651-180072118	"Enzymes, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 41.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"basophil: 17.0;classical monocyte: 38.1;eosinophil: 24.6;intermediate monocyte: 27.5;myeloid DC: 31.1;neutrophil: 68.1;non-classical monocyte: 23.8;plasmacytoid DC: 22.9"	"Group enriched"	"Detected in all"	11	"dendritic cells: 31.1;granulocytes: 68.1;monocytes: 38.1"	"Low region specificity"	"Detected in all"							HPA014499	Approved									"HPA014499: AB_1856328"	"unprognostic (2.01e-1)"	"prognostic favourable (6.32e-4)"	"unprognostic (2.43e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.02e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.41e-2)"	"unprognostic (4.17e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.38e-2)"	36.3	16.3	23.5	16.3	32.5	29.5	24.0	19.0	25.3	26.0	16.7	56.0	19.0	10.6	18.5	12.0	10.6	19.5	21.9	17.0	27.8	21.1	20.7	64.4	25.5	19.1	50.2	20.3	21.7	28.6	11.0	16.7	19.8	30.3	16.3	16.1	15.8	30.6	28.3	17.3	7.9	12.1	22.2	58.2	20.4	20.5	7.3	38.8	2.5	14.3	6.3	10.3	20.7	13.3	1.2	31.1	68.1	38.1	4.0	2.0	20.3	7.9	5.8	28.6	20.9	27.9	15.2	5.4	6.2	7.8	6.8	7.4	1.8	6.8	0.0	19.2	10.8	0.8	19.9	12.6	7.5	0.1	17.7	15.6	3.2	4.0	7.1	3.8	41.0	14.3	6.7	0.5	3.9	11.1	3.2	0.1	6.8	12.0	7.1	12.1	7.8	8.9	16.0	6.6	0.0	8.6	1.4	17.4	7.8	11.6	6.3	24.0	9.1	9.0	8.6	11.6	4.6	8.1	6.6	0.0	6.1	1.6	1.4	30.1	9.0	17.0	38.1	24.6	2.0	27.5	1.9	1.2	0.9	1.0	31.1	1.2	1.0	1.2	68.1	4.0	23.8	22.9	0.1	20.3	23.5	32.5	19.0	25.3	27.8	21.1	50.2	20.3	30.3	38.8
RNF133		ENSG00000188050	"Ring finger protein 133"	Q8WVZ7	7	122697712-122699156	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	59	"testis: 28.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.0;MCF7: 1.5;NTERA-2: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																		"unprognostic (2.82e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.04e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.67e-1)"	"unprognostic (8.87e-3)"	"unprognostic (3.56e-2)"	"unprognostic (3.72e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.02e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.61e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.6	0.2	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.9	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	4.0	0.0	1.5	0.0	0.0	1.2	1.1	0.0	0.0	0.8	0.0	0.4	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.1	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RNF135	MGC13061	ENSG00000181481	"Ring finger protein 135"	Q8IUD6	17	30968785-30999911	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 30.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021576, HPA052404"	Approved		Approved	Vesicles				Vesicles		"HPA021576: AB_1856331, HPA052404: "	"unprognostic (1.13e-1)"	"unprognostic (1.87e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.60e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (7.51e-5)"	"unprognostic (6.44e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.47e-1)"	18.2	11.6	6.5	15.9	7.1	7.1	28.8	6.4	6.1	16.3	22.2	7.2	16.5	9.7	15.7	16.8	18.4	11.8	14.4	7.4	7.1	4.8	19.5	6.0	19.0	28.0	6.8	2.5	15.1	11.7	15.0	5.9	19.2	6.3	18.1	13.2	13.6	13.3	14.8	7.5	21.4	16.7	13.9	6.1	22.7	10.0	8.8	4.8	6.0	25.0	12.7	18.8	13.0	19.1	11.8	18.4	21.7	25.1	5.4	5.3	9.7	5.8	12.2	0.7	12.1	16.7	13.3	10.3	4.7	7.0	4.6	4.0	0.0	4.4	4.7	6.9	8.9	7.5	6.0	5.7	3.6	4.5	2.6	2.2	3.6	0.0	11.7	5.9	5.1	13.2	30.2	4.8	15.6	7.2	0.0	16.2	7.3	7.8	0.0	6.0	4.9	6.6	12.4	0.0	17.3	6.3	8.4	4.5	0.2	6.7	2.8	6.7	18.5	9.2	6.3	0.0	1.6	7.4	5.3	0.2	0.5	3.4	8.1	10.2	6.2	9.1	24.0	12.1	5.3	21.8	2.9	11.8	2.8	2.7	18.4	11.2	1.5	2.7	21.7	5.4	25.1	6.6	3.8	9.7	6.5	7.1	6.4	6.1	7.1	4.8	6.8	2.5	6.3	4.8
RNF157	KIAA1917	ENSG00000141576	"Ring finger protein 157"	Q96PX1	17	76142453-76240373	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.5;skeletal muscle: 52.2;testis: 24.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 41.3;U-266/70: 21.9;U-266/84: 17.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 2.5;T-cells: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021854, HPA021991, HPA023922"	Uncertain		Approved	"Golgi apparatus,Vesicles"				"Golgi apparatus"	Vesicles	"HPA021854: AB_10600307, HPA021991: AB_10601112, HPA023922: AB_10602202"	"unprognostic (4.21e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.63e-3)"	"unprognostic (4.93e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.07e-3)"	"unprognostic (4.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.04e-3)"	"unprognostic (4.02e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.69e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.38e-1)"	10.5	3.5	21.0	3.4	19.4	2.3	2.5	10.7	36.5	1.5	7.6	8.0	0.4	8.2	1.9	3.6	1.5	2.4	1.8	3.6	26.4	15.5	5.1	1.4	1.4	4.5	19.7	12.0	1.4	3.6	8.8	2.7	2.1	25.3	1.8	6.6	6.8	1.9	2.0	52.2	1.5	7.3	2.2	11.3	3.0	2.4	24.7	5.9	0.0	3.8	1.5	2.8	1.5	0.5	0.7	0.4	2.5	0.3	1.1	8.5	1.4	0.1	3.4	12.4	4.5	4.0	2.0	5.7	0.1	3.9	0.8	0.4	1.4	1.3	0.0	1.8	0.3	0.1	10.9	0.0	0.7	41.3	3.7	0.0	1.2	1.9	0.6	0.5	4.7	1.1	0.0	1.5	0.0	0.1	6.4	0.1	1.5	3.3	1.8	0.3	2.0	8.8	0.0	0.1	0.0	1.5	1.3	2.2	10.2	2.2	0.0	4.9	0.3	2.1	0.0	0.8	1.0	6.1	3.9	21.9	17.6	0.0	0.3	0.0	6.3	2.5	0.3	0.4	2.3	0.2	4.9	0.3	5.1	4.0	0.2	0.7	8.5	5.5	1.7	1.1	0.3	0.4	2.1	1.4	21.0	19.4	10.7	36.5	26.4	15.5	19.7	12.0	25.3	5.9
RNF169	KIAA1991	ENSG00000166439	"Ring finger protein 169"	Q8NCN4	11	74748868-74842413	"Enzymes, Predicted intracellular proteins"	"DNA damage, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038505, HPA046138, HPA058368"	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"				"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA038505: , HPA046138: , HPA058368: "	"unprognostic (1.71e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-1)"	"unprognostic (6.47e-2)"	"prognostic unfavourable (8.04e-4)"	"unprognostic (2.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.34e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.21e-1)"	12.3	7.0	12.0	11.6	14.0	23.1	12.0	22.6	15.6	13.1	11.2	12.2	6.3	7.4	14.2	8.2	20.6	10.7	10.8	9.2	12.6	5.9	8.9	9.3	16.9	11.3	15.4	9.1	14.6	10.7	17.5	10.4	8.6	13.9	10.5	10.0	8.4	12.4	8.8	15.0	14.1	10.3	14.2	10.1	12.6	10.3	7.2	14.9	12.6	11.5	7.4	12.5	13.1	15.8	0.6	0.8	5.0	1.9	1.2	1.6	0.6	8.1	6.3	7.6	7.5	5.0	6.6	3.1	6.4	6.1	7.2	6.3	10.5	6.2	14.6	6.6	7.7	7.9	10.3	7.7	9.5	7.3	6.6	10.1	11.6	4.1	5.7	5.3	8.5	6.1	6.1	8.2	18.7	11.6	8.9	11.8	7.2	6.9	9.1	9.6	3.0	4.1	8.6	18.2	8.0	4.6	8.6	3.4	6.2	8.7	6.6	13.9	8.2	6.9	7.7	12.0	10.1	7.5	5.7	8.6	4.5	17.4	2.4	5.9	6.9	2.8	1.9	1.5	1.6	1.1	1.2	0.3	1.5	0.9	0.8	0.6	1.1	0.9	5.0	1.2	1.0	0.8	1.2	0.6	12.0	14.0	22.6	15.6	12.6	5.9	15.4	9.1	13.9	14.9
RNF182	MGC33993	ENSG00000180537	"Ring finger protein 182"	Q8N6D2	6	13924446-13980302	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"bone marrow: 12.9;brain: 17.6"	"Cell line enhanced"	"Detected in many"		"HeLa: 36.3;RPTEC TERT1: 29.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012309	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA012309: AB_1856349"	"unprognostic (1.29e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavourable (4.66e-5)"	"unprognostic (6.16e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.01e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.21e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.33e-5)"	"unprognostic (6.66e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.26e-1)"	1.2	0.7	7.6	0.6	6.2	12.9	1.2	16.6	17.6	1.2	0.7	7.5	2.0	0.8	1.6	2.5	1.0	2.7	0.9	1.0	11.0	7.3	2.6	0.5	5.7	0.8	6.8	8.5	1.1	3.6	0.5	2.0	2.9	14.3	0.9	0.6	2.2	1.9	4.7	0.9	0.8	1.1	1.0	5.1	0.5	0.6	7.0	2.9	0.0	3.0	0.0	0.4	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.7	5.2	0.0	1.8	2.2	0.3	2.6	3.6	7.4	7.1	0.1	0.0	0.0	0.0	2.8	0.0	6.1	0.0	13.5	0.0	2.0	0.1	36.3	0.0	0.0	0.0	0.0	1.2	0.0	11.3	0.1	0.1	0.2	0.0	5.1	0.0	0.0	0.9	2.9	10.1	1.5	1.2	0.4	29.1	0.0	6.3	6.0	0.2	0.0	10.2	0.0	1.0	2.7	9.0	1.9	0.1	6.0	0.0	0.0	0.0	6.1	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	6.2	16.6	12.1	11.0	7.3	6.8	8.5	14.3	2.9
RNF187	"RACO-1, RACO1"	ENSG00000168159	"Ring finger protein 187"	Q5TA31	1	228487061-228495766	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 75.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 8.7"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA030098	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA030098: AB_10602923"	"unprognostic (4.84e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (2.83e-4)"	"unprognostic (4.90e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.93e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.36e-1)"	"unprognostic (5.66e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.59e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.32e-2)"	15.7	30.3	25.6	12.5	28.1	12.3	10.3	33.2	54.7	11.4	10.7	15.5	12.5	14.7	12.9	12.2	18.0	14.2	14.5	17.7	25.2	24.9	16.2	20.4	11.5	9.8	20.2	29.3	20.2	19.4	22.3	16.4	8.8	22.7	15.0	6.6	12.3	30.3	12.6	55.5	15.5	13.2	8.6	16.3	19.0	14.2	9.5	11.4	11.1	27.9	19.4	11.2	10.0	13.1	2.0	1.7	8.7	2.1	1.0	2.3	0.6	9.3	7.0	4.9	10.3	5.4	3.5	9.5	7.8	4.8	4.9	3.7	3.6	6.5	21.2	16.3	8.9	7.4	6.2	6.6	1.8	9.6	8.0	6.4	5.2	4.6	14.7	7.3	12.6	6.1	11.8	3.8	5.1	4.3	10.2	41.5	3.5	5.2	11.6	6.5	11.0	7.2	9.9	4.5	20.0	3.5	5.9	10.9	11.0	7.9	16.5	21.0	11.6	17.5	9.9	6.1	6.3	6.6	7.4	75.5	22.6	11.6	16.4	7.7	10.2	0.0	1.1	8.7	1.3	2.1	1.5	1.2	1.5	2.3	1.4	2.0	1.4	1.2	0.3	1.0	1.4	1.7	1.3	0.6	25.6	28.1	33.2	47.3	25.2	24.9	20.2	29.3	22.7	11.4
RNF213	"C17orf27, KIAA1554, KIAA1618, MYMY2, NET57"	ENSG00000173821	"Ring finger protein 213"	Q63HN8	17	80260866-80398786	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Angiogenesis, Ubl conjugation pathway"	"Hydrolase, Transferase"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 36.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003347, HPA026790"	Approved		Supported	Cytosol				Cytosol		"HPA003347: AB_1079204, HPA026790: AB_10602296"	"unprognostic (8.98e-2)"	"unprognostic (1.60e-1)"	"unprognostic (8.97e-3)"	"prognostic unfavourable (4.65e-5)"	"unprognostic (7.39e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.52e-3)"	"unprognostic (8.92e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.56e-2)"	17.0	15.1	7.4	16.9	10.3	22.4	10.2	4.7	7.5	11.0	12.2	15.6	14.9	8.5	16.6	13.0	13.2	9.7	12.1	8.5	7.8	7.8	17.1	11.6	15.4	17.9	10.9	5.6	11.5	9.0	41.1	11.4	15.1	10.0	11.2	8.0	12.3	11.7	12.5	9.0	8.7	14.8	13.6	14.3	17.0	10.6	5.9	8.7	24.5	15.9	7.5	18.2	13.6	15.4	7.2	13.9	37.9	9.6	11.4	12.1	1.8	16.1	28.7	2.9	2.0	10.5	16.1	2.2	4.1	8.9	18.5	15.8	3.0	7.5	1.0	3.5	8.5	9.4	3.9	5.3	6.3	36.5	1.7	2.5	11.6	5.3	4.5	2.6	2.6	8.8	3.6	10.4	4.5	14.2	4.6	6.0	6.9	3.9	10.5	1.1	2.1	6.6	7.2	6.7	1.2	5.1	14.0	2.8	3.9	9.9	21.1	7.5	4.8	3.3	18.3	10.3	8.2	6.0	4.2	2.6	2.4	2.9	7.7	3.1	3.7	6.9	9.6	4.2	12.1	8.0	8.1	6.2	8.6	9.7	2.3	7.2	6.9	8.5	37.9	11.4	6.9	13.9	6.4	1.8	7.4	10.3	4.7	7.5	7.8	7.8	10.9	5.6	10.0	8.7
RNFT1	PTD016	ENSG00000189050	"Ring finger protein, transmembrane 1"	Q5M7Z0	17	59952240-59964761	"Enzymes, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 45.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA013739			Approved	Nucleoli				Nucleoli		"HPA013739: AB_1856382"	"unprognostic (1.61e-1)"	"unprognostic (2.83e-1)"	"prognostic favourable (6.57e-4)"	"unprognostic (3.04e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.08e-2)"	"prognostic favourable (7.48e-4)"	"unprognostic (5.42e-2)"	"unprognostic (3.45e-1)"	"unprognostic (8.26e-3)"	"unprognostic (9.44e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.05e-1)"	"prognostic favourable (2.57e-4)"	"unprognostic (2.60e-1)"	7.9	6.2	2.8	5.3	4.3	3.8	4.2	5.1	3.7	3.1	4.0	2.4	3.7	5.3	2.7	8.1	4.6	3.2	3.1	4.1	3.1	2.2	4.7	12.0	5.0	4.4	2.9	3.1	3.5	7.5	4.7	6.1	4.4	3.4	4.5	4.8	4.2	5.1	3.0	6.7	2.7	7.6	3.0	3.4	4.1	3.9	45.5	3.0	5.9	6.1	4.3	6.0	5.1	3.7	9.5	10.1	20.2	17.1	8.9	7.7	7.9	4.8	2.2	2.3	3.1	7.6	5.7	4.5	6.2	3.3	4.8	6.0	6.9	1.9	7.2	10.4	5.1	5.6	7.2	4.7	8.4	6.8	7.8	6.0	5.8	6.2	5.6	9.3	9.3	6.3	2.5	4.5	2.0	4.9	17.3	4.4	4.1	6.2	3.8	4.5	0.9	5.1	5.2	17.4	4.1	3.9	3.4	1.4	2.7	8.9	2.1	12.3	10.2	17.8	3.5	9.4	8.4	5.5	5.2	6.5	18.0	4.2	6.5	5.2	4.7	17.3	11.8	20.2	5.6	13.9	7.7	9.5	5.2	6.3	10.1	6.1	6.8	6.1	5.7	8.9	17.1	6.7	6.5	7.9	2.8	4.3	5.1	3.7	3.1	2.2	2.9	3.1	3.4	3.0
SH3RF2	"FLJ23654, Hepp1, POSHER, PPP1R39, RNF158"	ENSG00000156463	"SH3 domain containing ring finger 2"	Q8TEC5	5	145936579-146081791	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Protein phosphatase inhibitor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 40.8"	"Cell line enhanced"	"Detected in some"		"A-431: 10.5;CACO-2: 35.8;HBEC3-KT: 11.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"basal ganglia: 11.5;cerebral cortex: 2.9"	"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"dendritic cells: 1.4;T-cells: 1.6"	"Region enriched"	"Detected in single"	14	"basal ganglia: 23.9"	"Region enhanced"	"Detected in many"		"basal ganglia: 14.5"	"HPA035903, HPA058119"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm		"HPA035903: AB_10696515, HPA058119: "	"unprognostic (8.90e-3)"	"unprognostic (2.00e-3)"	"unprognostic (5.11e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.47e-2)"	"unprognostic (9.96e-3)"	"unprognostic (8.22e-2)"	"unprognostic (3.92e-1)"	"unprognostic (7.37e-3)"	"unprognostic (2.44e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.13e-3)"	2.6	0.6	1.2	6.2	11.5	0.0	2.9	0.2	2.9	6.4	19.1	0.4	0.4	9.2	2.9	2.2	22.2	3.6	40.8	23.5	0.8	0.3	0.8	4.6	1.9	0.0	0.3	1.1	1.0	14.3	0.0	3.3	0.3	0.1	2.2	8.5	0.9	16.9	1.0	21.7	33.1	21.4	1.2	0.5	0.2	11.9	6.4	0.6	0.6	3.8	19.6	16.1	0.9	10.0	0.0	1.4	0.3	0.1	0.0	1.6	0.3	10.5	2.9	0.1	0.6	0.0	0.0	0.0	0.1	0.8	2.2	0.9	35.8	9.9	0.0	5.6	0.4	9.8	0.0	11.5	2.1	0.1	0.1	0.0	4.2	4.8	0.6	0.0	0.0	0.1	6.2	3.3	7.9	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.8	0.8	0.0	0.1	0.0	4.6	1.0	0.0	0.0	0.6	0.2	0.2	3.4	0.0	5.0	0.4	9.2	0.8	3.4	0.0	0.0	0.0	5.6	0.0	0.1	0.3	0.0	0.0	1.2	0.0	0.0	0.0	1.6	0.7	1.4	0.0	0.0	1.5	0.2	0.0	0.1	0.0	0.8	0.3	1.2	11.5	0.2	2.9	0.8	0.3	0.3	1.1	0.1	0.6
TRIM16	EBBP	ENSG00000221926	"Tripartite motif containing 16"	O95361	17	15627960-15684311	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 52.9"	"Cell line enhanced"	"Detected in many"		"A549: 64.1;HaCaT: 51.8;HeLa: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"T-reg: 25.1"	"Lineage enriched"	"Detected in many"	11	"T-cells: 25.1"									"HPA023623, HPA066431"	Uncertain		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA023623: AB_1858273, HPA066431: "	"unprognostic (2.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.31e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavourable (3.94e-4)"	"unprognostic (1.94e-3)"	"unprognostic (3.75e-2)"	"unprognostic (4.65e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.08e-1)"	"unprognostic (8.48e-2)"	"unprognostic (9.21e-3)"	"prognostic unfavourable (6.71e-4)"	6.1	13.5	7.4	4.8	12.8	7.0	6.7	7.4	11.7	16.0	5.0	7.8	6.6	10.2	7.0	2.8	52.9	4.0	7.5	6.5	8.0	4.4	5.7	2.2	6.2	10.9	11.3	5.6	3.7	6.2	1.9	5.7	15.8	9.8	4.1	5.2	5.0	14.7	5.7	11.4	15.6	5.5	5.4	5.9	4.6	14.4	5.5	7.8	4.7	7.4	5.3	16.3	11.7	23.3	0.4	1.5	0.6	2.3	0.5	25.1	1.3	20.1	64.1	2.0	4.4	9.5	11.0	2.1	3.3	11.8	4.1	5.8	3.8	26.3	2.1	12.7	14.5	51.8	5.8	14.9	2.8	26.6	3.7	1.0	46.7	2.0	15.9	1.1	2.2	6.0	9.4	9.0	5.2	8.8	1.2	10.5	11.2	7.1	4.4	2.6	3.0	3.9	1.9	16.6	1.5	21.3	26.1	1.4	4.1	14.6	16.6	5.0	2.5	2.8	13.7	5.2	6.2	2.5	11.4	2.5	2.7	0.2	8.1	2.8	13.2	0.1	2.3	0.6	0.8	0.6	0.5	0.3	3.0	0.9	1.5	0.4	0.8	1.6	0.5	0.5	0.3	0.3	25.1	1.3	7.4	12.8	7.4	11.7	8.0	4.4	11.3	5.6	9.8	7.8
TRIM17	"RBCC, RNF16, terf"	ENSG00000162931	"Tripartite motif containing 17"	Q9Y577	1	228407940-228416861	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.8;testis: 18.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.6;HEL: 3.5;NTERA-2: 3.2;SH-SY5Y: 4.0;T-47d: 9.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA054908	Uncertain		Approved	Vesicles				Vesicles		"HPA054908: "	"prognostic favourable (1.86e-4)"	"unprognostic (2.12e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.74e-3)"	"unprognostic (7.42e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.96e-4)"	"unprognostic (3.88e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.33e-2)"	"unprognostic (3.64e-1)"	1.3	0.8	14.4	1.5	19.1	1.1	1.9	25.8	11.8	1.5	0.9	0.6	1.7	1.4	3.6	1.7	1.3	3.9	1.7	1.5	8.9	3.4	1.2	0.6	1.7	2.0	0.7	9.2	2.2	1.1	0.8	1.0	1.3	2.7	2.0	0.8	1.9	5.9	3.8	0.8	3.5	1.6	1.1	0.9	5.3	1.4	18.3	4.7	0.0	2.9	0.1	1.2	2.5	1.3	1.7	0.6	0.7	0.3	0.0	1.0	0.1	0.3	0.6	0.4	0.4	0.0	0.0	7.6	0.5	0.0	0.0	0.1	1.7	0.9	0.1	1.9	0.0	1.7	0.0	0.0	0.1	0.3	0.7	3.5	1.0	0.2	1.6	0.1	0.3	0.2	0.2	0.1	0.0	0.0	0.2	0.5	0.1	0.1	0.3	0.0	3.2	0.2	0.1	0.1	0.0	0.0	0.8	0.5	4.0	0.0	0.4	0.0	9.4	0.2	0.0	0.3	1.7	0.3	0.1	0.1	0.0	0.2	0.2	0.1	0.3	0.0	0.3	0.7	0.9	0.1	1.0	0.6	0.2	1.0	0.0	1.7	1.0	0.8	0.2	0.0	0.2	0.6	0.0	0.1	14.4	19.1	25.8	11.8	8.9	3.4	0.7	9.2	2.7	4.7
TRIM22	"GPSTAF50, RNF94, STAF50"	ENSG00000132274	"Tripartite motif containing 22"	Q8IYM9	11	5689689-5737089	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 37.3;BJ hTERT+ SV40 Large T+ RasG12V: 47.9;HSkMC: 42.0;TIME: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA003307, HPA003575"	Approved		Supported	"Nucleoplasm,Nuclear bodies"				"Nucleoplasm, Nuclear bodies"		"HPA003307: AB_1080381, HPA003575: AB_1080378"	"unprognostic (1.47e-2)"	"unprognostic (5.27e-3)"	"unprognostic (4.00e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.16e-2)"	34.3	6.9	8.8	32.8	13.3	22.2	17.3	3.2	10.3	14.4	12.2	10.6	15.1	6.5	20.0	18.9	17.6	17.2	20.2	12.4	10.3	6.6	13.9	19.3	29.8	62.2	15.5	6.5	21.9	5.6	2.1	8.1	9.4	13.3	20.4	13.7	15.0	17.2	14.6	7.1	7.8	28.7	13.5	22.9	65.4	11.2	6.3	12.0	35.6	15.5	13.4	40.6	19.8	13.5	49.0	55.2	33.0	50.3	18.0	58.1	47.3	0.8	0.2	3.4	0.6	18.5	37.3	1.0	10.9	19.1	20.8	47.9	0.3	2.2	23.0	3.3	15.4	2.3	7.6	11.4	2.0	0.5	0.0	1.3	1.2	0.4	24.3	3.5	2.2	42.0	10.8	4.1	1.9	25.6	0.5	1.2	22.6	0.4	12.0	3.6	9.8	1.2	14.9	0.8	0.5	10.9	3.5	0.4	0.8	1.0	1.0	0.4	1.2	3.9	33.4	12.9	7.0	0.6	0.6	1.3	1.1	2.5	16.2	6.4	1.7	27.4	35.7	23.8	35.8	43.5	47.0	46.5	39.0	37.8	42.8	49.0	35.2	33.7	33.0	18.0	50.3	55.2	58.1	47.3	8.8	13.3	3.2	10.3	10.3	6.6	15.5	6.5	13.3	12.0
TRIM23	"ARD1, ARFD1, RNF46"	ENSG00000113595	"Tripartite motif containing 23"	P36406	5	65589680-65625975	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039605	Approved									"HPA039605: AB_10673146"	"unprognostic (4.06e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.63e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.00e-3)"	"unprognostic (6.51e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.70e-1)"	8.6	12.7	15.0	6.6	17.9	7.6	9.4	25.8	34.3	11.5	7.8	9.5	7.3	4.5	10.6	7.0	9.0	8.6	6.3	12.3	16.3	15.2	10.2	11.8	6.6	7.7	14.4	18.8	16.2	6.5	11.1	11.6	7.9	22.1	12.9	5.3	4.1	5.7	9.4	14.8	6.6	5.2	9.3	14.2	8.2	5.6	10.9	14.0	7.5	12.4	4.4	7.6	7.5	7.6	6.0	3.8	14.5	4.5	5.6	9.9	4.5	6.3	8.7	9.3	14.0	14.5	14.6	7.0	12.1	11.6	10.4	12.8	8.0	6.1	4.9	14.6	8.5	5.1	9.1	7.1	16.1	5.1	9.6	3.9	11.9	5.0	13.5	2.4	5.5	11.4	6.0	11.6	10.5	5.0	4.5	7.0	12.2	5.9	5.0	2.7	5.1	3.6	4.7	16.9	7.0	5.4	6.5	5.5	7.7	11.6	3.5	9.6	7.6	3.3	8.5	8.1	8.7	10.1	8.9	8.7	8.0	6.0	9.5	4.7	8.1	14.5	4.0	9.5	5.6	3.0	6.9	4.7	6.1	4.9	3.6	6.0	9.9	7.5	10.1	5.6	4.5	3.8	6.9	4.5	15.0	17.9	25.8	31.1	16.3	15.2	14.4	18.8	22.1	14.0
TRIM33	"FLJ11429, KIAA1113, PTC7, RFG7, TF1G, TIF1G, TIF1GAMMA, TIFGAMMA"	ENSG00000197323	"Tripartite motif containing 33"	Q9UPN9	1	114392777-114511160	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 48.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004345	Supported		Approved	Nucleoplasm,Vesicles				Vesicles	Nucleoplasm	"HPA004345: AB_1858287"	"unprognostic (8.90e-2)"	"unprognostic (5.86e-2)"	"prognostic favourable (6.20e-4)"	"unprognostic (1.09e-2)"	"unprognostic (8.42e-3)"	"prognostic favourable (8.93e-4)"	"unprognostic (1.34e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.75e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.27e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-1)"	15.2	12.8	16.9	18.4	19.9	27.1	17.1	38.3	21.8	16.9	14.3	11.0	21.9	10.9	19.8	38.3	16.4	15.0	15.6	10.8	18.1	12.5	17.3	15.0	14.3	15.2	12.1	18.0	19.8	15.7	21.8	22.4	27.2	15.2	16.5	13.0	10.7	16.4	19.1	14.3	19.5	14.8	20.2	12.9	14.9	14.1	29.0	16.3	20.5	17.9	9.8	16.6	17.9	28.7	3.4	4.0	12.2	2.8	4.7	4.4	1.0	12.9	7.0	13.2	9.9	5.6	5.9	22.5	6.6	7.0	9.2	9.8	7.9	5.5	13.8	6.8	7.7	7.5	12.0	7.7	12.7	10.4	7.1	13.3	9.2	9.1	6.2	16.8	11.1	5.6	5.7	10.9	11.2	7.7	16.6	9.8	8.8	48.5	16.9	7.1	17.8	7.1	14.6	20.2	4.5	6.6	20.4	9.2	9.7	12.5	15.1	11.9	6.9	9.2	8.6	6.4	10.5	14.8	9.2	6.9	6.4	14.5	9.1	9.8	18.2	12.2	1.6	7.4	3.5	1.8	3.1	3.4	3.7	3.7	2.0	2.2	2.9	4.4	4.8	4.7	2.8	4.0	2.0	1.0	16.9	19.9	38.3	21.8	18.1	12.5	12.1	18.0	15.2	16.3
TRIM36	"HAPRIN, RBCC728, RNF98"	ENSG00000152503	"Tripartite motif containing 36"	Q9NQ86	5	115124762-115180546	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 88.8"	"Cell line enhanced"	"Detected in many"		"RH-30: 17.8;SCLC-21H: 19.9;SH-SY5Y: 14.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 9.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 7.5;non-classical monocyte: 7.7"	"Group enriched"	"Detected in many"	43	"dendritic cells: 7.5;granulocytes: 4.2;monocytes: 7.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA061321			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA061321: "	"unprognostic (6.36e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.33e-6)"	"unprognostic (2.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.82e-13)"	"unprognostic (4.95e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.80e-3)"	1.0	1.4	6.8	1.4	7.6	0.8	3.2	0.6	11.7	1.4	4.8	7.7	0.0	8.2	1.1	1.0	0.8	1.9	1.0	0.7	10.1	7.2	0.9	0.9	1.6	0.8	7.1	8.6	3.5	1.5	0.7	8.2	1.3	18.3	5.7	4.8	5.1	1.0	1.0	0.7	1.0	7.9	1.1	8.7	0.9	2.0	88.8	4.7	0.0	0.8	0.0	0.9	0.8	1.0	0.1	7.5	4.2	7.7	0.0	0.0	0.8	2.4	0.7	1.2	6.2	0.1	0.1	1.5	0.5	2.1	1.1	1.3	0.9	1.2	0.0	1.0	0.1	0.6	5.8	1.1	0.8	0.4	1.9	4.3	2.5	1.2	0.2	4.2	3.6	0.1	1.1	0.5	1.5	0.0	0.1	5.9	1.7	3.3	1.1	3.8	4.9	2.8	0.9	17.8	1.4	0.6	0.0	19.9	14.5	3.8	0.4	2.3	4.2	5.3	0.5	1.7	1.3	1.3	1.9	0.9	0.5	0.0	1.9	2.4	0.8	0.0	1.7	4.2	0.0	1.6	0.0	0.0	0.0	0.0	7.5	0.1	0.0	0.0	0.3	0.0	7.7	1.6	0.0	0.8	6.8	7.6	0.6	11.7	10.1	7.2	7.1	8.6	18.3	4.7
TRIM38	"RNF15, RORET"	ENSG00000112343	"Tripartite motif containing 38"	O00635	6	25962802-25991226	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA031685	Approved		Approved	"Plasma membrane,Cell Junctions,Centrosome"				Centrosome	"Plasma membrane, Cell Junctions"	"HPA031685: AB_10603218"	"unprognostic (6.62e-2)"	"unprognostic (1.65e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.51e-2)"	"unprognostic (7.79e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.78e-2)"	"prognostic favourable (8.95e-5)"	"unprognostic (2.81e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.36e-1)"	"unprognostic (4.49e-2)"	"prognostic favourable (8.20e-5)"	"prognostic favourable (4.94e-9)"	13.3	8.4	2.5	15.7	2.3	12.0	7.9	1.1	3.4	17.2	12.1	3.1	20.5	6.7	26.2	22.3	15.7	8.9	9.2	5.8	2.8	2.3	26.1	8.8	14.0	14.4	3.7	1.8	11.5	4.3	1.0	4.3	10.3	3.5	15.5	7.8	9.2	9.8	16.5	9.0	5.3	14.6	13.1	4.5	17.6	6.6	5.3	2.9	16.6	13.7	9.5	20.1	18.0	15.4	16.5	10.1	12.1	12.9	6.7	7.9	6.3	3.5	2.0	0.3	4.3	10.3	13.9	3.6	4.5	8.9	8.7	14.5	1.5	3.8	7.9	7.4	5.5	5.6	2.7	4.4	5.2	7.9	1.8	3.5	3.3	1.4	13.7	4.2	7.4	13.8	3.2	5.4	1.9	7.5	2.3	4.4	10.3	1.7	4.0	4.8	1.4	2.7	6.2	4.3	8.2	10.4	7.0	0.1	0.1	3.4	7.1	12.0	1.0	5.5	7.7	1.6	2.7	2.7	3.0	5.1	3.7	8.9	4.2	5.2	9.6	10.1	10.6	4.7	7.6	12.9	7.4	14.3	6.5	6.8	10.1	16.5	6.2	6.7	12.1	6.7	11.4	9.5	7.9	6.3	2.5	2.3	1.1	3.4	2.8	2.3	3.7	1.8	3.5	2.9
TRIM39	RNF23	ENSG00000204599	"Tripartite motif containing 39"	Q9HCM9	6	30326479-30343729	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA051120, HPA059496"	Uncertain		Supported	Cytosol				Cytosol		"HPA051120: , HPA059496: "	"unprognostic (2.90e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.38e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.47e-1)"	"unprognostic (9.44e-2)"	"prognostic favourable (2.50e-4)"	"unprognostic (1.30e-2)"	"unprognostic (4.69e-2)"	"unprognostic (6.35e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.39e-3)"	8.6	7.6	5.2	14.3	6.4	11.8	7.4	8.6	7.6	10.2	11.2	7.3	9.7	7.1	10.0	15.2	11.9	8.5	13.6	6.1	5.4	5.5	7.6	9.6	11.1	6.7	7.7	6.3	10.3	9.1	8.9	11.4	11.6	7.1	7.9	7.1	11.4	8.2	15.5	9.9	6.5	10.9	8.8	6.0	13.1	8.0	14.1	7.2	7.8	8.9	8.3	10.1	9.1	12.3	3.4	1.6	8.4	2.5	4.4	5.2	2.1	4.4	0.2	3.8	6.8	1.8	1.8	3.9	2.0	2.5	3.0	2.7	5.3	0.6	5.6	4.1	3.8	1.4	4.4	3.1	3.1	4.4	4.8	4.5	0.7	1.9	3.9	6.6	5.0	2.1	2.6	3.8	4.2	1.9	6.6	4.5	3.9	4.0	1.4	1.4	5.1	3.2	3.1	0.8	4.2	3.3	4.3	8.3	4.1	1.6	3.3	3.9	4.4	1.7	1.7	3.3	2.7	4.0	6.8	8.2	10.0	5.8	2.0	2.4	5.1	1.4	1.7	6.8	5.2	2.5	4.6	3.4	3.7	3.8	1.6	3.3	4.4	4.1	8.4	4.4	2.4	1.2	2.9	2.1	5.2	6.4	8.6	7.6	5.4	5.5	7.7	6.3	7.1	7.2
TRIM4	RNF87	ENSG00000146833	"Tripartite motif containing 4"	Q9C037	7	99876958-99919600	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA019356, HPA029461"	Approved		Supported	"Plasma membrane,Cytosol"				Cytosol	"Plasma membrane"	"HPA019356: AB_1856376, HPA029461: AB_10600834"	"unprognostic (1.88e-1)"	"unprognostic (2.97e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.46e-2)"	"unprognostic (1.80e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.60e-1)"	"prognostic favourable (7.36e-6)"	"unprognostic (1.00e-1)"	"unprognostic (2.38e-1)"	"unprognostic (7.46e-2)"	"unprognostic (5.65e-2)"	19.1	22.6	13.5	22.1	15.9	6.7	22.1	20.1	15.5	19.5	17.3	12.4	22.5	13.9	21.9	18.8	16.4	19.0	19.8	11.1	13.3	9.3	16.6	17.9	21.1	22.4	15.3	8.8	35.0	23.2	18.9	27.4	16.1	12.2	21.9	15.7	18.4	19.4	33.8	9.4	20.7	18.3	18.1	11.9	18.2	17.4	16.2	14.5	18.4	20.5	11.9	18.8	20.0	28.9	18.6	17.0	20.0	19.2	13.9	30.3	17.4	9.5	11.5	6.9	5.7	18.1	17.0	3.1	16.1	19.7	13.5	15.7	6.1	9.5	14.0	0.1	13.7	11.4	9.1	9.9	13.8	14.2	0.7	11.4	6.1	9.6	25.6	16.4	16.3	18.1	21.2	10.5	26.6	11.8	16.6	21.6	11.2	11.9	12.1	14.8	5.2	9.9	6.9	9.8	15.9	14.9	12.4	8.1	5.7	12.3	18.9	19.2	8.7	9.5	14.3	15.0	13.4	28.6	15.5	18.2	19.9	11.3	9.8	18.5	19.8	20.0	19.2	15.3	20.6	19.2	23.8	18.6	21.6	23.5	17.0	18.6	30.3	22.2	8.2	13.9	16.6	12.7	21.5	17.4	13.5	15.9	20.1	15.5	13.3	9.3	15.3	8.8	12.2	14.5
TRIM41	"MGC1127, RINCK"	ENSG00000146063	"Tripartite motif containing 41"	Q8WV44	5	181222499-181235809	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 43.7"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 38.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024204	Approved		Supported	"Nucleoli,Nuclear bodies"				"Nucleoli, Nuclear bodies"		"HPA024204: AB_1858299"	"unprognostic (1.13e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.93e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.56e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.66e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.07e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.45e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (4.22e-4)"	"unprognostic (2.68e-2)"	10.0	8.3	25.5	9.4	24.3	9.3	5.4	7.3	17.0	6.9	6.5	19.8	8.8	11.2	6.1	8.3	7.3	8.4	7.0	9.8	26.9	20.4	10.7	7.6	6.9	6.0	37.3	12.5	5.9	12.3	18.8	7.6	7.3	17.0	7.0	4.0	7.8	8.3	8.4	30.0	9.0	9.0	5.3	43.7	7.5	9.5	19.1	18.3	10.6	11.3	7.2	7.2	5.8	5.2	2.2	2.4	3.9	2.3	1.9	4.3	1.4	4.6	12.1	4.5	7.5	5.4	5.4	10.6	6.8	3.7	5.0	4.7	10.2	7.0	7.8	11.1	4.6	8.8	4.7	16.3	2.7	38.5	14.9	8.9	11.9	5.8	5.2	6.5	6.1	4.7	8.4	6.2	2.2	2.8	11.1	9.7	2.8	16.6	9.8	7.3	4.2	5.8	9.3	6.9	10.2	2.9	7.4	7.0	6.6	6.3	7.4	9.5	14.8	7.4	5.9	6.9	4.7	4.1	5.1	21.4	13.5	11.1	7.2	7.7	5.8	0.9	1.4	2.2	2.4	1.1	3.6	1.9	2.5	4.3	1.6	2.2	2.6	3.1	3.9	1.9	2.3	2.4	3.2	1.4	25.5	24.3	7.3	17.0	26.9	20.4	37.3	12.5	17.0	18.3
TRIM50	"FLJ32804, TRIM50A"	ENSG00000146755	"Tripartite motif containing 50"	Q86XT4	7	73312539-73328082	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"pancreas: 17.2;stomach 1: 22.8"	"Cell line enriched"	"Detected in single"	33	"Hep G2: 12.0"	"Group enriched"	"Detected in some"	8	"liver cancer: 2.9;renal cancer: 6.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA019862, HPA047843"	Uncertain		Approved	Cytosol				Cytosol		"HPA019862: AB_1858305, HPA047843: "	"unprognostic (1.93e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.07e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.33e-1)"	"prognostic favourable (9.36e-7)"	"unprognostic (3.91e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.25e-1)"	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0		0.0	17.2	0.2	0.0	0.3		0.0	0.0		0.0	0.0	1.8	0.0	1.0	0.0	0.0	0.1	22.8	4.4			0.0		0.0	0.0	0.0	0.9	0.3	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	12.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TRIM56	RNF109	ENSG00000169871	"Tripartite motif containing 56"	Q9BRZ2	7	101085439-101097967	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024358	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA024358: AB_1858308"	"unprognostic (6.47e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.44e-3)"	"unprognostic (8.30e-2)"	"prognostic unfavourable (3.87e-4)"	"unprognostic (2.63e-1)"	"unprognostic (4.11e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.47e-3)"	"unprognostic (8.13e-2)"	"unprognostic (1.49e-1)"	"prognostic favourable (2.13e-4)"	14.3	12.0	6.2	15.7	9.3	4.7	24.5	3.2	11.1	14.9	15.0	6.8	22.3	9.7	14.3	13.1	12.9	12.8	13.7	8.7	7.5	5.2	10.8	10.4	23.7	11.7	15.8	5.2	17.3	10.8	10.7	15.2	14.0	8.8	12.5	8.3	7.5	12.2	22.1	8.7	13.2	12.8	15.2	8.5	17.2	10.3	5.6	12.0	9.7	14.0	9.1	12.0	13.6	22.0	3.3	2.1	7.4	2.4	7.7	3.6	1.0	9.9	12.5	5.4	6.9	12.5	13.0	6.5	8.3	7.4	13.5	12.6	5.9	14.5	11.8	9.0	6.9	11.5	2.2	7.6	9.1	11.8	3.5	7.4	15.7	4.4	11.2	13.1	16.9	8.2	11.1	8.8	14.4	7.1	12.9	15.0	9.3	13.6	11.0	14.6	5.4	10.4	10.2	8.8	7.7	7.1	10.4	0.3	0.2	9.2	25.8	7.0	5.9	8.6	13.4	19.0	16.9	14.2	8.9	7.4	7.4	9.3	9.4	10.7	14.8	2.5	2.4	2.1	3.6	1.5	2.6	2.0	2.7	2.3	0.8	3.3	2.6	3.4	7.4	7.7	2.1	2.1	1.1	1.0	6.2	9.3	3.2	11.1	7.5	5.2	15.8	5.2	8.8	12.0
TRIM62	"DEAR1, FLJ10759"	ENSG00000116525	"Tripartite motif containing 62"	Q9BVG3	1	33145402-33182059	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 20.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050061			Approved	"Vesicles,Focal adhesion sites"				"Vesicles, Focal adhesion sites"		"HPA050061: "	"unprognostic (1.57e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.14e-2)"	"unprognostic (5.80e-2)"	"unprognostic (5.10e-5)"	"unprognostic (2.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.32e-2)"	"unprognostic (3.55e-3)"	"unprognostic (3.66e-1)"	"prognostic unfavourable (7.08e-5)"	"unprognostic (2.14e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.05e-3)"	4.8	11.8	10.1	6.4	19.2	9.3	6.2	19.0	13.9	5.6	4.9	31.8	1.6	5.6	4.9	6.9	6.9	5.1	4.9	5.3	12.3	10.5	5.3	2.7	5.6	9.6	28.1	9.1	6.7	4.8	7.5	9.2	19.6	15.4	8.7	5.4	5.0	10.8	7.5	6.7	20.5	5.8	6.9	12.8	8.3	6.5	4.0	23.7	8.7	6.3	5.1	10.4	9.8	7.3	3.0	1.8	6.0	3.5	1.7	8.5	2.1	2.9	2.3	20.7	3.4	5.2	2.3	6.3	2.9	8.7	5.4	4.8	2.4	3.0	4.7	3.2	2.6	6.0	4.1	3.8	5.2	4.5	3.2	5.4	2.5	1.9	5.0	1.7	13.5	4.5	3.5	7.2	1.8	5.4	0.8	3.1	5.5	7.8	5.3	1.7	4.9	2.9	6.7	10.9	2.2	3.5	7.7	5.0	3.1	3.2	12.3	13.8	3.4	1.2	5.2	2.3	3.2	6.6	2.2	5.8	2.5	2.3	4.3	3.2	2.8	2.2	2.0	6.0	2.7	3.5	4.6	2.2	4.1	3.7	1.8	3.0	2.8	2.7	4.4	1.7	2.2	0.8	8.5	2.1	10.1	19.2	19.0	13.9	12.3	10.5	28.1	9.1	15.4	23.7
TRIM69	"RNF36, Trif, TRIMLESS"	ENSG00000185880	"Tripartite motif containing 69"	Q86WT6	15	44728988-44767829	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 68.6"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.0;U-266/70: 13.5;U-266/84: 3.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"T-reg: 8.2"	"Lineage enriched"	"Detected in many"	7	"T-cells: 8.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028894	Enhanced									"HPA028894: AB_10603136"	"unprognostic (4.82e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.75e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.27e-2)"	"unprognostic (4.95e-2)"	"unprognostic (6.49e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.72e-2)"	"prognostic favourable (2.26e-5)"	"unprognostic (4.79e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.49e-2)"	4.6	3.9	9.0	4.0	10.8	3.0	3.9	7.2	9.1	3.5	4.4	5.1	1.7	3.6	3.4	3.7	4.7	3.4	4.1	11.0	7.9	7.9	4.7	3.8	3.8	4.9	7.5	5.4	3.8	2.8	3.4	4.9	3.1	5.3	5.9	4.2	3.7	3.7	3.2	14.0	4.1	4.0	5.3	5.7	6.7	3.9	68.6	4.7	3.9	5.3	5.2	5.5	4.1	8.1	1.2	0.0	0.1	0.3	0.0	8.2	0.3	0.2	0.0	0.4	0.7	0.5	1.2	0.0	0.1	0.5	0.8	2.4	0.0	0.3	0.2	0.2	0.0	0.0	0.3	0.0	0.6	2.6	0.0	0.3	0.1	0.0	0.9	0.0	0.2	1.4	0.9	0.2	0.2	0.2	0.0	4.0	0.4	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.4	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.3	13.5	3.3	2.0	0.4	0.4	0.1	0.0	0.0	0.0	0.6	0.2	1.2	1.2	1.9	1.8	0.0	0.0	0.3	1.2	0.1	0.0	0.3	0.0	8.2	0.3	9.0	10.8	7.2	9.1	7.9	7.9	7.5	5.4	5.3	4.7
TRIM7	"GNIP, RNF90"	ENSG00000146054	"Tripartite motif containing 7"	Q9C029	5	181193924-181205293	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 81.8;tongue: 34.0"	"Cell line enhanced"	"Detected in many"		"HaCaT: 11.2;HDLM-2: 23.8;PC-3: 13.2;TIME: 10.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	16	"cerebellum: 21.7"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"monocytes: 4.9;T-cells: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039213	Approved		Approved	Nucleoplasm,Vesicles,Cytosol				Vesicles	"Nucleoplasm, Cytosol"	"HPA039213: AB_10795173"	"unprognostic (6.58e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.10e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.89e-4)"	"unprognostic (3.45e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.16e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.90e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.15e-2)"	1.3	0.9	0.1	0.9	0.5	0.5	3.4	21.7	1.3	2.5	0.8	0.3	1.1	0.5	1.0	6.4	13.0	0.6	1.7	2.2	0.1	0.8	2.2	0.5	0.9	0.6	0.2	0.2	0.6	4.2	1.6	1.9	0.5	0.5	2.0	0.6	0.6	5.9	1.1	81.8	9.5	0.6	0.9	0.3	0.8	1.4	0.9	0.2	0.1	3.3	34.0	13.5	1.6	2.9	0.7	0.8	0.1	4.9	0.5	2.2	1.1	6.1	2.9	0.0	0.3	0.5	0.5	0.1	1.4	0.0	0.5	1.2	0.2	8.0	0.4	4.3	1.7	11.2	3.2	9.2	0.1	23.8	1.3	0.5	7.8	0.1	1.6	0.0	1.3	0.1	7.1	0.2	4.6	2.6	0.3	1.3	0.2	0.8	0.3	0.2	0.0	13.2	0.3	4.2	0.9	3.3	0.0	0.3	0.7	2.9	0.1	4.0	0.7	0.2	10.8	0.1	2.4	0.4	4.2	1.9	0.2	0.7	0.3	0.4	1.0	0.0	4.9	0.1	1.4	1.9	2.2	0.4	1.2	1.4	0.8	0.7	2.2	1.8	0.1	0.5	1.4	0.6	2.2	1.1	0.1	0.5	21.7	1.3	0.1	0.8	0.2	0.2	0.5	0.2
TRIM9	"RNF91, SPRING"	ENSG00000100505	"Tripartite motif containing 9"	Q9C026	14	50975262-51096061	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 61.5"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 19.3;HAP1: 13.7;HDLM-2: 21.0;SCLC-21H: 19.9"	"Cancer enriched"	"Detected in some"	8	"glioma: 25.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.22e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.10e-3)"	"unprognostic (6.67e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.24e-3)"	"unprognostic (7.66e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.00e-2)"	"unprognostic (7.57e-6)"	"unprognostic (1.85e-3)"	1.9	3.9	21.5	2.7	20.9	2.2	2.7	49.1	61.5	2.1	2.5	10.3	0.0	1.5	4.8	3.0	1.7	1.5	6.5	1.7	17.4	11.4	1.9	3.6	1.5	1.5	10.8	21.7	2.3	1.9	1.5	5.7	1.6	13.0	2.0	2.4	1.8	3.9	5.2	1.5	1.6	1.7	5.2	7.1	1.6	1.7	2.0	11.5	0.0	1.5	0.0	1.5	2.0	0.9	0.0	0.1	0.8	0.0	0.0	0.4	0.4	0.0	2.2	3.4	19.3	0.0	0.0	1.3	0.0	0.0	0.2	0.5	1.5	0.1	0.2	0.1	0.3	0.0	13.7	0.0	0.5	21.0	2.8	1.0	0.0	0.0	0.0	0.7	0.7	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.5	0.0	4.1	0.5	1.1	2.9	2.4	5.0	0.1	0.0	0.0	19.9	1.5	0.3	0.0	4.2	0.3	0.5	0.0	1.3	0.5	0.0	0.9	0.3	0.0	0.2	5.8	0.5	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.4	21.5	20.9	49.1	28.6	17.4	11.4	10.8	21.7	13.0	11.5
TRIML2	"FLJ25801, SPRYD6"	ENSG00000179046	"Tripartite motif family like 2"	Q8N7C3	4	188091273-188109603	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"placenta: 9.8;testis: 6.2"	"Cell line enhanced"	"Detected in some"		"A549: 21.1;BEWO: 11.7;hTCEpi: 13.7;NTERA-2: 21.7"	"Cancer enriched"	"Detected in some"	33	"testis cancer: 24.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043838	Uncertain		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA043838: AB_10963835"	"unprognostic (3.32e-1)"	"unprognostic (1.99e-1)"		"unprognostic (1.30e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.21e-5)"		"unprognostic (3.06e-2)"	"unprognostic (1.65e-3)"		"unprognostic (2.65e-1)"		"unprognostic (0.00e+0)"	"unprognostic (2.26e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.28e-3)"	0.1	0.1	0.2	0.1	1.4	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	9.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	6.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	21.1	0.0	0.0	0.0	0.1	11.7	0.1	0.9	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.5	4.0	0.1	0.0	1.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.1	4.9	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1
TRPC4AP	"C20orf188, dJ756N5.2, DKFZp586C1223, DKFZP727M231, PPP1R158, TRRP4AP"	ENSG00000100991	"Transient receptor potential cation channel subfamily C member 4 associated protein"	Q8TEL6	20	35002404-35092871	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051197, HPA065061"	Uncertain		Approved	Cytosol				Cytosol		"HPA051197: , HPA065061: "	"unprognostic (3.00e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (6.25e-8)"	"unprognostic (1.33e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (1.17e-5)"	"unprognostic (3.38e-1)"	"unprognostic (3.19e-2)"	"unprognostic (5.14e-3)"	"unprognostic (1.10e-1)"	36.5	43.3	26.3	30.1	38.2	51.4	35.1	36.7	48.3	27.7	31.9	64.0	36.9	30.7	33.9	31.8	31.5	28.4	30.1	30.1	29.0	31.0	30.4	41.9	38.7	32.3	43.5	34.0	30.4	45.3	41.3	47.9	48.1	43.6	32.9	31.6	29.2	39.9	33.1	50.5	35.0	31.8	32.5	31.9	43.7	37.3	24.5	38.8	46.9	34.8	23.0	34.9	29.0	28.5	10.9	23.2	28.6	20.9	14.2	15.9	13.3	16.1	19.8	17.7	18.2	27.5	26.5	27.2	26.3	31.0	30.2	34.9	43.3	24.3	15.1	25.2	30.3	21.6	16.0	37.5	23.5	8.0	12.5	38.6	17.0	39.5	27.4	22.4	26.5	29.4	23.7	22.6	19.4	33.5	18.1	18.3	24.0	12.2	27.0	25.4	13.9	27.1	17.0	25.6	15.4	26.0	21.1	15.7	15.8	28.3	48.2	18.4	17.4	18.3	32.8	37.8	17.1	20.3	15.7	16.8	9.0	12.6	40.8	11.1	19.2	16.4	16.7	28.1	14.8	18.3	15.8	10.9	12.4	15.9	23.2	10.1	11.0	11.5	28.6	14.2	20.9	10.1	14.0	13.3	26.3	38.2	36.7	48.3	29.0	31.0	43.5	34.0	43.6	38.8
UNKL	"C16orf28, FLJ23360, ZC3H5L, ZC3HDC5L"	ENSG00000059145	"Unkempt family like zinc finger"	Q9H9P5	16	1363205-1414751	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"HPA055801, HPA073949"	Uncertain		Supported	Cytosol				Cytosol		"HPA055801: , HPA073949: "	"unprognostic (5.32e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.88e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.90e-3)"	"unprognostic (8.07e-2)"	"unprognostic (5.18e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.89e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.55e-1)"	9.6	10.0	14.0	10.4	12.9	12.1	10.1	27.9	16.3	10.5	7.3	9.3	10.2	11.0	15.2	7.9	6.0	11.0	5.0	5.7	12.2	4.5	6.3	4.8	9.1	11.7	9.2	8.3	18.9	10.1	6.5	7.2	9.0	10.1	10.5	4.4	9.3	12.3	12.7	14.4	10.5	10.6	7.2	5.6	14.3	9.9	8.4	11.7	11.0	11.7	7.0	7.6	10.8	9.3	1.9	3.2	7.6	2.1	2.4	3.7	1.3	3.4	9.0	2.0	5.1	1.8	2.0	16.0	8.5	2.6	2.5	2.0	6.6	7.3	1.3	18.2	3.0	6.2	2.6	0.8	1.7	15.6	7.7	2.3	9.2	5.9	1.2	1.2	5.5	2.5	1.2	3.7	1.6	4.3	7.1	4.8	1.1	5.2	3.8	4.1	5.7	10.1	10.1	1.9	9.2	1.4	0.7	6.9	4.1	4.4	3.2	0.6	5.0	2.1	3.8	5.3	7.7	4.4	3.6	10.2	5.6	6.0	4.3	2.9	5.9	5.7	2.1	4.5	3.7	0.7	2.1	1.5	1.5	0.9	0.7	1.9	2.8	1.4	7.6	2.4	0.7	3.2	1.6	1.3	14.0	12.9	27.9	16.3	12.2	4.5	9.2	8.3	10.1	11.7
ZFP91	"PZF, ZNF757"	ENSG00000186660	"ZFP91 zinc finger protein"	Q96JP5	11	58579111-58621042	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"HPA024037, CAB025417"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB025417: , HPA024037: AB_1859051"	"unprognostic (6.10e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.33e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.33e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.36e-2)"	"prognostic unfavourable (3.74e-6)"	"unprognostic (3.16e-1)"	"unprognostic (1.75e-3)"	"unprognostic (3.12e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.00e-3)"	17.1	14.7	20.1	13.6	25.6	32.0	14.9	24.4	21.7	15.3	18.1	23.2	15.8	16.2	16.3	11.8	16.3	13.6	13.8	26.5	20.3	15.4	16.3	19.4	15.0	14.4	20.8	18.1	14.9	14.3	26.7	17.0	14.2	19.7	13.1	21.9	11.2	14.5	15.5	33.8	17.5	19.6	16.9	21.6	15.0	13.9	71.0	19.4	15.7	16.8	14.6	15.9	17.8	21.4	4.6	7.0	5.4	5.0	3.7	5.4	2.8	24.5	14.1	16.6	16.8	15.9	19.3	9.1	20.3	38.2	23.6	20.2	7.7	26.0	29.4	20.1	25.6	21.9	16.8	21.6	31.1	15.6	9.4	19.4	14.4	8.3	18.1	24.4	32.0	16.8	21.2	33.1	38.8	23.3	19.2	27.9	30.3	8.2	21.1	13.5	8.7	13.8	16.4	28.0	19.5	17.3	23.7	17.8	14.2	25.9	23.9	33.1	26.6	18.4	26.1	29.8	20.6	44.8	22.5	16.2	11.9	24.5	26.3	13.8	30.3	3.9	5.0	3.5	5.4	4.5	3.0	4.5	3.3	3.3	4.9	4.6	3.6	4.6	5.4	3.7	4.2	7.0	2.6	2.8	20.1	25.6	24.4	21.7	20.3	15.4	20.8	18.1	19.7	19.4
ZNF598	"FLJ00086, HEL2"	ENSG00000167962	"Zinc finger protein 598"		16	1997654-2009823	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"				"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041760, HPA041896"	Approved		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"		"HPA041760: AB_10794787, HPA041896: AB_10796464"	"unprognostic (9.43e-2)"	"unprognostic (1.34e-2)"	"unprognostic (8.17e-2)"	"unprognostic (6.76e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.22e-2)"	"unprognostic (7.07e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.81e-2)"	"unprognostic (7.81e-2)"	8.4	6.1	4.1	9.1	9.4	14.3	13.9	10.6	9.5	8.3	7.7	8.8	4.7	9.9	8.7	4.0	10.0	7.1	4.8	5.6	5.2	4.1	5.9	12.2	7.8	9.1	4.2	7.1	9.8	24.8	6.5	12.9	8.1	6.4	8.9	3.2	6.8	15.6	7.3	12.9	15.3	9.9	9.5	2.9	11.8	12.4	10.1	6.1	10.0	7.7	10.6	12.5	6.8	7.6	1.8	3.2	0.6	0.9	1.2	1.7	0.5	9.9	12.8	3.3	7.9	3.0	4.1	9.5	7.4	3.8	4.9	3.9	13.9	6.0	9.9	9.3	4.8	11.7	5.4	9.2	1.3	14.1	30.8	7.7	13.6	7.6	13.5	12.3	8.8	4.5	12.6	7.8	15.1	5.3	17.3	15.5	2.5	17.1	11.7	19.1	9.6	15.6	26.7	6.5	23.1	2.4	3.6	15.8	12.9	7.5	9.3	12.0	6.5	20.6	8.6	10.5	12.5	9.0	13.9	17.4	15.4	13.0	4.5	11.8	9.6	0.6	0.6	0.2	1.2	0.7	1.7	1.1	1.2	0.9	0.7	1.8	1.1	1.6	0.4	1.2	0.9	3.2	0.3	0.5	4.1	9.4	10.6	9.5	5.2	4.1	4.2	7.1	6.4	6.1
ZNRF4	"RNF204, spzn, Ssrzf1"	ENSG00000105428	"Zinc and ring finger 4"	Q8WWF5	19	5455431-5456856	"Enzymes, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	243	"testis: 90.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"																															0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ASB6		ENSG00000148331	"Ankyrin repeat and SOCS box containing 6"	Q9NWX5	9	129634604-129642169	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004341	Approved									"HPA004341: AB_1845070"	"unprognostic (1.60e-2)"	"unprognostic (7.57e-2)"	"prognostic unfavourable (1.06e-5)"	"unprognostic (9.29e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavourable (2.40e-5)"	"unprognostic (5.61e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.68e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.00e-2)"	9.7	15.2	12.9	10.8	18.3	30.8	17.8	17.9	27.7	9.9	8.4	12.6	4.9	10.0	10.6	8.6	13.5	14.3	8.9	10.3	13.5	10.9	12.2	8.3	9.4	14.3	11.1	13.8	10.4	14.6	13.2	12.1	12.5	14.8	10.0	7.2	13.5	14.4	13.0	7.7	18.7	9.9	10.2	10.0	15.0	12.9	11.7	10.5	13.7	12.0	7.3	11.5	9.8	11.7	9.0	9.6	9.1	8.5	14.3	14.9	9.6	6.9	11.5	8.4	19.0	9.2	9.1	13.9	13.3	9.1	14.1	8.6	12.9	10.2	6.2	7.9	16.8	19.2	11.1	13.3	5.8	12.2	17.6	5.7	22.6	5.9	13.5	12.5	11.3	12.0	9.4	17.4	8.2	10.9	12.3	9.3	9.6	17.4	13.2	10.1	14.6	26.7	12.4	9.2	12.3	12.2	6.6	17.5	21.9	13.2	17.0	10.8	14.4	7.8	11.8	19.8	10.8	23.5	13.6	12.7	13.2	10.1	15.8	9.3	13.1	8.5	8.5	9.1	14.9	8.5	13.5	9.0	10.2	14.3	9.6	8.0	12.7	10.7	4.8	14.3	8.4	8.9	11.4	9.6	12.9	18.3	17.9	27.7	13.5	10.9	11.1	13.8	14.8	10.5
ASB7		ENSG00000183475	"Ankyrin repeat and SOCS box containing 7"	Q9H672	15	100602534-100651705	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003300	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA003300: AB_1845071"	"unprognostic (1.38e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.91e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.18e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.46e-2)"	8.6	8.9	8.9	15.5	11.9	20.2	10.2	12.7	10.2	10.3	12.1	8.1	13.5	8.3	11.6	12.5	10.0	10.9	9.5	7.0	10.4	8.3	12.5	12.1	8.8	12.9	10.6	6.7	11.2	11.0	13.7	11.8	14.0	9.4	10.1	11.8	7.6	10.3	11.3	8.0	9.5	15.5	11.2	9.7	10.4	8.3	13.8	9.2	21.2	11.5	9.6	11.1	11.6	9.2	6.6	7.0	13.6	8.0	5.5	9.4	6.3	6.2	13.9	6.4	7.6	8.5	9.2	7.4	6.9	12.5	11.6	12.1	8.3	12.7	10.2	6.4	8.8	13.9	8.9	9.0	12.1	7.2	9.5	13.6	9.2	8.2	12.9	7.9	12.0	8.8	10.1	9.4	15.6	10.6	8.0	8.6	6.5	6.7	6.1	8.0	6.1	6.8	8.5	13.9	8.5	11.4	14.1	6.4	9.1	10.6	10.4	14.3	7.3	10.0	8.0	10.2	9.5	7.0	9.6	10.4	21.4	9.8	7.8	7.3	8.0	1.7	8.0	13.6	7.6	6.5	6.1	6.3	6.7	9.3	7.0	6.6	9.4	6.7	7.3	5.5	4.1	4.5	7.7	6.3	8.9	11.9	12.7	10.2	10.4	8.3	10.6	6.7	9.4	9.2
GRWD1	"GRWD, RRB1, WDR28"	ENSG00000105447	"Glutamate rich WD repeat containing 1"	Q9BQ67	19	48445773-48457022	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042643, HPA055680"	Approved		Enhanced	Nucleoplasm,Nucleoli				Nucleoli	Nucleoplasm	"HPA042643: AB_10795510, HPA055680: AB_2682884"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.46e-1)"	"unprognostic (7.77e-2)"	"prognostic unfavourable (2.16e-4)"	"unprognostic (1.71e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.69e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.07e-2)"	16.9	15.5	9.2	15.7	11.1	14.8	15.5	12.9	14.1	13.6	14.1	10.4	11.9	15.6	18.7	12.8	20.0	15.0	16.2	16.9	7.8	8.6	13.0	26.3	12.5	17.5	11.0	10.3	19.3	35.5	16.5	10.3	14.7	9.5	13.8	8.0	12.0	18.6	14.4	29.1	18.3	11.5	13.3	8.2	19.4	14.7	13.1	10.9	18.6	17.3	19.0	17.3	14.1	18.0	21.1	18.4	1.4	17.8	17.4	22.6	16.5	16.8	44.7	7.6	14.3	6.2	6.2	6.5	13.2	6.3	19.1	15.9	25.1	12.5	24.1	11.5	8.2	14.4	18.9	20.4	7.5	18.1	25.6	22.0	15.2	17.8	7.2	20.7	14.1	7.4	11.3	18.0	9.1	9.4	30.7	15.2	7.9	17.5	21.8	52.1	20.7	13.1	27.1	8.6	17.3	7.9	20.9	17.2	9.5	14.9	21.1	6.6	10.4	10.5	10.0	17.8	15.0	7.8	31.3	15.5	35.5	22.6	5.9	18.7	20.6	0.1	11.0	1.4	19.6	17.8	22.6	21.1	18.1	19.5	18.4	20.4	21.3	19.7	0.8	17.4	13.5	13.6	15.6	16.5	9.2	11.1	12.9	14.1	7.8	8.6	11.0	10.3	9.5	10.9
NTAN1		ENSG00000157045	"N-terminal asparagine amidase"	Q96AB6	16	15037853-15056079	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 31.2"	"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051418			Approved	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	"Golgi apparatus"	"HPA051418: "	"unprognostic (2.21e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavourable (6.69e-4)"	"unprognostic (1.87e-2)"	"unprognostic (9.16e-2)"	"unprognostic (8.11e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.30e-3)"	"prognostic unfavourable (9.07e-4)"	"unprognostic (4.35e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.10e-1)"	24.2	8.3	11.7	8.1	11.7	11.9	48.2	5.2	12.1	16.1	18.0	5.4	8.6	6.8	14.4	24.5	14.6	10.2	12.2	23.2	8.0	6.0	10.6	16.9	13.5	12.4	7.4	8.0	13.0	13.3	7.6	5.0	7.8	9.8	15.9	15.7	17.9	11.1	7.7	14.4	13.6	9.7	19.8	7.4	13.7	12.9	14.0	6.4	8.1	10.5	12.7	11.7	18.8	19.9	9.4	12.0	31.2	5.7	5.3	12.3	5.2	9.8	7.2	8.7	7.5	11.1	21.4	3.3	12.0	16.4	12.3	21.2	3.3	7.4	6.8	9.5	22.9	4.2	6.9	14.1	17.3	6.5	9.5	3.9	6.5	18.5	11.4	2.9	2.2	11.1	8.4	11.9	4.5	27.9	4.6	7.8	22.9	8.3	5.8	12.1	6.3	8.0	11.6	11.8	9.1	8.9	13.7	2.6	9.8	5.0	1.8	8.5	3.3	4.4	15.6	17.8	7.1	7.5	10.5	7.6	15.0	8.9	10.7	6.4	8.0	2.5	4.1	31.2	5.5	5.7	6.5	9.4	7.2	7.3	3.8	6.1	5.9	3.7	1.9	5.3	5.5	12.0	12.3	5.2	11.7	11.7	5.2	12.1	8.0	6.0	7.4	8.0	9.8	6.4
RSPO2	MGC35555	ENSG00000147655	"R-spondin 2"	Q6UXX9	8	107899316-108083648	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction, Wnt signaling pathway"	"Developmental protein, Heparin-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 27.0;placenta: 20.1"	"Cell line enhanced"	"Detected in some"		"HEK 293: 3.5;HEL: 3.3;NTERA-2: 2.0;U-138 MG: 3.5;U-266/70: 10.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"intermediate monocyte: 1.6"	"Lineage enriched"	"Detected in single"	17	"monocytes: 1.6"	"Group enriched"	"Detected in some"	7	"amygdala: 8.2;cerebral cortex: 18.2;hippocampal formation: 23.2"	"Group enriched"	"Detected in many"	5	"amygdala: 23.3;cerebral cortex: 18.0;hippocampal formation: 24.1;midbrain: 33.2"	"HPA024764, CAB025900, HPA053068"	Uncertain				"Secreted in other tissues"					"CAB025900: , HPA024764: AB_10603236, HPA053068: "	"unprognostic (1.10e-2)"		"unprognostic (2.18e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.33e-3)"		"unprognostic (1.82e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.31e-1)"		"unprognostic (1.40e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.17e-2)"	0.4	0.5	3.9	1.4	6.3	0.5	0.2	1.9	27.0	3.6	12.0	4.2	3.6	5.1	0.3	3.6	8.9	0.2	4.8	0.5	5.8	10.5	0.2	1.1	9.3	0.2	15.7	5.4	1.1	0.2	0.2	2.8	20.1	2.0	11.6	10.1	15.5	0.2	3.4	0.3	0.3	5.8	0.7	1.3	0.2	8.3	2.0	1.7	0.0	0.2	0.0	0.2	2.2	1.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	3.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	1.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	3.5	0.2	0.1	0.0	10.4	0.0	0.0	1.0	0.4	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	6.3	1.9	27.0	5.8	10.5	15.7	5.4	2.0	1.7
SMAD1	"JV4-1, MADH1, MADR1"	ENSG00000170365	"SMAD family member 1"	Q15797	4	145481194-145558079	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 45.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 22.2;non-classical monocyte: 11.9"	"Group enriched"	"Detected in many"	4	"granulocytes: 22.2;monocytes: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005389	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB005389: AB_656608"	"unprognostic (8.20e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.74e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.70e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.24e-2)"	"unprognostic (5.31e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.48e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.14e-3)"	"unprognostic (3.15e-2)"	20.4	7.8	19.9	7.9	21.3	3.8	21.1	17.9	17.8	18.5	15.5	14.3	13.6	11.9	33.2	22.7	16.2	20.3	13.7	10.3	13.5	10.3	12.7	37.4	11.0	11.9	9.3	10.0	12.3	13.1	33.7	14.7	8.7	12.2	13.6	16.9	7.8	17.5	16.0	22.6	20.2	15.3	24.6	12.6	10.1	11.4	10.5	14.3	15.3	15.2	14.9	10.3	16.5	21.9	0.0	4.0	22.2	11.9	1.2	0.7	0.8	3.8	5.0	9.5	11.4	3.7	5.4	4.7	5.5	13.3	9.0	6.9	2.4	14.2	3.3	3.3	12.6	5.6	10.7	12.3	5.4	0.0	5.4	0.0	4.2	5.0	9.9	6.4	1.0	7.4	14.6	4.8	9.5	45.6	4.3	0.1	11.4	3.7	9.6	0.1	8.8	6.2	18.5	8.8	11.5	9.8	6.8	14.8	7.1	7.8	17.1	3.4	5.8	0.0	13.7	4.4	6.1	4.5	3.4	12.6	0.0	22.3	7.0	0.1	4.5	22.2	2.1	0.8	0.0	5.3	0.0	0.0	0.4	0.0	4.0	0.0	0.2	0.0	0.0	1.2	11.9	0.0	0.7	0.8	19.9	21.3	17.9	14.9	13.5	10.3	9.3	10.0	12.2	14.3
TRIM5	"RNF88, TRIM5alpha"	ENSG00000132256	"Tripartite motif containing 5"	Q9C035	11	5663557-5938619	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Autophagy, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			"CAB013497, HPA023420, HPA023422"	Approved		Supported	Cytosol				Cytosol		"CAB013497: , HPA023420: AB_1856378, HPA023422: AB_1856379"	"unprognostic (2.60e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.88e-2)"	"unprognostic (4.74e-3)"	"unprognostic (5.48e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.76e-3)"	"unprognostic (8.54e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.12e-2)"	12.5	15.0	3.7	11.6	6.7	3.0	10.7	2.4	5.1	14.2	8.5	4.8	20.1	8.4	16.1	19.9	12.0	11.9	9.9	7.8	5.6	2.9	15.1	16.2	15.2	9.2	6.5	2.9	15.3	24.8	6.1	9.2	12.2	8.8	11.8	8.3	11.8	22.0	12.4	3.0	6.5	13.2	12.0	9.0	19.8	9.5	7.7	6.5	24.9	20.5	7.9	13.3	14.8	12.3	3.9	11.7	13.8	9.8	5.9	5.4	4.6	4.6	7.2	12.3	8.6	13.7	12.6	3.6	9.9	18.6	20.3	27.5	7.3	9.3	3.0	7.8	9.7	7.6	10.0	14.5	9.2	6.4	2.7	9.0	5.0	5.8	12.2	6.6	9.7	9.5	13.0	6.7	17.8	31.3	9.4	6.1	17.0	2.1	5.4	3.0	5.6	5.1	8.4	2.6	0.8	14.1	8.9	0.3	0.7	7.0	10.1	4.4	5.2	3.8	23.6	9.6	12.7	1.8	2.4	5.5	3.8	1.2	8.9	4.4	9.8	10.2	9.8	12.9	5.4	9.8	5.3	3.9	4.1	4.3	11.7	3.9	3.4	4.9	13.8	5.9	9.2	9.7	3.3	4.6	3.7	6.7	2.4	5.1	5.6	2.9	6.5	2.9	8.8	6.5
WSB2	"MGC10210, SBA2"	ENSG00000176871	"WD repeat and SOCS box containing 2"	Q9NYS7	12	118032694-118062430	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052606	Uncertain									"HPA052606: "	"unprognostic (5.02e-3)"	"unprognostic (4.57e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.91e-2)"	"prognostic unfavourable (2.42e-5)"	"unprognostic (2.42e-3)"	"unprognostic (4.66e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.05e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.42e-2)"	15.6	21.2	50.8	13.3	39.3	7.8	19.2	20.2	61.7	10.0	20.8	16.7	7.1	16.5	9.0	12.1	25.0	8.6	12.1	25.5	44.3	29.3	17.3	19.8	14.5	10.3	39.7	26.5	6.8	17.9	14.8	14.0	9.0	21.7	13.2	22.1	9.4	8.2	13.4	41.9	9.9	17.9	16.6	37.4	8.6	14.9	8.6	12.7	5.6	22.4	17.9	12.7	18.4	7.6	2.3	4.9	13.5	8.8	3.8	6.0	2.1	11.1	18.1	13.0	22.3	19.5	11.4	9.3	30.0	22.5	32.7	19.9	9.4	15.8	1.6	10.0	39.2	6.0	10.8	18.2	23.9	20.3	7.0	6.2	9.0	9.1	20.6	3.6	16.9	15.3	18.6	17.4	12.3	17.2	18.3	3.1	34.2	16.8	2.3	2.4	7.7	11.2	6.5	13.7	0.5	20.2	48.9	14.0	20.9	23.1	5.2	16.5	17.8	8.8	26.3	39.7	16.6	12.6	35.9	5.0	3.3	3.1	35.6	4.8	62.8	9.3	6.4	13.5	5.9	8.8	5.2	0.9	5.8	6.0	4.2	2.3	2.8	4.7	6.6	3.8	5.9	4.9	5.9	2.1	50.8	39.3	20.2	61.7	44.3	29.3	39.7	26.5	21.7	12.7
